ID   A0A024QZI9_HUMAN        Unreviewed;       594 AA.
AC   A0A024QZI9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 36.
DE   SubName: Full=Apobec-1 complementation factor, isoform CRA_c {ECO:0000313|EMBL:EAW54137.1};
GN   Name=ACF {ECO:0000313|EMBL:EAW54137.1};
GN   ORFNames=hCG_1811530 {ECO:0000313|EMBL:EAW54137.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54137.1};
RN   [1] {ECO:0000313|EMBL:EAW54137.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54137.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471083; EAW54137.1; -; Genomic_DNA.
DR   RefSeq; NP_001185749.1; NM_001198820.1.
DR   RefSeq; NP_620311.1; NM_138933.2.
DR   SMR; A0A024QZI9; -.
DR   PRIDE; A0A024QZI9; -.
DR   Antibodypedia; 27897; 183 antibodies.
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; ACF; -.
DR   MalaCards; ACF; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GenomeRNAi; 29974; -.
DR   Bgee; ENSG00000148584; Expressed in liver and 82 other tissues.
DR   ExpressionAtlas; A0A024QZI9; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR21245:SF8; PTHR21245:SF8; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   4: Predicted;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          64..142
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          144..226
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          239..311
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
SQ   SEQUENCE   594 AA;  65024 MW;  2F2C8897629F9E3C CRC64;
     MEAVCLGTCP EPEASMSTAI PGLKKGNNAL QSIILQTLLE KENGQRKYGG PPPGWDAAPP
     ERGCEIFIGK LPRDLFEDEL IPLCEKIGKI YEMRMMMDFN GNNRGYAFVT FSNKVEAKNA
     IKQLNNYEIR NGRLLGVCAS VDNCRLFVGG IPKTKKREEI LSEMKKVTEG VVDVIVYPSA
     ADKTKNRGFA FVEYESHRAA AMARRKLLPG RIQLWGHGIA VDWAEPEVEV DEDTMSSVKI
     LYVRNLMLST SEEMIEKEFN NIKPGAVERV KKIRDYAFVH FSNREDAVEA MKALNGKVLD
     GSPIEVTLAK PVDKDSYVRY TRGTGGRGTM LQGEYTYSLG QVYDPTTTYL GAPVFYAPQT
     YAAIPSLHFP ATKGHLSNRA IIRAPSVRGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   A0A024QZJ5_HUMAN        Unreviewed;       586 AA.
AC   A0A024QZJ5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 36.
DE   SubName: Full=Apobec-1 complementation factor, isoform CRA_b {ECO:0000313|EMBL:EAW54136.1};
GN   Name=ACF {ECO:0000313|EMBL:EAW54136.1};
GN   ORFNames=hCG_1811530 {ECO:0000313|EMBL:EAW54136.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54136.1};
RN   [1] {ECO:0000313|EMBL:EAW54136.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54136.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471083; EAW54136.1; -; Genomic_DNA.
DR   RefSeq; NP_001185747.1; NM_001198818.1.
DR   RefSeq; NP_055391.2; NM_014576.3.
DR   RefSeq; XP_016871649.1; XM_017016160.1.
DR   SMR; A0A024QZJ5; -.
DR   PRIDE; A0A024QZJ5; -.
DR   Antibodypedia; 27897; 183 antibodies.
DR   GeneID; 29974; -.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; ACF; -.
DR   MalaCards; ACF; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GenomeRNAi; 29974; -.
DR   Bgee; ENSG00000148584; Expressed in liver and 82 other tissues.
DR   ExpressionAtlas; A0A024QZJ5; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR21245:SF8; PTHR21245:SF8; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   4: Predicted;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          56..134
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          136..218
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          231..303
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
SQ   SEQUENCE   586 AA;  64256 MW;  A836BBA98FD1BD51 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR GAAGVRGLGG RGYLAYTGLG RGYQVKGDKR EDKLYDILPG
     MELTPMNPVT LKPQGIKLAP QILEEICQKN NWGQPVYQLH SAIGQDQRQL FLYKITIPAL
     ASQNPAIHPF TPPKLSAFVD EAKTYAAEYT LQTLGIPTDG GDGTMATAAA AATAFPGYAV
     PNATAPVSAA QLKQAVTLGQ DLAAYTTYEV YPTFAVTARG DGYGTF
//
ID   A0A024QZM7_HUMAN        Unreviewed;       594 AA.
AC   A0A024QZM7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 37.
DE   SubName: Full=Apobec-1 complementation factor, isoform CRA_a {ECO:0000313|EMBL:EAW54138.1};
GN   Name=ACF {ECO:0000313|EMBL:EAW54138.1};
GN   ORFNames=hCG_1811530 {ECO:0000313|EMBL:EAW54138.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54138.1};
RN   [1] {ECO:0000313|EMBL:EAW54138.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54138.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471083; EAW54138.1; -; Genomic_DNA.
DR   RefSeq; NP_620310.1; NM_138932.2.
DR   RefSeq; XP_005269775.1; XM_005269718.2.
DR   RefSeq; XP_005269777.1; XM_005269720.3.
DR   SMR; A0A024QZM7; -.
DR   PRIDE; A0A024QZM7; -.
DR   Antibodypedia; 27897; 183 antibodies.
DR   GeneID; 29974; -.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; ACF; -.
DR   MalaCards; ACF; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   HOGENOM; CLU_022960_5_1_1; -.
DR   PhylomeDB; A0A024QZM7; -.
DR   GenomeRNAi; 29974; -.
DR   Bgee; ENSG00000148584; Expressed in liver and 82 other tissues.
DR   ExpressionAtlas; A0A024QZM7; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR21245:SF8; PTHR21245:SF8; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   4: Predicted;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          56..134
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          136..218
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          231..303
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
SQ   SEQUENCE   594 AA;  65202 MW;  AA5EF76BD8815807 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR EIYMNVPVGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   B4E1E3_HUMAN            Unreviewed;       587 AA.
AC   B4E1E3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 66.
DE   SubName: Full=cDNA FLJ61033, highly similar to APOBEC1 complementation factor {ECO:0000313|EMBL:BAG64755.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64755.1};
RN   [1] {ECO:0000313|EMBL:BAG64755.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:BAG64755.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK303801; BAG64755.1; -; mRNA.
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; NP_001185749.1; NM_001198820.1.
DR   PeptideAtlas; B4E1E3; -.
DR   PRIDE; B4E1E3; -.
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   CTD; 29974; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   OrthoDB; 1384330at2759; -.
DR   GenomeRNAi; 29974; -.
DR   Genevisible; B4E1E3; HS.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR21245:SF8; PTHR21245:SF8; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          49..127
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          129..211
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          224..296
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
SQ   SEQUENCE   587 AA;  64453 MW;  FAB6C3ABA54CD26A CRC64;
     MSTAIPGLKK GNNALQSIIL QTLLEKENGQ RKYGGPPPGW DAAPPERGCE IFIGKLPRDL
     FEDELIPLCE KIGKIYEMRM MMDFNGNNRG YAFVTFSNKV EAKNAIKQLN NYEIRNGRLL
     GVCASVDNCR LFVGGIPKTK KREEILSEMK KVTEGVVDVI VYPSAADKTK NRGFAFVEYE
     SHRAAAMARR KLLPGRIQLW GHGIAVDWAE PEVEVDEDTM SSVKILYVRN LMLSTSEEMI
     EKEFNNIKPG AVERVKKIRD YAFVHFSNRE DAVEAMKALN GKVLDGSPIE VTLAKPVDKD
     SYVRYTRGTG GRGTMLQGEY TYSLGQVYDP TTTYLGAPVF YAPQTYAAIP SLHFPATKGH
     LSNRAIIRAP SVREIYMNVP VGAAGVRGLG GRGYLAYTGL GRGYQVKGDK REDKLYDILP
     GMELTPMNPV TLKPQGIKLA PQILEEICQK NNWGQPVYQL HSAIGQDQRQ LFLYEITIPA
     LASQNPAIHP FTPPKLSAFV DEAKTYAAEY TLQTLGIPTD GGDGTMATAA AAATAFPGYA
     VPNATAPVSA AQLKQAVTLG QDLAAYTTYE VYPTFAVTAR GDGYGTF
//
ID   F8W9F8_HUMAN            Unreviewed;       602 AA.
AC   F8W9F8;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   22-APR-2020, entry version 68.
DE   SubName: Full=APOBEC1 complementation factor {ECO:0000313|Ensembl:ENSP00000378868};
GN   Name=A1CF {ECO:0000313|Ensembl:ENSP00000378868};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000378868, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000378868, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000378868}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL512366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589794; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; XP_011538031.1; XM_011539729.2.
DR   jPOST; F8W9F8; -.
DR   PeptideAtlas; F8W9F8; -.
DR   PRIDE; F8W9F8; -.
DR   ProteomicsDB; 30319; -.
DR   Antibodypedia; 27897; 183 antibodies.
DR   Ensembl; ENST00000395489; ENSP00000378868; ENSG00000148584.
DR   GeneID; 29974; -.
DR   UCSC; uc010qho.3; human.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   HGNC; HGNC:24086; A1CF.
DR   OpenTargets; ENSG00000148584; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GeneTree; ENSGT00940000158678; -.
DR   OMA; YEAYPAF; -.
DR   OrthoDB; 1384330at2759; -.
DR   ChiTaRS; A1CF; human.
DR   GenomeRNAi; 29974; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148584; Expressed in liver and 82 other tissues.
DR   ExpressionAtlas; F8W9F8; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016554; P:cytidine to uridine editing; IEA:Ensembl.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0010609; P:mRNA localization resulting in posttranscriptional regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0016556; P:mRNA modification; IEA:Ensembl.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR21245:SF8; PTHR21245:SF8; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:F8W9F8,
KW   ECO:0000213|MaxQB:F8W9F8, ECO:0000213|PeptideAtlas:F8W9F8,
KW   ECO:0000213|ProteomicsDB:F8W9F8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          64..142
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          144..226
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          239..311
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
SQ   SEQUENCE   602 AA;  65971 MW;  EF5B389E70154C87 CRC64;
     MEAVCLGTCP EPEASMSTAI PGLKKGNNAL QSIILQTLLE KENGQRKYGG PPPGWDAAPP
     ERGCEIFIGK LPRDLFEDEL IPLCEKIGKI YEMRMMMDFN GNNRGYAFVT FSNKVEAKNA
     IKQLNNYEIR NGRLLGVCAS VDNCRLFVGG IPKTKKREEI LSEMKKVTEG VVDVIVYPSA
     ADKTKNRGFA FVEYESHRAA AMARRKLLPG RIQLWGHGIA VDWAEPEVEV DEDTMSSVKI
     LYVRNLMLST SEEMIEKEFN NIKPGAVERV KKIRDYAFVH FSNREDAVEA MKALNGKVLD
     GSPIEVTLAK PVDKDSYVRY TRGTGGRGTM LQGEYTYSLG QVYDPTTTYL GAPVFYAPQT
     YAAIPSLHFP ATKGHLSNRA IIRAPSVREI YMNVPVGAAG VRGLGGRGYL AYTGLGRGYQ
     VKGDKREDKL YDILPGMELT PMNPVTLKPQ GIKLAPQILE EICQKNNWGQ PVYQLHSAIG
     QDQRQLFLYK ITIPALASQN PAIHPFTPPK LSAFVDEAKT YAAEYTLQTL GIPTDGGDGT
     MATAAAAATA FPGYAVPNAT APVSAAQLKQ AVTLGQDLAA YTTYEVYPTF AVTARGDGYG
     TF
//
ID   A1CF_HUMAN              Reviewed;         594 AA.
AC   Q9NQ94; A1L4F2; A8K7G7; B7ZM14; Q5SZQ0; Q9NQ93; Q9NQX8; Q9NQX9; Q9NXC9;
AC   Q9NZD3;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 169.
DE   RecName: Full=APOBEC1 complementation factor;
DE   AltName: Full=APOBEC1-stimulating protein;
GN   Name=A1CF; Synonyms=ACF, ASP {ECO:0000312|EMBL:CAB94754.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAB94754.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND INTERACTION
RP   WITH APOBEC1.
RC   TISSUE=Liver {ECO:0000312|EMBL:CAB94754.1}, and
RC   Small intestine {ECO:0000312|EMBL:CAB94755.1};
RX   PubMed=10781591; DOI=10.1074/jbc.m001786200;
RA   Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., Greeve J.;
RT   "Purification and molecular cloning of a novel essential component of the
RT   apolipoprotein B mRNA editing enzyme-complex.";
RL   J. Biol. Chem. 275:19848-19856(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAF34824.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH APOBEC1,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=10669759; DOI=10.1128/mcb.20.5.1846-1854.2000;
RA   Mehta A., Kinter M.T., Sherman N.E., Driscoll D.M.;
RT   "Molecular cloning of APOBEC-1 complementation factor, a novel RNA-binding
RT   protein involved in the editing of apolipoprotein B mRNA.";
RL   Mol. Cell. Biol. 20:1846-1854(2000).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAF76221.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Liver;
RA   Sowden M.P., Smith H.C.;
RT   "Human APOBEC-1 complementation factor related protein.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAA91086.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5] {ECO:0000312|EMBL:AL512366}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAF76221.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SYNCRIP.
RX   PubMed=11134005; DOI=10.1074/jbc.m006435200;
RA   Blanc V., Navaratnam N., Henderson J.O., Anant S., Kennedy S., Jarmuz A.,
RA   Scott J., Davidson N.O.;
RT   "Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that
RT   interacts with both apobec-1 and apobec-1 complementation factor to
RT   modulate C to U editing.";
RL   J. Biol. Chem. 276:10272-10283(2001).
RN   [9] {ECO:0000305}
RP   GENE STRUCTURE, AND ALTERNATIVE SPLICING.
RX   PubMed=11718896; DOI=10.1016/s0167-4781(01)00295-0;
RA   Henderson J.O., Blanc V., Davidson N.O.;
RT   "Isolation, characterization and developmental regulation of the human
RT   apobec-1 complementation factor (ACF) gene.";
RL   Biochim. Biophys. Acta 1522:22-30(2001).
RN   [10] {ECO:0000305}
RP   RNA-BINDING DOMAIN, AND MUTAGENESIS OF PHE-59; PHE-100; PHE-139; PHE-183;
RP   TYR-234 AND PHE-270.
RX   PubMed=11871661; DOI=10.1017/s1355838202015649;
RA   Mehta A., Driscoll D.M.;
RT   "Identification of domains in apobec-1 complementation factor required for
RT   RNA binding and apolipoprotein-B mRNA editing.";
RL   RNA 8:69-82(2002).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12881431; DOI=10.1093/emboj/cdg369;
RA   Chester A., Somasekaram A., Tzimina M., Jarmuz A., Gisbourne J.,
RA   O'Keefe R., Scott J., Navaratnam N.;
RT   "The apolipoprotein B mRNA editing complex performs a multifunctional cycle
RT   and suppresses nonsense-mediated decay.";
RL   EMBO J. 22:3971-3982(2003).
RN   [12] {ECO:0000305}
RP   NUCLEAR LOCALIZATION SIGNAL, AND INTERACTION WITH TNPO2.
RX   PubMed=12896982; DOI=10.1074/jbc.m302951200;
RA   Blanc V., Kennedy S., Davidson N.O.;
RT   "A novel nuclear localization signal in the auxiliary domain of apobec-1
RT   complementation factor regulates nucleocytoplasmic import and shuttling.";
RL   J. Biol. Chem. 278:41198-41204(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14] {ECO:0000305, ECO:0000312|EMBL:AAF76221.1}
RP   STRUCTURE BY NMR OF 223-308.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA recognition motif of human APOBEC-1
RT   complementation factor, ACF.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Essential component of the apolipoprotein B mRNA editing
CC       enzyme complex which is responsible for the postranscriptional editing
CC       of a CAA codon for Gln to a UAA codon for stop in APOB mRNA. Binds to
CC       APOB mRNA and is probably responsible for docking the catalytic
CC       subunit, APOBEC1, to the mRNA to allow it to deaminate its target
CC       cytosine. The complex also protects the edited APOB mRNA from nonsense-
CC       mediated decay. {ECO:0000269|PubMed:10669759,
CC       ECO:0000269|PubMed:10781591, ECO:0000269|PubMed:12881431}.
CC   -!- SUBUNIT: Part of the apolipoprotein B mRNA editing complex with
CC       APOBEC1. Interacts with TNPO2; TNPO2 may be responsible for transport
CC       of A1CF into the nucleus. Interacts with SYNCRIP. Interacts with
CC       CELF2/CUGBP2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NQ94; Q5BKX5-3: C19orf54; NbExp=3; IntAct=EBI-2809489, EBI-11976299;
CC       Q9NQ94-2; O95810: CAVIN2; NbExp=3; IntAct=EBI-10311892, EBI-742141;
CC       Q9NQ94; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-2809489, EBI-3867333;
CC       Q9NQ94; Q7L591-3: DOK3; NbExp=3; IntAct=EBI-2809489, EBI-10694655;
CC       Q9NQ94; Q16610: ECM1; NbExp=3; IntAct=EBI-2809489, EBI-947964;
CC       Q9NQ94; Q04637-9: EIF4G1; NbExp=3; IntAct=EBI-2809489, EBI-12012124;
CC       Q9NQ94; Q14192: FHL2; NbExp=3; IntAct=EBI-2809489, EBI-701903;
CC       Q9NQ94; Q13643: FHL3; NbExp=3; IntAct=EBI-2809489, EBI-741101;
CC       Q9NQ94; Q16082: HSPB2; NbExp=3; IntAct=EBI-2809489, EBI-739395;
CC       Q9NQ94; Q96G42: KLHDC7B; NbExp=3; IntAct=EBI-2809489, EBI-9478422;
CC       Q9NQ94; Q15323: KRT31; NbExp=3; IntAct=EBI-2809489, EBI-948001;
CC       Q9NQ94; O76011: KRT34; NbExp=3; IntAct=EBI-2809489, EBI-1047093;
CC       Q9NQ94; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-2809489, EBI-8487781;
CC       Q9NQ94; O43482: OIP5; NbExp=3; IntAct=EBI-2809489, EBI-536879;
CC       Q9NQ94; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-2809489, EBI-949255;
CC       Q9NQ94; Q7Z3K3: POGZ; NbExp=3; IntAct=EBI-2809489, EBI-1389308;
CC       Q9NQ94; Q04864: REL; NbExp=3; IntAct=EBI-2809489, EBI-307352;
CC       Q9NQ94; Q9UFD9: RIMBP3; NbExp=3; IntAct=EBI-2809489, EBI-10182375;
CC       Q9NQ94; Q8NCR6: SMRP1; NbExp=3; IntAct=EBI-2809489, EBI-10269322;
CC       Q9NQ94; Q13077: TRAF1; NbExp=6; IntAct=EBI-2809489, EBI-359224;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12881431}.
CC       Endoplasmic reticulum {ECO:0000250}. Cytoplasm
CC       {ECO:0000269|PubMed:12881431}. Note=Predominantly nuclear where it
CC       localizes to heterochromatin. Also cytoplasmic where it is found at the
CC       outer surface of the endoplasmic reticulum (By similarity). Shuttles
CC       between the nucleus and cytoplasm. May be transported into the nucleus
CC       by the nuclear import protein TNPO2/TRN2 or by APOBEC1. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1 {ECO:0000269|PubMed:10781591};
CC         IsoId=Q9NQ94-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:10669759, ECO:0000269|PubMed:10781591};
CC         IsoId=Q9NQ94-2; Sequence=VSP_051929;
CC       Name=3;
CC         IsoId=Q9NQ94-3; Sequence=VSP_051926, VSP_051929;
CC       Name=4 {ECO:0000305};
CC         IsoId=Q9NQ94-4; Sequence=VSP_051927, VSP_051929;
CC       Name=5 {ECO:0000269|PubMed:11718896};
CC         IsoId=Q9NQ94-5; Sequence=VSP_051925;
CC       Name=6 {ECO:0000269|PubMed:11718896};
CC         IsoId=Q9NQ94-6; Sequence=VSP_051928;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain,
CC       liver, pancreas, colon and spleen. {ECO:0000269|PubMed:10669759}.
CC   -!- DOMAIN: The RRM domains are necessary but not sufficient for binding to
CC       APOB mRNA. Additional residues in the pre-RRM and C-terminal regions
CC       are required for RNA-binding and for complementing APOBEC1 activity.
CC       {ECO:0000269|PubMed:11871661}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Major isoform found in 66-78% of cDNA
CC       clones. {ECO:0000269|PubMed:11718896}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Does not exhibit APOBEC1 complementation
CC       activity. {ECO:0000269|PubMed:11718896, ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Does not exhibit APOBEC1 complementation
CC       activity. {ECO:0000269|PubMed:11718896}.
CC   -!- MISCELLANEOUS: [Isoform 6]: Minor isoform found in 2-3% of cDNA clones.
CC       {ECO:0000269|PubMed:11718896}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91086.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ272078; CAB94754.1; -; mRNA.
DR   EMBL; AJ272079; CAB94755.1; -; mRNA.
DR   EMBL; AF209192; AAF34824.1; -; mRNA.
DR   EMBL; AF271789; AAF76221.1; -; mRNA.
DR   EMBL; AF271790; AAF76222.1; -; mRNA.
DR   EMBL; AK000324; BAA91086.1; ALT_FRAME; mRNA.
DR   EMBL; AK291982; BAF84671.1; -; mRNA.
DR   EMBL; AL512366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589794; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54133.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54134.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54135.1; -; Genomic_DNA.
DR   EMBL; BC130519; AAI30520.1; -; mRNA.
DR   EMBL; BC144196; AAI44197.1; -; mRNA.
DR   CCDS; CCDS7241.1; -. [Q9NQ94-2]
DR   CCDS; CCDS7242.1; -. [Q9NQ94-1]
DR   CCDS; CCDS7243.1; -. [Q9NQ94-4]
DR   RefSeq; NP_001185747.1; NM_001198818.1. [Q9NQ94-2]
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; NP_001185749.1; NM_001198820.1. [Q9NQ94-4]
DR   RefSeq; NP_055391.2; NM_014576.3. [Q9NQ94-2]
DR   RefSeq; NP_620310.1; NM_138932.2. [Q9NQ94-1]
DR   RefSeq; NP_620311.1; NM_138933.2. [Q9NQ94-4]
DR   RefSeq; XP_005269775.1; XM_005269718.2. [Q9NQ94-1]
DR   RefSeq; XP_005269777.1; XM_005269720.3.
DR   RefSeq; XP_016871649.1; XM_017016160.1.
DR   PDB; 2CPD; NMR; -; A=223-308.
DR   PDBsum; 2CPD; -.
DR   SMR; Q9NQ94; -.
DR   BioGrid; 119004; 11.
DR   ComplexPortal; CPX-1097; C-to-U editosome complex.
DR   IntAct; Q9NQ94; 23.
DR   STRING; 9606.ENSP00000378868; -.
DR   iPTMnet; Q9NQ94; -.
DR   PhosphoSitePlus; Q9NQ94; -.
DR   BioMuta; A1CF; -.
DR   DMDM; 74761651; -.
DR   jPOST; Q9NQ94; -.
DR   MassIVE; Q9NQ94; -.
DR   MaxQB; Q9NQ94; -.
DR   PaxDb; Q9NQ94; -.
DR   PeptideAtlas; Q9NQ94; -.
DR   PRIDE; Q9NQ94; -.
DR   ProteomicsDB; 82112; -. [Q9NQ94-1]
DR   ProteomicsDB; 82113; -. [Q9NQ94-2]
DR   ProteomicsDB; 82114; -. [Q9NQ94-3]
DR   ProteomicsDB; 82115; -. [Q9NQ94-4]
DR   ProteomicsDB; 82116; -. [Q9NQ94-5]
DR   ProteomicsDB; 82117; -. [Q9NQ94-6]
DR   Antibodypedia; 27897; 183 antibodies.
DR   Ensembl; ENST00000282641; ENSP00000282641; ENSG00000148584. [Q9NQ94-2]
DR   Ensembl; ENST00000373993; ENSP00000363105; ENSG00000148584. [Q9NQ94-1]
DR   Ensembl; ENST00000373995; ENSP00000363107; ENSG00000148584. [Q9NQ94-4]
DR   Ensembl; ENST00000373997; ENSP00000363109; ENSG00000148584. [Q9NQ94-2]
DR   Ensembl; ENST00000374001; ENSP00000363113; ENSG00000148584. [Q9NQ94-2]
DR   Ensembl; ENST00000395495; ENSP00000378873; ENSG00000148584. [Q9NQ94-4]
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   UCSC; uc001jjh.4; human. [Q9NQ94-1]
DR   CTD; 29974; -.
DR   DisGeNET; 29974; -.
DR   GeneCards; A1CF; -.
DR   HGNC; HGNC:24086; A1CF.
DR   HPA; ENSG00000148584; Group enriched (intestine, liver).
DR   MIM; 618199; gene.
DR   neXtProt; NX_Q9NQ94; -.
DR   OpenTargets; ENSG00000148584; -.
DR   PharmGKB; PA162375098; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GeneTree; ENSGT00940000158678; -.
DR   HOGENOM; CLU_022960_5_1_1; -.
DR   InParanoid; Q9NQ94; -.
DR   OrthoDB; 1384330at2759; -.
DR   PhylomeDB; Q9NQ94; -.
DR   TreeFam; TF314932; -.
DR   Reactome; R-HSA-72200; mRNA Editing: C to U Conversion.
DR   Reactome; R-HSA-75094; Formation of the Editosome.
DR   ChiTaRS; A1CF; human.
DR   EvolutionaryTrace; Q9NQ94; -.
DR   GeneWiki; ACF_(gene); -.
DR   GenomeRNAi; 29974; -.
DR   Pharos; Q9NQ94; Tbio.
DR   PRO; PR:Q9NQ94; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9NQ94; protein.
DR   Bgee; ENSG00000148584; Expressed in liver and 82 other tissues.
DR   ExpressionAtlas; Q9NQ94; baseline and differential.
DR   Genevisible; Q9NQ94; HS.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0016554; P:cytidine to uridine editing; TAS:Reactome.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR21245:SF8; PTHR21245:SF8; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Endoplasmic reticulum;
KW   mRNA processing; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; RNA-binding.
FT   CHAIN           1..594
FT                   /note="APOBEC1 complementation factor"
FT                   /id="PRO_0000081482"
FT   DOMAIN          56..134
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          136..218
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          231..303
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          360..409
FT                   /note="Required for nuclear localization"
FT                   /evidence="ECO:0000269|PubMed:12896982"
FT   MOD_RES         499
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         1..84
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11718896"
FT                   /id="VSP_051925"
FT   VAR_SEQ         1..33
FT                   /note="MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MLCSPSFCKLCWKRK
FT                   K (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_051926"
FT   VAR_SEQ         1..33
FT                   /note="MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MEAVCLGTCPEPEAS
FT                   MSTAIPGLKKGNNALQSIILQTLLEK (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_051927"
FT   VAR_SEQ         202..256
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11718896"
FT                   /id="VSP_051928"
FT   VAR_SEQ         381..388
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10669759,
FT                   ECO:0000303|PubMed:10781591, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_051929"
FT   VARIANT         555
FT                   /note="V -> M (in dbSNP:rs9073)"
FT                   /id="VAR_052201"
FT   VARIANT         558
FT                   /note="A -> S (in dbSNP:rs11817448)"
FT                   /id="VAR_059821"
FT   MUTAGEN         59
FT                   /note="F->A: Greatly reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:11871661"
FT   MUTAGEN         100
FT                   /note="F->A: Greatly reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:11871661"
FT   MUTAGEN         139
FT                   /note="F->A: Greatly reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:11871661"
FT   MUTAGEN         183
FT                   /note="F->A: Greatly reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:11871661"
FT   MUTAGEN         234
FT                   /note="Y->A: Slightly reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:11871661"
FT   MUTAGEN         270
FT                   /note="F->A: Slightly reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:11871661"
FT   CONFLICT        191
FT                   /note="A -> T (in Ref. 2; AAF34824)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        277
FT                   /note="E -> K (in Ref. 2 and 3)"
FT                   /evidence="ECO:0000305"
FT   STRAND          232..237
FT                   /evidence="ECO:0000244|PDB:2CPD"
FT   HELIX           244..252
FT                   /evidence="ECO:0000244|PDB:2CPD"
FT   STRAND          259..264
FT                   /evidence="ECO:0000244|PDB:2CPD"
FT   STRAND          266..275
FT                   /evidence="ECO:0000244|PDB:2CPD"
FT   HELIX           276..286
FT                   /evidence="ECO:0000244|PDB:2CPD"
FT   STRAND          287..291
FT                   /evidence="ECO:0000244|PDB:2CPD"
FT   STRAND          294..299
FT                   /evidence="ECO:0000244|PDB:2CPD"
SQ   SEQUENCE   594 AA;  65202 MW;  AA5EF76BD8815807 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR EIYMNVPVGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   A0A5F9ZHU3_HUMAN        Unreviewed;       418 AA.
AC   A0A5F9ZHU3;
DT   11-DEC-2019, integrated into UniProtKB/TrEMBL.
DT   11-DEC-2019, sequence version 1.
DT   22-APR-2020, entry version 3.
DE   RecName: Full=Non-specific serine/threonine protein kinase {ECO:0000256|SAAS:SAAS01060667};
DE            EC=2.7.11.1 {ECO:0000256|SAAS:SAAS01060667};
GN   Name=AKT3 {ECO:0000313|Ensembl:ENSP00000500597};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000500597, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000500597, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000500597}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2019) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000256|SAAS:SAAS01127769};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000256|SAAS:SAAS01127730};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000256|RuleBase:RU000304}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC096539; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL592151; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016855474.1; XM_016999985.1.
DR   Ensembl; ENST00000672578; ENSP00000500597; ENSG00000117020.
DR   GeneID; 10000; -.
DR   HGNC; HGNC:393; AKT3.
DR   OpenTargets; ENSG00000117020; -.
DR   GeneTree; ENSGT00940000157060; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   CDD; cd05593; STKc_PKB_gamma; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR034675; Akt3.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR039029; RAC_gamma-like.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24351:SF199; PTHR24351:SF199; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593399};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Kinase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Proteomics identification {ECO:0000213|EPD:A0A5F9ZHU3,
KW   ECO:0000213|MaxQB:A0A5F9ZHU3, ECO:0000213|PeptideAtlas:A0A5F9ZHU3,
KW   ECO:0000213|ProteomicsDB:A0A5F9ZHU3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Serine/threonine-protein kinase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706};
KW   Transferase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706}.
FT   DOMAIN          1..46
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   DOMAIN          87..344
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   DOMAIN          345..418
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51285"
FT   REGION          397..418
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          34..54
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   418 AA;  48581 MW;  B59B6792D913EFB2 CRC64;
     MKTERPKPNT FIIRCLQWTT VIERTFHVDT PEEREEWTEA IQAVADRLQR QEEERMNCSP
     TSQIDNIGEE EMDASTTHHK RKTMNDFDYL KLLGKGTFGK VILVREKASG KYYAMKILKK
     EVIIAKDEVA HTLTESRVLK NTRHPFLTSL KYSFQTKDRL CFVMEYVNGG ELFFHLSRER
     VFSEDRTRFY GAEIVSALDY LHSGKIVYRD LKLENLMLDK DGHIKITDFG LCKEGITDAA
     TMKTFCGTPE YLAPEVLEDN DYGRAVDWWG LGVVMYEMMC GRLPFYNQDH EKLFELILME
     DIKFPRTLSS DAKSLLSGLL IKDPNKRLGG GPDDAKEIMR HSFFSGVNWQ DVYDKKLVPP
     FKPQVTSETD TRYFDEEFTA QTITITPPEK YDEDGMDCMD NERRPHFPQF SYSASGRE
//
ID   AKT3_HUMAN              Reviewed;         479 AA.
AC   Q9Y243; Q0VAA6; Q5VTI1; Q5VTI2; Q96QV3; Q9UFP5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-APR-2020, entry version 209.
DE   RecName: Full=RAC-gamma serine/threonine-protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase Akt-3;
DE   AltName: Full=Protein kinase B gamma;
DE            Short=PKB gamma;
DE   AltName: Full=RAC-PK-gamma;
DE   AltName: Full=STK-2;
GN   Name=AKT3; Synonyms=PKBG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS.
RX   PubMed=10092583; DOI=10.1074/jbc.274.14.9133;
RA   Brodbeck D., Cron P., Hemmings B.A.;
RT   "A human protein kinase B gamma with regulatory phosphorylation sites in
RT   the activation loop and in the C-terminal hydrophobic domain.";
RL   J. Biol. Chem. 274:9133-9136(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10208883; DOI=10.1006/bbrc.1999.0559;
RA   Nakatani K., Sakaue H., Thompson D.A., Weigel R.J., Roth R.A.;
RT   "Identification of a human Akt3 (protein kinase B gamma) which contains the
RT   regulatory serine phosphorylation site.";
RL   Biochem. Biophys. Res. Commun. 257:906-910(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10491192; DOI=10.1046/j.1432-1327.1999.00774.x;
RA   Masure S., Haefner B., Wesselink J.-J., Hoefnagel E., Mortier E.,
RA   Verhasselt P., Tuytelaars A., Gordon R., Richardson A.;
RT   "Molecular cloning, expression and characterization of the human
RT   serine/threonine kinase Akt-3.";
RL   Eur. J. Biochem. 265:353-360(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li X., Yu L., Huang H., Zhang M., Zhao Y., Zhao S.;
RT   "Cloning of a novel human cDNA, STK-2, which encodes a rat serine-threonine
RT   protein kinase (STK) homolog.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND MUTAGENESIS OF THR-305
RP   AND THR-447.
RX   PubMed=11387345; DOI=10.1074/jbc.m104633200;
RA   Brodbeck D., Hill M.M., Hemmings B.A.;
RT   "Two splice variants of PKB gamma have different regulatory capacity
RT   depending on the presence or absence of the regulatory phosphorylation site
RT   Ser-472 in the C-terminal hydrophobic domain.";
RL   J. Biol. Chem. 276:29550-29558(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   CHARACTERIZATION, AND PHOSPHORYLATION AT THR-305 BY PDPK1.
RX   PubMed=9512493; DOI=10.1042/bj3310299;
RA   Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D.R.;
RT   "Activation of protein kinase B beta and gamma isoforms by insulin in vivo
RT   and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison
RT   with protein kinase B alpha.";
RL   Biochem. J. 331:299-308(1998).
RN   [11]
RP   PHOSPHORYLATION AT SER-472.
RX   PubMed=12162751; DOI=10.1021/bi026065r;
RA   Hodgkinson C.P., Sale E.M., Sale G.J.;
RT   "Characterization of PDK2 activity against protein kinase B gamma.";
RL   Biochemistry 41:10351-10359(2002).
RN   [12]
RP   INTERACTION WITH TCL1A.
RX   PubMed=11707444; DOI=10.1074/jbc.m107069200;
RA   Laine J., Kuenstle G., Obata T., Noguchi M.;
RT   "Differential regulation of Akt kinase isoforms by the members of the TCL1
RT   oncogene family.";
RL   J. Biol. Chem. 277:3743-3751(2002).
RN   [13]
RP   INTERACTION WITH TCL1A.
RX   PubMed=11839817; DOI=10.1128/mcb.22.5.1513-1525.2002;
RA   Kuenstle G., Laine J., Pierron G., Kagami S., Nakajima H., Hoh F.,
RA   Roumestand C., Stern M.H., Noguchi M.;
RT   "Identification of Akt association and oligomerization domains of the Akt
RT   kinase coactivator TCL1.";
RL   Mol. Cell. Biol. 22:1513-1525(2002).
RN   [14]
RP   INVOLVEMENT IN TUMORS.
RX   PubMed=15466193; DOI=10.1158/0008-5472.can-04-1399;
RA   Stahl J.M., Sharma A., Cheung M., Zimmerman M., Cheng J.Q., Bosenberg M.W.,
RA   Kester M., Sandirasegarane L., Robertson G.P.;
RT   "Deregulated Akt3 activity promotes development of malignant melanoma.";
RL   Cancer Res. 64:7002-7010(2004).
RN   [15]
RP   INVOLVEMENT IN CANCER.
RX   PubMed=17178867; DOI=10.1158/0008-5472.can-06-1968;
RA   Cristiano B.E., Chan J.C., Hannan K.M., Lundie N.A., Marmy-Conus N.J.,
RA   Campbell I.G., Phillips W.A., Robbie M., Hannan R.D., Pearson R.B.;
RT   "A specific role for AKT3 in the genesis of ovarian cancer through
RT   modulation of G(2)-M phase transition.";
RL   Cancer Res. 66:11718-11725(2006).
RN   [16]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16540465; DOI=10.1074/jbc.m601384200;
RA   Zhang X., Zhang S., Yamane H., Wahl R., Ali A., Lofgren J.A., Kendall R.L.;
RT   "Kinetic mechanism of AKT/PKB enzyme family.";
RL   J. Biol. Chem. 281:13949-13956(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [18]
RP   FUNCTION.
RX   PubMed=18524868; DOI=10.1096/fj.08-106468;
RA   Wright G.L., Maroulakou I.G., Eldridge J., Liby T.L., Sridharan V.,
RA   Tsichlis P.N., Muise-Helmericks R.C.;
RT   "VEGF stimulation of mitochondrial biogenesis: requirement of AKT3
RT   kinase.";
RL   FASEB J. 22:3264-3275(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   UBIQUITINATION BY TTC3.
RX   PubMed=20059950; DOI=10.1016/j.devcel.2009.09.007;
RA   Suizu F., Hiramuki Y., Okumura F., Matsuda M., Okumura A.J., Hirata N.,
RA   Narita M., Kohno T., Yokota J., Bohgaki M., Obuse C., Hatakeyama S.,
RA   Obata T., Noguchi M.;
RT   "The E3 ligase TTC3 facilitates ubiquitination and degradation of
RT   phosphorylated Akt.";
RL   Dev. Cell 17:800-810(2009).
RN   [21]
RP   INTERACTION WITH TRAF6.
RX   PubMed=19713527; DOI=10.1126/science.1175065;
RA   Yang W.-L., Wang J., Chan C.-H., Lee S.-W., Campos A.D., Lamothe B.,
RA   Hur L., Grabiner B.C., Lin X., Darnay B.G., Lin H.-K.;
RT   "The E3 ligase TRAF6 regulates Akt ubiquitination and activation.";
RL   Science 325:1134-1138(2009).
RN   [22]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20018949; DOI=10.1152/ajpcell.00375.2009;
RA   Santi S.A., Lee H.;
RT   "The Akt isoforms are present at distinct subcellular locations.";
RL   Am. J. Physiol. 298:C580-C591(2010).
RN   [23]
RP   INVOLVEMENT IN TUMORS.
RX   PubMed=20167810; DOI=10.1093/neuonc/nop026;
RA   Mure H., Matsuzaki K., Kitazato K.T., Mizobuchi Y., Kuwayama K., Kageji T.,
RA   Nagahiro S.;
RT   "Akt2 and Akt3 play a pivotal role in malignant gliomas.";
RL   Neuro-oncol. 12:221-232(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   FUNCTION.
RX   PubMed=21191416; DOI=10.1038/jid.2010.361;
RA   Moriya C., Jinnin M., Yamane K., Maruo K., Muchemwa F.C., Igata T.,
RA   Makino T., Fukushima S., Ihn H.;
RT   "Expression of matrix metalloproteinase-13 is controlled by IL-13 via
RT   PI3K/Akt3 and PKC-delta in normal human dermal fibroblasts.";
RL   J. Invest. Dermatol. 131:655-661(2011).
RN   [26]
RP   REVIEW ON FUNCTION.
RX   PubMed=21620960; DOI=10.1016/j.cellsig.2011.05.004;
RA   Hers I., Vincent E.E., Tavare J.M.;
RT   "Akt signalling in health and disease.";
RL   Cell. Signal. 23:1515-1527(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-447, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) OF 1-118.
RA   Vollmar M., Wang J., Zhang Y., Elkins J.M., Burgess-Brown N., Chaikuad A.,
RA   Pike A.C.W., Von Delft F., Bountra C., Arrowsmith C.H., Weigelt J.,
RA   Edwards A., Knapp S.;
RT   "The crystal structure of the PH domain of human Akt3 protein kinase.";
RL   Submitted (DEC-2009) to the PDB data bank.
RN   [29]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-171.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [30]
RP   VARIANT MELANOMA LYS-17, AND CHARACTERIZATION OF VARIANT MELANOMA LYS-17.
RX   PubMed=18813315; DOI=10.1038/sj.bjc.6604637;
RA   Davies M.A., Stemke-Hale K., Tellez C., Calderone T.L., Deng W.,
RA   Prieto V.G., Lazar A.J., Gershenwald J.E., Mills G.B.;
RT   "A novel AKT3 mutation in melanoma tumours and cell lines.";
RL   Br. J. Cancer 99:1265-1268(2008).
RN   [31]
RP   VARIANTS MPPH2 SER-229 AND TRP-465.
RX   PubMed=22729224; DOI=10.1038/ng.2331;
RA   Riviere J.B., Mirzaa G.M., O'Roak B.J., Beddaoui M., Alcantara D.,
RA   Conway R.L., St-Onge J., Schwartzentruber J.A., Gripp K.W., Nikkel S.M.,
RA   Worthylake T., Sullivan C.T., Ward T.R., Butler H.E., Kramer N.A.,
RA   Albrecht B., Armour C.M., Armstrong L., Caluseriu O., Cytrynbaum C.,
RA   Drolet B.A., Innes A.M., Lauzon J.L., Lin A.E., Mancini G.M.,
RA   Meschino W.S., Reggin J.D., Saggar A.K., Lerman-Sagie T., Uyanik G.,
RA   Weksberg R., Zirn B., Beaulieu C.L., Majewski J., Bulman D.E.,
RA   O'Driscoll M., Shendure J., Graham J.M. Jr., Boycott K.M., Dobyns W.B.;
RT   "De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA
RT   cause a spectrum of related megalencephaly syndromes.";
RL   Nat. Genet. 44:934-940(2012).
RN   [32]
RP   VARIANT MPPH2 LYS-17.
RX   PubMed=22729223; DOI=10.1038/ng.2329;
RA   Lee J.H., Huynh M., Silhavy J.L., Kim S., Dixon-Salazar T., Heiberg A.,
RA   Scott E., Bafna V., Hill K.J., Collazo A., Funari V., Russ C.,
RA   Gabriel S.B., Mathern G.W., Gleeson J.G.;
RT   "De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway
RT   cause hemimegalencephaly.";
RL   Nat. Genet. 44:941-945(2012).
RN   [33]
RP   VARIANT MPPH2 LYS-17.
RX   PubMed=22500628; DOI=10.1016/j.neuron.2012.03.010;
RA   Poduri A., Evrony G.D., Cai X., Elhosary P.C., Beroukhim R., Lehtinen M.K.,
RA   Hills L.B., Heinzen E.L., Hill A., Hill R.S., Barry B.J., Bourgeois B.F.,
RA   Riviello J.J., Barkovich A.J., Black P.M., Ligon K.L., Walsh C.A.;
RT   "Somatic activation of AKT3 causes hemispheric developmental brain
RT   malformations.";
RL   Neuron 74:41-48(2012).
RN   [34]
RP   VARIANT MPPH2 SER-229.
RX   PubMed=23745724; DOI=10.1111/cge.12188;
RA   Nakamura K., Kato M., Tohyama J., Shiohama T., Hayasaka K., Nishiyama K.,
RA   Kodera H., Nakashima M., Tsurusaki Y., Miyake N., Matsumoto N., Saitsu H.;
RT   "AKT3 and PIK3R2 mutations in two patients with megalencephaly-related
RT   syndromes: MCAP and MPPH.";
RL   Clin. Genet. 85:396-398(2014).
CC   -!- FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein
CC       kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate
CC       many processes including metabolism, proliferation, cell survival,
CC       growth and angiogenesis. This is mediated through serine and/or
CC       threonine phosphorylation of a range of downstream substrates. Over 100
CC       substrate candidates have been reported so far, but for most of them,
CC       no isoform specificity has been reported. AKT3 is the least studied AKT
CC       isoform. It plays an important role in brain development and is crucial
CC       for the viability of malignant glioma cells. AKT3 isoform may also be
CC       the key molecule in up-regulation and down-regulation of MMP13 via
CC       IL13. Required for the coordination of mitochondrial biogenesis with
CC       growth factor-induced increases in cellular energy demands. Down-
CC       regulation by RNA interference reduces the expression of the
CC       phosphorylated form of BAD, resulting in the induction of caspase-
CC       dependent apoptosis. {ECO:0000269|PubMed:18524868,
CC       ECO:0000269|PubMed:21191416}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Two specific sites, one in the kinase domain (Thr-
CC       305) and the other in the C-terminal regulatory region (Ser-472), need
CC       to be phosphorylated for its full activation (By similarity). IGF-1
CC       leads to the activation of AKT3, which may play a role in regulating
CC       cell survival. {ECO:0000250}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=87.9 uM for ATP (for purified and in vitro activated AKT3)
CC         {ECO:0000269|PubMed:16540465};
CC         KM=12.4 uM for peptide substrate (for purified and in vitro activated
CC         AKT3) {ECO:0000269|PubMed:16540465};
CC         KM=118.7 uM for ATP (for recombinant myristoylated AKT3 expressed and
CC         immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465};
CC         KM=2.3 uM for peptide substrate (for recombinant myristoylated AKT3
CC         expressed and immunoprecipitated from Rat-1 cells)
CC         {ECO:0000269|PubMed:16540465};
CC   -!- SUBUNIT: Interacts (via PH domain) with TCL1A; this enhances AKT3
CC       phosphorylation and activation. Interacts with TRAF6. Interacts with
CC       KCTD20 (By similarity). Interacts with BTBD10 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9WUA6, ECO:0000269|PubMed:11707444,
CC       ECO:0000269|PubMed:11839817, ECO:0000269|PubMed:19713527}.
CC   -!- INTERACTION:
CC       Q9Y243; P42574: CASP3; NbExp=2; IntAct=EBI-296115, EBI-524064;
CC       Q9Y243; Q16543: CDC37; NbExp=2; IntAct=EBI-296115, EBI-295634;
CC       Q9Y243; P53804: TTC3; NbExp=2; IntAct=EBI-296115, EBI-2681313;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20018949}. Cytoplasm
CC       {ECO:0000269|PubMed:20018949}. Membrane {ECO:0000269|PubMed:20018949};
CC       Peripheral membrane protein {ECO:0000269|PubMed:20018949}.
CC       Note=Membrane-associated after cell stimulation leading to its
CC       translocation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PKB gamma;
CC         IsoId=Q9Y243-1; Sequence=Displayed;
CC       Name=2; Synonyms=PKB gamma 1;
CC         IsoId=Q9Y243-2; Sequence=VSP_004947;
CC   -!- TISSUE SPECIFICITY: In adult tissues, it is highly expressed in brain,
CC       lung and kidney, but weakly in heart, testis and liver. In fetal
CC       tissues, it is highly expressed in heart, liver and brain and not at
CC       all in kidney.
CC   -!- DOMAIN: Binding of the PH domain to the phosphatidylinositol 3-kinase
CC       alpha (PI(3)K) results in its targeting to the plasma membrane.
CC   -!- PTM: Phosphorylation on Thr-305 and Ser-472 is required for full
CC       activity. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. When fully phosphorylated and translocated into the
CC       nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3,
CC       leading to its degradation by the proteasome.
CC       {ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:20059950,
CC       ECO:0000269|PubMed:9512493}.
CC   -!- PTM: O-GlcNAcylation at Thr-302 and Thr-309 inhibits activating
CC       phosphorylation at Thr-305 via disrupting the interaction between AKT
CC       and PDK1. {ECO:0000250}.
CC   -!- DISEASE: Note=AKT3 is a key modulator of several tumors like melanoma,
CC       glioma and ovarian cancer. Active AKT3 increases progressively during
CC       melanoma tumor progression with highest levels present in advanced-
CC       stage metastatic melanomas. Promotes melanoma tumorigenesis by
CC       decreasing apoptosis. Plays a key role in the genesis of ovarian
CC       cancers through modulation of G2/M phase transition. With AKT2, plays a
CC       pivotal role in the biology of glioblastoma.
CC   -!- DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus
CC       syndrome 2 (MPPH2) [MIM:615937]: A syndrome characterized by
CC       megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also
CC       be seen. There is considerable phenotypic similarity between this
CC       disorder and the megalencephaly-capillary malformation syndrome.
CC       {ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223,
CC       ECO:0000269|PubMed:22729224, ECO:0000269|PubMed:23745724}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. RAC subfamily. {ECO:0000305}.
CC   -!- CAUTION: In light of strong homologies in the primary amino acid
CC       sequence, the 3 AKT kinases were long surmised to play redundant and
CC       overlapping roles. More recent studies has brought into question the
CC       redundancy within AKT kinase isoforms and instead pointed to isoform
CC       specific functions in different cellular events and diseases. AKT1 is
CC       more specifically involved in cellular survival pathways, by inhibiting
CC       apoptotic processes; whereas AKT2 is more specific for the insulin
CC       receptor signaling pathway. Moreover, while AKT1 and AKT2 are often
CC       implicated in many aspects of cellular transformation, the 2 isoforms
CC       act in a complementary opposing manner. The role of AKT3 is less clear,
CC       though it appears to be predominantly expressed in brain.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AKT3ID615ch1q44.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF124141; AAD29089.1; -; mRNA.
DR   EMBL; AF135794; AAD24196.1; -; mRNA.
DR   EMBL; AF085234; AAL40392.1; -; mRNA.
DR   EMBL; AJ245709; CAB53537.1; -; mRNA.
DR   EMBL; AL117525; CAB55977.1; ALT_TERM; mRNA.
DR   EMBL; AY005799; AAF91073.1; -; mRNA.
DR   EMBL; AC096539; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL592151; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471148; EAW77093.1; -; Genomic_DNA.
DR   EMBL; CH471148; EAW77094.1; -; Genomic_DNA.
DR   EMBL; BC121154; AAI21155.1; -; mRNA.
DR   CCDS; CCDS31076.1; -. [Q9Y243-2]
DR   CCDS; CCDS31077.1; -. [Q9Y243-1]
DR   PIR; A59380; A59380.
DR   PIR; T17287; T17287.
DR   RefSeq; NP_001193658.1; NM_001206729.1. [Q9Y243-2]
DR   RefSeq; NP_005456.1; NM_005465.4. [Q9Y243-1]
DR   RefSeq; NP_859029.1; NM_181690.2. [Q9Y243-2]
DR   RefSeq; XP_005273051.1; XM_005272994.4.
DR   RefSeq; XP_005273052.1; XM_005272995.2.
DR   PDB; 2X18; X-ray; 1.46 A; A/B/C/D/E/F/G/H=1-118.
DR   PDBsum; 2X18; -.
DR   SMR; Q9Y243; -.
DR   BioGrid; 115318; 33.
DR   DIP; DIP-32584N; -.
DR   IntAct; Q9Y243; 40.
DR   MINT; Q9Y243; -.
DR   STRING; 9606.ENSP00000263826; -.
DR   BindingDB; Q9Y243; -.
DR   ChEMBL; CHEMBL4816; -.
DR   DrugCentral; Q9Y243; -.
DR   GuidetoPHARMACOLOGY; 2286; -.
DR   iPTMnet; Q9Y243; -.
DR   PhosphoSitePlus; Q9Y243; -.
DR   BioMuta; AKT3; -.
DR   DMDM; 12643943; -.
DR   EPD; Q9Y243; -.
DR   jPOST; Q9Y243; -.
DR   MassIVE; Q9Y243; -.
DR   PaxDb; Q9Y243; -.
DR   PeptideAtlas; Q9Y243; -.
DR   PRIDE; Q9Y243; -.
DR   ProteomicsDB; 85641; -. [Q9Y243-1]
DR   ProteomicsDB; 85642; -. [Q9Y243-2]
DR   ABCD; Q9Y243; -.
DR   Antibodypedia; 3402; 1103 antibodies.
DR   DNASU; 10000; -.
DR   Ensembl; ENST00000263826; ENSP00000263826; ENSG00000117020. [Q9Y243-1]
DR   Ensembl; ENST00000336199; ENSP00000336943; ENSG00000117020. [Q9Y243-2]
DR   Ensembl; ENST00000366540; ENSP00000355498; ENSG00000117020. [Q9Y243-2]
DR   Ensembl; ENST00000613395; ENSP00000479922; ENSG00000275199. [Q9Y243-2]
DR   Ensembl; ENST00000619536; ENSP00000483054; ENSG00000275199. [Q9Y243-2]
DR   Ensembl; ENST00000621586; ENSP00000479081; ENSG00000275199. [Q9Y243-1]
DR   Ensembl; ENST00000673466; ENSP00000500582; ENSG00000117020. [Q9Y243-1]
DR   GeneID; 10000; -.
DR   KEGG; hsa:10000; -.
DR   UCSC; uc001hzz.2; human. [Q9Y243-1]
DR   CTD; 10000; -.
DR   DisGeNET; 10000; -.
DR   GeneCards; AKT3; -.
DR   GeneReviews; AKT3; -.
DR   HGNC; HGNC:393; AKT3.
DR   HPA; ENSG00000117020; Low tissue specificity.
DR   MalaCards; AKT3; -.
DR   MIM; 611223; gene.
DR   MIM; 615937; phenotype.
DR   neXtProt; NX_Q9Y243; -.
DR   OpenTargets; ENSG00000117020; -.
DR   Orphanet; 99802; Hemimegalencephaly.
DR   Orphanet; 83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome.
DR   PharmGKB; PA24686; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00940000157060; -.
DR   HOGENOM; CLU_000288_11_0_1; -.
DR   InParanoid; Q9Y243; -.
DR   KO; K04456; -.
DR   OMA; CQIMSVD; -.
DR   OrthoDB; 787710at2759; -.
DR   PhylomeDB; Q9Y243; -.
DR   TreeFam; TF102004; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-198323; AKT phosphorylates targets in the cytosol.
DR   Reactome; R-HSA-198693; AKT phosphorylates targets in the nucleus.
DR   Reactome; R-HSA-199418; Negative regulation of the PI3K/AKT network.
DR   Reactome; R-HSA-211163; AKT-mediated inactivation of FOXO1A.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5674400; Constitutive Signaling by AKT1 E17K in Cancer.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-HSA-6804759; Regulation of TP53 Activity through Association with Co-factors.
DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-HSA-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   Reactome; R-HSA-8941332; RUNX2 regulates genes involved in cell migration.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-9614399; Regulation of localization of FOXO transcription factors.
DR   Reactome; R-HSA-9634638; Estrogen-dependent nuclear events downstream of ESR-membrane signaling.
DR   SABIO-RK; Q9Y243; -.
DR   SignaLink; Q9Y243; -.
DR   SIGNOR; Q9Y243; -.
DR   ChiTaRS; AKT3; human.
DR   GeneWiki; AKT3; -.
DR   GenomeRNAi; 10000; -.
DR   Pharos; Q9Y243; Tchem.
DR   PRO; PR:Q9Y243; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9Y243; protein.
DR   Bgee; ENSG00000117020; Expressed in neocortex and 235 other tissues.
DR   ExpressionAtlas; Q9Y243; baseline and differential.
DR   Genevisible; Q9Y243; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0000002; P:mitochondrial genome maintenance; IMP:UniProtKB.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:1905564; P:positive regulation of vascular endothelial cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IMP:UniProtKB.
DR   CDD; cd01241; PH_PKB; 1.
DR   CDD; cd05593; STKc_PKB_gamma; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR034675; Akt3.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR039026; PH_PKB.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR039029; RAC_gamma-like.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24351:SF199; PTHR24351:SF199; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Disease mutation; Disulfide bond; Glycoprotein; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..479
FT                   /note="RAC-gamma serine/threonine-protein kinase"
FT                   /id="PRO_0000085611"
FT   DOMAIN          5..107
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          148..405
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          406..479
FT                   /note="AGC-kinase C-terminal"
FT   NP_BIND         154..162
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        271
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         177
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         305
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000269|PubMed:9512493"
FT   MOD_RES         447
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         472
FT                   /note="Phosphoserine; by PKC/PRKCZ"
FT                   /evidence="ECO:0000269|PubMed:12162751"
FT   CARBOHYD        302
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        309
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        59..76
FT                   /evidence="ECO:0000250"
FT   DISULFID        293..307
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         452..479
FT                   /note="YDEDGMDCMDNERRPHFPQFSYSASGRE -> CQQSDCGMLGNWKK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166,
FT                   ECO:0000303|PubMed:11387345, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_004947"
FT   VARIANT         17
FT                   /note="E -> K (in MPPH2 and melanoma; results in activation
FT                   of AKT; dbSNP:rs397514606)"
FT                   /evidence="ECO:0000269|PubMed:18813315,
FT                   ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223"
FT                   /id="VAR_065830"
FT   VARIANT         171
FT                   /note="G -> R (in a glioblastoma multiforme sample; somatic
FT                   mutation; dbSNP:rs1402272180)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040358"
FT   VARIANT         229
FT                   /note="N -> S (in MPPH2; dbSNP:rs397514605)"
FT                   /evidence="ECO:0000269|PubMed:22729224,
FT                   ECO:0000269|PubMed:23745724"
FT                   /id="VAR_069260"
FT   VARIANT         465
FT                   /note="R -> W (in MPPH2; disease phenotype overlaps with
FT                   megalencephaly-capillary malformation syndrome;
FT                   dbSNP:rs587776935)"
FT                   /evidence="ECO:0000269|PubMed:22729224"
FT                   /id="VAR_069261"
FT   MUTAGEN         305
FT                   /note="T->A: No activation after pervanadate treatment."
FT                   /evidence="ECO:0000269|PubMed:11387345"
FT   MUTAGEN         305
FT                   /note="T->D: 2-fold increase of phosphorylation steady
FT                   state level, no activation after pervanadate treatment."
FT                   /evidence="ECO:0000269|PubMed:11387345"
FT   MUTAGEN         447
FT                   /note="T->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:11387345"
FT   MUTAGEN         447
FT                   /note="T->D: No effect."
FT                   /evidence="ECO:0000269|PubMed:11387345"
FT   MUTAGEN         472
FT                   /note="S->A: 67% decrease of activity after pervanadate
FT                   treatment."
FT                   /evidence="ECO:0000269|PubMed:10092583"
FT   MUTAGEN         472
FT                   /note="S->D: 1.4-fold increase of phosphorylation steady
FT                   state level, 50% decrease of activity after pervanadate
FT                   treatment."
FT                   /evidence="ECO:0000269|PubMed:10092583"
FT   CONFLICT        279
FT                   /note="L -> R (in Ref. 9; AAI21155)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..15
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          17..30
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          33..41
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   HELIX           44..46
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          51..55
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          60..64
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          66..68
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          71..75
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   TURN            80..82
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   STRAND          84..88
FT                   /evidence="ECO:0000244|PDB:2X18"
FT   HELIX           92..113
FT                   /evidence="ECO:0000244|PDB:2X18"
SQ   SEQUENCE   479 AA;  55775 MW;  F08BDDE6502E78FB CRC64;
     MSDVTIVKEG WVQKRGEYIK NWRPRYFLLK TDGSFIGYKE KPQDVDLPYP LNNFSVAKCQ
     LMKTERPKPN TFIIRCLQWT TVIERTFHVD TPEEREEWTE AIQAVADRLQ RQEEERMNCS
     PTSQIDNIGE EEMDASTTHH KRKTMNDFDY LKLLGKGTFG KVILVREKAS GKYYAMKILK
     KEVIIAKDEV AHTLTESRVL KNTRHPFLTS LKYSFQTKDR LCFVMEYVNG GELFFHLSRE
     RVFSEDRTRF YGAEIVSALD YLHSGKIVYR DLKLENLMLD KDGHIKITDF GLCKEGITDA
     ATMKTFCGTP EYLAPEVLED NDYGRAVDWW GLGVVMYEMM CGRLPFYNQD HEKLFELILM
     EDIKFPRTLS SDAKSLLSGL LIKDPNKRLG GGPDDAKEIM RHSFFSGVNW QDVYDKKLVP
     PFKPQVTSET DTRYFDEEFT AQTITITPPE KYDEDGMDCM DNERRPHFPQ FSYSASGRE
//
ID   A0A024R178_HUMAN        Unreviewed;       606 AA.
AC   A0A024R178;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 54.
DE   SubName: Full=V-raf murine sarcoma 3611 viral oncogene homolog, isoform CRA_b {ECO:0000313|EMBL:EAW59312.1};
DE   SubName: Full=V-raf murine sarcoma 3611 viral oncogene-like protein isoform 1 {ECO:0000313|EMBL:ALQ33372.1};
GN   Name=ARAF {ECO:0000313|EMBL:EAW59312.1};
GN   ORFNames=hCG_29140 {ECO:0000313|EMBL:EAW59312.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59312.1};
RN   [1] {ECO:0000313|EMBL:EAW59312.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59312.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33372.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU177914; ALQ33372.1; -; mRNA.
DR   EMBL; CH471164; EAW59311.1; -; Genomic_DNA.
DR   EMBL; CH471164; EAW59312.1; -; Genomic_DNA.
DR   RefSeq; NP_001645.1; NM_001654.4.
DR   RefSeq; XP_011542210.1; XM_011543908.2.
DR   Antibodypedia; 11388; 661 antibodies.
DR   GeneID; 369; -.
DR   KEGG; hsa:369; -.
DR   CTD; 369; -.
DR   EuPathDB; HostDB:ENSG00000078061.12; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   HOGENOM; CLU_023684_1_1_1; -.
DR   KO; K08845; -.
DR   OrthoDB; 243095at2759; -.
DR   ChiTaRS; ARAF; human.
DR   GenomeRNAi; 369; -.
DR   Bgee; ENSG00000078061; Expressed in muscle of leg and 213 other tissues.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS01233598};
KW   Kinase {ECO:0000256|SAAS:SAAS01233601};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00253054};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS01233598};
KW   Serine/threonine-protein kinase {ECO:0000256|SAAS:SAAS01233601};
KW   Transferase {ECO:0000256|SAAS:SAAS01233601};
KW   Zinc {ECO:0000256|SAAS:SAAS00253075}.
FT   DOMAIN          19..91
FT                   /note="RBD"
FT                   /evidence="ECO:0000259|PROSITE:PS50898"
FT   DOMAIN          98..144
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50081"
FT   DOMAIN          310..570
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   REGION          160..207
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          240..290
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        160..188
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        240..271
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        272..290
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   606 AA;  67585 MW;  D23E5711304AA468 CRC64;
     MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK VRGLNQDCCV
     VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN FVRKTFFSLA FCDFCLKFLF
     HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN RQQFYHSVQD LSGGSRQHEA PSNRPLNELL
     TPQGPSPRTQ HCDPEHFPFP APANAPLQRI RSTSTPNVHM VSTTAPMDSN LIQLTGQSFS
     TDAAGSRGGS DGTPRGSPSP ASVSSGRKSP HSKSPAEQRE RKSLADDKKK VKNLGYRDSG
     YYWEVPPSEV QLLKRIGTGS FGTVFRGRWH GDVAVKVLKV SQPTAEQAQA FKNEMQVLRK
     TRHVNILLFM GFMTRPGFAI ITQWCEGSSL YHHLHVADTR FDMVQLIDVA RQTAQGMDYL
     HAKNIIHRDL KSNNIFLHEG LTVKIGDFGL ATVKTRWSGA QPLEQPSGSV LWMAAEVIRM
     QDPNPYSFQS DVYAYGVVLY ELMTGSLPYS HIGCRDQIIF MVGRGYLSPD LSKISSNCPK
     AMRRLLSDCL KFQREERPLF PQILATIELL QRSLPKIERS ASEPSLHRTQ ADELPACLLS
     AARLVP
//
ID   ARAF_HUMAN              Reviewed;         606 AA.
AC   P10398; P07557; Q5H9B2; Q5H9B3;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   22-APR-2020, entry version 223.
DE   RecName: Full=Serine/threonine-protein kinase A-Raf;
DE            EC=2.7.11.1;
DE   AltName: Full=Proto-oncogene A-Raf;
DE   AltName: Full=Proto-oncogene A-Raf-1;
DE   AltName: Full=Proto-oncogene Pks;
GN   Name=ARAF; Synonyms=ARAF1, PKS, PKS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3029685; DOI=10.1093/nar/15.2.595;
RA   Beck T.W., Huleihel M., Gunnell M., Bonner T.I., Rapp U.R.;
RT   "The complete coding sequence of the human A-raf-1 oncogene and
RT   transforming activity of a human A-raf carrying retrovirus.";
RL   Nucleic Acids Res. 15:595-609(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8020955; DOI=10.1006/geno.1994.1125;
RA   Lee J.-E., Beck T.W., Brennscheidt U., DeGennaro L.J., Rapp U.R.;
RT   "The complete sequence and promoter activity of the human A-raf-1 gene
RT   (ARAF1).";
RL   Genomics 20:43-55(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION (ISOFORM 2), AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=17535970; DOI=10.1083/jcb.200703195;
RA   Yokoyama T., Takano K., Yoshida A., Katada F., Sun P., Takenawa T.,
RA   Andoh T., Endo T.;
RT   "DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK
RT   pathway, is required for myogenic differentiation.";
RL   J. Cell Biol. 177:781-793(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 292-589 (ISOFORM 1).
RX   PubMed=3529082; DOI=10.1073/pnas.83.17.6312;
RA   Mark G.E., Seeley T.W., Shows T.B., Mountz J.D.;
RT   "Pks, a raf-related sequence in humans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6312-6316(1986).
RN   [9]
RP   INTERACTION WITH NELFD.
RX   PubMed=11952167; DOI=10.1023/a:1014437024129;
RA   Yin X.L., Chen S., Gu J.X.;
RT   "Identification of TH1 as an interaction partner of A-Raf kinase.";
RL   Mol. Cell. Biochem. 231:69-74(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-318, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION IN TOR SIGNALING.
RX   PubMed=22609986; DOI=10.1038/ncb2507;
RA   Gan X., Wang J., Wang C., Sommer E., Kozasa T., Srinivasula S., Alessi D.,
RA   Offermanns S., Simon M.I., Wu D.;
RT   "PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and
RT   cell migration downstream of Galpha12.";
RL   Nat. Cell Biol. 14:686-696(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-162; THR-253;
RP   SER-257 AND SER-269, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181; SER-186 AND SER-257, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   STRUCTURE BY NMR OF 19-91.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal RAS-binding domain (RBD) in human A-
RT   RAF kinase.";
RL   Submitted (JUL-2005) to the PDB data bank.
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-98; CYS-331 AND ASP-578.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the transduction of mitogenic signals from the
CC       cell membrane to the nucleus. May also regulate the TOR signaling
CC       cascade. {ECO:0000269|PubMed:22609986}.
CC   -!- FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic
CC       differentiation by inducing cell cycle arrest, the expression of
CC       myogenin and other muscle-specific proteins, and myotube formation.
CC       {ECO:0000269|PubMed:22609986}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with TH1L/NELFD. {ECO:0000269|PubMed:11952167}.
CC   -!- INTERACTION:
CC       P10398; P00966: ASS1; NbExp=4; IntAct=EBI-365961, EBI-536842;
CC       P10398; P15056: BRAF; NbExp=6; IntAct=EBI-365961, EBI-365980;
CC       P10398; Q9UNS2: COPS3; NbExp=3; IntAct=EBI-365961, EBI-350590;
CC       P10398; P31327: CPS1; NbExp=3; IntAct=EBI-365961, EBI-536811;
CC       P10398; Q12805: EFEMP1; NbExp=3; IntAct=EBI-365961, EBI-536772;
CC       P10398; P01112: HRAS; NbExp=3; IntAct=EBI-365961, EBI-350145;
CC       P10398; P08238: HSP90AB1; NbExp=8; IntAct=EBI-365961, EBI-352572;
CC       P10398; O43187: IRAK2; NbExp=2; IntAct=EBI-365961, EBI-447733;
CC       P10398; Q92985: IRF7; NbExp=2; IntAct=EBI-365961, EBI-968267;
CC       P10398; P36507: MAP2K2; NbExp=7; IntAct=EBI-365961, EBI-1056930;
CC       P10398; Q8IXH7: NELFCD; NbExp=5; IntAct=EBI-365961, EBI-536725;
CC       P10398; O95848: NUDT14; NbExp=3; IntAct=EBI-365961, EBI-536866;
CC       P10398; Q96KB5: PBK; NbExp=3; IntAct=EBI-365961, EBI-536853;
CC       P10398; P14618: PKM; NbExp=2; IntAct=EBI-365961, EBI-353408;
CC       P10398; O94906: PRPF6; NbExp=4; IntAct=EBI-365961, EBI-536755;
CC       P10398; P53611: RABGGTB; NbExp=3; IntAct=EBI-365961, EBI-536715;
CC       P10398; P62070: RRAS2; NbExp=3; IntAct=EBI-365961, EBI-491037;
CC       P10398; P31947: SFN; NbExp=3; IntAct=EBI-365961, EBI-476295;
CC       P10398; O43615: TIMM44; NbExp=3; IntAct=EBI-365961, EBI-861737;
CC       P10398; Q3ZCQ8: TIMM50; NbExp=4; IntAct=EBI-365961, EBI-355175;
CC       P10398; P58753: TIRAP; NbExp=2; IntAct=EBI-365961, EBI-528644;
CC       P10398; P62258: YWHAE; NbExp=3; IntAct=EBI-365961, EBI-356498;
CC       P10398; P63104: YWHAZ; NbExp=6; IntAct=EBI-365961, EBI-347088;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10398-1; Sequence=Displayed;
CC       Name=2; Synonyms=DA-Raf1;
CC         IsoId=P10398-2; Sequence=VSP_045609, VSP_045610;
CC   -!- TISSUE SPECIFICITY: Predominantly in urogenital tissues.
CC   -!- MISCELLANEOUS: [Isoform 2]: Has a wider tissue distribution than
CC       isoform 1, and acts as dominant-negative antagonist. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. RAF subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X04790; CAA28476.1; -; mRNA.
DR   EMBL; L24038; AAA65219.1; -; Genomic_DNA.
DR   EMBL; U01337; AAB03517.1; -; Genomic_DNA.
DR   EMBL; AB158254; BAE66645.1; -; mRNA.
DR   EMBL; BT019864; AAV38667.1; -; mRNA.
DR   EMBL; AL542736; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z84466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002466; AAH02466.1; -; mRNA.
DR   EMBL; M13829; AAB08754.1; -; mRNA.
DR   CCDS; CCDS35232.1; -. [P10398-1]
DR   CCDS; CCDS59164.1; -. [P10398-2]
DR   PIR; A53026; TVHUAF.
DR   RefSeq; NP_001243125.1; NM_001256196.1.
DR   RefSeq; NP_001243126.1; NM_001256197.1. [P10398-2]
DR   RefSeq; NP_001645.1; NM_001654.4. [P10398-1]
DR   RefSeq; XP_011542210.1; XM_011543908.2.
DR   PDB; 1WXM; NMR; -; A=19-91.
DR   PDB; 2MSE; NMR; -; D=19-91.
DR   PDBsum; 1WXM; -.
DR   PDBsum; 2MSE; -.
DR   SMR; P10398; -.
DR   BioGrid; 106864; 125.
DR   CORUM; P10398; -.
DR   DIP; DIP-31374N; -.
DR   IntAct; P10398; 114.
DR   MINT; P10398; -.
DR   STRING; 9606.ENSP00000290277; -.
DR   BindingDB; P10398; -.
DR   ChEMBL; CHEMBL1169596; -.
DR   DrugBank; DB00171; ATP.
DR   DrugCentral; P10398; -.
DR   GuidetoPHARMACOLOGY; 1933; -.
DR   iPTMnet; P10398; -.
DR   PhosphoSitePlus; P10398; -.
DR   BioMuta; ARAF; -.
DR   DMDM; 1730068; -.
DR   CPTAC; CPTAC-1339; -.
DR   CPTAC; CPTAC-1343; -.
DR   CPTAC; CPTAC-1344; -.
DR   CPTAC; CPTAC-1345; -.
DR   EPD; P10398; -.
DR   jPOST; P10398; -.
DR   MassIVE; P10398; -.
DR   MaxQB; P10398; -.
DR   PaxDb; P10398; -.
DR   PeptideAtlas; P10398; -.
DR   PRIDE; P10398; -.
DR   ProteomicsDB; 52601; -. [P10398-1]
DR   ProteomicsDB; 62876; -.
DR   TopDownProteomics; P10398-1; -. [P10398-1]
DR   Antibodypedia; 11388; 661 antibodies.
DR   DNASU; 369; -.
DR   Ensembl; ENST00000377039; ENSP00000366238; ENSG00000078061. [P10398-2]
DR   Ensembl; ENST00000377045; ENSP00000366244; ENSG00000078061. [P10398-1]
DR   GeneID; 369; -.
DR   KEGG; hsa:369; -.
DR   UCSC; uc031tjj.2; human. [P10398-1]
DR   CTD; 369; -.
DR   DisGeNET; 369; -.
DR   GeneCards; ARAF; -.
DR   HGNC; HGNC:646; ARAF.
DR   HPA; ENSG00000078061; Low tissue specificity.
DR   MalaCards; ARAF; -.
DR   MIM; 311010; gene.
DR   neXtProt; NX_P10398; -.
DR   OpenTargets; ENSG00000078061; -.
DR   PharmGKB; PA24928; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   GeneTree; ENSGT00940000159633; -.
DR   HOGENOM; CLU_023684_1_1_1; -.
DR   InParanoid; P10398; -.
DR   KO; K08845; -.
DR   OrthoDB; 243095at2759; -.
DR   PhylomeDB; P10398; -.
DR   TreeFam; TF317006; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   Reactome; R-HSA-9649948; Signaling downstream of RAS mutants.
DR   SignaLink; P10398; -.
DR   SIGNOR; P10398; -.
DR   ChiTaRS; ARAF; human.
DR   EvolutionaryTrace; P10398; -.
DR   GeneWiki; ARAF; -.
DR   GenomeRNAi; 369; -.
DR   Pharos; P10398; Tchem.
DR   PRO; PR:P10398; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P10398; protein.
DR   Bgee; ENSG00000078061; Expressed in muscle of leg and 213 other tissues.
DR   ExpressionAtlas; P10398; baseline and differential.
DR   Genevisible; P10398; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..606
FT                   /note="Serine/threonine-protein kinase A-Raf"
FT                   /id="PRO_0000085622"
FT   DOMAIN          19..91
FT                   /note="RBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00262"
FT   DOMAIN          310..570
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ZN_FING         98..144
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   NP_BIND         316..324
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        429
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   METAL           99
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           112
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           115
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           125
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           128
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           133
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           136
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           144
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   BINDING         336
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         181
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         253
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         318
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   VAR_SEQ         186
FT                   /note="S -> R (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17535970, ECO:0000303|Ref.5"
FT                   /id="VSP_045609"
FT   VAR_SEQ         187..606
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17535970, ECO:0000303|Ref.5"
FT                   /id="VSP_045610"
FT   VARIANT         98
FT                   /note="M -> T (in dbSNP:rs56197559)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040375"
FT   VARIANT         331
FT                   /note="G -> C (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040376"
FT   VARIANT         578
FT                   /note="E -> D (in dbSNP:rs55852926)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040377"
FT   CONFLICT        368
FT                   /note="L -> P (in Ref. 8; AAB08754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        378
FT                   /note="F -> V (in Ref. 8; AAB08754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        469
FT                   /note="S -> P (in Ref. 8; AAB08754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        478
FT                   /note="I -> T (in Ref. 8; AAB08754)"
FT                   /evidence="ECO:0000305"
FT   STRAND          19..24
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   STRAND          26..28
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   STRAND          30..34
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   HELIX           42..50
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   TURN            51..53
FT                   /evidence="ECO:0000244|PDB:2MSE"
FT   STRAND          56..67
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   STRAND          69..72
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   STRAND          74..78
FT                   /evidence="ECO:0000244|PDB:1WXM"
FT   HELIX           79..81
FT                   /evidence="ECO:0000244|PDB:2MSE"
FT   STRAND          82..84
FT                   /evidence="ECO:0000244|PDB:2MSE"
FT   STRAND          85..90
FT                   /evidence="ECO:0000244|PDB:1WXM"
SQ   SEQUENCE   606 AA;  67585 MW;  D23E5711304AA468 CRC64;
     MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK VRGLNQDCCV
     VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN FVRKTFFSLA FCDFCLKFLF
     HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN RQQFYHSVQD LSGGSRQHEA PSNRPLNELL
     TPQGPSPRTQ HCDPEHFPFP APANAPLQRI RSTSTPNVHM VSTTAPMDSN LIQLTGQSFS
     TDAAGSRGGS DGTPRGSPSP ASVSSGRKSP HSKSPAEQRE RKSLADDKKK VKNLGYRDSG
     YYWEVPPSEV QLLKRIGTGS FGTVFRGRWH GDVAVKVLKV SQPTAEQAQA FKNEMQVLRK
     TRHVNILLFM GFMTRPGFAI ITQWCEGSSL YHHLHVADTR FDMVQLIDVA RQTAQGMDYL
     HAKNIIHRDL KSNNIFLHEG LTVKIGDFGL ATVKTRWSGA QPLEQPSGSV LWMAAEVIRM
     QDPNPYSFQS DVYAYGVVLY ELMTGSLPYS HIGCRDQIIF MVGRGYLSPD LSKISSNCPK
     AMRRLLSDCL KFQREERPLF PQILATIELL QRSLPKIERS ASEPSLHRTQ ADELPACLLS
     AARLVP
//
ID   Q96II5_HUMAN            Unreviewed;       609 AA.
AC   Q96II5; A6NIT1;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   22-APR-2020, entry version 169.
DE   SubName: Full=ARAF protein {ECO:0000313|EMBL:AAH07514.1};
DE   SubName: Full=Serine/threonine-protein kinase A-Raf {ECO:0000313|Ensembl:ENSP00000290277};
GN   Name=ARAF {ECO:0000313|EMBL:AAH07514.1,
GN   ECO:0000313|Ensembl:ENSP00000290277};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07514.1};
RN   [1] {ECO:0000313|EMBL:AAH07514.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph {ECO:0000313|EMBL:AAH07514.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000290277, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [4] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [5] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [6] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12] {ECO:0000313|Ensembl:ENSP00000290277}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [13] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KF459100; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007514; AAH07514.1; -; mRNA.
DR   RefSeq; NP_001243125.1; NM_001256196.1.
DR   IntAct; Q96II5; 11.
DR   Antibodypedia; 11388; 661 antibodies.
DR   Ensembl; ENST00000290277; ENSP00000290277; ENSG00000078061.
DR   GeneID; 369; -.
DR   UCSC; uc033ecb.2; human.
DR   CTD; 369; -.
DR   EuPathDB; HostDB:ENSG00000078061.12; -.
DR   HGNC; HGNC:646; ARAF.
DR   OpenTargets; ENSG00000078061; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   GeneTree; ENSGT00940000159633; -.
DR   OMA; DTVSKRC; -.
DR   OrthoDB; 243095at2759; -.
DR   ChiTaRS; ARAF; human.
DR   GenomeRNAi; 369; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000078061; Expressed in muscle of leg and 213 other tissues.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0020021; P:immortalization of host cell; IEA:Ensembl.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS01233598};
KW   Kinase {ECO:0000256|SAAS:SAAS01233601};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00253054};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS01233598};
KW   Proteomics identification {ECO:0000213|EPD:Q96II5,
KW   ECO:0000213|MaxQB:Q96II5, ECO:0000213|PeptideAtlas:Q96II5,
KW   ECO:0000213|ProteomicsDB:Q96II5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Serine/threonine-protein kinase {ECO:0000256|SAAS:SAAS01233601};
KW   Transferase {ECO:0000256|SAAS:SAAS01233601};
KW   Zinc {ECO:0000256|SAAS:SAAS00253075}.
FT   DOMAIN          19..91
FT                   /note="RBD"
FT                   /evidence="ECO:0000259|PROSITE:PS50898"
FT   DOMAIN          98..144
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50081"
FT   DOMAIN          313..573
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   REGION          162..210
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          243..293
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        162..191
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        243..274
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..293
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   609 AA;  67926 MW;  38B52E7C303E06CF CRC64;
     MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK VRGLNQDCCV
     VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN FVRKTFFSLA FCDFCLKFLF
     HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN RQQPSRFYHS VQDLSGGSRQ HEAPSNRPLN
     ELLTPQGPSP RTQHCDPEHF PFPAPANAPL QRIRSTSTPN VHMVSTTAPM DSNLIQLTGQ
     SFSTDAAGSR GGSDGTPRGS PSPASVSSGR KSPHSKSPAE QRERKSLADD KKKVKNLGYR
     DSGYYWEVPP SEVQLLKRIG TGSFGTVFRG RWHGDVAVKV LKVSQPTAEQ AQAFKNEMQV
     LRKTRHVNIL LFMGFMTRPG FAIITQWCEG SSLYHHLHVA DTRFDMVQLI DVARQTAQGM
     DYLHAKNIIH RDLKSNNIFL HEGLTVKIGD FGLATVKTRW SGAQPLEQPS GSVLWMAAEV
     IRMQDPNPYS FQSDVYAYGV VLYELMTGSL PYSHIGCRDQ IIFMVGRGYL SPDLSKISSN
     CPKAMRRLLS DCLKFQREER PLFPQILATI ELLQRSLPKI ERSASEPSLH RTQADELPAC
     LLSAARLVP
//
ID   RHG05_HUMAN             Reviewed;        1502 AA.
AC   Q13017; A1L375; A1L376; A8KAA1; D3DS89; D3DS90; Q05BE8; Q05BU8; Q59ER0;
AC   Q6DHZ3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 2.
DT   22-APR-2020, entry version 178.
DE   RecName: Full=Rho GTPase-activating protein 5;
DE   AltName: Full=Rho-type GTPase-activating protein 5;
DE   AltName: Full=p190-B {ECO:0000303|PubMed:28894085, ECO:0000303|PubMed:8537347};
GN   Name=ARHGAP5; Synonyms=RHOGAP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Mesangial cell;
RX   PubMed=8537347; DOI=10.1074/jbc.270.52.30919;
RA   Burbelo P.D., Miyamoto S., Utani A., Brill S., Yamada K.M., Hall A.,
RA   Yamada Y.;
RT   "p190-B, a new member of the Rho GAP family, and Rho are induced to cluster
RT   after integrin cross-linking.";
RL   J. Biol. Chem. 270:30919-30926(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1239 (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 364-1499 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NITRATION [LARGE SCALE ANALYSIS] AT TYR-550, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary adenoma;
RX   PubMed=16777052; DOI=10.1016/j.ab.2006.05.024;
RA   Zhan X., Desiderio D.M.;
RT   "Nitroproteins from a human pituitary adenoma tissue discovered with a
RT   nitrotyrosine affinity column and tandem mass spectrometry.";
RL   Anal. Biochem. 354:279-289(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-765 AND SER-1202, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-968; SER-1115; SER-1176;
RP   SER-1195; SER-1202 AND SER-1218, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1195 AND SER-1202, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-765; SER-951 AND SER-1202,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1173 AND SER-1176, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590; SER-765; SER-968;
RP   SER-1173; SER-1176; SER-1195; SER-1202 AND SER-1218, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1173 AND SER-1195, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 1245-1456.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminus extended RhoGAP domain from human Rho
RT   GTPase activating protein 5 variant.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [17] {ECO:0000244|PDB:5U4V}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 590-763, AND DOMAIN.
RX   PubMed=28894085; DOI=10.1038/s41467-017-00483-x;
RA   Stiegler A.L., Boggon T.J.;
RT   "p190RhoGAP proteins contain pseudoGTPase domains.";
RL   Nat. Commun. 8:506-506(2017).
CC   -!- FUNCTION: GTPase-activating protein for Rho family members
CC       (PubMed:8537347). {ECO:0000269|PubMed:8537347}.
CC   -!- SUBUNIT: May interact with RASA1/p120GAP. {ECO:0000305|PubMed:8537347}.
CC   -!- INTERACTION:
CC       Q13017-1; Q8IZD9: DOCK3; NbExp=2; IntAct=EBI-25409992, EBI-1752361;
CC       Q13017; P61588: Rnd3; Xeno; NbExp=2; IntAct=EBI-7237884, EBI-6930266;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8537347}. Cell
CC       membrane {ECO:0000269|PubMed:8537347}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:8537347}. Note=Also membrane-associated in a
CC       fibrillar pattern that colocalizes with the alpha5-beta1 integrin
CC       receptor (ITGA5/ITGB1) for fibronectin. {ECO:0000269|PubMed:8537347}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q13017-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13017-2; Sequence=VSP_034166;
CC       Name=3;
CC         IsoId=Q13017-3; Sequence=VSP_034164, VSP_034167;
CC       Name=4;
CC         IsoId=Q13017-4; Sequence=VSP_034165;
CC   -!- TISSUE SPECIFICITY: Detected in skin fibroblasts (at protein level)
CC       (PubMed:8537347). {ECO:0000269|PubMed:8537347}.
CC   -!- DOMAIN: The pG1 pseudoGTPase domain does not bind GTP.
CC       {ECO:0000269|PubMed:28894085}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA95963.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH32723.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U17032; AAA95963.1; ALT_FRAME; mRNA.
DR   EMBL; CH471078; EAW65935.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65936.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65937.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65938.1; -; Genomic_DNA.
DR   EMBL; BC032723; AAH32723.1; ALT_SEQ; mRNA.
DR   EMBL; BC050059; AAH50059.1; -; mRNA.
DR   EMBL; BC075799; AAH75799.1; -; mRNA.
DR   EMBL; BC129928; AAI29929.1; -; mRNA.
DR   EMBL; BC129929; AAI29930.1; -; mRNA.
DR   EMBL; AK292966; BAF85655.1; -; mRNA.
DR   EMBL; AB209751; BAD92988.1; -; mRNA.
DR   CCDS; CCDS32062.1; -. [Q13017-1]
DR   CCDS; CCDS45095.1; -. [Q13017-2]
DR   PIR; B59431; B59431.
DR   RefSeq; NP_001025226.1; NM_001030055.1. [Q13017-1]
DR   RefSeq; NP_001164.2; NM_001173.2. [Q13017-2]
DR   RefSeq; XP_005267692.1; XM_005267635.3. [Q13017-1]
DR   RefSeq; XP_005267693.1; XM_005267636.3. [Q13017-1]
DR   RefSeq; XP_016876776.1; XM_017021287.1.
DR   RefSeq; XP_016876777.1; XM_017021288.1. [Q13017-2]
DR   PDB; 2EE4; NMR; -; A=1255-1456.
DR   PDB; 2EE5; NMR; -; A=1245-1456.
DR   PDB; 5U4V; X-ray; 2.60 A; A=590-763.
DR   PDBsum; 2EE4; -.
DR   PDBsum; 2EE5; -.
DR   PDBsum; 5U4V; -.
DR   SMR; Q13017; -.
DR   BioGrid; 106887; 17.
DR   IntAct; Q13017; 8.
DR   MINT; Q13017; -.
DR   STRING; 9606.ENSP00000371897; -.
DR   iPTMnet; Q13017; -.
DR   PhosphoSitePlus; Q13017; -.
DR   BioMuta; ARHGAP5; -.
DR   DMDM; 190358871; -.
DR   EPD; Q13017; -.
DR   jPOST; Q13017; -.
DR   MassIVE; Q13017; -.
DR   MaxQB; Q13017; -.
DR   PaxDb; Q13017; -.
DR   PeptideAtlas; Q13017; -.
DR   PRIDE; Q13017; -.
DR   ProteomicsDB; 59102; -. [Q13017-1]
DR   ProteomicsDB; 59103; -. [Q13017-2]
DR   ProteomicsDB; 59104; -. [Q13017-3]
DR   ProteomicsDB; 59105; -. [Q13017-4]
DR   Antibodypedia; 23106; 134 antibodies.
DR   Ensembl; ENST00000345122; ENSP00000371897; ENSG00000100852. [Q13017-1]
DR   Ensembl; ENST00000396582; ENSP00000379827; ENSG00000100852. [Q13017-3]
DR   Ensembl; ENST00000433497; ENSP00000407395; ENSG00000100852. [Q13017-4]
DR   Ensembl; ENST00000539826; ENSP00000441692; ENSG00000100852. [Q13017-1]
DR   Ensembl; ENST00000556611; ENSP00000452222; ENSG00000100852. [Q13017-2]
DR   GeneID; 394; -.
DR   KEGG; hsa:394; -.
DR   UCSC; uc001wrl.4; human. [Q13017-1]
DR   CTD; 394; -.
DR   DisGeNET; 394; -.
DR   GeneCards; ARHGAP5; -.
DR   HGNC; HGNC:675; ARHGAP5.
DR   HPA; ENSG00000100852; Low tissue specificity.
DR   MIM; 602680; gene.
DR   neXtProt; NX_Q13017; -.
DR   OpenTargets; ENSG00000100852; -.
DR   PharmGKB; PA24959; -.
DR   eggNOG; KOG4271; Eukaryota.
DR   eggNOG; ENOG410XR4E; LUCA.
DR   GeneTree; ENSGT00940000154553; -.
DR   HOGENOM; CLU_004268_0_0_1; -.
DR   InParanoid; Q13017; -.
DR   KO; K13709; -.
DR   OMA; HIDKVND; -.
DR   OrthoDB; 110157at2759; -.
DR   PhylomeDB; Q13017; -.
DR   TreeFam; TF324451; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   SignaLink; Q13017; -.
DR   SIGNOR; Q13017; -.
DR   ChiTaRS; ARHGAP5; human.
DR   EvolutionaryTrace; Q13017; -.
DR   GeneWiki; ARHGAP5; -.
DR   GenomeRNAi; 394; -.
DR   Pharos; Q13017; Tbio.
DR   PRO; PR:Q13017; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q13017; protein.
DR   Bgee; ENSG00000100852; Expressed in corpus callosum and 228 other tissues.
DR   ExpressionAtlas; Q13017; baseline and differential.
DR   Genevisible; Q13017; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:ProtInc.
DR   GO; GO:0003924; F:GTPase activity; TAS:ProtInc.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007266; P:Rho protein signal transduction; TAS:ProtInc.
DR   Gene3D; 1.10.10.440; -; 3.
DR   Gene3D; 1.10.555.10; -; 1.
DR   InterPro; IPR002713; FF_domain.
DR   InterPro; IPR036517; FF_domain_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039007; pG1.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR032835; RhoGAP-FF1.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR039006; RhoGAP_pG2.
DR   InterPro; IPR001806; Small_GTPase.
DR   Pfam; PF01846; FF; 1.
DR   Pfam; PF00071; Ras; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF16512; RhoGAP-FF1; 1.
DR   SMART; SM00441; FF; 4.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF81698; SSF81698; 1.
DR   PROSITE; PS51676; FF; 4.
DR   PROSITE; PS51852; PG1; 1.
DR   PROSITE; PS51853; PG2; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cytoplasm;
KW   GTPase activation; Membrane; Nitration; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat.
FT   CHAIN           1..1502
FT                   /note="Rho GTPase-activating protein 5"
FT                   /id="PRO_0000056702"
FT   DOMAIN          267..325
FT                   /note="FF 1"
FT   DOMAIN          366..420
FT                   /note="FF 2"
FT   DOMAIN          427..481
FT                   /note="FF 3"
FT   DOMAIN          482..548
FT                   /note="FF 4"
FT   DOMAIN          590..763
FT                   /note="pG1 pseudoGTPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01199"
FT   DOMAIN          779..944
FT                   /note="pG2 pseudoGTPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01200"
FT   DOMAIN          1262..1449
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   COMPBIAS        1225..1245
FT                   /note="Lys-rich"
FT   MOD_RES         550
FT                   /note="Nitrated tyrosine"
FT                   /evidence="ECO:0000244|PubMed:16777052"
FT   MOD_RES         590
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         765
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         951
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         968
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1173
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1218
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..1265
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034164"
FT   VAR_SEQ         1..1261
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034165"
FT   VAR_SEQ         1240
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_034166"
FT   VAR_SEQ         1266..1288
FT                   /note="DLVTAEKPIPLFVEKCVEFIEDT -> MSLPPPPPGPLPLRRRRRRPTLL
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034167"
FT   VARIANT         17
FT                   /note="I -> V (in dbSNP:rs17386818)"
FT                   /id="VAR_043980"
FT   CONFLICT        80
FT                   /note="Q -> R (in Ref. 3; AAH50059)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        409
FT                   /note="E -> G (in Ref. 4; BAF85655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541
FT                   /note="L -> F (in Ref. 5; BAD92988)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        620
FT                   /note="D -> G (in Ref. 4; BAF85655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1383
FT                   /note="D -> G (in Ref. 3; AAH50059)"
FT                   /evidence="ECO:0000305"
FT   STRAND          595..601
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   HELIX           606..615
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   STRAND          622..625
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   STRAND          628..637
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   STRAND          656..664
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   HELIX           665..683
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   STRAND          696..701
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   HELIX           711..725
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   STRAND          729..732
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   HELIX           743..760
FT                   /evidence="ECO:0000244|PDB:5U4V"
FT   STRAND          1258..1262
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1264..1267
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1276..1287
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   TURN            1293..1297
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1302..1314
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1320..1323
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1327..1340
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   STRAND          1341..1343
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   TURN            1348..1350
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1351..1358
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1363..1373
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   TURN            1374..1376
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1381..1397
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1399..1402
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1406..1417
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   STRAND          1425..1427
FT                   /evidence="ECO:0000244|PDB:2EE5"
FT   HELIX           1434..1443
FT                   /evidence="ECO:0000244|PDB:2EE4"
FT   HELIX           1445..1448
FT                   /evidence="ECO:0000244|PDB:2EE4"
SQ   SEQUENCE   1502 AA;  172460 MW;  2E01B5B1D007984D CRC64;
     MMAKNKEPRP PSYTISIVGL SGTEKDKGNC GVGKSCLCNR FVRSKADEYY PEHTSVLSTI
     DFGGRVVNND HFLYWGDIIQ NSEDGVECKI HVIEQTEFID DQTFLPHRST NLQPYIKRAA
     ASKLQSAEKL MYICTDQLGL EQDFEQKQMP EGKLNVDGFL LCIDVSQGCN RKFDDQLKFV
     NNLFVQLSKS KKPVIIAATK CDECVDHYLR EVQAFASNKK NLLVVETSAR FNVNIETCFT
     ALVQMLDKTR SKPKIIPYLD AYKTQRQLVV TATDKFEKLV QTVRDYHATW KTVSNKLKNH
     PDYEEYINLE GTRKARNTFS KHIEQLKQEH IRKRREEYIN TLPRAFNTLL PNLEEIEHLN
     WSEALKLMEK RADFQLCFVV LEKTPWDETD HIDKINDRRI PFDLLSTLEA EKVYQNHVQH
     LISEKRRVEM KEKFKKTLEK IQFISPGQPW EEVMCFVMED EAYKYITEAD SKEVYGRHQR
     EIVEKAKEEF QEMLFEHSEL FYDLDLNATP SSDKMSEIHT VLSEEPRYKA LQKLAPDRES
     LLLKHIGFVY HPTKETCLSG QNCTDIKVEQ LLASSLLQLD HGRLRLYHDS TNIDKVNLFI
     LGKDGLAQEL ANEIRTQSTD DEYALDGKIY ELDLRPVDAK SPYFLSQLWT AAFKPHGCFC
     VFNSIESLSF IGEFIGKIRT EASQIRKDKY MANLPFTLIL ANQRDSISKN LPILRHQGQQ
     LANKLQCPFV DVPAGTYPRK FNETQIKQAL RGVLESVKHN LDVVSPIPAN KDLSEADLRI
     VMCAMCGDPF SVDLILSPFL DSHSCSAAQA GQNNSLMLDK IIGEKRRRIQ ITILSYHSSI
     GVRKDELVHG YILVYSAKRK ASMGMLRAFL SEVQDTIPVQ LVAVTDSQAD FFENEAIKEL
     MTEGEHIATE ITAKFTALYS LSQYHRQTEV FTLFFSDVLE KKNMIENSYL SDNTRESTHQ
     SEDVFLPSPR DCFPYNNYPD SDDDTEAPPP YSPIGDDVQL LPTPSDRSRY RLDLEGNEYP
     IHSTPNCHDH ERNHKVPPPI KPKPVVPKTN VKKLDPNLLK TIEAGIGKNP RKQTSRVPLA
     HPEDMDPSDN YAEPIDTIFK QKGYSDEIYV VPDDSQNRIK IRNSFVNNTQ GDEENGFSDR
     TSKSHGERRP SKYKYKSKTL FSKAKSYYRR THSDASDDEA FTTSKTKRKG RHRGSEEDPL
     LSPVETWKGG IDNPAITSDQ ELDDKKMKKK THKVKEDKKQ KKKTKNFNPP TRRNWESNYF
     GMPLQDLVTA EKPIPLFVEK CVEFIEDTGL CTEGLYRVSG NKTDQDNIQK QFDQDHNINL
     VSMEVTVNAV AGALKAFFAD LPDPLIPYSL HPELLEAAKI PDKTERLHAL KEIVKKFHPV
     NYDVFRYVIT HLNRVSQQHK INLMTADNLS ICFWPTLMRP DFENREFLST TKIHQSVVET
     FIQQCQFFFY NGEIVETTNI VAPPPPSNPG QLVEPMVPLQ LPPPLQPQLI QPQLQTDPLG
     II
//
ID   A0A0X9JFN5_HUMAN        Unreviewed;       242 AA.
AC   A0A0X9JFN5;
DT   13-APR-2016, integrated into UniProtKB/TrEMBL.
DT   13-APR-2016, sequence version 1.
DT   22-APR-2020, entry version 15.
DE   SubName: Full=BCL-2-like protein 12 isoform 16 {ECO:0000313|EMBL:ALU57790.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ALU57790.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALU57790.1};
RN   [1] {ECO:0000313|EMBL:ALU57790.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26797417;
RA   Adamopoulos P.G., Kontos C.K., Tsiakanikas P., Scorilas A.;
RT   "Identification of novel alternative splice variants of the BCL2L12 gene in
RT   human cancer cells using next-generation sequencing methodology.";
RL   Cancer Lett. 0:0-0(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KR820282; ALU57790.1; -; mRNA.
DR   RefSeq; XP_016882834.1; XM_017027345.1.
DR   PeptideAtlas; A0A0X9JFN5; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   242 AA;  26968 MW;  F818AC905E09EF2C CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPS
     PAQEEPTDFL SRLRRCLPCS LGRGAAPSES PRPCSLPIRP CYGLEPGPAT PDFYALVAQR
     LEQLVQEQLK SPPSPELQGP PSTEKEAILR RLVALLEEEA EVINQKEGIL AVSPVDLNLP
     LD
//
ID   I6LJZ5_HUMAN            Unreviewed;       243 AA.
AC   I6LJZ5;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 36.
DE   SubName: Full=BCL2L12 protein isoform 4 {ECO:0000313|EMBL:ACZ28444.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28444.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28444.1};
RN   [1] {ECO:0000313|EMBL:ACZ28444.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12, a
RT   new member of the BCL2 gene family, and their expression analysis in cancer
RT   cells.";
RL   Gene 505:153-166(2012).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ868798; ACZ28444.1; -; mRNA.
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   SMR; I6LJZ5; -.
DR   PeptideAtlas; I6LJZ5; -.
DR   PRIDE; I6LJZ5; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
FT   REGION          109..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   243 AA;  27124 MW;  3FA60713C2F14D29 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKEGI LAVSPVDLNL
     PLD
//
ID   I6LJZ6_HUMAN            Unreviewed;       176 AA.
AC   I6LJZ6;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 55.
DE   SubName: Full=BCL2-like 12 (Proline rich), isoform CRA_c {ECO:0000313|EMBL:EAW52516.1};
DE   SubName: Full=BCL2L12 protein isoform 2 {ECO:0000313|EMBL:ACZ28445.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28445.1};
GN   ORFNames=hCG_21122 {ECO:0000313|EMBL:EAW52516.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28445.1};
RN   [1] {ECO:0000313|EMBL:EAW52516.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW52516.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACZ28445.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12, a
RT   new member of the BCL2 gene family, and their expression analysis in cancer
RT   cells.";
RL   Gene 505:153-166(2012).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ868799; ACZ28445.1; -; mRNA.
DR   EMBL; CH471177; EAW52516.1; -; Genomic_DNA.
DR   RefSeq; NP_001269446.1; NM_001282517.1.
DR   RefSeq; XP_016882835.1; XM_017027346.1.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
FT   REGION          136..176
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   176 AA;  19133 MW;  DC503A642100CAE4 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     PSYSRLLCFG GPAAGTAGPR AAEISAQPRI TGSPIDREGS HTAEAGGPAG GGGRSH
//
ID   I6LJZ7_HUMAN            Unreviewed;       269 AA.
AC   I6LJZ7;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=BCL2L12 protein isoform 5 {ECO:0000313|EMBL:ACZ28448.1};
DE   SubName: Full=Bcl-2-like protein 12 {ECO:0000313|Ensembl:ENSP00000483272};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28448.1,
GN   ECO:0000313|Ensembl:ENSP00000483272};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28448.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483272, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000313|EMBL:ACZ28448.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12, a
RT   new member of the BCL2 gene family, and their expression analysis in cancer
RT   cells.";
RL   Gene 505:153-166(2012).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24129315}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24129315;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000483272}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ868802; ACZ28448.1; -; mRNA.
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   Antibodypedia; 18662; 198 antibodies.
DR   Ensembl; ENST00000619007; ENSP00000483272; ENSG00000126453.
DR   GeneID; 83596; -.
DR   UCSC; uc031rlz.2; human.
DR   CTD; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   OpenTargets; ENSG00000126453; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00940000154318; -.
DR   HOGENOM; CLU_090353_0_0_1; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; Expressed in muscle of leg and 152 other tissues.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:I6LJZ7,
KW   ECO:0000213|MaxQB:I6LJZ7, ECO:0000213|PeptideAtlas:I6LJZ7,
KW   ECO:0000213|ProteomicsDB:I6LJZ7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REGION          109..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   269 AA;  29906 MW;  EA91BF1B1009E9DE CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKVMG ICPTPWQGQE
     LRNGGHPGCF TRGLELAIGL SSFSEAATR
//
ID   I6LJZ8_HUMAN            Unreviewed;       222 AA.
AC   I6LJZ8;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 33.
DE   SubName: Full=BCL2L12 protein isoform 6 {ECO:0000313|EMBL:ACZ28450.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28450.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28450.1};
RN   [1] {ECO:0000313|EMBL:ACZ28450.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12, a
RT   new member of the BCL2 gene family, and their expression analysis in cancer
RT   cells.";
RL   Gene 505:153-166(2012).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ911906; ACZ28450.1; -; mRNA.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   PeptideAtlas; I6LJZ8; -.
DR   PRIDE; I6LJZ8; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
FT   REGION          109..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   222 AA;  24608 MW;  35F5D3B92C575850 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPGGHP GCFTRGLELA IGLSSFSEAA TR
//
ID   I6LJZ9_HUMAN            Unreviewed;       193 AA.
AC   I6LJZ9;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 49.
DE   SubName: Full=BCL2L12 protein isoform 8 {ECO:0000313|EMBL:ACZ28451.1};
DE   SubName: Full=Bcl-2-like protein 12 {ECO:0000313|Ensembl:ENSP00000482154};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28451.1,
GN   ECO:0000313|Ensembl:ENSP00000482154};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28451.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000482154, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000313|EMBL:ACZ28451.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12, a
RT   new member of the BCL2 gene family, and their expression analysis in cancer
RT   cells.";
RL   Gene 505:153-166(2012).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:24129315}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24129315;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [6] {ECO:0000313|Ensembl:ENSP00000482154}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ911907; ACZ28451.1; -; mRNA.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   Antibodypedia; 18662; 198 antibodies.
DR   Ensembl; ENST00000614495; ENSP00000482154; ENSG00000126453.
DR   GeneID; 83596; -.
DR   UCSC; uc031rlv.2; human.
DR   CTD; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   OpenTargets; ENSG00000126453; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00940000154318; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; Expressed in muscle of leg and 152 other tissues.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:I6LJZ9,
KW   ECO:0000213|PeptideAtlas:I6LJZ9, ECO:0000213|ProteomicsDB:I6LJZ9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   193 AA;  21446 MW;  85570CAEDBF99664 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGGH PGCFTRGLEL
     AIGLSSFSEA ATR
//
ID   B2L12_HUMAN             Reviewed;         334 AA.
AC   Q9HB09; Q3SY11; Q3SY13; Q96I96; Q9HB08;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-APR-2020, entry version 146.
DE   RecName: Full=Bcl-2-like protein 12;
DE            Short=Bcl2-L-12;
DE   AltName: Full=Bcl-2-related proline-rich protein;
GN   Name=BCL2L12; Synonyms=BPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=11401436; DOI=10.1006/geno.2000.6455;
RA   Scorilas A., Kyriakopoulou L., Yousef G.M., Ashworth L.K., Kwamie A.,
RA   Diamandis E.P.;
RT   "Molecular cloning, physical mapping, and expression analysis of a novel
RT   gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2
RT   domain of the Bcl-2 family.";
RL   Genomics 72:217-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; THR-117; SER-121 AND
RP   SER-242, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242 AND SER-243, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195; SER-245 AND SER-273, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-144, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- INTERACTION:
CC       Q9HB09-2; P08107: HSPA1B; NbExp=2; IntAct=EBI-6969019, EBI-629985;
CC       Q9HB09-1; P0CG48: UBC; NbExp=3; IntAct=EBI-6968951, EBI-3390054;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HB09-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB09-2; Sequence=VSP_000522, VSP_000523;
CC       Name=3;
CC         IsoId=Q9HB09-3; Sequence=VSP_043269;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in breast, thymus, prostate, fetal
CC       liver, colon, placenta, pancreas, small intestine, spinal cord, kidney,
CC       and bone marrow and to a lesser extent in many other tissues. Isoform 2
CC       is primarily expressed in skeletal muscle.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCL2L12ID773ch19q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF289220; AAG29495.1; -; Genomic_DNA.
DR   EMBL; AF289220; AAG29496.1; -; Genomic_DNA.
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007724; AAH07724.2; -; mRNA.
DR   EMBL; BC104004; AAI04005.1; -; mRNA.
DR   EMBL; BC104005; AAI04006.1; -; mRNA.
DR   EMBL; BC104006; AAI04007.1; -; mRNA.
DR   CCDS; CCDS12776.1; -. [Q9HB09-1]
DR   CCDS; CCDS46144.1; -. [Q9HB09-3]
DR   RefSeq; NP_001035758.1; NM_001040668.1. [Q9HB09-3]
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   RefSeq; NP_001269446.1; NM_001282517.1. [Q9HB09-2]
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   RefSeq; NP_619580.1; NM_138639.1. [Q9HB09-1]
DR   RefSeq; XP_016882835.1; XM_017027346.1. [Q9HB09-2]
DR   SMR; Q9HB09; -.
DR   BioGrid; 123692; 13.
DR   IntAct; Q9HB09; 6.
DR   STRING; 9606.ENSP00000482218; -.
DR   iPTMnet; Q9HB09; -.
DR   PhosphoSitePlus; Q9HB09; -.
DR   SwissPalm; Q9HB09; -.
DR   BioMuta; BCL2L12; -.
DR   DMDM; 23396468; -.
DR   EPD; Q9HB09; -.
DR   jPOST; Q9HB09; -.
DR   MassIVE; Q9HB09; -.
DR   MaxQB; Q9HB09; -.
DR   PaxDb; Q9HB09; -.
DR   PeptideAtlas; Q9HB09; -.
DR   PRIDE; Q9HB09; -.
DR   ProteomicsDB; 81467; -. [Q9HB09-1]
DR   ProteomicsDB; 81468; -. [Q9HB09-2]
DR   ProteomicsDB; 81469; -. [Q9HB09-3]
DR   Antibodypedia; 18662; 198 antibodies.
DR   DNASU; 83596; -.
DR   Ensembl; ENST00000246785; ENSP00000246785; ENSG00000126453. [Q9HB09-1]
DR   Ensembl; ENST00000441864; ENSP00000393803; ENSG00000126453. [Q9HB09-3]
DR   Ensembl; ENST00000616144; ENSP00000482218; ENSG00000126453. [Q9HB09-1]
DR   GeneID; 83596; -.
DR   KEGG; hsa:83596; -.
DR   UCSC; uc002ppa.4; human. [Q9HB09-1]
DR   CTD; 83596; -.
DR   DisGeNET; 83596; -.
DR   GeneCards; BCL2L12; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   HPA; ENSG00000126453; Low tissue specificity.
DR   MIM; 610837; gene.
DR   neXtProt; NX_Q9HB09; -.
DR   OpenTargets; ENSG00000126453; -.
DR   PharmGKB; PA25306; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00940000154318; -.
DR   InParanoid; Q9HB09; -.
DR   OMA; HGGWAGI; -.
DR   OrthoDB; 1368289at2759; -.
DR   PhylomeDB; Q9HB09; -.
DR   TreeFam; TF338350; -.
DR   SIGNOR; Q9HB09; -.
DR   ChiTaRS; BCL2L12; human.
DR   GeneWiki; BCL2L12; -.
DR   GenomeRNAi; 83596; -.
DR   Pharos; Q9HB09; Tbio.
DR   PRO; PR:Q9HB09; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9HB09; protein.
DR   Bgee; ENSG00000126453; Expressed in muscle of leg and 152 other tissues.
DR   ExpressionAtlas; Q9HB09; baseline and differential.
DR   Genevisible; Q9HB09; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:1990001; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IEA:Ensembl.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   InterPro; IPR036834; Blc2-like_sf.
DR   SUPFAM; SSF56854; SSF56854; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Methylation; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..334
FT                   /note="Bcl-2-like protein 12"
FT                   /id="PRO_0000143072"
FT   MOTIF           311..322
FT                   /note="BH2"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         117
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         144
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         242
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         120
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043269"
FT   VAR_SEQ         121..176
FT                   /note="SPAQEEPTDFLSRLRRCLPCSLGRGAAPSESPRPCSLPIRPCYGLEPGPATP
FT                   DFYA -> PSYSRLLCFGGPAAGTAGPRAAEISAQPRITGSPIDREGSHTAEAGGPAGG
FT                   GGRSH (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000522"
FT   VAR_SEQ         177..334
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000523"
FT   VARIANT         47
FT                   /note="G -> V (in dbSNP:rs2060263)"
FT                   /id="VAR_048419"
FT   CONFLICT        270
FT                   /note="P -> S (in Ref. 3; AAH07724)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   334 AA;  36821 MW;  5398E54C83E7CAB7 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKLAS DPALRSKLVR
     LSSDSFARLV ELFCSRDDSS RPSRACPGPP PPSPEPLARL ALAMELSRRV AGLGGTLAGL
     SVEHVHSFTP WIQAHGGWEG ILAVSPVDLN LPLD
//
ID   A0N0Q1_HUMAN            Unreviewed;       360 AA.
AC   A0N0Q1; A0A024R2J7;
DT   12-DEC-2006, integrated into UniProtKB/TrEMBL.
DT   12-DEC-2006, sequence version 1.
DT   22-APR-2020, entry version 118.
DE   SubName: Full=Chemokine (C-C motif) receptor 4 {ECO:0000313|EMBL:ABK41942.1};
DE   SubName: Full=Chemokine (C-C motif) receptor 4, isoform CRA_a {ECO:0000313|EMBL:EAW64440.1};
DE   SubName: Full=cDNA FLJ75821, highly similar to Homo sapiens chemokine (C-C motif) receptor 4 (CCR4), mRNA {ECO:0000313|EMBL:BAF85363.1};
GN   Name=CCR4 {ECO:0000313|EMBL:ABK41942.1};
GN   ORFNames=hCG_1776165 {ECO:0000313|EMBL:EAW64440.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABK41942.1};
RN   [1] {ECO:0000313|EMBL:EAW64440.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW64440.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ABK41942.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF85363.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAF85363.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00594957}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF064759; ABK41942.1; -; Genomic_DNA.
DR   EMBL; AK292674; BAF85363.1; -; mRNA.
DR   EMBL; CH471055; EAW64440.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64441.1; -; Genomic_DNA.
DR   RefSeq; NP_005499.1; NM_005508.4.
DR   RefSeq; XP_016861176.1; XM_017005687.1.
DR   Antibodypedia; 11668; 721 antibodies.
DR   DNASU; 1233; -.
DR   GeneID; 1233; -.
DR   KEGG; hsa:1233; -.
DR   CTD; 1233; -.
DR   EuPathDB; HostDB:ENSG00000183813.6; -.
DR   PharmGKB; PA26169; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   eggNOG; ENOG410XRW9; LUCA.
DR   HOGENOM; CLU_009579_8_3_1; -.
DR   KO; K04179; -.
DR   OMA; STVDHDL; -.
DR   OrthoDB; 900867at2759; -.
DR   GenomeRNAi; 1233; -.
DR   Bgee; ENSG00000183813; Expressed in leukocyte and 48 other tissues.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl.
DR   GO; GO:0006935; P:chemotaxis; IEA:Ensembl.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0002507; P:tolerance induction; IEA:Ensembl.
DR   InterPro; IPR002239; Chemokine_CCR4.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR10489:SF608; PTHR10489:SF608; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR01109; CHEMOKINER4.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   G-protein coupled receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00334369};
KW   Membrane {ECO:0000256|SAAS:SAAS00334380, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00334369};
KW   Transducer {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00334369};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00334380, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00334380,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        45..65
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        77..100
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        112..130
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        151..174
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        200..222
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        243..264
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        284..307
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          56..304
FT                   /note="G_PROTEIN_RECEP_F1_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50262"
SQ   SEQUENCE   360 AA;  41403 MW;  51EBE12AD1FAFABF CRC64;
     MNPTDIADTT LDESIYSNYY LYESIPKPCT KEGIKAFGEL FLPPLYSLVF VFGLLGNSVV
     VLVLFKYKRL RSMTDVYLLN LAISDLLFVF SLPFWGYYAA DQWVFGLGLC KMISWMYLVG
     FYSGIFFVML MSIDRYLAIV HAVFSLRART LTYGVITSLA TWSVAVFASL PGFLFSTCYT
     ERNHTYCKTK YSLNSTTWKV LSSLEINILG LVIPLGIMLF CYSMIIRTLQ HCKNEKKNKA
     VKMIFAVVVL FLGFWTPYNI VLFLETLVEL EVLQDCTFER YLDYAIQATE TLAFVHCCLN
     PIIYFFLGEK FRKYILQLFK TCRGLFVLCQ YCGLLQIYSA DTPSSSYTQS TMDHDLHDAL
//
ID   CCR4_HUMAN              Reviewed;         360 AA.
AC   P51679; Q9ULY6; Q9ULY7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-APR-2020, entry version 169.
DE   RecName: Full=C-C chemokine receptor type 4;
DE            Short=C-C CKR-4;
DE            Short=CC-CKR-4;
DE            Short=CCR-4;
DE            Short=CCR4;
DE   AltName: Full=K5-5;
DE   AltName: CD_antigen=CD194;
GN   Name=CCR4; Synonyms=CMKBR4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RX   PubMed=7642634; DOI=10.1074/jbc.270.33.19495;
RA   Power C.A., Meyer A., Nemeth K., Bacon K.B., Hoogewerf A.J.,
RA   Proudfoot A.E.I., Wells T.N.C.;
RT   "Molecular cloning and functional expression of a novel CC chemokine
RT   receptor cDNA from a human basophilic cell line.";
RL   J. Biol. Chem. 270:19495-19500(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-130 AND SER-178.
RX   PubMed=11196669; DOI=10.1038/sj.gene.6363638;
RA   Kato H., Tsuchiya N., Izumi S., Miyamasu M., Nakajima T., Kawasaki H.,
RA   Hirai K., Tokunaga K.;
RT   "New variations of human CC-chemokine receptors CCR3 and CCR4.";
RL   Genes Immun. 1:97-104(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=9169480; DOI=10.1074/jbc.272.23.15036;
RA   Imai T., Baba M., Nishimura M., Kakizaki M., Takagi S., Yoshie O.;
RT   "The T cell-directed CC chemokine TARC is a highly specific biological
RT   ligand for CC chemokine receptor 4.";
RL   J. Biol. Chem. 272:15036-15042(1997).
RN   [6]
RP   FUNCTION.
RX   PubMed=9430724; DOI=10.1074/jbc.273.3.1764;
RA   Imai T., Chantry D., Raport C.J., Wood C.L., Nishimura M., Godiska R.,
RA   Yoshie O., Gray P.W.;
RT   "Macrophage-derived chemokine is a functional ligand for the CC chemokine
RT   receptor 4.";
RL   J. Biol. Chem. 273:1764-1768(1998).
RN   [7]
RP   FUNCTION.
RX   PubMed=10466728; DOI=10.1038/23495;
RA   Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P.,
RA   Andrew D.P., Warnke R., Ruffing N., Kassam N., Wu L., Butcher E.C.;
RT   "The chemokine receptor CCR4 in vascular recognition by cutaneous but not
RT   intestinal memory T cells.";
RL   Nature 400:776-780(1999).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND PHOSPHORYLATION.
RX   PubMed=10754297; DOI=10.4049/jimmunol.164.8.4048;
RA   Inngjerdingen M., Damaj B., Maghazachi A.A.;
RT   "Human NK cells express CC chemokine receptors 4 and 8 and respond to
RT   thymus and activation-regulated chemokine, macrophage-derived chemokine,
RT   and I-309.";
RL   J. Immunol. 164:4048-4054(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=16137713; DOI=10.1016/j.lfs.2005.05.070;
RA   Wang Y., Zhang Y., Yang X., Han W., Liu Y., Xu Q., Zhao R., Di C., Song Q.,
RA   Ma D.;
RT   "Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4
RT   (CCR4).";
RL   Life Sci. 78:614-621(2006).
CC   -!- FUNCTION: High affinity receptor for the C-C type chemokines
CC       CCL17/TARC, CCL22/MDC and CKLF isoform 1/CKLF1. The activity of this
CC       receptor is mediated by G(i) proteins which activate a
CC       phosphatidylinositol-calcium second messenger system. Can function as a
CC       chemoattractant homing receptor on circulating memory lymphocytes and
CC       as a coreceptor for some primary HIV-2 isolates. In the CNS, could
CC       mediate hippocampal-neuron survival. {ECO:0000269|PubMed:10466728,
CC       ECO:0000269|PubMed:10754297, ECO:0000269|PubMed:16137713,
CC       ECO:0000269|PubMed:9169480, ECO:0000269|PubMed:9430724}.
CC   -!- INTERACTION:
CC       P51679; Q92583: CCL17; NbExp=2; IntAct=EBI-7847466, EBI-16640146;
CC       P51679; A5PKU2: TUSC5; NbExp=3; IntAct=EBI-7847466, EBI-11988865;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the thymus, in
CC       peripheral blood leukocytes, including T-cells, mostly CD4+ cells, and
CC       basophils, and in platelets; at lower levels, in the spleen and in
CC       monocytes. Detected also in macrophages, IL-2-activated natural killer
CC       cells and skin-homing memory T-cells, mostly the ones expressing the
CC       cutaneous lymphocyte antigen (CLA). Expressed in brain microvascular
CC       and coronary artery endothelial cells. {ECO:0000269|PubMed:10754297}.
CC   -!- PTM: In natural killer cells, CCL22 binding induces phosphorylation on
CC       yet undefined Ser/Thr residues, most probably by beta-adrenergic
CC       receptor kinases 1 and 2. {ECO:0000269|PubMed:10754297}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CC chemokine receptors entry;
CC       URL="https://en.wikipedia.org/wiki/CC_chemokine_receptors";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X85740; CAA59743.1; -; mRNA.
DR   EMBL; AB023888; BAA86965.1; -; Genomic_DNA.
DR   EMBL; AB023889; BAA86966.1; -; Genomic_DNA.
DR   EMBL; AB023890; BAA86967.1; -; Genomic_DNA.
DR   EMBL; AB023891; BAA86968.1; -; Genomic_DNA.
DR   EMBL; AB023892; BAA86969.1; -; Genomic_DNA.
DR   EMBL; AY322539; AAP84352.1; -; Genomic_DNA.
DR   EMBL; BC069139; AAH69139.1; -; mRNA.
DR   EMBL; BC071751; AAH71751.1; -; mRNA.
DR   EMBL; BC074935; AAH74935.1; -; mRNA.
DR   CCDS; CCDS2656.1; -.
DR   PIR; A57160; A57160.
DR   RefSeq; NP_005499.1; NM_005508.4.
DR   RefSeq; XP_016861176.1; XM_017005687.1.
DR   BioGrid; 107638; 6.
DR   DIP; DIP-5848N; -.
DR   IntAct; P51679; 33.
DR   MINT; P51679; -.
DR   STRING; 9606.ENSP00000332659; -.
DR   BindingDB; P51679; -.
DR   ChEMBL; CHEMBL2414; -.
DR   DrugBank; DB15570; FLX475.
DR   DrugCentral; P51679; -.
DR   GuidetoPHARMACOLOGY; 61; -.
DR   iPTMnet; P51679; -.
DR   PhosphoSitePlus; P51679; -.
DR   BioMuta; CCR4; -.
DR   DMDM; 1705894; -.
DR   MassIVE; P51679; -.
DR   PaxDb; P51679; -.
DR   PeptideAtlas; P51679; -.
DR   PRIDE; P51679; -.
DR   ProteomicsDB; 56366; -.
DR   ABCD; P51679; -.
DR   Antibodypedia; 11668; 721 antibodies.
DR   DNASU; 1233; -.
DR   Ensembl; ENST00000330953; ENSP00000332659; ENSG00000183813.
DR   GeneID; 1233; -.
DR   KEGG; hsa:1233; -.
DR   UCSC; uc003cfg.2; human.
DR   CTD; 1233; -.
DR   DisGeNET; 1233; -.
DR   GeneCards; CCR4; -.
DR   HGNC; HGNC:1605; CCR4.
DR   HPA; ENSG00000183813; Group enriched (blood, lymphoid tissue).
DR   MIM; 604836; gene.
DR   neXtProt; NX_P51679; -.
DR   OpenTargets; ENSG00000183813; -.
DR   PharmGKB; PA26169; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   eggNOG; ENOG410XRW9; LUCA.
DR   GeneTree; ENSGT00980000198481; -.
DR   HOGENOM; CLU_009579_8_3_1; -.
DR   InParanoid; P51679; -.
DR   KO; K04179; -.
DR   OMA; STVDHDL; -.
DR   OrthoDB; 900867at2759; -.
DR   PhylomeDB; P51679; -.
DR   TreeFam; TF330966; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P51679; -.
DR   GeneWiki; CCR4; -.
DR   GenomeRNAi; 1233; -.
DR   Pharos; P51679; Tclin.
DR   PRO; PR:P51679; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P51679; protein.
DR   Bgee; ENSG00000183813; Expressed in leukocyte and 48 other tissues.
DR   ExpressionAtlas; P51679; baseline and differential.
DR   Genevisible; P51679; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0019957; F:C-C chemokine binding; IBA:GO_Central.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IBA:GO_Central.
DR   GO; GO:0019956; F:chemokine binding; IBA:GO_Central.
DR   GO; GO:0004950; F:chemokine receptor activity; TAS:ProtInc.
DR   GO; GO:0019722; P:calcium-mediated signaling; IBA:GO_Central.
DR   GO; GO:0060326; P:cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0002507; P:tolerance induction; IEA:Ensembl.
DR   InterPro; IPR002239; Chemokine_CCR4.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR10489:SF608; PTHR10489:SF608; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR01109; CHEMOKINER4.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..360
FT                   /note="C-C chemokine receptor type 4"
FT                   /id="PRO_0000069245"
FT   TOPO_DOM        1..39
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        40..67
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        68..77
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        78..98
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        99..111
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        112..133
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        134..150
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..175
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        176..206
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        207..226
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        227..242
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        243..267
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        268..284
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        285..308
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        309..360
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        183
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        194
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        110..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         130
FT                   /note="L -> V"
FT                   /evidence="ECO:0000269|PubMed:11196669"
FT                   /id="VAR_010669"
FT   VARIANT         178
FT                   /note="C -> S (in dbSNP:rs753825374)"
FT                   /evidence="ECO:0000269|PubMed:11196669"
FT                   /id="VAR_010670"
SQ   SEQUENCE   360 AA;  41403 MW;  51EBE12AD1FAFABF CRC64;
     MNPTDIADTT LDESIYSNYY LYESIPKPCT KEGIKAFGEL FLPPLYSLVF VFGLLGNSVV
     VLVLFKYKRL RSMTDVYLLN LAISDLLFVF SLPFWGYYAA DQWVFGLGLC KMISWMYLVG
     FYSGIFFVML MSIDRYLAIV HAVFSLRART LTYGVITSLA TWSVAVFASL PGFLFSTCYT
     ERNHTYCKTK YSLNSTTWKV LSSLEINILG LVIPLGIMLF CYSMIIRTLQ HCKNEKKNKA
     VKMIFAVVVL FLGFWTPYNI VLFLETLVEL EVLQDCTFER YLDYAIQATE TLAFVHCCLN
     PIIYFFLGEK FRKYILQLFK TCRGLFVLCQ YCGLLQIYSA DTPSSSYTQS TMDHDLHDAL
//
ID   A0N0Q0_HUMAN            Unreviewed;       378 AA.
AC   A0N0Q0;
DT   12-DEC-2006, integrated into UniProtKB/TrEMBL.
DT   12-DEC-2006, sequence version 1.
DT   22-APR-2020, entry version 117.
DE   SubName: Full=Chemokine (C-C motif) receptor 7 {ECO:0000313|EMBL:ABK41941.1};
DE   SubName: Full=cDNA FLJ45911 fis, clone PEBLM2005615, highly similar to C-C chemokine receptor type 7 {ECO:0000313|EMBL:BAG54575.1};
GN   Name=CCR7 {ECO:0000313|EMBL:ABK41941.1};
GN   ORFNames=hCG_1643840 {ECO:0000313|EMBL:EAW60669.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABK41941.1};
RN   [1] {ECO:0000313|EMBL:EAW60669.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG54575.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Oshima A., Takahashi-Fujii A., Tanase T., Imose N., Takeuchi K., Arita M.,
RA   Musashino K., Yuuki H., Hara H., Sugiyama T., Irie R., Otsuki T., Sato H.,
RA   Wakamatsu A., Ishii S., Yamamoto J., Isono Y., Kawai-Hio Y., Saito K.,
RA   Nishikawa T., Kimura K., Yamashita H., Matsuo K., Nakamura Y., Sekine M.,
RA   Kikuchi H., Kanda K., Wagatsuma M., Murakawa K., Kanehori K., Sugiyama A.,
RA   Kawakami B., Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K.,
RA   Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW60669.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ABK41941.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00594957}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF064758; ABK41941.1; -; Genomic_DNA.
DR   EMBL; AK127810; BAG54575.1; -; mRNA.
DR   EMBL; CH471152; EAW60669.1; -; Genomic_DNA.
DR   RefSeq; NP_001829.1; NM_001838.3.
DR   Antibodypedia; 3533; 1024 antibodies.
DR   DNASU; 1236; -.
DR   GeneID; 1236; -.
DR   KEGG; hsa:1236; -.
DR   CTD; 1236; -.
DR   EuPathDB; HostDB:ENSG00000126353.3; -.
DR   PharmGKB; PA26172; -.
DR   eggNOG; ENOG410IMBE; Eukaryota.
DR   eggNOG; ENOG4110ZGY; LUCA.
DR   KO; K04182; -.
DR   OMA; TLYESVC; -.
DR   OrthoDB; 715251at2759; -.
DR   GenomeRNAi; 1236; -.
DR   Bgee; ENSG00000126353; Expressed in blood and 121 other tissues.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl.
DR   GO; GO:0006935; P:chemotaxis; IEA:Ensembl.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0072610; P:interleukin-12 secretion; IEA:Ensembl.
DR   GO; GO:0097029; P:mature conventional dendritic cell differentiation; IEA:Ensembl.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; IEA:Ensembl.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; IEA:Ensembl.
DR   GO; GO:2000526; P:positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation; IEA:Ensembl.
DR   GO; GO:0002922; P:positive regulation of humoral immune response; IEA:Ensembl.
DR   GO; GO:0002885; P:positive regulation of hypersensitivity; IEA:Ensembl.
DR   GO; GO:2000522; P:positive regulation of immunological synapse formation; IEA:Ensembl.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:2000525; P:positive regulation of T cell costimulation; IEA:Ensembl.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0050706; P:regulation of interleukin-1 beta secretion; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   G-protein coupled receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00334369};
KW   Membrane {ECO:0000256|SAAS:SAAS00334380, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00334369};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transducer {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00334369};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00334380, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00334380,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           25..378
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014296520"
FT   TRANSMEM        59..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        96..116
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        122..150
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        171..191
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        225..249
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        261..279
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        310..329
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          75..326
FT                   /note="G_PROTEIN_RECEP_F1_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50262"
SQ   SEQUENCE   378 AA;  42874 MW;  D4CB4213841A1BD4 CRC64;
     MDLGKPMKSV LVVALLVIFQ VCLCQDEVTD DYIGDNTTVD YTLFESLCSK KDVRNFKAWF
     LPIMYSIICF VGLLGNGLVV LTYIYFKRLK TMTDTYLLNL AVADILFLLT LPFWAYSAAK
     SWVFGVHFCK LIFAIYKMSF FSGMLLLLCI SIDRYVAIVQ AVSAHRHRAR VLLISKLSCV
     GIWILATVLS IPELLYSDLQ RSSSEQAMRC SLITEHVEAF ITIQVAQMVI GFLVPLLAMS
     FCYLVIIRTL LQARNFERNK AIKVIIAVVV VFIVFQLPYN GVVLAQTVAN FNITSSTCEL
     SKQLNIAYDV TYSLACVRCC VNPFLYAFIG VKFRNDLFKL FKDLGCLSQE QLRQWSSCRH
     IRRSSMSVEA ETTTTFSP
//
ID   J3KSS9_HUMAN            Unreviewed;       372 AA.
AC   J3KSS9;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 56.
DE   SubName: Full=C-C chemokine receptor type 7 {ECO:0000313|Ensembl:ENSP00000462631};
GN   Name=CCR7 {ECO:0000313|Ensembl:ENSP00000462631};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000462631, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000462631, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000462631}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2012) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00594957}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC004585; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001288645.1; NM_001301716.1.
DR   RefSeq; NP_001288646.1; NM_001301717.1.
DR   RefSeq; NP_001288647.1; NM_001301718.1.
DR   PRIDE; J3KSS9; -.
DR   Antibodypedia; 3533; 1024 antibodies.
DR   Ensembl; ENST00000579344; ENSP00000462631; ENSG00000126353.
DR   GeneID; 1236; -.
DR   UCSC; uc060eyz.1; human.
DR   CTD; 1236; -.
DR   EuPathDB; HostDB:ENSG00000126353.3; -.
DR   HGNC; HGNC:1608; CCR7.
DR   OpenTargets; ENSG00000126353; -.
DR   eggNOG; ENOG410IMBE; Eukaryota.
DR   eggNOG; ENOG4110ZGY; LUCA.
DR   GeneTree; ENSGT00950000182749; -.
DR   GenomeRNAi; 1236; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000126353; Expressed in blood and 121 other tissues.
DR   ExpressionAtlas; J3KSS9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:InterPro.
DR   GO; GO:0006935; P:chemotaxis; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   G-protein coupled receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00334369};
KW   Membrane {ECO:0000256|SAAS:SAAS00334380, ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:J3KSS9,
KW   ECO:0000213|PeptideAtlas:J3KSS9, ECO:0000213|ProteomicsDB:J3KSS9};
KW   Receptor {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00334369};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transducer {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00334369};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00334380, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00334380,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           19..372
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003772096"
FT   TRANSMEM        53..78
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        90..110
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        116..144
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        165..185
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        219..243
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        255..273
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        304..323
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          69..320
FT                   /note="G_PROTEIN_RECEP_F1_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50262"
SQ   SEQUENCE   372 AA;  42232 MW;  6BAC116ADF458B5B CRC64;
     MKSVLVVALL VIFQVCLCQD EVTDDYIGDN TTVDYTLFES LCSKKDVRNF KAWFLPIMYS
     IICFVGLLGN GLVVLTYIYF KRLKTMTDTY LLNLAVADIL FLLTLPFWAY SAAKSWVFGV
     HFCKLIFAIY KMSFFSGMLL LLCISIDRYV AIVQAVSAHR HRARVLLISK LSCVGIWILA
     TVLSIPELLY SDLQRSSSEQ AMRCSLITEH VEAFITIQVA QMVIGFLVPL LAMSFCYLVI
     IRTLLQARNF ERNKAIKVII AVVVVFIVFQ LPYNGVVLAQ TVANFNITSS TCELSKQLNI
     AYDVTYSLAC VRCCVNPFLY AFIGVKFRND LFKLFKDLGC LSQEQLRQWS SCRHIRRSSM
     SVEAETTTTF SP
//
ID   CCR7_HUMAN              Reviewed;         378 AA.
AC   P32248;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   22-APR-2020, entry version 185.
DE   RecName: Full=C-C chemokine receptor type 7;
DE            Short=C-C CKR-7;
DE            Short=CC-CKR-7;
DE            Short=CCR-7;
DE   AltName: Full=BLR2;
DE   AltName: Full=CDw197;
DE   AltName: Full=Epstein-Barr virus-induced G-protein coupled receptor 1;
DE            Short=EBI1;
DE            Short=EBV-induced G-protein coupled receptor 1;
DE   AltName: Full=MIP-3 beta receptor;
DE   AltName: CD_antigen=CD197;
DE   Flags: Precursor;
GN   Name=CCR7; Synonyms=CMKBR7, EBI1, EVI1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8383238;
RA   Birkenbach M.P., Josefsen K., Yalamanchili R.R., Lenoir G.M., Kieff E.;
RT   "Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-
RT   coupled peptide receptors.";
RL   J. Virol. 67:2209-2220(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7851893; DOI=10.1006/geno.1994.1553;
RA   Schweickart V.L., Raport C.J., Godiska R., Byers M.G., Eddy R.L. Jr.,
RA   Shows T.B., Gray P.W.;
RT   "Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled
RT   receptor encoded on human chromosome 17q12-q21.2.";
RL   Genomics 23:643-650(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for the MIP-3-beta chemokine. Probable mediator of
CC       EBV effects on B-lymphocytes or of normal lymphocyte functions.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in various lymphoid tissues and activated
CC       B- and T-lymphocytes, strongly up-regulated in B-cells infected with
CC       Epstein-Barr virus and T-cells infected with herpesvirus 6 or 7.
CC   -!- INDUCTION: By Epstein-Barr virus (EBV).
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CC chemokine receptors entry;
CC       URL="https://en.wikipedia.org/wiki/CC_chemokine_receptors";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L08176; AAA58615.1; -; mRNA.
DR   EMBL; L31584; AAA74230.1; -; Genomic_DNA.
DR   EMBL; L31582; AAA74230.1; JOINED; Genomic_DNA.
DR   EMBL; L31583; AAA74230.1; JOINED; Genomic_DNA.
DR   EMBL; L31581; AAA74231.1; -; mRNA.
DR   EMBL; AY587876; AAT52232.1; -; mRNA.
DR   EMBL; BC035343; AAH35343.1; -; mRNA.
DR   CCDS; CCDS11369.1; -.
DR   PIR; A45680; A45680.
DR   PIR; B55735; B55735.
DR   RefSeq; NP_001288643.1; NM_001301714.1.
DR   RefSeq; NP_001288645.1; NM_001301716.1.
DR   RefSeq; NP_001288646.1; NM_001301717.1.
DR   RefSeq; NP_001288647.1; NM_001301718.1.
DR   RefSeq; NP_001829.1; NM_001838.3.
DR   PDB; 6QZH; X-ray; 2.10 A; A=46-247.
DR   PDBsum; 6QZH; -.
DR   SMR; P32248; -.
DR   BioGrid; 107641; 2.
DR   DIP; DIP-5855N; -.
DR   IntAct; P32248; 4.
DR   MINT; P32248; -.
DR   STRING; 9606.ENSP00000246657; -.
DR   BindingDB; P32248; -.
DR   ChEMBL; CHEMBL4594; -.
DR   GuidetoPHARMACOLOGY; 64; -.
DR   iPTMnet; P32248; -.
DR   PhosphoSitePlus; P32248; -.
DR   BioMuta; CCR7; -.
DR   DMDM; 1352335; -.
DR   MassIVE; P32248; -.
DR   MaxQB; P32248; -.
DR   PaxDb; P32248; -.
DR   PeptideAtlas; P32248; -.
DR   PRIDE; P32248; -.
DR   ProteomicsDB; 54856; -.
DR   Antibodypedia; 3533; 1024 antibodies.
DR   DNASU; 1236; -.
DR   Ensembl; ENST00000246657; ENSP00000246657; ENSG00000126353.
DR   GeneID; 1236; -.
DR   KEGG; hsa:1236; -.
DR   UCSC; uc002huw.4; human.
DR   CTD; 1236; -.
DR   DisGeNET; 1236; -.
DR   GeneCards; CCR7; -.
DR   HGNC; HGNC:1608; CCR7.
DR   HPA; ENSG00000126353; Group enriched (blood, lymphoid tissue).
DR   MIM; 600242; gene.
DR   neXtProt; NX_P32248; -.
DR   OpenTargets; ENSG00000126353; -.
DR   PharmGKB; PA26172; -.
DR   eggNOG; ENOG410IMBE; Eukaryota.
DR   eggNOG; ENOG4110ZGY; LUCA.
DR   GeneTree; ENSGT00950000182749; -.
DR   InParanoid; P32248; -.
DR   KO; K04182; -.
DR   OMA; TLYESVC; -.
DR   OrthoDB; 715251at2759; -.
DR   PhylomeDB; P32248; -.
DR   TreeFam; TF330966; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P32248; -.
DR   GeneWiki; C-C_chemokine_receptor_type_7; -.
DR   GenomeRNAi; 1236; -.
DR   Pharos; P32248; Tbio.
DR   PRO; PR:P32248; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P32248; protein.
DR   Bgee; ENSG00000126353; Expressed in blood and 121 other tissues.
DR   ExpressionAtlas; P32248; baseline and differential.
DR   Genevisible; P32248; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0019957; F:C-C chemokine binding; IBA:GO_Central.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; ISS:BHF-UCL.
DR   GO; GO:0038117; F:C-C motif chemokine 19 receptor activity; IDA:UniProtKB.
DR   GO; GO:0038121; F:C-C motif chemokine 21 receptor activity; IDA:UniProtKB.
DR   GO; GO:0035757; F:chemokine (C-C motif) ligand 19 binding; IPI:BHF-UCL.
DR   GO; GO:0035758; F:chemokine (C-C motif) ligand 21 binding; IPI:BHF-UCL.
DR   GO; GO:0019956; F:chemokine binding; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; TAS:BHF-UCL.
DR   GO; GO:0090630; P:activation of GTPase activity; IC:BHF-UCL.
DR   GO; GO:0019722; P:calcium-mediated signaling; IBA:GO_Central.
DR   GO; GO:0060326; P:cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IDA:BHF-UCL.
DR   GO; GO:0006935; P:chemotaxis; IBA:GO_Central.
DR   GO; GO:0002407; P:dendritic cell chemotaxis; IC:BHF-UCL.
DR   GO; GO:0001768; P:establishment of T cell polarity; IC:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; NAS:BHF-UCL.
DR   GO; GO:0072610; P:interleukin-12 secretion; ISS:BHF-UCL.
DR   GO; GO:0097022; P:lymphocyte migration into lymph node; TAS:BHF-UCL.
DR   GO; GO:0097029; P:mature conventional dendritic cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0002408; P:myeloid dendritic cell chemotaxis; IDA:BHF-UCL.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; IC:BHF-UCL.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IC:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IC:BHF-UCL.
DR   GO; GO:2000147; P:positive regulation of cell motility; IC:BHF-UCL.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IC:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISS:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IC:BHF-UCL.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IC:BHF-UCL.
DR   GO; GO:2000526; P:positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation; ISS:BHF-UCL.
DR   GO; GO:0002922; P:positive regulation of humoral immune response; ISS:BHF-UCL.
DR   GO; GO:0002885; P:positive regulation of hypersensitivity; ISS:BHF-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IC:BHF-UCL.
DR   GO; GO:2000522; P:positive regulation of immunological synapse formation; ISS:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IC:BHF-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IC:BHF-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IC:BHF-UCL.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; IC:BHF-UCL.
DR   GO; GO:2000525; P:positive regulation of T cell costimulation; ISS:BHF-UCL.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:2000547; P:regulation of dendritic cell dendrite assembly; ISS:BHF-UCL.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; ISS:BHF-UCL.
DR   GO; GO:0050706; P:regulation of interleukin-1 beta secretion; ISS:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IC:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071731; P:response to nitric oxide; IC:BHF-UCL.
DR   GO; GO:0034695; P:response to prostaglandin E; IC:BHF-UCL.
DR   GO; GO:0031529; P:ruffle organization; IC:BHF-UCL.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Polymorphism; Receptor; Reference proteome; Signal;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..378
FT                   /note="C-C chemokine receptor type 7"
FT                   /id="PRO_0000012735"
FT   TOPO_DOM        25..59
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..86
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        87..95
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        96..116
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        117..130
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        131..152
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        153..170
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        171..191
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        192..219
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        220..247
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        248..263
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        264..289
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..313
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        314..331
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..378
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        36
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        129..210
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         7
FT                   /note="M -> V (in dbSNP:rs2228015)"
FT                   /id="VAR_049383"
FT   CONFLICT        182..183
FT                   /note="IW -> SA (in Ref. 1; AAA58615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337
FT                   /note="L -> I (in Ref. 1; AAA58615)"
FT                   /evidence="ECO:0000305"
FT   HELIX           56..84
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           85..89
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           92..108
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           111..119
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           125..157
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           168..171
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           173..190
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           191..195
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   STRAND          196..200
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   STRAND          209..212
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           221..231
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           233..247
FT                   /evidence="ECO:0000244|PDB:6QZH"
SQ   SEQUENCE   378 AA;  42874 MW;  D4CB4213841A1BD4 CRC64;
     MDLGKPMKSV LVVALLVIFQ VCLCQDEVTD DYIGDNTTVD YTLFESLCSK KDVRNFKAWF
     LPIMYSIICF VGLLGNGLVV LTYIYFKRLK TMTDTYLLNL AVADILFLLT LPFWAYSAAK
     SWVFGVHFCK LIFAIYKMSF FSGMLLLLCI SIDRYVAIVQ AVSAHRHRAR VLLISKLSCV
     GIWILATVLS IPELLYSDLQ RSSSEQAMRC SLITEHVEAF ITIQVAQMVI GFLVPLLAMS
     FCYLVIIRTL LQARNFERNK AIKVIIAVVV VFIVFQLPYN GVVLAQTVAN FNITSSTCEL
     SKQLNIAYDV TYSLACVRCC VNPFLYAFIG VKFRNDLFKL FKDLGCLSQE QLRQWSSCRH
     IRRSSMSVEA ETTTTFSP
//
ID   B4E0L1_HUMAN            Unreviewed;       124 AA.
AC   B4E0L1;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 35.
DE   SubName: Full=cDNA FLJ52125, highly similar to T-cell-specific surface glycoprotein CD28 {ECO:0000313|EMBL:BAG64473.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64473.1};
RN   [1] {ECO:0000313|EMBL:BAG64473.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAG64473.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK303421; BAG64473.1; -; mRNA.
DR   RefSeq; NP_001230006.1; NM_001243077.1.
DR   RefSeq; NP_001230007.1; NM_001243078.1.
DR   MaxQB; B4E0L1; -.
DR   PeptideAtlas; B4E0L1; -.
DR   PRIDE; B4E0L1; -.
DR   GeneID; 940; -.
DR   CTD; 940; -.
DR   eggNOG; ENOG410IXMM; Eukaryota.
DR   eggNOG; ENOG410Z063; LUCA.
DR   GenomeRNAi; 940; -.
DR   Genevisible; B4E0L1; HS.
DR   GO; GO:0042129; P:regulation of T cell proliferation; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR040216; CTLA4/CD28.
DR   InterPro; IPR013783; Ig-like_fold.
DR   PANTHER; PTHR11494; PTHR11494; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           19..124
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002803440"
SQ   SEQUENCE   124 AA;  14072 MW;  3A91FF25D56AFB29 CRC64;
     MLRLLLALNL FPSIQVTGNK ILVKQSPMLV AYDNAVNLSC KYSYNLFSRE FRASLHKGLD
     SAVEVCVVYG NYSQQLQVYS KTGFNCDGKL GNESVTFYLQ NLYVNHYPCE RETPLSKSPI
     SRTF
//
ID   CD28_HUMAN              Reviewed;         220 AA.
AC   P10747; A8KAC1; Q13964; Q52M23; Q70WG0; Q8NI54; Q8NI55; Q8NI56; Q8WXJ2;
AC   Q9BYV0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   22-APR-2020, entry version 203.
DE   RecName: Full=T-cell-specific surface glycoprotein CD28;
DE   AltName: Full=TP44;
DE   AltName: CD_antigen=CD28;
DE   Flags: Precursor;
GN   Name=CD28;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2825196; DOI=10.1073/pnas.84.23.8573;
RA   Aruffo A., Seed B.;
RT   "Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression
RT   system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8573-8577(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=2162892;
RA   Lee K.P., Taylor C., Petryniak B., Turka L.A., June C.H., Thompson C.B.;
RT   "The genomic organization of the CD28 gene. Implications for the regulation
RT   of CD28 mRNA expression and heterogeneity.";
RL   J. Immunol. 145:344-352(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RX   PubMed=11916166; DOI=10.1016/s0198-8859(01)00354-8;
RA   Deshpande M., Venuprasad K., Parab P.B., Saha B., Mitra D.;
RT   "A novel CD28 mRNA variant and simultaneous presence of various CD28 mRNA
RT   isoforms in human T lymphocytes.";
RL   Hum. Immunol. 63:20-23(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 4 AND 6), AND CHARACTERIZATION
RP   (ISOFORM 3).
RC   TISSUE=Peripheral blood T-cell;
RX   PubMed=11877290; DOI=10.1182/blood.v99.6.2138;
RA   Hanawa H., Ma Y., Mikolajczak S.A., Charles M.L., Yoshida T., Yoshida R.,
RA   Strathdee C.A., Litchfield D.W., Ochi A.;
RT   "A novel costimulatory signaling in human T lymphocytes by a splice variant
RT   of CD28.";
RL   Blood 99:2138-2145(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
RA   Gan S.U., Hare J., Krivoshchapov L., Hui K.M., Galea-Lauri J., Farzaneh F.,
RA   Darling D.;
RT   "New human CD28 isoforms generated by a novel splicing event in the
RT   5'UTR.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-178 (ISOFORM 1).
RX   PubMed=11735222; DOI=10.1006/geno.2001.6655;
RA   Ling V., Wu P.W., Finnerty H.F., Agostino M.J., Graham J.R., Chen S.,
RA   Jussiff J.M., Fisk G.J., Miller C.P., Collins M.;
RT   "Assembly and annotation of human chromosome 2q33 sequence containing the
RT   CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative,
RT   and microarray approaches.";
RL   Genomics 78:155-168(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=8617933;
RA   Blotta M.H., Marshall J.D., DeKruyff R.H., Umetsu D.T.;
RT   "Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a
RT   costimulatory signal that up-regulates IL-4 synthesis.";
RL   J. Immunol. 156:3133-3140(1996).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-209, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [14]
RP   FUNCTION (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3), INTERACTION WITH
RP   CD40LG (ISOFORM 3), AND PHOSPHORYLATION (ISOFORM 3).
RX   PubMed=15067037; DOI=10.1084/jem.20031705;
RA   Mikolajczak S.A., Ma B.Y., Yoshida T., Yoshida R., Kelvin D.J., Ochi A.;
RT   "The modulation of CD40 ligand signaling by transmembrane CD28 splice
RT   variant in human T cells.";
RL   J. Exp. Med. 199:1025-1031(2004).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-71 AND ASN-129.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189 AND TYR-191, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 17-152 IN COMPLEX WITH THE FAB
RP   FRAGMENT OF A MITOGENIC ANTIBODY, DISULFIDE BONDS, AND GLYCOSYLATION AT
RP   ASN-37 AND ASN-105.
RX   PubMed=15696168; DOI=10.1038/ni1170;
RA   Evans E.J., Esnouf R.M., Manso-Sancho R., Gilbert R.J., James J.R., Yu C.,
RA   Fennelly J.A., Vowles C., Hanke T., Walse B., Hunig T., Sorensen P.,
RA   Stuart D.I., Davis S.J.;
RT   "Crystal structure of a soluble CD28-Fab complex.";
RL   Nat. Immunol. 6:271-279(2005).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 189-196 IN COMPLEX WITH GRB2, AND
RP   INTERACTION WITH GRB2.
RX   PubMed=24098653; DOI=10.1371/journal.pone.0074482;
RA   Higo K., Ikura T., Oda M., Morii H., Takahashi J., Abe R., Ito N.;
RT   "High resolution crystal structure of the Grb2 SH2 domain with a
RT   phosphopeptide derived from CD28.";
RL   PLoS ONE 8:E74482-E74482(2013).
CC   -!- FUNCTION: Involved in T-cell activation, the induction of cell
CC       proliferation and cytokine production and promotion of T-cell survival.
CC       Enhances the production of IL4 and IL10 in T-cells in conjunction with
CC       TCR/CD3 ligation and CD40L costimulation (PubMed:8617933). Isoform 3
CC       enhances CD40L-mediated activation of NF-kappa-B and kinases MAPK8 and
CC       PAK2 in T-cells (PubMed:15067037). {ECO:0000269|PubMed:15067037,
CC       ECO:0000269|PubMed:8617933}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with DUSP14. Binds to
CC       CD80/B7-1 and CD86/B7-2/B70. Interacts with GRB2. Isoform 3 interacts
CC       with CD40LG (PubMed:15067037). {ECO:0000269|PubMed:15067037,
CC       ECO:0000269|PubMed:15696168, ECO:0000269|PubMed:24098653}.
CC   -!- INTERACTION:
CC       P10747-1; P01552: entB; Xeno; NbExp=5; IntAct=EBI-15945088, EBI-1027464;
CC       P10747; P27986: PIK3R1; NbExp=10; IntAct=EBI-4314301, EBI-79464;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell surface
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=P10747-1; Sequence=Displayed;
CC       Name=2; Synonyms=CD28-S2;
CC         IsoId=P10747-2; Sequence=VSP_002494;
CC       Name=3; Synonyms=CD28i;
CC         IsoId=P10747-3; Sequence=VSP_002495;
CC       Name=4; Synonyms=CD28-S1;
CC         IsoId=P10747-4; Sequence=VSP_002496;
CC       Name=5;
CC         IsoId=P10747-5; Sequence=VSP_002495, VSP_002497, VSP_002498;
CC       Name=6; Synonyms=CD28-S3;
CC         IsoId=P10747-6; Sequence=VSP_002495, VSP_002499;
CC       Name=7;
CC         IsoId=P10747-7; Sequence=VSP_047701;
CC   -!- TISSUE SPECIFICITY: Expressed in T-cells and plasma cells, but not in
CC       less mature B-cells.
CC   -!- PTM: CD40LG induces tyrosine phosphorylation of isoform 3.
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CD28 entry;
CC       URL="https://en.wikipedia.org/wiki/CD28";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02988; AAA60581.1; -; mRNA.
DR   EMBL; M37815; AAA51944.1; -; Genomic_DNA.
DR   EMBL; M37812; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37813; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37814; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37815; AAA51945.1; -; Genomic_DNA.
DR   EMBL; M37812; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; M37813; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; M37814; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; AJ295273; CAC29237.1; -; mRNA.
DR   EMBL; AF222341; AAF33792.1; -; mRNA.
DR   EMBL; AF222342; AAF33793.1; -; mRNA.
DR   EMBL; AF222343; AAF33794.1; -; mRNA.
DR   EMBL; AJ517504; CAD57003.1; -; mRNA.
DR   EMBL; EF064755; ABK41938.1; -; Genomic_DNA.
DR   EMBL; AK292986; BAF85675.1; -; mRNA.
DR   EMBL; AK313313; BAG36118.1; -; mRNA.
DR   EMBL; AC125238; AAY24123.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70348.1; -; Genomic_DNA.
DR   EMBL; BC093698; AAH93698.1; -; mRNA.
DR   EMBL; BC112085; AAI12086.1; -; mRNA.
DR   EMBL; AF411057; AAL40931.1; -; Genomic_DNA.
DR   CCDS; CCDS2361.1; -. [P10747-1]
DR   CCDS; CCDS58749.1; -. [P10747-2]
DR   PIR; A39983; RWHU28.
DR   RefSeq; NP_001230006.1; NM_001243077.1. [P10747-4]
DR   RefSeq; NP_001230007.1; NM_001243078.1. [P10747-2]
DR   RefSeq; NP_006130.1; NM_006139.3. [P10747-1]
DR   RefSeq; XP_011510496.1; XM_011512194.2. [P10747-7]
DR   RefSeq; XP_011510499.1; XM_011512197.2. [P10747-3]
DR   PDB; 1YJD; X-ray; 2.70 A; C=17-152.
DR   PDB; 3WA4; X-ray; 1.35 A; B=189-196.
DR   PDB; 5AUL; X-ray; 1.10 A; B=189-196.
DR   PDB; 5GJH; X-ray; 1.20 A; B/D=189-196.
DR   PDB; 5GJI; X-ray; 0.90 A; B=189-196.
DR   PDB; 6O8D; X-ray; 3.55 A; C=19-136.
DR   PDBsum; 1YJD; -.
DR   PDBsum; 3WA4; -.
DR   PDBsum; 5AUL; -.
DR   PDBsum; 5GJH; -.
DR   PDBsum; 5GJI; -.
DR   PDBsum; 6O8D; -.
DR   SMR; P10747; -.
DR   BioGrid; 107378; 20.
DR   CORUM; P10747; -.
DR   DIP; DIP-6043N; -.
DR   ELM; P10747; -.
DR   IntAct; P10747; 10.
DR   MINT; P10747; -.
DR   STRING; 9606.ENSP00000324890; -.
DR   ChEMBL; CHEMBL5191; -.
DR   GuidetoPHARMACOLOGY; 2863; -.
DR   iPTMnet; P10747; -.
DR   PhosphoSitePlus; P10747; -.
DR   BioMuta; CD28; -.
DR   DMDM; 115973; -.
DR   jPOST; P10747; -.
DR   MassIVE; P10747; -.
DR   MaxQB; P10747; -.
DR   PaxDb; P10747; -.
DR   PeptideAtlas; P10747; -.
DR   PRIDE; P10747; -.
DR   ProteomicsDB; 52645; -. [P10747-1]
DR   ProteomicsDB; 52646; -. [P10747-2]
DR   ProteomicsDB; 52647; -. [P10747-3]
DR   ProteomicsDB; 52648; -. [P10747-4]
DR   ProteomicsDB; 52649; -. [P10747-5]
DR   ProteomicsDB; 52650; -. [P10747-6]
DR   ProteomicsDB; 68570; -.
DR   ABCD; P10747; -.
DR   Antibodypedia; 19958; 2209 antibodies.
DR   Ensembl; ENST00000324106; ENSP00000324890; ENSG00000178562. [P10747-1]
DR   Ensembl; ENST00000374481; ENSP00000363605; ENSG00000178562. [P10747-2]
DR   Ensembl; ENST00000458610; ENSP00000393648; ENSG00000178562. [P10747-7]
DR   GeneID; 940; -.
DR   KEGG; hsa:940; -.
DR   UCSC; uc002vah.6; human. [P10747-1]
DR   CTD; 940; -.
DR   DisGeNET; 940; -.
DR   GeneCards; CD28; -.
DR   HGNC; HGNC:1653; CD28.
DR   HPA; ENSG00000178562; Tissue enhanced (blood, lymphoid tissue).
DR   MalaCards; CD28; -.
DR   MIM; 186760; gene.
DR   neXtProt; NX_P10747; -.
DR   OpenTargets; ENSG00000178562; -.
DR   Orphanet; 2584; Classic mycosis fungoides.
DR   Orphanet; 3162; Sezary syndrome.
DR   PharmGKB; PA26207; -.
DR   eggNOG; ENOG410IXMM; Eukaryota.
DR   eggNOG; ENOG410Z063; LUCA.
DR   GeneTree; ENSGT00530000063873; -.
DR   HOGENOM; CLU_154699_0_0_1; -.
DR   InParanoid; P10747; -.
DR   KO; K06470; -.
DR   OMA; HQLQFHS; -.
DR   OrthoDB; 1222373at2759; -.
DR   PhylomeDB; P10747; -.
DR   TreeFam; TF335679; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-164939; Nef mediated downregulation of CD28 cell surface expression.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-389356; CD28 co-stimulation.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   SignaLink; P10747; -.
DR   SIGNOR; P10747; -.
DR   ChiTaRS; CD28; human.
DR   EvolutionaryTrace; P10747; -.
DR   GeneWiki; CD28; -.
DR   GenomeRNAi; 940; -.
DR   Pharos; P10747; Tbio.
DR   PRO; PR:P10747; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P10747; protein.
DR   Bgee; ENSG00000178562; Expressed in leukocyte and 102 other tissues.
DR   Genevisible; P10747; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098636; C:protein complex involved in cell adhesion; IDA:MGI.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; NAS:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; IDA:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0042089; P:cytokine biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0006959; P:humoral immune response; TAS:UniProtKB.
DR   GO; GO:0002376; P:immune system process; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0002863; P:positive regulation of inflammatory response to antigenic stimulus; IEA:Ensembl.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; IDA:UniProtKB.
DR   GO; GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; IDA:UniProtKB.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IDA:UniProtKB.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; NAS:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; NAS:UniProtKB.
DR   GO; GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045066; P:regulatory T cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0042110; P:T cell activation; IGI:BHF-UCL.
DR   GO; GO:0031295; P:T cell costimulation; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IBA:GO_Central.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR008093; CD28.
DR   InterPro; IPR040216; CTLA4/CD28.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013106; Ig_V-set.
DR   PANTHER; PTHR11494; PTHR11494; 1.
DR   Pfam; PF15910; V-set_2; 1.
DR   PRINTS; PR01717; CD28ANTIGEN.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT   CHAIN           19..220
FT                   /note="T-cell-specific surface glycoprotein CD28"
FT                   /id="PRO_0000014652"
FT   TOPO_DOM        19..152
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        180..220
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..137
FT                   /note="Ig-like V-type"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         191
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         209
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15144186"
FT   CARBOHYD        37
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        105
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   CARBOHYD        129
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   DISULFID        40..112
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   DISULFID        66..86
FT                   /evidence="ECO:0000269|PubMed:15696168"
FT   VAR_SEQ         1..17
FT                   /note="MLRLLLALNLFPSIQVT -> MPCGLSALIMCPKGMVAVVVAVDDGDSQALA
FT                   (in isoform 7)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_047701"
FT   VAR_SEQ         19..137
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11877290"
FT                   /id="VSP_002494"
FT   VAR_SEQ         40..137
FT                   /note="CKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYSKTGFNCDGKLG
FT                   NESVTFYLQNLYVNQTDIYFCKIEVMYPPPYLDNEKSNGTIIHVKG -> W (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11877290"
FT                   /id="VSP_002496"
FT   VAR_SEQ         40..124
FT                   /note="CKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYSKTGFNCDGKLG
FT                   NESVTFYLQNLYVNQTDIYFCKIEVMYPPPYLD -> Y (in isoform 3,
FT                   isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11877290,
FT                   ECO:0000303|PubMed:11916166"
FT                   /id="VSP_002495"
FT   VAR_SEQ         138..139
FT                   /note="KH -> EE (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11916166"
FT                   /id="VSP_002497"
FT   VAR_SEQ         140..220
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11916166"
FT                   /id="VSP_002498"
FT   VAR_SEQ         152..207
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11877290"
FT                   /id="VSP_002499"
FT   STRAND          27..30
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          35..43
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          49..58
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          64..74
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          77..79
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          81..83
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          85..90
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          92..101
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   HELIX           104..106
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          108..121
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          123..125
FT                   /evidence="ECO:0000244|PDB:1YJD"
FT   STRAND          131..134
FT                   /evidence="ECO:0000244|PDB:1YJD"
SQ   SEQUENCE   220 AA;  25066 MW;  1D9B6552A5878D0F CRC64;
     MLRLLLALNL FPSIQVTGNK ILVKQSPMLV AYDNAVNLSC KYSYNLFSRE FRASLHKGLD
     SAVEVCVVYG NYSQQLQVYS KTGFNCDGKL GNESVTFYLQ NLYVNQTDIY FCKIEVMYPP
     PYLDNEKSNG TIIHVKGKHL CPSPLFPGPS KPFWVLVVVG GVLACYSLLV TVAFIIFWVR
     SKRSRLLHSD YMNMTPRRPG PTRKHYQPYA PPRDFAAYRS
//
ID   CAD17_HUMAN             Reviewed;         832 AA.
AC   Q12864; Q15336; Q2M2E0;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   22-APR-2020, entry version 170.
DE   RecName: Full=Cadherin-17;
DE   AltName: Full=Intestinal peptide-associated transporter HPT-1;
DE   AltName: Full=Liver-intestine cadherin;
DE            Short=LI-cadherin;
DE   Flags: Precursor;
GN   Name=CDH17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND VARIANTS
RP   GLU-115 AND ASP-734.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=8153632; DOI=10.1126/science.8153632;
RA   Dantzig A.H., Hoskins J., Tabas L.B., Bright S., Shepard R.L.,
RA   Jenkins I.L., Duckworth D.C., Sportsman J.R., MacKensen D.,
RA   Rosteck P.R. Jr., Skatrud P.L.;
RT   "Association of intestinal peptide transport with a protein related to the
RT   cadherin superfamily.";
RL   Science 264:430-433(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-446.
RA   Boettinger A., Kreft B., Fieger C., Dlouhy B., Berndorff D., Goessner R.,
RA   Tauber R.;
RT   "Molecular cloning of human LI-cadherin: evidence for a novel type of
RT   cadherin within the cadherin superfamily.";
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-115 AND ASP-734.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They
CC       preferentially interact with themselves in a homophilic manner in
CC       connecting cells; cadherins may thus contribute to the sorting of
CC       heterogeneous cell types. LI-cadherin may have a role in the
CC       morphological organization of liver and intestine. Involved in
CC       intestinal peptide transport. {ECO:0000269|PubMed:8153632}.
CC   -!- INTERACTION:
CC       Q12864; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-12278850, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the gastrointestinal tract and
CC       pancreatic duct. Not detected in kidney, lung, liver, brain, adrenal
CC       gland and skin. {ECO:0000269|PubMed:8153632}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of each
CC       cadherin domain and rigidify the connections, imparting a strong
CC       curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDH17ID40020ch8q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07969; AAA19021.1; -; mRNA.
DR   EMBL; X83228; CAA58231.1; -; mRNA.
DR   EMBL; AP003351; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC112013; AAI12014.1; -; mRNA.
DR   EMBL; BC113464; AAI13465.1; -; mRNA.
DR   CCDS; CCDS6260.1; -.
DR   PIR; S55396; S55396.
DR   RefSeq; NP_001138135.1; NM_001144663.1.
DR   RefSeq; NP_004054.3; NM_004063.3.
DR   SMR; Q12864; -.
DR   IntAct; Q12864; 1.
DR   STRING; 9606.ENSP00000027335; -.
DR   iPTMnet; Q12864; -.
DR   PhosphoSitePlus; Q12864; -.
DR   BioMuta; CDH17; -.
DR   DMDM; 308153624; -.
DR   jPOST; Q12864; -.
DR   MassIVE; Q12864; -.
DR   MaxQB; Q12864; -.
DR   PaxDb; Q12864; -.
DR   PeptideAtlas; Q12864; -.
DR   PRIDE; Q12864; -.
DR   ProteomicsDB; 58991; -.
DR   ABCD; Q12864; -.
DR   Antibodypedia; 12841; 442 antibodies.
DR   DNASU; 1015; -.
DR   Ensembl; ENST00000027335; ENSP00000027335; ENSG00000079112.
DR   Ensembl; ENST00000450165; ENSP00000401468; ENSG00000079112.
DR   GeneID; 1015; -.
DR   KEGG; hsa:1015; -.
DR   UCSC; uc003ygh.3; human.
DR   CTD; 1015; -.
DR   DisGeNET; 1015; -.
DR   GeneCards; CDH17; -.
DR   HGNC; HGNC:1756; CDH17.
DR   HPA; ENSG00000079112; Tissue enriched (intestine).
DR   MIM; 603017; gene.
DR   neXtProt; NX_Q12864; -.
DR   OpenTargets; ENSG00000079112; -.
DR   PharmGKB; PA26290; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00940000157655; -.
DR   HOGENOM; CLU_016170_0_0_1; -.
DR   InParanoid; Q12864; -.
DR   KO; K06811; -.
DR   OMA; WNEPGAH; -.
DR   OrthoDB; 190556at2759; -.
DR   PhylomeDB; Q12864; -.
DR   TreeFam; TF316817; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   SIGNOR; Q12864; -.
DR   ChiTaRS; CDH17; human.
DR   GeneWiki; CDH17; -.
DR   GenomeRNAi; 1015; -.
DR   Pharos; Q12864; Tbio.
DR   PRO; PR:Q12864; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q12864; protein.
DR   Bgee; ENSG00000079112; Expressed in colonic mucosa and 85 other tissues.
DR   ExpressionAtlas; Q12864; baseline and differential.
DR   Genevisible; Q12864; HS.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016342; C:catenin complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0005427; F:proton-dependent oligopeptide secondary active transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0034332; P:adherens junction organization; IBA:GO_Central.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0000902; P:cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; IBA:GO_Central.
DR   GO; GO:0007043; P:cell-cell junction assembly; IBA:GO_Central.
DR   GO; GO:0002314; P:germinal center B cell differentiation; IEA:Ensembl.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0002315; P:marginal zone B cell differentiation; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0035672; P:oligopeptide transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0006857; P:oligopeptide transport; ISS:UniProtKB.
DR   GO; GO:0033626; P:positive regulation of integrin activation by cell surface receptor linked signal transduction; IMP:UniProtKB.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 6.
DR   SUPFAM; SSF49313; SSF49313; 7.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 6.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane; Glycoprotein; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..832
FT                   /note="Cadherin-17"
FT                   /id="PRO_0000003812"
FT   TOPO_DOM        23..787
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        788..808
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        809..832
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          30..128
FT                   /note="Cadherin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          129..244
FT                   /note="Cadherin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          245..340
FT                   /note="Cadherin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          341..449
FT                   /note="Cadherin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          450..566
FT                   /note="Cadherin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          567..667
FT                   /note="Cadherin 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          668..777
FT                   /note="Cadherin 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   CARBOHYD        149
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        250
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        419
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        456
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        546
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        587
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        722
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         115
FT                   /note="K -> E (in dbSNP:rs2243518)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8153632"
FT                   /id="VAR_055567"
FT   VARIANT         446
FT                   /note="I -> T (in dbSNP:rs1131829)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_031694"
FT   VARIANT         734
FT                   /note="E -> D (in dbSNP:rs1051623)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8153632"
FT                   /id="VAR_031695"
FT   VARIANT         739
FT                   /note="E -> A (in dbSNP:rs1051624)"
FT                   /id="VAR_031696"
SQ   SEQUENCE   832 AA;  92219 MW;  2707547DD2DB4202 CRC64;
     MILQAHLHSL CLLMLYLATG YGQEGKFSGP LKPMTFSIYE GQEPSQIIFQ FKANPPAVTF
     ELTGETDNIF VIEREGLLYY NRALDRETRS THNLQVAALD ANGIIVEGPV PITIKVKDIN
     DNRPTFLQSK YEGSVRQNSR PGKPFLYVNA TDLDDPATPN GQLYYQIVIQ LPMINNVMYF
     QINNKTGAIS LTREGSQELN PAKNPSYNLV ISVKDMGGQS ENSFSDTTSV DIIVTENIWK
     APKPVEMVEN STDPHPIKIT QVRWNDPGAQ YSLVDKEKLP RFPFSIDQEG DIYVTQPLDR
     EEKDAYVFYA VAKDEYGKPL SYPLEIHVKV KDINDNPPTC PSPVTVFEVQ ENERLGNSIG
     TLTAHDRDEE NTANSFLNYR IVEQTPKLPM DGLFLIQTYA GMLQLAKQSL KKQDTPQYNL
     TIEVSDKDFK TLCFVQINVI DINDQIPIFE KSDYGNLTLA EDTNIGSTIL TIQATDADEP
     FTGSSKILYH IIKGDSEGRL GVDTDPHTNT GYVIIKKPLD FETAAVSNIV FKAENPEPLV
     FGVKYNASSF AKFTLIVTDV NEAPQFSQHV FQAKVSEDVA IGTKVGNVTA KDPEGLDISY
     SLRGDTRGWL KIDHVTGEIF SVAPLDREAG SPYRVQVVAT EVGGSSLSSV SEFHLILMDV
     NDNPPRLAKD YTGLFFCHPL SAPGSLIFEA TDDDQHLFRG PHFTFSLGSG SLQNDWEVSK
     INGTHARLST RHTEFEEREY VVLIRINDGG RPPLEGIVSL PVTFCSCVEG SCFRPAGHQT
     GIPTVGMAVG ILLTTLLVIG IILAVVFIRI KKDKGKDNVE SAQASEVKPL RS
//
ID   CSF1R_HUMAN             Reviewed;         972 AA.
AC   P07333; B5A955; D3DQG2; Q6LDW5; Q6LDY4; Q86VW7;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   22-APR-2020, entry version 224.
DE   RecName: Full=Macrophage colony-stimulating factor 1 receptor;
DE   AltName: Full=CSF-1 receptor;
DE            Short=CSF-1-R;
DE            Short=CSF-1R;
DE            Short=M-CSF-R;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-Fms;
DE   AltName: CD_antigen=CD115;
DE   Flags: Precursor;
GN   Name=CSF1R; Synonyms=FMS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2524025;
RA   Hampe A., Shamoon B.M., Gobet M., Sherr C.J., Galibert F.;
RT   "Nucleotide sequence and structural organization of the human FMS proto-
RT   oncogene.";
RL   Oncogene Res. 4:9-17(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2421165; DOI=10.1038/320277a0;
RA   Coussens L., van Beveren C., Smith D., Chen E., Mitchell R.L., Isacke C.M.,
RA   Verma I.M., Ullrich A.;
RT   "Structural alteration of viral homologue of receptor proto-oncogene fms at
RT   carboxyl terminus.";
RL   Nature 320:277-280(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=9027509; DOI=10.1006/geno.1996.4482;
RA   Andre C., Hampe A., Lachaume P., Martin E., Wang X.P., Manus V., Hu W.X.,
RA   Galibert F.;
RT   "Sequence analysis of two genomic regions containing the KIT and the FMS
RT   receptor tyrosine kinase genes.";
RL   Genomics 39:216-226(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=18593464; DOI=10.1186/ar2447;
RA   Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D.,
RA   Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.;
RT   "Novel splice variants derived from the receptor tyrosine kinase
RT   superfamily are potential therapeutics for rheumatoid arthritis.";
RL   Arthritis Res. Ther. 10:R73-R73(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
RX   PubMed=2524648; DOI=10.1128/mcb.9.3.1336;
RA   Visvader J., Verma I.M.;
RT   "Differential transcription of exon 1 of the human c-fms gene in placental
RT   trophoblasts and monocytes.";
RL   Mol. Cell. Biol. 9:1336-1341(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
RX   PubMed=3525854;
RA   Wheeler E.F., Roussel M.F., Hampe A., Walker M.H., Fried V.A., Look A.T.,
RA   Rettenmier C.W., Sherr C.J.;
RT   "The amino-terminal domain of the v-fms oncogene product includes a
RT   functional signal peptide that directs synthesis of a transforming
RT   glycoprotein in the absence of feline leukemia virus gag sequences.";
RL   J. Virol. 59:224-233(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
RC   TISSUE=Placenta;
RA   Flick M.B., Sapi E., Kacinski B.M.;
RT   "Expression of a novel exon in the 5' UTR of human c-fms transcripts.";
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 244-295.
RX   PubMed=4028159; DOI=10.1016/0092-8674(85)90099-6;
RA   Nienhuis A.W., Bunn H.F., Turner P.H., Gopal T.V., Nash W.G., O'Brien S.J.,
RA   Sherr C.J.;
RT   "Expression of the human c-fms proto-oncogene in hematopoietic cells and
RT   its deletion in the 5q- syndrome.";
RL   Cell 42:421-428(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 874-972 (ISOFORM 1).
RX   PubMed=3532121; DOI=10.1073/pnas.83.20.7800;
RA   Browning P.J., Bunn H.F., Cline A., Shuman M., Nienhuis A.W.;
RT   "'Replacement' of COOH-terminal truncation of v-fms with c-fms sequences
RT   markedly reduces transformation potential.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7800-7804(1986).
RN   [13]
RP   FUNCTION IN CELL PROLIFERATION.
RX   PubMed=7683918;
RA   Bourette R.P., Mouchiroud G., Ouazana R., Morle F., Godet J.,
RA   Blanchet J.P.;
RT   "Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine
RT   pluripotent hematopoietic NFS-60 cells induces long-term proliferation in
RT   response to CSF-1 without loss of erythroid differentiation potential.";
RL   Blood 81:2511-2520(1993).
RN   [14]
RP   INTERACTION WITH SRC; FYN AND YES1, AND MUTAGENESIS OF TYR-809.
RX   PubMed=7681396; DOI=10.1002/j.1460-2075.1993.tb05735.x;
RA   Courtneidge S.A., Dhand R., Pilat D., Twamley G.M., Waterfield M.D.,
RA   Roussel M.F.;
RT   "Activation of Src family kinases by colony stimulating factor-1, and their
RT   association with its receptor.";
RL   EMBO J. 12:943-950(1993).
RN   [15]
RP   INDUCTION BY GLUCOCORTICOIDS.
RX   PubMed=7845678;
RA   Sapi E., Flick M.B., Gilmore-Hebert M., Rodov S., Kacinski B.M.;
RT   "Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human
RT   breast carcinoma cells by glucocorticoids.";
RL   Oncogene 10:529-542(1995).
RN   [16]
RP   MUTAGENESIS OF TYR-708 AND ASP-802.
RX   PubMed=10340379; DOI=10.1038/sj.onc.1202646;
RA   Morley G.M., Uden M., Gullick W.J., Dibb N.J.;
RT   "Cell specific transformation by c-fms activating loop mutations is
RT   attributable to constitutive receptor degradation.";
RL   Oncogene 18:3076-3084(1999).
RN   [17]
RP   FUNCTION IN CELLULAR SIGNALING; PHOSPHORYLATION OF INPP5D AND ACTIVATION OF
RP   AKT1.
RX   PubMed=12882960; DOI=10.1074/jbc.m305021200;
RA   Baran C.P., Tridandapani S., Helgason C.D., Humphries R.K., Krystal G.,
RA   Marsh C.B.;
RT   "The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively
RT   regulate macrophage colony-stimulating factor-induced Akt activity.";
RL   J. Biol. Chem. 278:38628-38636(2003).
RN   [18]
RP   FUNCTION IN REGULATION OF CELL PROLIFERATION; CELL ADHESION; CELL SHAPE AND
RP   INTEGRITY OF CELL JUNCTIONS, MUTAGENESIS OF LEU-301 AND TYR-969, AND ROLE
RP   IN DISEASE.
RX   PubMed=15117969; DOI=10.1083/jcb.200309102;
RA   Wrobel C.N., Debnath J., Lin E., Beausoleil S., Roussel M.F., Brugge J.S.;
RT   "Autocrine CSF-1R activation promotes Src-dependent disruption of mammary
RT   epithelial architecture.";
RL   J. Cell Biol. 165:263-273(2004).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-302 AND ASN-353.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [20]
RP   FUNCTION AS CSF1 RECEPTOR, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, ROLE IN
RP   DISEASE, AND ACTIVITY REGULATION.
RX   PubMed=16648572; DOI=10.1158/1535-7163.mct-05-0359;
RA   Guo J., Marcotte P.A., McCall J.O., Dai Y., Pease L.J., Michaelides M.R.,
RA   Davidsen S.K., Glaser K.B.;
RT   "Inhibition of phosphorylation of the colony-stimulating factor-1 receptor
RT   (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine
RT   kinase inhibitors.";
RL   Mol. Cancer Ther. 5:1007-1013(2006).
RN   [21]
RP   FUNCTION IN CELL PROLIFERATION, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION,
RP   ROLE IN DISEASE, AND ACTIVITY REGULATION.
RX   PubMed=17121910; DOI=10.1158/1535-7163.mct-05-0313;
RA   Ohno H., Kubo K., Murooka H., Kobayashi Y., Nishitoba T., Shibuya M.,
RA   Yoneda T., Isoe T.;
RT   "A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast
RT   differentiation and osteolytic bone destruction in a bone metastasis
RT   model.";
RL   Mol. Cancer Ther. 5:2634-2643(2006).
RN   [22]
RP   FUNCTION IN REGULATION OF CELL PROLIFERATION AND CELL SHAPE, CATALYTIC
RP   ACTIVITY, UBIQUITINATION, ACTIVITY REGULATION, AND MUTAGENESIS OF ASP-802.
RX   PubMed=16170366; DOI=10.1038/sj.onc.1209007;
RA   Taylor J.R., Brownlow N., Domin J., Dibb N.J.;
RT   "FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor
RT   imatinib and mutation of Asp-802 to Val confers resistance.";
RL   Oncogene 25:147-151(2006).
RN   [23]
RP   FUNCTION AS IL34 RECEPTOR.
RX   PubMed=18467591; DOI=10.1126/science.1154370;
RA   Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., Halenbeck R., Wu G.,
RA   Zhou A., Behrens D., Hollenbaugh D., Linnemann T., Qin M., Wong J., Chu K.,
RA   Doberstein S.K., Williams L.T.;
RT   "Discovery of a cytokine and its receptor by functional screening of the
RT   extracellular proteome.";
RL   Science 320:807-811(2008).
RN   [24]
RP   ROLE IN DISEASE, AND ACTIVITY REGULATION.
RX   PubMed=18814279; DOI=10.1002/ijc.23903;
RA   Hiraga T., Nakamura H.;
RT   "Imatinib mesylate suppresses bone metastases of breast cancer by
RT   inhibiting osteoclasts through the blockade of c-Fms signals.";
RL   Int. J. Cancer 124:215-222(2009).
RN   [25]
RP   ROLE IN DISEASE.
RX   PubMed=19934330; DOI=10.1158/0008-5472.can-09-1868;
RA   Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R.,
RA   Condeelis J.S.;
RT   "Invasion of human breast cancer cells in vivo requires both paracrine and
RT   autocrine loops involving the colony-stimulating factor-1 receptor.";
RL   Cancer Res. 69:9498-9506(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-699 AND SER-713, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   AUTOPHOSPHORYLATION, AND ACTIVITY REGULATION.
RX   PubMed=20156689; DOI=10.1016/j.bmc.2010.01.056;
RA   Mashkani B., Griffith R., Ashman L.K.;
RT   "Colony stimulating factor-1 receptor as a target for small molecule
RT   inhibitors.";
RL   Bioorg. Med. Chem. 18:1789-1797(2010).
RN   [28]
RP   FUNCTION AS RECEPTOR FOR IL34 AND CSF1, PHOSPHORYLATION AT TYR-546;
RP   TYR-699; TYR-708; TYR-723 AND TYR-809, AUTOPHOSPHORYLATION, ACTIVITY
RP   REGULATION, AND INTERACTION WITH IL34 AND CSF1.
RX   PubMed=20489731; DOI=10.1038/cdd.2010.60;
RA   Chihara T., Suzu S., Hassan R., Chutiwitoonchai N., Hiyoshi M.,
RA   Motoyoshi K., Kimura F., Okada S.;
RT   "IL-34 and M-CSF share the receptor Fms but are not identical in biological
RT   activity and signal activation.";
RL   Cell Death Differ. 17:1917-1927(2010).
RN   [29]
RP   FUNCTION IN RELEASE OF PROINFLAMMATORY CHEMOKINES.
RX   PubMed=20829061; DOI=10.1016/j.cyto.2010.08.005;
RA   Eda H., Zhang J., Keith R.H., Michener M., Beidler D.R., Monahan J.B.;
RT   "Macrophage-colony stimulating factor and interleukin-34 induce chemokines
RT   in human whole blood.";
RL   Cytokine 52:215-220(2010).
RN   [30]
RP   FUNCTION AS IL34 AND CSF1 RECEPTOR; ACTIVATION OF MAPK1/ERK2; MAPK3/ERK1;
RP   PHOSPHORYLATION AT TYR-723, AND AUTOPHOSPHORYLATION.
RX   PubMed=20504948; DOI=10.1189/jlb.1209822;
RA   Wei S., Nandi S., Chitu V., Yeung Y.G., Yu W., Huang M., Williams L.T.,
RA   Lin H., Stanley E.R.;
RT   "Functional overlap but differential expression of CSF-1 and IL-34 in their
RT   CSF-1 receptor-mediated regulation of myeloid cells.";
RL   J. Leukoc. Biol. 88:495-505(2010).
RN   [31]
RP   REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION.
RX   PubMed=15519852; DOI=10.1016/j.tcb.2004.09.016;
RA   Pixley F.J., Stanley E.R.;
RT   "CSF-1 regulation of the wandering macrophage: complexity in action.";
RL   Trends Cell Biol. 14:628-638(2004).
RN   [32]
RP   REVIEW ON FUNCTION IN IMMUNITY AND INFLAMMATION, AND ROLE IN DISEASE.
RX   PubMed=16337366; DOI=10.1016/j.coi.2005.11.006;
RA   Chitu V., Stanley E.R.;
RT   "Colony-stimulating factor-1 in immunity and inflammation.";
RL   Curr. Opin. Immunol. 18:39-48(2006).
RN   [33]
RP   REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION.
RX   PubMed=18687298; DOI=10.1016/j.intimp.2008.04.016;
RA   Douglass T.G., Driggers L., Zhang J.G., Hoa N., Delgado C., Williams C.C.,
RA   Dan Q., Sanchez R., Jeffes E.W., Wepsic H.T., Myers M.P., Koths K.,
RA   Jadus M.R.;
RT   "Macrophage colony stimulating factor: not just for macrophages anymore! A
RT   gateway into complex biologies.";
RL   Int. Immunopharmacol. 8:1354-1376(2008).
RN   [34]
RP   REVIEW.
RX   PubMed=19132917; DOI=10.1146/annurev.immunol.021908.132557;
RA   Auffray C., Sieweke M.H., Geissmann F.;
RT   "Blood monocytes: development, heterogeneity, and relationship with
RT   dendritic cells.";
RL   Annu. Rev. Immunol. 27:669-692(2009).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 538-922 IN COMPLEXES WITH
RP   ARYLAMIDE AND QUINOLONE INHIBITORS, AND DOMAIN.
RX   PubMed=17132624; DOI=10.1074/jbc.m608183200;
RA   Schubert C., Schalk-Hihi C., Struble G.T., Ma H.C., Petrounia I.P.,
RA   Brandt B., Deckman I.C., Patch R.J., Player M.R., Spurlino J.C.,
RA   Springer B.A.;
RT   "Crystal structure of the tyrosine kinase domain of colony-stimulating
RT   factor-1 receptor (cFMS) in complex with two inhibitors.";
RL   J. Biol. Chem. 282:4094-4101(2007).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 543-918 IN AUTOINHIBITED
RP   CONFORMATION, AND DOMAIN.
RX   PubMed=17292918; DOI=10.1016/j.jmb.2007.01.036;
RA   Walter M., Lucet I.S., Patel O., Broughton S.E., Bamert R., Williams N.K.,
RA   Fantino E., Wilks A.F., Rossjohn J.;
RT   "The 2.7 A crystal structure of the autoinhibited human c-Fms kinase
RT   domain.";
RL   J. Mol. Biol. 367:839-847(2007).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 538-922 IN COMPLEX WITH
RP   PYRIMIDINOPYRIDONE INHIBITOR, AND CATALYTIC ACTIVITY.
RX   PubMed=18342505; DOI=10.1016/j.bmcl.2008.02.070;
RA   Huang H., Hutta D.A., Hu H., DesJarlais R.L., Schubert C., Petrounia I.P.,
RA   Chaikin M.A., Manthey C.L., Player M.R.;
RT   "Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-
RT   inflammatory FMS inhibitors.";
RL   Bioorg. Med. Chem. Lett. 18:2355-2361(2008).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 538-922 IN COMPLEX WITH
RP   INHIBITOR, CATALYTIC ACTIVITY, AND FUNCTION IN INFLAMMATION AND DISEASE.
RX   PubMed=19193011; DOI=10.1021/jm801406h;
RA   Huang H., Hutta D.A., Rinker J.M., Hu H., Parsons W.H., Schubert C.,
RA   DesJarlais R.L., Crysler C.S., Chaikin M.A., Donatelli R.R., Chen Y.,
RA   Cheng D., Zhou Z., Yurkow E., Manthey C.L., Player M.R.;
RT   "Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory
RT   macrophage colony-stimulating factor-1 receptor inhibitors.";
RL   J. Med. Chem. 52:1081-1099(2009).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 538-922 IN COMPLEXES WITH
RP   INHIBITORS, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=20137931; DOI=10.1016/j.bmcl.2010.01.078;
RA   Meyers M.J., Pelc M., Kamtekar S., Day J., Poda G.I., Hall M.K.,
RA   Michener M.L., Reitz B.A., Mathis K.J., Pierce B.S., Parikh M.D.,
RA   Mischke D.A., Long S.A., Parlow J.J., Anderson D.R., Thorarensen A.;
RT   "Structure-based drug design enables conversion of a DFG-in binding CSF-1R
RT   kinase inhibitor to a DFG-out binding mode.";
RL   Bioorg. Med. Chem. Lett. 20:1543-1547(2010).
RN   [41]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-32; ARG-362; SER-413; VAL-536; HIS-693;
RP   ASP-920 AND GLN-921.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [42]
RP   VARIANTS HDLS 774-CYS--ASN-814 DEL; 585-GLY--LYS-619 DELINS ALA; GLU-589;
RP   LYS-633; THR-766; PRO-770; ASN-775; THR-794; TYR-837; SER-849; PHE-849 DEL;
RP   PRO-868; THR-875 AND THR-878, VARIANTS HIS-710; ARG-747 AND ASP-920, AND
RP   CHARACTERIZATION OF VARIANTS HDLS LYS-633; THR-766 AND THR-875.
RX   PubMed=22197934; DOI=10.1038/ng.1027;
RA   Rademakers R., Baker M., Nicholson A.M., Rutherford N.J., Finch N.,
RA   Soto-Ortolaza A., Lash J., Wider C., Wojtas A., DeJesus-Hernandez M.,
RA   Adamson J., Kouri N., Sundal C., Shuster E.A., Aasly J., MacKenzie J.,
RA   Roeber S., Kretzschmar H.A., Boeve B.F., Knopman D.S., Petersen R.C.,
RA   Cairns N.J., Ghetti B., Spina S., Garbern J., Tselis A.C., Uitti R.,
RA   Das P., Van Gerpen J.A., Meschia J.F., Levy S., Broderick D.F.,
RA   Graff-Radford N., Ross O.A., Miller B.B., Swerdlow R.H., Dickson D.W.,
RA   Wszolek Z.K.;
RT   "Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause
RT   hereditary diffuse leukoencephalopathy with spheroids.";
RL   Nat. Genet. 44:200-205(2012).
RN   [43]
RP   VARIANTS HDLS THR-766 AND HIS-782, CHARACTERIZATION OF VARIANTS HDLS
RP   HIS-782 AND THR-875, AND AUTOPHOSPHORYLATION.
RX   PubMed=23408870; DOI=10.1212/wnl.0b013e31828726a7;
RA   Nicholson A.M., Baker M.C., Finch N.A., Rutherford N.J., Wider C.,
RA   Graff-Radford N.R., Nelson P.T., Clark H.B., Wszolek Z.K., Dickson D.W.,
RA   Knopman D.S., Rademakers R.;
RT   "CSF1R mutations link POLD and HDLS as a single disease entity.";
RL   Neurology 80:1033-1040(2013).
RN   [44]
RP   VARIANTS HDLS ARG-653; PHE-843 AND THR-906.
RX   PubMed=24532199; DOI=10.1007/s00415-014-7257-3;
RA   Battisti C., Di Donato I., Bianchi S., Monti L., Formichi P., Rufa A.,
RA   Taglia I., Cerase A., Dotti M.T., Federico A.;
RT   "Hereditary diffuse leukoencephalopathy with axonal spheroids: three
RT   patients with stroke-like presentation carrying new mutations in the CSF1R
RT   gene.";
RL   J. Neurol. 261:768-772(2014).
RN   [45]
RP   VARIANTS HDLS ASP-765; GLU-781; THR-794 AND SER-824, CHARACTERIZATION OF
RP   VARIANTS HDLS ASP-765; GLU-781; THR-794 AND SER-824, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=24336230; DOI=10.1212/wnl.0000000000000046;
RA   Konno T., Tada M., Tada M., Koyama A., Nozaki H., Harigaya Y.,
RA   Nishimiya J., Matsunaga A., Yoshikura N., Ishihara K., Arakawa M.,
RA   Isami A., Okazaki K., Yokoo H., Itoh K., Yoneda M., Kawamura M.,
RA   Inuzuka T., Takahashi H., Nishizawa M., Onodera O., Kakita A., Ikeuchi T.;
RT   "Haploinsufficiency of CSF-1R and clinicopathologic characterization in
RT   patients with HDLS.";
RL   Neurology 82:139-148(2014).
RN   [46]
RP   INVOLVEMENT IN BANDDOS, VARIANTS BANDDOS LEU-132; GLN-481--972-CYS DEL AND
RP   LYS-627 DEL, CHARACTERIZATION OF VARIANTS BANDDOS LEU-132 AND LYS-627 DEL,
RP   AND FUNCTION.
RX   PubMed=30982609; DOI=10.1016/j.ajhg.2019.03.004;
RA   Guo L., Bertola D.R., Takanohashi A., Saito A., Segawa Y., Yokota T.,
RA   Ishibashi S., Nishida Y., Yamamoto G.L., Franco J.F.D.S., Honjo R.S.,
RA   Kim C.A., Musso C.M., Timmons M., Pizzino A., Taft R.J., Lajoie B.,
RA   Knight M.A., Fischbeck K.H., Singleton A.B., Ferreira C.R., Wang Z.,
RA   Yan L., Garbern J.Y., Simsek-Kiper P.O., Ohashi H., Robey P.G., Boyde A.,
RA   Matsumoto N., Miyake N., Spranger J., Schiffmann R., Vanderver A.,
RA   Nishimura G., Passos-Bueno M.R.D.S., Simons C., Ishikawa K., Ikegawa S.;
RT   "Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-
RT   Pyle Disease Spectrum and Degenerative Encephalopathy with Brain
RT   Malformation.";
RL   Am. J. Hum. Genet. 104:925-935(2019).
RN   [47]
RP   VARIANT BANDDOS GLN-643, AND FUNCTION.
RX   PubMed=30982608; DOI=10.1016/j.ajhg.2019.03.010;
RA   Oosterhof N., Chang I.J., Karimiani E.G., Kuil L.E., Jensen D.M., Daza R.,
RA   Young E., Astle L., van der Linde H.C., Shivaram G.M., Demmers J.,
RA   Latimer C.S., Keene C.D., Loter E., Maroofian R., van Ham T.J.,
RA   Hevner R.F., Bennett J.T.;
RT   "Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy
RT   and Can Result in Congenital Absence of Microglia.";
RL   Am. J. Hum. Genet. 104:936-947(2019).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor
CC       for CSF1 and IL34 and plays an essential role in the regulation of
CC       survival, proliferation and differentiation of hematopoietic precursor
CC       cells, especially mononuclear phagocytes, such as macrophages and
CC       monocytes. Promotes the release of proinflammatory chemokines in
CC       response to IL34 and CSF1, and thereby plays an important role in
CC       innate immunity and in inflammatory processes. Plays an important role
CC       in the regulation of osteoclast proliferation and differentiation, the
CC       regulation of bone resorption, and is required for normal bone and
CC       tooth development. Required for normal male and female fertility, and
CC       for normal development of milk ducts and acinar structures in the
CC       mammary gland during pregnancy. Promotes reorganization of the actin
CC       cytoskeleton, regulates formation of membrane ruffles, cell adhesion
CC       and cell migration, and promotes cancer cell invasion. Activates
CC       several signaling pathways in response to ligand binding, including the
CC       ERK1/2 and the JNK pathway (PubMed:20504948, PubMed:30982609).
CC       Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2
CC       leads to the production of the cellular signaling molecules
CC       diacylglycerol and inositol 1,4,5-trisphosphate, that then lead to the
CC       activation of protein kinase C family members, especially PRKCD.
CC       Phosphorylation of PIK3R1, the regulatory subunit of
CC       phosphatidylinositol 3-kinase, leads to activation of the AKT1
CC       signaling pathway. Activated CSF1R also mediates activation of the MAP
CC       kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family kinases
CC       SRC, FYN and YES1. Activated CSF1R transmits signals both via proteins
CC       that directly interact with phosphorylated tyrosine residues in its
CC       intracellular domain, or via adapter proteins, such as GRB2. Promotes
CC       activation of STAT family members STAT3, STAT5A and/or STAT5B. Promotes
CC       tyrosine phosphorylation of SHC1 and INPP5D/SHIP-1. Receptor signaling
CC       is down-regulated by protein phosphatases, such as INPP5D/SHIP-1, that
CC       dephosphorylate the receptor and its downstream effectors, and by rapid
CC       internalization of the activated receptor. In the central nervous
CC       system, may play a role in the development of microglia macrophages
CC       (PubMed:30982608). {ECO:0000269|PubMed:12882960,
CC       ECO:0000269|PubMed:15117969, ECO:0000269|PubMed:16170366,
CC       ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:16648572,
CC       ECO:0000269|PubMed:17121910, ECO:0000269|PubMed:18467591,
CC       ECO:0000269|PubMed:18814279, ECO:0000269|PubMed:19193011,
CC       ECO:0000269|PubMed:19934330, ECO:0000269|PubMed:20489731,
CC       ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061,
CC       ECO:0000269|PubMed:30982608, ECO:0000269|PubMed:30982609,
CC       ECO:0000269|PubMed:7683918}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,
CC         ECO:0000269|PubMed:16170366, ECO:0000269|PubMed:16648572,
CC         ECO:0000269|PubMed:17121910, ECO:0000269|PubMed:18342505,
CC         ECO:0000269|PubMed:19193011, ECO:0000269|PubMed:20137931};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. CSF1 or IL34 binding leads to dimerization and
CC       activation by autophosphorylation on tyrosine residues. Inhibited by
CC       imatinib/STI-571 (Gleevec), dasatinib, sunitinib/SU11248,
CC       lestaurtinib/CEP-701, midostaurin/PKC-412, Ki20227, linifanib/ABT-869,
CC       Axitinib/AG013736, sorafenib/BAY 43-9006 and GW2580.
CC       {ECO:0000269|PubMed:16170366, ECO:0000269|PubMed:16648572,
CC       ECO:0000269|PubMed:17121910, ECO:0000269|PubMed:18814279,
CC       ECO:0000269|PubMed:20137931, ECO:0000269|PubMed:20156689,
CC       ECO:0000269|PubMed:20489731}.
CC   -!- SUBUNIT: Interacts with INPPL1/SHIP2 and THOC5 (By similarity).
CC       Monomer. Homodimer. Interacts with CSF1 and IL34. Interaction with
CC       dimeric CSF1 or IL34 leads to receptor homodimerization. Interacts
CC       (tyrosine phosphorylated) with PLCG2 (via SH2 domain). Interacts
CC       (tyrosine phosphorylated) with PIK3R1 (via SH2 domain). Interacts
CC       (tyrosine phosphorylated) with FYN, YES1 and SRC (via SH2 domain).
CC       Interacts (tyrosine phosphorylated) with CBL, GRB2 and SLA2.
CC       {ECO:0000250, ECO:0000269|PubMed:18342505, ECO:0000269|PubMed:19193011,
CC       ECO:0000269|PubMed:20489731, ECO:0000269|PubMed:7681396}.
CC   -!- INTERACTION:
CC       P07333; P09603: CSF1; NbExp=13; IntAct=EBI-2835440, EBI-2872294;
CC       P07333; Q6ZMJ4-1: IL34; NbExp=9; IntAct=EBI-2835440, EBI-15978980;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P07333-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P07333-2; Sequence=VSP_047757, VSP_047758;
CC   -!- TISSUE SPECIFICITY: Expressed in bone marrow and in differentiated
CC       blood mononuclear cells.
CC   -!- INDUCTION: Up-regulated by glucocorticoids.
CC       {ECO:0000269|PubMed:7845678}.
CC   -!- DOMAIN: The juxtamembrane domain functions as autoinhibitory region.
CC       Phosphorylation of tyrosine residues in this region leads to a
CC       conformation change and activation of the kinase.
CC   -!- DOMAIN: The activation loop plays an important role in the regulation
CC       of kinase activity. Phosphorylation of tyrosine residues in this region
CC       leads to a conformation change and activation of the kinase.
CC   -!- PTM: Autophosphorylated in response to CSF1 or IL34 binding
CC       (PubMed:24336230, PubMed:20489731, PubMed:23408870). Phosphorylation at
CC       Tyr-561 is important for normal down-regulation of signaling by
CC       ubiquitination, internalization and degradation. Phosphorylation at
CC       Tyr-561 and Tyr-809 is important for interaction with SRC family
CC       members, including FYN, YES1 and SRC, and for subsequent activation of
CC       these protein kinases. Phosphorylation at Tyr-699 and Tyr-923 is
CC       important for interaction with GRB2. Phosphorylation at Tyr-723 is
CC       important for interaction with PIK3R1. Phosphorylation at Tyr-708 is
CC       important for normal receptor degradation. Phosphorylation at Tyr-723
CC       and Tyr-809 is important for interaction with PLCG2. Phosphorylation at
CC       Tyr-969 is important for interaction with CBL. Dephosphorylation by
CC       PTPN2 negatively regulates downstream signaling and macrophage
CC       differentiation. {ECO:0000269|PubMed:16170366,
CC       ECO:0000269|PubMed:20489731, ECO:0000269|PubMed:23408870,
CC       ECO:0000269|PubMed:24336230}.
CC   -!- PTM: Ubiquitinated. Becomes rapidly polyubiquitinated after
CC       autophosphorylation, leading to its degradation.
CC       {ECO:0000269|PubMed:16170366}.
CC   -!- DISEASE: Note=Aberrant expression of CSF1 or CSF1R can promote cancer
CC       cell proliferation, invasion and formation of metastases.
CC       Overexpression of CSF1 or CSF1R is observed in a significant percentage
CC       of breast, ovarian, prostate, and endometrial cancers.
CC   -!- DISEASE: Note=Aberrant expression of CSF1 or CSF1R may play a role in
CC       inflammatory diseases, such as rheumatoid arthritis,
CC       glomerulonephritis, atherosclerosis, and allograft rejection.
CC   -!- DISEASE: Leukoencephalopathy, diffuse hereditary, with spheroids (HDLS)
CC       [MIM:221820]: An autosomal dominant adult-onset rapidly progressive
CC       neurodegenerative disorder characterized by variable behavioral,
CC       cognitive, and motor changes. Patients often die of dementia within 6
CC       years of onset. Brain imaging shows patchy abnormalities in the
CC       cerebral white matter, predominantly affecting the frontal and parietal
CC       lobes. {ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:23408870,
CC       ECO:0000269|PubMed:24336230, ECO:0000269|PubMed:24532199}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Brain abnormalities, neurodegeneration, and dysosteosclerosis
CC       (BANDDOS) [MIM:618476]: An autosomal recessive disease with variable
CC       manifestations. Main features are brain malformations with calcifying
CC       leukoencephalopathy, progressive neurodegeneration, and bone sclerotic
CC       features. The age at onset ranges from infancy to early adulthood.
CC       Neurologic features include loss of previous motor and language skills,
CC       cognitive impairment, spasticity, and focal seizures. Brain imaging
CC       shows periventricular white matter abnormalities and calcifications,
CC       large cisterna magna or Dandy-Walker malformation, and sometimes
CC       agenesis of the corpus callosum. {ECO:0000269|PubMed:30982608,
CC       ECO:0000269|PubMed:30982609}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CSF1RID40161ch5q32.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03663; CAA27300.1; -; mRNA.
DR   EMBL; U63963; AAB51696.1; -; Genomic_DNA.
DR   EMBL; M25786; AAA58421.1; -; mRNA.
DR   EMBL; EU826593; ACF47629.1; -; mRNA.
DR   EMBL; AC011382; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61749.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61750.1; -; Genomic_DNA.
DR   EMBL; BC047521; AAH47521.1; -; mRNA.
DR   EMBL; M14002; AAA35849.1; -; Genomic_DNA.
DR   EMBL; U78096; AAB51235.1; -; Genomic_DNA.
DR   EMBL; M11067; AAA35848.1; -; Genomic_DNA.
DR   EMBL; M14193; AAA35834.1; -; mRNA.
DR   CCDS; CCDS4302.1; -. [P07333-1]
DR   PIR; S08123; TVHUMD.
DR   RefSeq; NP_001275634.1; NM_001288705.2. [P07333-1]
DR   RefSeq; NP_005202.2; NM_005211.3. [P07333-1]
DR   PDB; 2I0V; X-ray; 2.80 A; A=538-678, A=753-922.
DR   PDB; 2I0Y; X-ray; 1.90 A; A=538-678, A=753-922.
DR   PDB; 2I1M; X-ray; 1.80 A; A=538-678, A=753-922.
DR   PDB; 2OGV; X-ray; 2.70 A; A=543-918.
DR   PDB; 3BEA; X-ray; 2.02 A; A=538-678, A=753-922.
DR   PDB; 3DPK; X-ray; 1.95 A; A=538-678, A=771-922.
DR   PDB; 3KRJ; X-ray; 2.10 A; A=538-678, A=753-922.
DR   PDB; 3KRL; X-ray; 2.40 A; A=538-678, A=753-922.
DR   PDB; 3LCD; X-ray; 2.50 A; A=538-919.
DR   PDB; 3LCO; X-ray; 3.40 A; A=550-919.
DR   PDB; 4DKD; X-ray; 3.00 A; C=20-299.
DR   PDB; 4HW7; X-ray; 2.90 A; A=542-919.
DR   PDB; 4LIQ; X-ray; 2.60 A; E=2-512.
DR   PDB; 4R7H; X-ray; 2.80 A; A=542-919.
DR   PDB; 4R7I; X-ray; 2.75 A; A=542-919.
DR   PDB; 4WRL; X-ray; 2.80 A; A/C=20-296.
DR   PDB; 4WRM; X-ray; 6.85 A; A=20-504.
DR   PDB; 6IG8; X-ray; 1.80 A; A=550-919.
DR   PDB; 6N33; X-ray; 2.25 A; A=542-919.
DR   PDB; 6T2W; X-ray; 1.70 A; A=542-919.
DR   PDBsum; 2I0V; -.
DR   PDBsum; 2I0Y; -.
DR   PDBsum; 2I1M; -.
DR   PDBsum; 2OGV; -.
DR   PDBsum; 3BEA; -.
DR   PDBsum; 3DPK; -.
DR   PDBsum; 3KRJ; -.
DR   PDBsum; 3KRL; -.
DR   PDBsum; 3LCD; -.
DR   PDBsum; 3LCO; -.
DR   PDBsum; 4DKD; -.
DR   PDBsum; 4HW7; -.
DR   PDBsum; 4LIQ; -.
DR   PDBsum; 4R7H; -.
DR   PDBsum; 4R7I; -.
DR   PDBsum; 4WRL; -.
DR   PDBsum; 4WRM; -.
DR   PDBsum; 6IG8; -.
DR   PDBsum; 6N33; -.
DR   PDBsum; 6T2W; -.
DR   SMR; P07333; -.
DR   BioGrid; 107823; 30.
DR   DIP; DIP-59421N; -.
DR   IntAct; P07333; 31.
DR   MINT; P07333; -.
DR   STRING; 9606.ENSP00000286301; -.
DR   BindingDB; P07333; -.
DR   ChEMBL; CHEMBL1844; -.
DR   DrugBank; DB07167; 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE.
DR   DrugBank; DB07202; 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE.
DR   DrugBank; DB06080; ABT-869.
DR   DrugBank; DB12147; Erdafitinib.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB12978; Pexidartinib.
DR   DrugBank; DB01268; Sunitinib.
DR   DrugCentral; P07333; -.
DR   GuidetoPHARMACOLOGY; 1806; -.
DR   GlyConnect; 1955; -.
DR   iPTMnet; P07333; -.
DR   PhosphoSitePlus; P07333; -.
DR   BioMuta; CSF1R; -.
DR   DMDM; 547770; -.
DR   EPD; P07333; -.
DR   jPOST; P07333; -.
DR   MassIVE; P07333; -.
DR   PaxDb; P07333; -.
DR   PeptideAtlas; P07333; -.
DR   PRIDE; P07333; -.
DR   ProteomicsDB; 51993; -. [P07333-1]
DR   ProteomicsDB; 5930; -.
DR   ABCD; P07333; -.
DR   Antibodypedia; 1201; 1716 antibodies.
DR   DNASU; 1436; -.
DR   Ensembl; ENST00000286301; ENSP00000286301; ENSG00000182578. [P07333-1]
DR   Ensembl; ENST00000543093; ENSP00000445282; ENSG00000182578. [P07333-2]
DR   GeneID; 1436; -.
DR   KEGG; hsa:1436; -.
DR   UCSC; uc003lrm.3; human. [P07333-1]
DR   CTD; 1436; -.
DR   DisGeNET; 1436; -.
DR   GeneCards; CSF1R; -.
DR   GeneReviews; CSF1R; -.
DR   HGNC; HGNC:2433; CSF1R.
DR   HPA; ENSG00000182578; Tissue enhanced (blood, lymphoid tissue).
DR   MalaCards; CSF1R; -.
DR   MIM; 164770; gene.
DR   MIM; 221820; phenotype.
DR   MIM; 618476; phenotype.
DR   neXtProt; NX_P07333; -.
DR   OpenTargets; ENSG00000182578; -.
DR   Orphanet; 313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia.
DR   PharmGKB; PA26936; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00940000155506; -.
DR   HOGENOM; CLU_000288_49_0_1; -.
DR   InParanoid; P07333; -.
DR   KO; K05090; -.
DR   OMA; TFQQICF; -.
DR   OrthoDB; 236292at2759; -.
DR   PhylomeDB; P07333; -.
DR   TreeFam; TF325768; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   Reactome; R-HSA-8853884; Transcriptional Regulation by VENTX.
DR   SignaLink; P07333; -.
DR   SIGNOR; P07333; -.
DR   ChiTaRS; CSF1R; human.
DR   EvolutionaryTrace; P07333; -.
DR   GeneWiki; Colony_stimulating_factor_1_receptor; -.
DR   GenomeRNAi; 1436; -.
DR   Pharos; P07333; Tclin.
DR   PRO; PR:P07333; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P07333; protein.
DR   Bgee; ENSG00000182578; Expressed in spleen and 201 other tissues.
DR   ExpressionAtlas; P07333; baseline and differential.
DR   Genevisible; P07333; HS.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:1990682; C:CSF1-CSF1R complex; ISS:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019955; F:cytokine binding; IDA:UniProtKB.
DR   GO; GO:0019838; F:growth factor binding; IBA:GO_Central.
DR   GO; GO:0005011; F:macrophage colony-stimulating factor receptor activity; IMP:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:ARUK-UCL.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0008283; P:cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0045217; P:cell-cell junction maintenance; IMP:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IMP:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IBA:GO_Central.
DR   GO; GO:0030097; P:hemopoiesis; IMP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0038145; P:macrophage colony-stimulating factor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0030225; P:macrophage differentiation; TAS:UniProtKB.
DR   GO; GO:0060603; P:mammary gland duct morphogenesis; TAS:UniProtKB.
DR   GO; GO:0061518; P:microglial cell proliferation; IEA:Ensembl.
DR   GO; GO:0030224; P:monocyte differentiation; TAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:0030316; P:osteoclast differentiation; ISS:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; ISS:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0044794; P:positive regulation by host of viral process; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:2000147; P:positive regulation of cell motility; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0090197; P:positive regulation of chemokine secretion; IMP:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:UniProtKB.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:2000249; P:regulation of actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0045124; P:regulation of bone resorption; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0002931; P:response to ischemia; ISS:ARUK-UCL.
DR   GO; GO:0031529; P:ruffle organization; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR030658; CSF-1_receptor.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF500947; CSF-1_receptor; 1.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Disease mutation; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Inflammatory response; Innate immunity; Kinase;
KW   Membrane; Neurodegeneration; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Receptor; Reference proteome; Repeat; Signal;
KW   Transferase; Transmembrane; Transmembrane helix; Tyrosine-protein kinase;
KW   Ubl conjugation.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..972
FT                   /note="Macrophage colony-stimulating factor 1 receptor"
FT                   /id="PRO_0000016765"
FT   TOPO_DOM        20..517
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        518..538
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        539..972
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          21..104
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          107..197
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          203..290
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          299..399
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          402..502
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          582..910
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         588..596
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          542..574
FT                   /note="Regulatory juxtamembrane domain"
FT   REGION          796..818
FT                   /note="Activation loop"
FT   ACT_SITE        778
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         616
FT                   /note="ATP"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         546
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20489731"
FT   MOD_RES         561
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09581"
FT   MOD_RES         699
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000244|PubMed:19369195,
FT                   ECO:0000269|PubMed:20489731"
FT   MOD_RES         708
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20489731"
FT   MOD_RES         713
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19369195"
FT   MOD_RES         723
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20489731"
FT   MOD_RES         809
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20489731"
FT   MOD_RES         923
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09581"
FT   MOD_RES         969
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09581"
FT   CARBOHYD        45
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        240
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        302
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        335
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        353
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        412
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        428
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        480
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        127..177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        224..278
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        419..485
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         297..306
FT                   /note="ESAYLNLSSE -> GTPSPSLCPA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:18593464"
FT                   /id="VSP_047757"
FT   VAR_SEQ         307..972
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:18593464"
FT                   /id="VSP_047758"
FT   VARIANT         32
FT                   /note="V -> G (in dbSNP:rs56048668)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042038"
FT   VARIANT         132
FT                   /note="P -> L (in BANDDOS; impairs phosphorylation of JNK
FT                   kinases upon stimulation with CSF1; dbSNP:rs1351319114)"
FT                   /evidence="ECO:0000269|PubMed:30982609"
FT                   /id="VAR_083140"
FT   VARIANT         245
FT                   /note="A -> S (in dbSNP:rs41338945)"
FT                   /id="VAR_061290"
FT   VARIANT         279
FT                   /note="V -> M (in dbSNP:rs3829986)"
FT                   /id="VAR_049718"
FT   VARIANT         362
FT                   /note="H -> R (in dbSNP:rs10079250)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042039"
FT   VARIANT         413
FT                   /note="G -> S (in dbSNP:rs34951517)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042040"
FT   VARIANT         481..972
FT                   /note="Missing (in BANDDOS; dbSNP:rs917027829)"
FT                   /evidence="ECO:0000269|PubMed:30982609"
FT                   /id="VAR_083141"
FT   VARIANT         536
FT                   /note="L -> V (in dbSNP:rs55942044)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042041"
FT   VARIANT         585..619
FT                   /note="GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK -> A (in HDLS)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067396"
FT   VARIANT         589
FT                   /note="G -> E (in HDLS; dbSNP:rs281860268)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067397"
FT   VARIANT         627
FT                   /note="Missing (in BANDDOS; impairs phosphorylation of JNK
FT                   kinases upon stimulation with CSF1; dbSNP:rs1554101963)"
FT                   /evidence="ECO:0000269|PubMed:30982609"
FT                   /id="VAR_083142"
FT   VARIANT         633
FT                   /note="E -> K (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs281860269)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067398"
FT   VARIANT         643
FT                   /note="H -> Q (in BANDDOS; dbSNP:rs184499252)"
FT                   /evidence="ECO:0000269|PubMed:30982608"
FT                   /id="VAR_083143"
FT   VARIANT         653
FT                   /note="C -> R (in HDLS; dbSNP:rs690016559)"
FT                   /evidence="ECO:0000269|PubMed:24532199"
FT                   /id="VAR_072081"
FT   VARIANT         693
FT                   /note="P -> H (in a lung squamous cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042042"
FT   VARIANT         710
FT                   /note="R -> H (in dbSNP:rs201569135)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067399"
FT   VARIANT         747
FT                   /note="G -> R (in dbSNP:rs41355444)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067400"
FT   VARIANT         765
FT                   /note="G -> D (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs690016566)"
FT                   /evidence="ECO:0000269|PubMed:24336230"
FT                   /id="VAR_083144"
FT   VARIANT         766
FT                   /note="M -> T (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs281860270)"
FT                   /evidence="ECO:0000269|PubMed:22197934,
FT                   ECO:0000269|PubMed:23408870"
FT                   /id="VAR_067401"
FT   VARIANT         770
FT                   /note="A -> P (in HDLS; dbSNP:rs281860271)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067402"
FT   VARIANT         774..814
FT                   /note="Missing (in HDLS)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067403"
FT   VARIANT         775
FT                   /note="I -> N (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs281860273)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067404"
FT   VARIANT         781
FT                   /note="A -> E (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs587777247)"
FT                   /evidence="ECO:0000269|PubMed:24336230"
FT                   /id="VAR_083145"
FT   VARIANT         782
FT                   /note="R -> H (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs281860281)"
FT                   /evidence="ECO:0000269|PubMed:23408870"
FT                   /id="VAR_083146"
FT   VARIANT         794
FT                   /note="I -> T (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs281860274)"
FT                   /evidence="ECO:0000269|PubMed:22197934,
FT                   ECO:0000269|PubMed:24336230"
FT                   /id="VAR_067405"
FT   VARIANT         824
FT                   /note="P -> S (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1)"
FT                   /evidence="ECO:0000269|PubMed:24336230"
FT                   /id="VAR_083147"
FT   VARIANT         837
FT                   /note="D -> Y (in HDLS; dbSNP:rs387906662)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067406"
FT   VARIANT         843
FT                   /note="I -> F (in HDLS; dbSNP:rs690016558)"
FT                   /evidence="ECO:0000269|PubMed:24532199"
FT                   /id="VAR_072082"
FT   VARIANT         849
FT                   /note="F -> S (in HDLS; dbSNP:rs281860277)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067407"
FT   VARIANT         849
FT                   /note="Missing (in HDLS)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067408"
FT   VARIANT         868
FT                   /note="L -> P (in HDLS; dbSNP:rs281860278)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067409"
FT   VARIANT         875
FT                   /note="M -> T (in HDLS; impairs autophosphorylation upon
FT                   stimulation with CSF1; dbSNP:rs281860279)"
FT                   /evidence="ECO:0000269|PubMed:22197934,
FT                   ECO:0000269|PubMed:23408870"
FT                   /id="VAR_067410"
FT   VARIANT         878
FT                   /note="P -> T (in HDLS; dbSNP:rs281860280)"
FT                   /evidence="ECO:0000269|PubMed:22197934"
FT                   /id="VAR_067411"
FT   VARIANT         906
FT                   /note="I -> T (in HDLS; dbSNP:rs690016560)"
FT                   /evidence="ECO:0000269|PubMed:24532199"
FT                   /id="VAR_072083"
FT   VARIANT         920
FT                   /note="E -> D (in dbSNP:rs34030164)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:22197934"
FT                   /id="VAR_042043"
FT   VARIANT         921
FT                   /note="R -> Q (in dbSNP:rs56059682)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042044"
FT   VARIANT         969
FT                   /note="Y -> C (in dbSNP:rs1801271)"
FT                   /id="VAR_011953"
FT   MUTAGEN         301
FT                   /note="L->S: Constitutive kinase activity."
FT                   /evidence="ECO:0000269|PubMed:15117969"
FT   MUTAGEN         708
FT                   /note="Y->F: Impairs degradation of activated CSF1R."
FT                   /evidence="ECO:0000269|PubMed:10340379"
FT   MUTAGEN         802
FT                   /note="D->V: Constitutive kinase activity. Loss of
FT                   inhibition by imatinib."
FT                   /evidence="ECO:0000269|PubMed:10340379,
FT                   ECO:0000269|PubMed:16170366"
FT   MUTAGEN         809
FT                   /note="Y->F: Reduced kinase activity. Reduced interaction
FT                   with SRC, FYN and YES1."
FT                   /evidence="ECO:0000269|PubMed:7681396"
FT   MUTAGEN         969
FT                   /note="Y->F: Abolishes down-regulation of activated CSF1R."
FT                   /evidence="ECO:0000269|PubMed:15117969"
FT   CONFLICT        54
FT                   /note="P -> A (in Ref. 2; CAA27300)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="P -> H (in Ref. 7; AAH47521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        354
FT                   /note="A -> V (in Ref. 7; AAH47521)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        629
FT                   /note="A -> S (in Ref. 7; AAH47521)"
FT                   /evidence="ECO:0000305"
FT   STRAND          22..25
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          27..32
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          38..43
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          49..51
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   TURN            55..57
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          58..62
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          64..73
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   HELIX           76..78
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          80..85
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          95..101
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          108..111
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          113..118
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          123..125
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          127..130
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   HELIX           132..137
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          139..142
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   HELIX           143..145
FT                   /evidence="ECO:0000244|PDB:4WRL"
FT   STRAND          154..157
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   TURN            158..160
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          161..166
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   HELIX           169..171
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          173..181
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          184..187
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          191..196
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          204..208
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          210..215
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          216..218
FT                   /evidence="ECO:0000244|PDB:4DKD"
FT   STRAND          220..231
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          234..239
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          248..252
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          257..267
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   TURN            270..272
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          274..282
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          285..298
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          300..304
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          309..314
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          319..329
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          332..338
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          340..342
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          351..354
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          361..368
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   HELIX           373..375
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          377..385
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          388..411
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          414..425
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          428..437
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   TURN            443..445
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          446..454
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          456..459
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          466..473
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          479..488
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          493..498
FT                   /evidence="ECO:0000244|PDB:4LIQ"
FT   STRAND          551..553
FT                   /evidence="ECO:0000244|PDB:6IG8"
FT   STRAND          556..560
FT                   /evidence="ECO:0000244|PDB:3BEA"
FT   HELIX           566..568
FT                   /evidence="ECO:0000244|PDB:6IG8"
FT   HELIX           573..575
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          581..590
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          592..601
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          605..607
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          612..618
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           624..640
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          649..653
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          655..658
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          660..664
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           671..682
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   TURN            684..686
FT                   /evidence="ECO:0000244|PDB:6IG8"
FT   TURN            742..744
FT                   /evidence="ECO:0000244|PDB:2OGV"
FT   HELIX           753..771
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           781..783
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          785..787
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           788..790
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          791..794
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           798..800
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           803..805
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   TURN            806..808
FT                   /evidence="ECO:0000244|PDB:3LCO"
FT   STRAND          809..811
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   STRAND          815..817
FT                   /evidence="ECO:0000244|PDB:6IG8"
FT   HELIX           819..821
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           824..829
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           834..848
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   TURN            849..851
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           863..871
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           883..892
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           897..899
FT                   /evidence="ECO:0000244|PDB:2I1M"
FT   HELIX           903..920
FT                   /evidence="ECO:0000244|PDB:2I1M"
SQ   SEQUENCE   972 AA;  107984 MW;  A8D99BE237573FE8 CRC64;
     MGPGVLLLLL VATAWHGQGI PVIEPSVPEL VVKPGATVTL RCVGNGSVEW DGPPSPHWTL
     YSDGSSSILS TNNATFQNTG TYRCTEPGDP LGGSAAIHLY VKDPARPWNV LAQEVVVFED
     QDALLPCLLT DPVLEAGVSL VRVRGRPLMR HTNYSFSPWH GFTIHRAKFI QSQDYQCSAL
     MGGRKVMSIS IRLKVQKVIP GPPALTLVPA ELVRIRGEAA QIVCSASSVD VNFDVFLQHN
     NTKLAIPQQS DFHNNRYQKV LTLNLDQVDF QHAGNYSCVA SNVQGKHSTS MFFRVVESAY
     LNLSSEQNLI QEVTVGEGLN LKVMVEAYPG LQGFNWTYLG PFSDHQPEPK LANATTKDTY
     RHTFTLSLPR LKPSEAGRYS FLARNPGGWR ALTFELTLRY PPEVSVIWTF INGSGTLLCA
     ASGYPQPNVT WLQCSGHTDR CDEAQVLQVW DDPYPEVLSQ EPFHKVTVQS LLTVETLEHN
     QTYECRAHNS VGSGSWAFIP ISAGAHTHPP DEFLFTPVVV ACMSIMALLL LLLLLLLYKY
     KQKPKYQVRW KIIESYEGNS YTFIDPTQLP YNEKWEFPRN NLQFGKTLGA GAFGKVVEAT
     AFGLGKEDAV LKVAVKMLKS TAHADEKEAL MSELKIMSHL GQHENIVNLL GACTHGGPVL
     VITEYCCYGD LLNFLRRKAE AMLGPSLSPG QDPEGGVDYK NIHLEKKYVR RDSGFSSQGV
     DTYVEMRPVS TSSNDSFSEQ DLDKEDGRPL ELRDLLHFSS QVAQGMAFLA SKNCIHRDVA
     ARNVLLTNGH VAKIGDFGLA RDIMNDSNYI VKGNARLPVK WMAPESIFDC VYTVQSDVWS
     YGILLWEIFS LGLNPYPGIL VNSKFYKLVK DGYQMAQPAF APKNIYSIMQ ACWALEPTHR
     PTFQQICSFL QEQAQEDRRE RDYTNLPSSS RSGGSGSSSS ELEEESSSEH LTCCEQGDIA
     QPLLQPNNYQ FC
//
ID   F6KRI5_HUMAN            Unreviewed;       537 AA.
AC   F6KRI5;
DT   27-JUL-2011, integrated into UniProtKB/TrEMBL.
DT   27-JUL-2011, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Catenin alpha 2 isoform CTNNA2b {ECO:0000313|EMBL:AEF32484.1};
GN   Name=CTNNA2 {ECO:0000313|EMBL:AEF32484.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEF32484.1};
RN   [1] {ECO:0000313|EMBL:AEF32484.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:AEF32484.1};
RX   PubMed=21708131; DOI=10.1016/j.bbrc.2011.06.085;
RA   Kask M., Pruunsild P., Timmusk T.;
RT   "Bidirectional transcription from human LRRTM2/CTNNA1 and LRRTM1/CTNNA2
RT   gene loci leads to expression of N-terminally truncated CTNNA1 and CTNNA2
RT   isoforms.";
RL   Biochem. Biophys. Res. Commun. 411:56-61(2011).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ589336; AEF32484.1; -; mRNA.
DR   RefSeq; NP_001269529.1; NM_001282600.1.
DR   SMR; F6KRI5; -.
DR   PRIDE; F6KRI5; -.
DR   Antibodypedia; 8335; 116 antibodies.
DR   GeneID; 1496; -.
DR   CTD; 1496; -.
DR   EuPathDB; HostDB:ENSG00000066032.18; -.
DR   eggNOG; KOG3681; Eukaryota.
DR   eggNOG; ENOG410XSRU; LUCA.
DR   HOGENOM; CLU_015314_0_0_1; -.
DR   ChiTaRS; CTNNA2; human.
DR   GenomeRNAi; 1496; -.
DR   Bgee; ENSG00000066032; Expressed in frontal pole and 135 other tissues.
DR   ExpressionAtlas; F6KRI5; baseline and differential.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR036723; Alpha-catenin/vinculin-like_sf.
DR   InterPro; IPR001033; Alpha_catenin.
DR   InterPro; IPR006077; Vinculin/catenin.
DR   PANTHER; PTHR18914; PTHR18914; 1.
DR   Pfam; PF01044; Vinculin; 1.
DR   PRINTS; PR00805; ALPHACATENIN.
DR   SUPFAM; SSF47220; SSF47220; 3.
PE   2: Evidence at transcript level;
FT   REGION          271..291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          501..523
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        501..515
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   537 AA;  59868 MW;  71B24F41F0B4D6FB CRC64;
     MTKKTRDLRR QLRKAVMDHI SDSFLETNVP LLVLIEAAKS GNEKEVKEYA QVFREHANKL
     VEVANLACSI SNNEEGVKLV RMAATQIDSL CPQVINAALT LAARPQSKVA QDNMDVFKDQ
     WEKQVRVLTE AVDDITSVDD FLSVSENHIL EDVNKCVIAL QEGDVDTLDR TAGAIRGRAA
     RVIHIINAEM ENYEAGVYTE KVLEATKLLS ETVMPRFAEQ VEVAIEALSA NVPQPFEENE
     FIDASRLVYD GVRDIRKAVL MIRTPEELED DSDFEQEDYD VRSRTSVQTE DDQLIAGQSA
     RAIMAQLPQE EKAKIAEQVE IFHQEKSKLD AEVAKWDDSG NDIIVLAKQM CMIMMEMTDF
     TRGKGPLKNT SDVINAAKKI AEAGSRMDKL ARAVADQCPD SACKQDLLAY LQRIALYCHQ
     LNICSKVKAE VQNLGGELIV SGLDSATSLI QAAKNLMNAV VLTVKASYVA STKYQKVYGT
     AAVNSPVVSW KMKAPEKKPL VKREKPEEFQ TRVRRGSQKK HISPVQALSE FKAMDSF
//
ID   CTNA2_HUMAN             Reviewed;         953 AA.
AC   P26232; B3KXE5; B7Z2W7; B7Z352; B7Z898; Q4ZFW1; Q53R26; Q53R33; Q53T67;
AC   Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Catenin alpha-2;
DE   AltName: Full=Alpha N-catenin;
DE   AltName: Full=Alpha-catenin-related protein;
GN   Name=CTNNA2; Synonyms=CAPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8432524; DOI=10.1006/geno.1993.1004;
RA   Claverie J.-M., Hardelin J.-P., Legouis R., Levilliers J., Bougueleret L.,
RA   Mattei M.-G., Petit C.;
RT   "Characterization and chromosomal assignment of a human cDNA encoding a
RT   protein related to the murine 102-kDa cadherin-associated protein (alpha-
RT   catenin).";
RL   Genomics 15:13-20(1993).
RN   [2]
RP   SEQUENCE REVISION TO C-TERMINUS.
RA   Hardelin J.-P.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4 AND 5).
RC   TISSUE=Brain, Hippocampus, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Hippocampus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH ZNF639, AND SUBCELLULAR LOCATION.
RX   PubMed=16182284; DOI=10.1016/j.yexcr.2005.06.018;
RA   Bogaerts S., Vanlandschoot A., van Hengel J., van Roy F.;
RT   "Nuclear translocation of alphaN-catenin by the novel zinc finger
RT   transcriptional repressor ZASC1.";
RL   Exp. Cell Res. 311:1-13(2005).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM 6).
RX   PubMed=18163523; DOI=10.1002/ajmg.b.30679;
RA   Mexal S., Berger R., Pearce L., Barton A., Logel J., Adams C.E., Ross R.G.,
RA   Freedman R., Leonard S.;
RT   "Regulation of a novel alphaN-catenin splice variant in schizophrenic
RT   smokers.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 147:759-768(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   FUNCTION, INTERACTION WITH F-ACTIN, TISSUE SPECIFICITY, INVOLVEMENT IN
RP   CDCBM9, VARIANTS CDCBM9 494-ARG--PHE-953 DEL; 781-ARG--PHE-953 DEL AND
RP   930-ARG--PHE-953 DEL, AND CHARACTERIZATION OF VARIANT CDCBM9
RP   781-ARG--PHE-953 DEL.
RX   PubMed=30013181; DOI=10.1038/s41588-018-0166-0;
RA   Schaffer A.E., Breuss M.W., Caglayan A.O., Al-Sanaa N., Al-Abdulwahed H.Y.,
RA   Kaymakcalan H., Yilmaz C., Zaki M.S., Rosti R.O., Copeland B., Baek S.T.,
RA   Musaev D., Scott E.C., Ben-Omran T., Kariminejad A., Kayserili H.,
RA   Mojahedi F., Kara M., Cai N., Silhavy J.L., Elsharif S., Fenercioglu E.,
RA   Barshop B.A., Kara B., Wang R., Stanley V., James K.N., Nachnani R.,
RA   Kalur A., Megahed H., Incecik F., Danda S., Alanay Y., Faqeih E.,
RA   Melikishvili G., Mansour L., Miller I., Sukhudyan B., Chelly J.,
RA   Dobyns W.B., Bilguvar K., Jamra R.A., Gunel M., Gleeson J.G.;
RT   "Biallelic loss of human CTNNA2, encoding alphaN-catenin, leads to ARP2/3
RT   complex overactivity and disordered cortical neuronal migration.";
RL   Nat. Genet. 50:1093-1101(2018).
CC   -!- FUNCTION: May function as a linker between cadherin adhesion receptors
CC       and the cytoskeleton to regulate cell-cell adhesion and differentiation
CC       in the nervous system (By similarity). Required for proper regulation
CC       of cortical neuronal migration and neurite growth (PubMed:30013181). It
CC       acts as negative regulator of Arp2/3 complex activity and Arp2/3-
CC       mediated actin polymerization (PubMed:30013181). It thereby suppresses
CC       excessive actin branching which would impair neurite growth and
CC       stability (PubMed:30013181). Regulates morphological plasticity of
CC       synapses and cerebellar and hippocampal lamination during development.
CC       Functions in the control of startle modulation (By similarity).
CC       {ECO:0000250|UniProtKB:Q61301, ECO:0000269|PubMed:30013181}.
CC   -!- SUBUNIT: Interacts with CDH1 and CDH2 (By similarity). Interacts with
CC       ZNF639; recruits CTNNA2 to the nucleus (PubMed:16182284). Interacts
CC       with F-actin (PubMed:30013181). {ECO:0000250|UniProtKB:P30997,
CC       ECO:0000269|PubMed:16182284, ECO:0000269|PubMed:30013181}.
CC   -!- INTERACTION:
CC       P26232; Q9UID6: ZNF639; NbExp=7; IntAct=EBI-3953920, EBI-947476;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q61301};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q61301}; Cytoplasmic
CC       side {ECO:0000250|UniProtKB:Q61301}. Cytoplasm
CC       {ECO:0000269|PubMed:16182284}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q61301}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:Q61301}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q61301}. Nucleus {ECO:0000269|PubMed:16182284}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=AlphaN-catenin II;
CC         IsoId=P26232-1; Sequence=Displayed;
CC       Name=2; Synonyms=AlphaN-catenin I;
CC         IsoId=P26232-2; Sequence=VSP_020337;
CC       Name=3;
CC         IsoId=P26232-3; Sequence=VSP_038009;
CC       Name=4;
CC         IsoId=P26232-4; Sequence=VSP_038008, VSP_020337;
CC       Name=5;
CC         IsoId=P26232-5; Sequence=VSP_038007, VSP_020337;
CC       Name=6; Synonyms=AlphaN-catenin III;
CC         IsoId=P26232-6; Sequence=VSP_038005, VSP_038006, VSP_020337;
CC   -!- TISSUE SPECIFICITY: Expressed in neural tissues, with strongest
CC       expression in fetal and adult brain. Expressed in the developing
CC       cortical plate and marginal zone of 20-week-old human fetal brain.
CC       {ECO:0000269|PubMed:30013181}.
CC   -!- DISEASE: Cortical dysplasia, complex, with other brain malformations 9
CC       (CDCBM9) [MIM:618174]: An autosomal recessive disorder characterized by
CC       neurodevelopmental delay apparent from early infancy, acquired
CC       microcephaly, hypotonic cerebral palsy, inability to ambulate or speak,
CC       and intractable seizures. Brain imaging shows pachygyria with severe
CC       cortical gray matter thickening, paucity of gyri without an obvious
CC       posterior-anterior gradient or focal dysplasias, hypogenesis of the
CC       corpus callosum, and cerebellar hypoplasia.
CC       {ECO:0000269|PubMed:30013181}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the vinculin/alpha-catenin family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94151; AAA58407.2; -; mRNA.
DR   EMBL; AK127226; BAG54457.1; -; mRNA.
DR   EMBL; AK295181; BAH12003.1; -; mRNA.
DR   EMBL; AK295493; BAH12088.1; -; mRNA.
DR   EMBL; AK303035; BAH13884.1; -; mRNA.
DR   EMBL; BX537769; CAD97832.1; -; mRNA.
DR   EMBL; AC008067; AAY15073.1; -; Genomic_DNA.
DR   EMBL; AC010975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011741; AAX93241.1; -; Genomic_DNA.
DR   EMBL; AC011746; AAY15008.1; -; Genomic_DNA.
DR   EMBL; AC016670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016716; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093322; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096573; AAY14758.1; -; Genomic_DNA.
DR   EMBL; AC096753; AAY14763.1; -; Genomic_DNA.
DR   EMBL; AC104780; AAX88946.1; -; Genomic_DNA.
DR   EMBL; FJ695201; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAW99564.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99565.1; -; Genomic_DNA.
DR   EMBL; BC052996; AAH52996.1; -; mRNA.
DR   CCDS; CCDS42703.2; -. [P26232-2]
DR   CCDS; CCDS54371.1; -. [P26232-3]
DR   CCDS; CCDS62944.1; -. [P26232-1]
DR   CCDS; CCDS62945.1; -. [P26232-6]
DR   CCDS; CCDS74531.1; -. [P26232-4]
DR   PIR; A45011; A45011.
DR   RefSeq; NP_001158355.1; NM_001164883.1. [P26232-3]
DR   RefSeq; NP_001269526.1; NM_001282597.2. [P26232-1]
DR   RefSeq; NP_001269527.1; NM_001282598.1. [P26232-5]
DR   RefSeq; NP_001269528.1; NM_001282599.1. [P26232-6]
DR   RefSeq; NP_001269529.1; NM_001282600.1. [P26232-4]
DR   RefSeq; NP_001307739.1; NM_001320810.1.
DR   RefSeq; NP_004380.2; NM_004389.3. [P26232-2]
DR   RefSeq; XP_011530857.1; XM_011532555.2. [P26232-1]
DR   RefSeq; XP_011530858.1; XM_011532556.2. [P26232-1]
DR   RefSeq; XP_016858892.1; XM_017003403.1. [P26232-2]
DR   PDB; 6DUW; X-ray; 2.20 A; A=651-953.
DR   PDBsum; 6DUW; -.
DR   SMR; P26232; -.
DR   BioGrid; 107877; 29.
DR   DIP; DIP-60979N; -.
DR   IntAct; P26232; 21.
DR   STRING; 9606.ENSP00000384638; -.
DR   iPTMnet; P26232; -.
DR   PhosphoSitePlus; P26232; -.
DR   SwissPalm; P26232; -.
DR   BioMuta; CTNNA2; -.
DR   DMDM; 114152793; -.
DR   EPD; P26232; -.
DR   jPOST; P26232; -.
DR   MassIVE; P26232; -.
DR   MaxQB; P26232; -.
DR   PeptideAtlas; P26232; -.
DR   PRIDE; P26232; -.
DR   ProteomicsDB; 54314; -. [P26232-1]
DR   ProteomicsDB; 54315; -. [P26232-2]
DR   ProteomicsDB; 54316; -. [P26232-3]
DR   ProteomicsDB; 54317; -. [P26232-4]
DR   ProteomicsDB; 54318; -. [P26232-5]
DR   ProteomicsDB; 54319; -. [P26232-6]
DR   TopDownProteomics; P26232-6; -. [P26232-6]
DR   Antibodypedia; 8335; 116 antibodies.
DR   Ensembl; ENST00000343114; ENSP00000341500; ENSG00000066032. [P26232-6]
DR   Ensembl; ENST00000402739; ENSP00000384638; ENSG00000066032. [P26232-1]
DR   Ensembl; ENST00000466387; ENSP00000418191; ENSG00000066032. [P26232-2]
DR   Ensembl; ENST00000496558; ENSP00000419295; ENSG00000066032. [P26232-2]
DR   Ensembl; ENST00000541047; ENSP00000444675; ENSG00000066032. [P26232-4]
DR   Ensembl; ENST00000629316; ENSP00000486160; ENSG00000066032. [P26232-3]
DR   GeneID; 1496; -.
DR   KEGG; hsa:1496; -.
DR   UCSC; uc010yse.3; human. [P26232-1]
DR   CTD; 1496; -.
DR   DisGeNET; 1496; -.
DR   GeneCards; CTNNA2; -.
DR   HGNC; HGNC:2510; CTNNA2.
DR   HPA; ENSG00000066032; Tissue enhanced (blood, brain, epididymis).
DR   MalaCards; CTNNA2; -.
DR   MIM; 114025; gene.
DR   MIM; 618174; phenotype.
DR   neXtProt; NX_P26232; -.
DR   OpenTargets; ENSG00000066032; -.
DR   PharmGKB; PA27013; -.
DR   GeneTree; ENSGT00950000182729; -.
DR   HOGENOM; CLU_015314_2_0_1; -.
DR   InParanoid; P26232; -.
DR   KO; K05691; -.
DR   OMA; QDELMNN; -.
DR   OrthoDB; 953344at2759; -.
DR   PhylomeDB; P26232; -.
DR   TreeFam; TF313686; -.
DR   Reactome; R-HSA-525793; Myogenesis.
DR   SIGNOR; P26232; -.
DR   ChiTaRS; CTNNA2; human.
DR   GenomeRNAi; 1496; -.
DR   Pharos; P26232; Tbio.
DR   PRO; PR:P26232; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P26232; protein.
DR   Bgee; ENSG00000066032; Expressed in frontal pole and 135 other tissues.
DR   ExpressionAtlas; P26232; baseline and differential.
DR   Genevisible; P26232; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:InterPro.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0098890; C:extrinsic component of postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0098888; C:extrinsic component of presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IEA:Ensembl.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IEA:Ensembl.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0048854; P:brain morphogenesis; ISS:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0098885; P:modification of postsynaptic actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0034316; P:negative regulation of Arp2/3 complex-mediated actin nucleation; IMP:UniProtKB.
DR   GO; GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome.
DR   GO; GO:0060134; P:prepulse inhibition; ISS:UniProtKB.
DR   GO; GO:0021942; P:radial glia guided migration of Purkinje cell; ISS:UniProtKB.
DR   GO; GO:2001222; P:regulation of neuron migration; IMP:UniProtKB.
DR   GO; GO:0010975; P:regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0051823; P:regulation of synapse structural plasticity; ISS:UniProtKB.
DR   InterPro; IPR036723; Alpha-catenin/vinculin-like_sf.
DR   InterPro; IPR001033; Alpha_catenin.
DR   InterPro; IPR006077; Vinculin/catenin.
DR   InterPro; IPR000633; Vinculin_CS.
DR   PANTHER; PTHR18914; PTHR18914; 1.
DR   Pfam; PF01044; Vinculin; 2.
DR   PRINTS; PR00805; ALPHACATENIN.
DR   SUPFAM; SSF47220; SSF47220; 4.
DR   PROSITE; PS00663; VINCULIN_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Differentiation; Disease mutation; Lissencephaly;
KW   Membrane; Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..953
FT                   /note="Catenin alpha-2"
FT                   /id="PRO_0000064263"
FT   MOD_RES         632
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61301"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         651
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61301"
FT   MOD_RES         901
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61301"
FT   MOD_RES         939
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61301"
FT   VAR_SEQ         1..368
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038008"
FT   VAR_SEQ         1..351
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_038005"
FT   VAR_SEQ         1
FT                   /note="M -> MSGLICLQYGLWHGQKIDFGGPRRLLQRNRGEGSM (in isoform
FT                   5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038007"
FT   VAR_SEQ         352
FT                   /note="N -> MDGWRRPLQSVGKVCEKNMKTSEMHTMSGAQ (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_038006"
FT   VAR_SEQ         766..858
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038009"
FT   VAR_SEQ         811..858
FT                   /note="Missing (in isoform 2, isoform 4, isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_020337"
FT   VARIANT         494..953
FT                   /note="Missing (in CDCBM9)"
FT                   /evidence="ECO:0000269|PubMed:30013181"
FT                   /id="VAR_081335"
FT   VARIANT         781..953
FT                   /note="Missing (in CDCBM9; loss-of-function variant
FT                   resulting in decreased neurite length and impaired neuronal
FT                   migration in patient-derived nerve cells; no protein
FT                   detected in patient cells)"
FT                   /evidence="ECO:0000269|PubMed:30013181"
FT                   /id="VAR_081336"
FT   VARIANT         930..953
FT                   /note="Missing (in CDCBM9; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30013181"
FT                   /id="VAR_081337"
FT   CONFLICT        122
FT                   /note="T -> A (in Ref. 3; BAH12003)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        182
FT                   /note="E -> K (in Ref. 1; AAA58407)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        309
FT                   /note="S -> SS (in Ref. 5; AAY15008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        651..652
FT                   /note="SR -> RG (in Ref. 1; AAA58407)"
FT                   /evidence="ECO:0000305"
FT   HELIX           677..702
FT                   /evidence="ECO:0000244|PDB:6DUW"
FT   HELIX           710..729
FT                   /evidence="ECO:0000244|PDB:6DUW"
FT   HELIX           738..765
FT                   /evidence="ECO:0000244|PDB:6DUW"
FT   HELIX           769..792
FT                   /evidence="ECO:0000244|PDB:6DUW"
FT   STRAND          798..802
FT                   /evidence="ECO:0000244|PDB:6DUW"
FT   STRAND          805..809
FT                   /evidence="ECO:0000244|PDB:6DUW"
FT   HELIX           861..894
FT                   /evidence="ECO:0000244|PDB:6DUW"
SQ   SEQUENCE   953 AA;  105313 MW;  5FC88907B37E8A6C CRC64;
     MTSATSPIIL KWDPKSLEIR TLTVERLLEP LVTQVTTLVN TSNKGPSGKK KGRSKKAHVL
     AASVEQATQN FLEKGEQIAK ESQDLKEELV AAVEDVRKQG ETMRIASSEF ADDPCSSVKR
     GTMVRAARAL LSAVTRLLIL ADMADVMRLL SHLKIVEEAL EAVKNATNEQ DLANRFKEFG
     KEMVKLNYVA ARRQQELKDP HCRDEMAAAR GALKKNATML YTASQAFLRH PDVAATRANR
     DYVFKQVQEA IAGISNAAQA TSPTDEAKGH TGIGELAAAL NEFDNKIILD PMTFSEARFR
     PSLEERLESI ISGAALMADS SCTRDDRRER IVAECNAVRQ ALQDLLSEYM NNTGRKEKGD
     PLNIAIDKMT KKTRDLRRQL RKAVMDHISD SFLETNVPLL VLIEAAKSGN EKEVKEYAQV
     FREHANKLVE VANLACSISN NEEGVKLVRM AATQIDSLCP QVINAALTLA ARPQSKVAQD
     NMDVFKDQWE KQVRVLTEAV DDITSVDDFL SVSENHILED VNKCVIALQE GDVDTLDRTA
     GAIRGRAARV IHIINAEMEN YEAGVYTEKV LEATKLLSET VMPRFAEQVE VAIEALSANV
     PQPFEENEFI DASRLVYDGV RDIRKAVLMI RTPEELEDDS DFEQEDYDVR SRTSVQTEDD
     QLIAGQSARA IMAQLPQEEK AKIAEQVEIF HQEKSKLDAE VAKWDDSGND IIVLAKQMCM
     IMMEMTDFTR GKGPLKNTSD VINAAKKIAE AGSRMDKLAR AVADQCPDSA CKQDLLAYLQ
     RIALYCHQLN ICSKVKAEVQ NLGGELIVSG TGVQSTFTTF YEVDCDVIDG GRASQLSTHL
     PTCAEGAPIG SGSSDSSMLD SATSLIQAAK NLMNAVVLTV KASYVASTKY QKVYGTAAVN
     SPVVSWKMKA PEKKPLVKRE KPEEFQTRVR RGSQKKHISP VQALSEFKAM DSF
//
ID   Q49AD3_HUMAN            Unreviewed;       687 AA.
AC   Q49AD3;
DT   13-SEP-2005, integrated into UniProtKB/TrEMBL.
DT   13-SEP-2005, sequence version 1.
DT   22-APR-2020, entry version 70.
DE   SubName: Full=CTNNA2 protein {ECO:0000313|EMBL:AAH40458.1};
GN   Name=CTNNA2 {ECO:0000313|EMBL:AAH40458.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH40458.1};
RN   [1] {ECO:0000313|EMBL:AAH40458.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH40458.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC040458; AAH40458.1; -; mRNA.
DR   RefSeq; NP_004380.2; NM_004389.3.
DR   PeptideAtlas; Q49AD3; -.
DR   PRIDE; Q49AD3; -.
DR   GeneID; 1496; -.
DR   CTD; 1496; -.
DR   PharmGKB; PA27009; -.
DR   eggNOG; KOG3681; Eukaryota.
DR   eggNOG; ENOG410XSRU; LUCA.
DR   ChiTaRS; CTNNA2; human.
DR   GenomeRNAi; 1496; -.
DR   Genevisible; Q49AD3; HS.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR036723; Alpha-catenin/vinculin-like_sf.
DR   InterPro; IPR001033; Alpha_catenin.
DR   InterPro; IPR006077; Vinculin/catenin.
DR   PANTHER; PTHR18914; PTHR18914; 1.
DR   Pfam; PF01044; Vinculin; 2.
DR   PRINTS; PR00805; ALPHACATENIN.
DR   SUPFAM; SSF47220; SSF47220; 4.
PE   2: Evidence at transcript level;
FT   REGION          651..673
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        651..665
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   687 AA;  76384 MW;  C7FB874BFAFCA16D CRC64;
     MLYTASQAFL RHPDVAATRA NRDYVFKQVQ EAIAGISNAA QATSPTDEAK GHTGIGELAA
     ALNEFDNKII LDPMTFSEAR FRQSLEERLE SIISGAALMA DSSCTRDDRR ERIVAECNAV
     RQALQDLLSE YMNNTGRKEK GDPLNIAIDK MTKKTRDLRR QLRKAVMDHI SDSFLETNVP
     LLVLIEAAKS GNEKEVKEYA QVFREHANKL VEVANLACSI SNNEEGVKLV RMAATQIDSL
     CPQVINAALT LAARPQSKVA QDNMDVFKDQ WEKQVRVLTE AVDDITSVDD FLSVSENHIL
     EDVNKCVIAL QEGDVDTLDR TAGAIRGRAA RVIHIINAEM ENYEAGVYTE KVLEATKLLS
     ETVMPRFAEQ VEVAIEALSA NVPQPFEENE FIDASRLVYD GVRDIRKAVL MIRTPEELED
     DSDFEQEDYD VRSRTSVQTE DDQLIAGQSA RAIMAQLPQE EKAKIAEQVE IFHQEKSKLD
     AEVAKWDDSG NDIIVLAKQM CMIMMEMTDF TRGKGPLKNT SDVINAAKKI AEAGSRMDKL
     ARAVADQCPD SACKQDLLAY LQRIALYCHQ LNICSKVKAE VQNLGGELIV SGLDSATSLI
     QAAKNLMNAV VLTVKASYVA STKYQKVYGT AAVNSPVVSW KMKAPEKKPL VKREKPEEFQ
     TRVRRGSQKK HISPVQALSE FKAMDSF
//
ID   B4DJU1_HUMAN            Unreviewed;       792 AA.
AC   B4DJU1;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 55.
DE   SubName: Full=cDNA FLJ61296, highly similar to Catenin delta-2 {ECO:0000313|EMBL:BAG58953.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58953.1};
RN   [1] {ECO:0000313|EMBL:BAG58953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thalamus {ECO:0000313|EMBL:BAG58953.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK296232; BAG58953.1; -; mRNA.
DR   RefSeq; NP_001275646.1; NM_001288717.1.
DR   PeptideAtlas; B4DJU1; -.
DR   PRIDE; B4DJU1; -.
DR   GeneID; 1501; -.
DR   CTD; 1501; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   OrthoDB; 233858at2759; -.
DR   SignaLink; B4DJU1; -.
DR   GenomeRNAi; 1501; -.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   2: Evidence at transcript level;
FT   REPEAT          159..192
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REPEAT          203..246
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REPEAT          459..496
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          81..108
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          609..646
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        609..642
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   792 AA;  87216 MW;  CECEED1CD929EA20 CRC64;
     MRSLSQSQGD PLPPAHTGTY RTSTAPSSPG VDSVPLQRTG SQHGPQNAAA ATFQRASYAA
     GPASNYADPY RQLQYCPSVE SPYSKSGPAL PPEGTLARSP SIDSIQKDPR EFGWRDPELP
     EVIQMLQHQF PSVQSNAAAY LQHLCFGDNK IKAEIRRQGG IQLLVDLLDH RMTEVHRSAC
     GALRNLVYGK ANDDNKIALK NCGGIPALVR LLRKTTDLEI RELVTGVLWN LSSCDALKMP
     IIQDALAVLT NAVIIPHSGW ENSPLQDDRK IQLHSSQVLR NATGCLRNVS SAGEEARRRM
     RECDGLTDAL LYVIQSALGS SEIDSKTVEN CVCILRNLSY RLAAETSQGQ HMGTDELDGL
     LCGEANGKDA ESSGCWGKKK KKKKSQDQWD GVGPLPDCAE PPKGIQMLWH PSIVKPYLTL
     LSECSNPDTL EGAAGALQNL AAGSWKWSVY IRAAVRKEKG LPILVELLRI NNDRVVCAVA
     TALRNMALDV RNKELIGKYA MRDLVHRLPG GNNSNNTASK AMSDDTVTAV CCTLHEVITK
     NMENAKALRD AGGIEKLVGI SKSKGDKHSP KVVKAASQVL NSMWQYRDLR SLYKKDGWSQ
     YHFVASSSTI ERDRQRPYSS SRTPSISPVR VSPNNRSASA PASPREMISL KERKTDYECT
     GSNATYHGAK GEHTSRKDAM TAQNTGISTL YRNSYGAPAE DIKHNQVSAQ PVPQEPSRKD
     YETYQPFQNS TRNYDESFFE DQVHHRPPAS EYTMHLGLKS TGNYVDFYSA ARPYSELNYE
     TSHYPASPDS WV
//
ID   B4DRK2_HUMAN            Unreviewed;       888 AA.
AC   B4DRK2;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 93.
DE   SubName: Full=Catenin delta-2 {ECO:0000313|Ensembl:ENSP00000426887};
DE   SubName: Full=cDNA FLJ56233, highly similar to Catenin delta-2 {ECO:0000313|EMBL:BAG61314.1};
GN   Name=CTNND2 {ECO:0000313|Ensembl:ENSP00000426887};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61314.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000426887, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000313|EMBL:BAG61314.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000426887}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC003954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876929; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK299300; BAG61314.1; -; mRNA.
DR   RefSeq; NP_001275645.1; NM_001288716.1.
DR   ProteomicsDB; 4956; -.
DR   Antibodypedia; 9404; 186 antibodies.
DR   Ensembl; ENST00000503622; ENSP00000426887; ENSG00000169862.
DR   GeneID; 1501; -.
DR   UCSC; uc011cmy.3; human.
DR   CTD; 1501; -.
DR   EuPathDB; HostDB:ENSG00000169862.18; -.
DR   HGNC; HGNC:2516; CTNND2.
DR   OpenTargets; ENSG00000169862; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00940000154952; -.
DR   HOGENOM; CLU_007897_0_1_1; -.
DR   OrthoDB; 233858at2759; -.
DR   ChiTaRS; CTNND2; human.
DR   GenomeRNAi; 1501; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000169862; Expressed in dorsolateral prefrontal cortex and 151 other tissues.
DR   ExpressionAtlas; B4DRK2; baseline and differential.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 2.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:B4DRK2,
KW   ECO:0000213|PeptideAtlas:B4DRK2, ECO:0000213|ProteomicsDB:B4DRK2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REPEAT          255..288
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REPEAT          299..342
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REPEAT          555..592
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          41..142
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          180..199
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          705..742
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..17
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        45..65
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        75..91
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        96..142
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        705..738
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   888 AA;  97980 MW;  26FB89944FD220C5 CRC64;
     MSSMSSAEEQ FQWQSQDGQK DIEDELTTGL ELVDSCIRSL QESGILDPQD YSTGETGSRA
     SYSSQHGHLG PELRALQSPE HHIDPIYEDR VYQKPPMRSL SQSQGDPLPP AHTGTYRTST
     APSSPGVDSV PLQRTGSQHG PQNAAAATFQ RASYAAGPAS NYADPYRQLQ YCPSVESPYS
     KSGPALPPEG TLARSPSIDS IQKDPREFGW RDPELPEVIQ MLQHQFPSVQ SNAAAYLQHL
     CFGDNKIKAE IRRQGGIQLL VDLLDHRMTE VHRSACGALR NLVYGKANDD NKIALKNCGG
     IPALVRLLRK TTDLEIRELV TGVLWNLSSC DALKMPIIQD ALAVLTNAVI IPHSGWENSP
     LQDDRKIQLH SSQVLRNATG CLRNVSSAGE EARRRMRECD GLTDALLYVI QSALGSSEID
     SKTVENCVCI LRNLSYRLAA ETSQGQHMGT DELDGLLCGE ANGKDAESSG CWGKKKKKKK
     SQDQWDGVGP LPDCAEPPKG IQMLWHPSIV KPYLTLLSEC SNPDTLEGAA GALQNLAAGS
     WKWSVYIRAA VRKEKGLPIL VELLRIDNDR VVCAVATALR NMALDVRNKE LIGKYAMRDL
     VHRLPGGNNS NNTASKAMSD DTVTAVCCTL HEVITKNMEN AKALRDAGGI EKLVGISKSK
     GDKHSPKVVK AASQVLNSMW QYRDLRSLYK KDGWSQYHFV ASSSTIERDR QRPYSSSRTP
     SISPVRVSPN NRSASAPASP REMISLKERK TDYECTGSNA TYHGAKGEHT SRKDAMTAQN
     TGISTLYRNS YGAPAEDIKH NQVSAQPVPQ EPSRKDYETY QPFQNSTRNY DESFFEDQVH
     HRPPASEYTM HLGLKSTGNY VDFYSAARPY SELNYETSHY PASPDSWV
//
ID   E7EPC8_HUMAN            Unreviewed;      1134 AA.
AC   E7EPC8;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   22-APR-2020, entry version 65.
DE   SubName: Full=Catenin delta-2 {ECO:0000313|Ensembl:ENSP00000426510};
GN   Name=CTNND2 {ECO:0000313|Ensembl:ENSP00000426510};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000426510, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000426510, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000426510}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC003954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876929; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001275644.1; NM_001288715.1.
DR   SMR; E7EPC8; -.
DR   jPOST; E7EPC8; -.
DR   MaxQB; E7EPC8; -.
DR   PeptideAtlas; E7EPC8; -.
DR   PRIDE; E7EPC8; -.
DR   ProteomicsDB; 17330; -.
DR   Antibodypedia; 9404; 186 antibodies.
DR   Ensembl; ENST00000511377; ENSP00000426510; ENSG00000169862.
DR   GeneID; 1501; -.
DR   UCSC; uc010itt.4; human.
DR   CTD; 1501; -.
DR   EuPathDB; HostDB:ENSG00000169862.18; -.
DR   HGNC; HGNC:2516; CTNND2.
DR   OpenTargets; ENSG00000169862; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00940000154952; -.
DR   OrthoDB; 233858at2759; -.
DR   SignaLink; E7EPC8; -.
DR   ChiTaRS; CTNND2; human.
DR   GenomeRNAi; 1501; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000169862; Expressed in dorsolateral prefrontal cortex and 151 other tissues.
DR   ExpressionAtlas; E7EPC8; baseline and differential.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:E7EPC8,
KW   ECO:0000213|PeptideAtlas:E7EPC8, ECO:0000213|ProteomicsDB:E7EPC8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REPEAT          501..534
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REPEAT          545..588
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REPEAT          801..838
FT                   /note="ARM"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          43..151
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          165..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          341..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          426..450
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          951..988
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..17
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        54..119
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        124..140
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        205..221
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..392
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        951..984
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1134 AA;  123083 MW;  331E63AC6B230E3D CRC64;
     MSSMSSAEEQ FQWQSQDGQK DIEDELTTGL ELVDSCIRSL QESGILDPQD YSTGERPSLL
     SQSALQLNSK PEGSFQYPAS YHSNQTLALG ETTPSQLPAR GTQARATGQS FSQGTTSRAG
     HLAGPEPAPP PPPPPREPFA PSLGSAFHLP DAPPAAAAAA LYYSSSTLPA PPRGGSPLAA
     PQGGSPTKLQ RGGSAPEGAT YAAPRGSSPK QSPSRLAKSY STSSPINIVV SSAGLSPIRV
     TSPPTVQSTI SSSPIHQLSS TIGTYATLSP TKRLVHASEQ YSKHSQELYA TATLQRPGSL
     AAGSRASYSS QHGHLGPELR ALQSPEHHID PIYEDRVYQK PPMRSLSQSQ GDPLPPAHTG
     TYRTSTAPSS PGVDSVPLQR TGSQHGPQNA AAATFQRASY AAGPASNYAD PYRQLQYCPS
     VESPYSKSGP ALPPEGTLAR SPSIDSIQKD PREFGWRDPE LPEVIQMLQH QFPSVQSNAA
     AYLQHLCFGD NKIKAEIRRQ GGIQLLVDLL DHRMTEVHRS ACGALRNLVY GKANDDNKIA
     LKNCGGIPAL VRLLRKTTDL EIRELVTGVL WNLSSCDALK MPIIQDALAV LTNAVIIPHS
     GWENSPLQDD RKIQLHSSQV LRNATGCLRN VSSAGEEARR RMRECDGLTD ALLYVIQSAL
     GSSEIDSKTV ENCVCILRNL SYRLAAETSQ GQHMGTDELD GLLCGEANGK DAESSGCWGK
     KKKKKKSQDQ WDGVGPLPDC AEPPKGIQML WHPSIVKPYL TLLSECSNPD TLEGAAGALQ
     NLAAGSWKWS VYIRAAVRKE KGLPILVELL RIDNDRVVCA VATALRNMAL DVRNKELIGK
     YAMRDLVHRL PGGNNSNNTA SKAMSDDTVT AVCCTLHEVI TKNMENAKAL RDAGGIEKLV
     GISKSKGDKH SPKVVKAASQ VLNSMWQYRD LRSLYKKDGW SQYHFVASSS TIERDRQRPY
     SSSRTPSISP VRVSPNNRSA SAPASPREMI SLKERKTDYE CTGSNATYHG AKGEHTSRKD
     AMTAQNTGIS TLYRNSYGAP AEDIKHNQVS AQPVPQEPSR KDYETYQPFQ NSTRNYDESF
     FEDQVHHRPP ASEYTMHLGL KSTGNYVDFY SAARPYSELN YETSHYPASP DSWV
//
ID   CTND2_HUMAN             Reviewed;        1225 AA.
AC   Q9UQB3; B0FTZ7; O00379; O15390; O43206; O43840; Q13589; Q9UM66; Q9UPM3;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 3.
DT   22-APR-2020, entry version 169.
DE   RecName: Full=Catenin delta-2;
DE   AltName: Full=Delta-catenin;
DE   AltName: Full=GT24;
DE   AltName: Full=Neural plakophilin-related ARM-repeat protein;
DE            Short=NPRAP;
DE   AltName: Full=Neurojungin;
GN   Name=CTNND2; Synonyms=NPRAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH PSEN1.
RX   PubMed=9223106; DOI=10.1097/00001756-199705260-00054;
RA   Zhou J., Liyanage U., Medina M., Ho C., Simmons A.D., Lovett M.,
RA   Kosik K.S.;
RT   "Presenilin 1 interaction in the brain with a novel member of the Armadillo
RT   family.";
RL   NeuroReport 8:2085-2090(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=9971746; DOI=10.1083/jcb.144.3.519;
RA   Lu Q., Paredes M., Medina M., Zhou J., Cavallo R., Peifer M., Orecchio L.,
RA   Kosik K.S.;
RT   "Delta-catenin, an adhesive junction-associated protein which promotes cell
RT   scattering.";
RL   J. Cell Biol. 144:519-532(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH PSEN1.
RC   TISSUE=Fetal brain;
RX   PubMed=10208590; DOI=10.1097/00001756-199902250-00022;
RA   Tanahashi H., Tabira T.;
RT   "Isolation of human delta-catenin and its binding specificity with
RT   presenilin 1.";
RL   NeuroReport 10:563-568(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-275; THR-482 AND
RP   ARG-810.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 186-1225 (ISOFORM 1), AND INTERACTION WITH
RP   PSEN1.
RC   TISSUE=Brain;
RX   PubMed=10037471; DOI=10.1046/j.1471-4159.1999.0720999.x;
RA   Levesque G., Yu G., Nishimura M., Zhang D.M., Levesque L., Yu H., Xu D.,
RA   Liang Y., Rogaeva E.A., Ikeda M., Duthie M., Murgolo N., Wang L.,
RA   VanderVere P., Bayne M.L., Strader C.D., Rommens J.M., Fraser P.E.,
RA   St George-Hyslop P.H.;
RT   "Presenilins interact with armadillo proteins including neural-specific
RT   plakophilin-related protein and beta-catenin.";
RL   J. Neurochem. 72:999-1008(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 350-1225 (ISOFORM 1), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Fetal brain;
RX   PubMed=9342840; DOI=10.1046/j.1432-0436.1997.6150293.x;
RA   Paffenholz R., Franke W.W.;
RT   "Identification and localization of a neurally expressed member of the
RT   plakoglobin/armadillo multigene family.";
RL   Differentiation 61:293-304(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 689-1225 (ISOFORM 1).
RA   Fraser P.E., Levesque G., Rogaeva E.A., Yu G., St George-Hyslop P.H.;
RT   "A novel gene from the arm family.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 746-1225 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 865-1225 (ISOFORMS 1/2).
RX   PubMed=9049630; DOI=10.1101/gr.7.2.118;
RA   Simmons A.D., Overhauser J., Lovett M.;
RT   "Isolation of cDNAs from the Cri-du-chat critical region by direct
RT   screening of a chromosome 5-specific cDNA library.";
RL   Genome Res. 7:118-127(1997).
RN   [12]
RP   INTERACTION WITH ARHGEF28.
RX   PubMed=17993462; DOI=10.1074/jbc.m707158200;
RA   Kim H., Han J.-R., Park J., Oh M., James S.E., Chang S., Lu Q., Lee K.Y.,
RA   Ki H., Song W.-J., Kim K.;
RT   "Delta-catenin-induced dendritic morphogenesis. An essential role of
RT   p190RhoGEF interaction through Akt1-mediated phosphorylation.";
RL   J. Biol. Chem. 283:977-987(2008).
RN   [13]
RP   INTERACTION WITH GSK3A AND GSK3B, AND PHOSPHORYLATION BY GSK3B.
RX   PubMed=19706605; DOI=10.1074/jbc.m109.002659;
RA   Oh M., Kim H., Yang I., Park J.H., Cong W.T., Baek M.C., Bareiss S., Ki H.,
RA   Lu Q., No J., Kwon I., Choi J.K., Kim K.;
RT   "GSK-3 phosphorylates delta-catenin and negatively regulates its stability
RT   via ubiquitination/proteosome-mediated proteolysis.";
RL   J. Biol. Chem. 284:28579-28589(2009).
RN   [14]
RP   INTERACTION WITH FRMPD2.
RX   PubMed=19706687; DOI=10.1242/jcs.046854;
RA   Stenzel N., Fetzer C.P., Heumann R., Erdmann K.S.;
RT   "PDZ-domain-directed basolateral targeting of the peripheral membrane
RT   protein FRMPD2 in epithelial cells.";
RL   J. Cell Sci. 122:3374-3384(2009).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH DNM2.
RX   PubMed=22022388; DOI=10.1371/journal.pone.0025379;
RA   Koutras C., Levesque G.;
RT   "Identification of novel NPRAP/delta-catenin-interacting proteins and the
RT   direct association of NPRAP with dynamin 2.";
RL   PLoS ONE 6:E25379-E25379(2011).
RN   [16]
RP   INTERACTION WITH CCDC85B.
RX   PubMed=25009281; DOI=10.1091/mbc.e13-08-0492;
RA   Markham N.O., Doll C.A., Dohn M.R., Miller R.K., Yu H., Coffey R.J.,
RA   McCrea P.D., Gamse J.T., Reynolds A.B.;
RT   "DIPA-family coiled-coils bind conserved isoform-specific head domain of
RT   p120-catenin family: potential roles in hydrocephalus and heterotopia.";
RL   Mol. Biol. Cell 25:2592-2603(2014).
RN   [17]
RP   FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH CTNNB1, INVOLVEMENT IN
RP   AUTISM, VARIANTS SER-34; LEU-189; LEU-224; CYS-275; HIS-330; HIS-454;
RP   ASN-465; THR-482; PRO-507; CYS-713 AND MET-862, AND CHARACTERIZATION OF
RP   VARIANTS SER-34; LEU-189; LEU-224; CYS-275; HIS-330; HIS-454; ASN-465;
RP   THR-482; PRO-507; CYS-713; ARG-810 AND MET-862.
RX   PubMed=25807484; DOI=10.1038/nature14186;
RA   Turner T.N., Sharma K., Oh E.C., Liu Y.P., Collins R.L., Sosa M.X.,
RA   Auer D.R., Brand H., Sanders S.J., Moreno-De-Luca D., Pihur V., Plona T.,
RA   Pike K., Soppet D.R., Smith M.W., Cheung S.W., Martin C.L., State M.W.,
RA   Talkowski M.E., Cook E., Huganir R., Katsanis N., Chakravarti A.;
RT   "Loss of delta-catenin function in severe autism.";
RL   Nature 520:51-56(2015).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-1159.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Has a critical role in neuronal development, particularly in
CC       the formation and/or maintenance of dendritic spines and synapses
CC       (PubMed:25807484). Involved in the regulation of Wnt signaling
CC       (PubMed:25807484). It probably acts on beta-catenin turnover,
CC       facilitating beta-catenin interaction with GSK3B, phosphorylation,
CC       ubiquitination and degradation (By similarity). Functions as a
CC       transcriptional activator when bound to ZBTB33 (By similarity). May be
CC       involved in neuronal cell adhesion and tissue morphogenesis and
CC       integrity by regulating adhesion molecules.
CC       {ECO:0000250|UniProtKB:O35927, ECO:0000269|PubMed:25807484,
CC       ECO:0000269|PubMed:9971746}.
CC   -!- SUBUNIT: Binds to E-cadherin at a juxtamembrane site within the
CC       cytoplasmic domain (By similarity). Interacts with PDZD2 (By
CC       similarity). Interacts with ZBTB33 (By similarity). Binds to PSEN1
CC       (PubMed:10037471) (PubMed:10208590) (PubMed:9223106). Interacts with
CC       ARHGEF28 (PubMed:17993462). Interacts (via the extreme C-terminus) with
CC       FRMPD2 (via the PDZ 2 domain) (PubMed:19706687). Interacts with CDK5
CC       (By similarity). Interacts with CTNNB1 (PubMed:25807484). Interacts
CC       with GSK3A and GSK3B (PubMed:19706605). Interacts with DNM2
CC       (PubMed:22022388). Interacts with CCDC85B (PubMed:25009281).
CC       {ECO:0000250|UniProtKB:O35116, ECO:0000250|UniProtKB:O35927,
CC       ECO:0000269|PubMed:10037471, ECO:0000269|PubMed:10208590,
CC       ECO:0000269|PubMed:17993462, ECO:0000269|PubMed:19706605,
CC       ECO:0000269|PubMed:19706687, ECO:0000269|PubMed:22022388,
CC       ECO:0000269|PubMed:25009281, ECO:0000269|PubMed:25807484,
CC       ECO:0000269|PubMed:9223106}.
CC   -!- INTERACTION:
CC       Q9UQB3; Q12959: DLG1; NbExp=2; IntAct=EBI-7266482, EBI-357481;
CC       Q9UQB3; Q14160: SCRIB; NbExp=2; IntAct=EBI-7266482, EBI-357345;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O35927}. Cell
CC       junction, adherens junction {ECO:0000250|UniProtKB:O35927}. Cell
CC       projection, dendrite {ECO:0000250|UniProtKB:O35116}. Perikaryon
CC       {ECO:0000269|PubMed:22022388}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=NPRAPa;
CC         IsoId=Q9UQB3-1; Sequence=Displayed;
CC       Name=2; Synonyms=NPRAPc;
CC         IsoId=Q9UQB3-2; Sequence=VSP_006746;
CC   -!- TISSUE SPECIFICITY: Expressed in brain; highest expression is observed
CC       in fetal brain (PubMed:25807484). {ECO:0000269|PubMed:25807484}.
CC   -!- PTM: O-glycosylated. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by CDK5 (By similarity). Phosphorylated by GSK3B
CC       (PubMed:19706605). {ECO:0000250|UniProtKB:O35116,
CC       ECO:0000269|PubMed:19706605}.
CC   -!- DISEASE: Note=Defects in CTNND2, including deleterious missense and
CC       copy number variants (CNVs) are involved in autism, a complex
CC       multifactorial, pervasive developmental disorder characterized by
CC       impairments in reciprocal social interaction and communication,
CC       restricted and stereotyped patterns of interests and activities, and
CC       the presence of developmental abnormalities by 3 years of age. Most
CC       individuals with autism also manifest moderate mental retardation.
CC       {ECO:0000269|PubMed:25807484}.
CC   -!- SIMILARITY: Belongs to the beta-catenin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB68599.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB88185.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ctnnd2/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U96136; AAC63103.1; -; mRNA.
DR   EMBL; AB013805; BAA36163.1; -; mRNA.
DR   EMBL; AC003089; AAB83940.1; -; Genomic_DNA.
DR   EMBL; EU350953; ABY59658.1; -; Genomic_DNA.
DR   EMBL; AC003954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004633; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010433; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113390; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127460; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471102; EAX08053.1; -; Genomic_DNA.
DR   EMBL; U81004; AAD00453.1; -; mRNA.
DR   EMBL; U52351; AAB97957.1; -; mRNA.
DR   EMBL; U72665; AAB68599.1; ALT_INIT; mRNA.
DR   EMBL; AF035302; AAB88185.1; ALT_FRAME; mRNA.
DR   EMBL; U52828; AAB96357.1; -; mRNA.
DR   CCDS; CCDS3881.1; -. [Q9UQB3-1]
DR   RefSeq; NP_001275644.1; NM_001288715.1.
DR   RefSeq; NP_001275645.1; NM_001288716.1.
DR   RefSeq; NP_001275646.1; NM_001288717.1.
DR   RefSeq; NP_001323.1; NM_001332.3. [Q9UQB3-1]
DR   SMR; Q9UQB3; -.
DR   BioGrid; 107882; 10.
DR   CORUM; Q9UQB3; -.
DR   DIP; DIP-1138N; -.
DR   IntAct; Q9UQB3; 10.
DR   MINT; Q9UQB3; -.
DR   STRING; 9606.ENSP00000307134; -.
DR   iPTMnet; Q9UQB3; -.
DR   PhosphoSitePlus; Q9UQB3; -.
DR   BioMuta; CTNND2; -.
DR   DMDM; 84028193; -.
DR   jPOST; Q9UQB3; -.
DR   MassIVE; Q9UQB3; -.
DR   PaxDb; Q9UQB3; -.
DR   PeptideAtlas; Q9UQB3; -.
DR   PRIDE; Q9UQB3; -.
DR   ProteomicsDB; 85530; -. [Q9UQB3-1]
DR   ProteomicsDB; 85531; -. [Q9UQB3-2]
DR   Antibodypedia; 9404; 186 antibodies.
DR   DNASU; 1501; -.
DR   Ensembl; ENST00000304623; ENSP00000307134; ENSG00000169862. [Q9UQB3-1]
DR   GeneID; 1501; -.
DR   KEGG; hsa:1501; -.
DR   UCSC; uc003jfa.3; human. [Q9UQB3-1]
DR   CTD; 1501; -.
DR   DisGeNET; 1501; -.
DR   GeneCards; CTNND2; -.
DR   HGNC; HGNC:2516; CTNND2.
DR   HPA; ENSG00000169862; Tissue enriched (brain).
DR   MalaCards; CTNND2; -.
DR   MIM; 604275; gene.
DR   neXtProt; NX_Q9UQB3; -.
DR   OpenTargets; ENSG00000169862; -.
DR   Orphanet; 86814; Benign adult familial myoclonic epilepsy.
DR   Orphanet; 281; Monosomy 5p.
DR   PharmGKB; PA27017; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00940000154952; -.
DR   HOGENOM; CLU_007897_0_0_1; -.
DR   InParanoid; Q9UQB3; -.
DR   KO; K23491; -.
DR   OMA; SYADPYR; -.
DR   OrthoDB; 233858at2759; -.
DR   PhylomeDB; Q9UQB3; -.
DR   TreeFam; TF321877; -.
DR   SignaLink; Q9UQB3; -.
DR   SIGNOR; Q9UQB3; -.
DR   ChiTaRS; CTNND2; human.
DR   GenomeRNAi; 1501; -.
DR   Pharos; Q9UQB3; Tbio.
DR   PRO; PR:Q9UQB3; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9UQB3; protein.
DR   Bgee; ENSG00000169862; Expressed in dorsolateral prefrontal cortex and 151 other tissues.
DR   ExpressionAtlas; Q9UQB3; baseline and differential.
DR   Genevisible; Q9UQB3; HS.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0005911; C:cell-cell junction; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; IBA:GO_Central.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0007043; P:cell-cell junction assembly; IBA:GO_Central.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; IMP:UniProtKB.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0050808; P:synapse organization; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autism; Autism spectrum disorder; Cell adhesion;
KW   Cell junction; Cell projection; Coiled coil; Developmental protein;
KW   Disease mutation; Glycoprotein; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Wnt signaling pathway.
FT   CHAIN           1..1225
FT                   /note="Catenin delta-2"
FT                   /id="PRO_0000064299"
FT   REPEAT          394..438
FT                   /note="ARM 1"
FT   REPEAT          540..579
FT                   /note="ARM 2"
FT   REPEAT          582..621
FT                   /note="ARM 3"
FT   REPEAT          626..666
FT                   /note="ARM 4"
FT   REPEAT          682..724
FT                   /note="ARM 5"
FT   REPEAT          728..773
FT                   /note="ARM 6"
FT   REPEAT          835..875
FT                   /note="ARM 7"
FT   REPEAT          882..921
FT                   /note="ARM 8"
FT   REPEAT          975..1018
FT                   /note="ARM 9"
FT   COILED          49..84
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        216..226
FT                   /note="Poly-Pro"
FT   COMPBIAS        811..817
FT                   /note="Poly-Lys"
FT   MOD_RES         209
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         264
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         276
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         282
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         296
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         514
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         516
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         1065
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   MOD_RES         1076
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35927"
FT   VAR_SEQ         823..880
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006746"
FT   VARIANT         34
FT                   /note="G -> S (probable disease-associated mutation found
FT                   in autism; hypomorphic mutation affecting dendritic spines
FT                   development and maintenance; results in reduced interaction
FT                   with CTNNB1; dbSNP:rs151129181)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073387"
FT   VARIANT         189
FT                   /note="P -> L (probable disease-associated mutation found
FT                   in autism; hypomorphic mutation affecting Wnt signaling;
FT                   dbSNP:rs149573037)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073388"
FT   VARIANT         224
FT                   /note="P -> L (probable disease-associated mutation found
FT                   in autism; hypomorphic mutation affecting Wnt signaling;
FT                   dbSNP:rs769623284)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073389"
FT   VARIANT         275
FT                   /note="G -> C (found in patients with autism; unknown
FT                   pathological significance; has no effect on Wnt signaling;
FT                   dbSNP:rs61749844)"
FT                   /evidence="ECO:0000269|PubMed:25807484, ECO:0000269|Ref.4"
FT                   /id="VAR_062270"
FT   VARIANT         330
FT                   /note="R -> H (polymorphism; has no effect on Wnt
FT                   signaling; dbSNP:rs199506424)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073390"
FT   VARIANT         454
FT                   /note="R -> H (probable disease-associated mutation found
FT                   in autism; hypomorphic mutation affecting Wnt signaling;
FT                   dbSNP:rs750266236)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073391"
FT   VARIANT         465
FT                   /note="D -> N (polymorphism; has no effect on Wnt
FT                   signaling; dbSNP:rs200377770)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073392"
FT   VARIANT         482
FT                   /note="A -> T (polymorphism; has no effect on Wnt
FT                   signaling; dbSNP:rs61750706)"
FT                   /evidence="ECO:0000269|PubMed:25807484, ECO:0000269|Ref.4"
FT                   /id="VAR_062271"
FT   VARIANT         507
FT                   /note="Q -> P (probable disease-associated mutation found
FT                   in autism; hypomorphic mutation affecting Wnt signaling;
FT                   dbSNP:rs142843736)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073393"
FT   VARIANT         713
FT                   /note="R -> C (probable disease-associated mutation found
FT                   in autism; loss-of-function mutation affecting dendritic
FT                   spines development and maintenance; results in reduced
FT                   interaction with CTNNB1; dbSNP:rs768575356)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073394"
FT   VARIANT         810
FT                   /note="G -> R (polymorphism; has no effect on Wnt
FT                   signaling; dbSNP:rs61754599)"
FT                   /evidence="ECO:0000269|PubMed:25807484, ECO:0000269|Ref.4"
FT                   /id="VAR_062272"
FT   VARIANT         862
FT                   /note="T -> M (found in patients with autism; unknown
FT                   pathological significance; has no effect on Wnt signaling;
FT                   dbSNP:rs773517967)"
FT                   /evidence="ECO:0000269|PubMed:25807484"
FT                   /id="VAR_073395"
FT   VARIANT         1159
FT                   /note="P -> S (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036162"
FT   CONFLICT        426
FT                   /note="D -> V (in Ref. 1; AAC63103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="D -> V (in Ref. 1; AAC63103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        725
FT                   /note="A -> P (in Ref. 1; AAC63103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        894
FT                   /note="L -> R (in Ref. 1; AAC63103 and 11; AAB96357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        909
FT                   /note="V -> A (in Ref. 1; AAC63103 and 11; AAB96357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        980
FT                   /note="A -> G (in Ref. 8; AAB97957)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1102
FT                   /note="A -> G (in Ref. 7; AAD00453 and 9; AAB68599)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1225 AA;  132656 MW;  4A24ACC3E22BFE83 CRC64;
     MFARKPPGAA PLGAMPVPDQ PSSASEKTSS LSPGLNTSNG DGSETETTSA ILASVKEQEL
     QFERLTRELE AERQIVASQL ERCKLGSETG SMSSMSSAEE QFQWQSQDGQ KDIEDELTTG
     LELVDSCIRS LQESGILDPQ DYSTGERPSL LSQSALQLNS KPEGSFQYPA SYHSNQTLAL
     GETTPSQLPA RGTQARATGQ SFSQGTTSRA GHLAGPEPAP PPPPPPREPF APSLGSAFHL
     PDAPPAAAAA ALYYSSSTLP APPRGGSPLA APQGGSPTKL QRGGSAPEGA TYAAPRGSSP
     KQSPSRLAKS YSTSSPINIV VSSAGLSPIR VTSPPTVQST ISSSPIHQLS STIGTYATLS
     PTKRLVHASE QYSKHSQELY ATATLQRPGS LAAGSRASYS SQHGHLGPEL RALQSPEHHI
     DPIYEDRVYQ KPPMRSLSQS QGDPLPPAHT GTYRTSTAPS SPGVDSVPLQ RTGSQHGPQN
     AAAATFQRAS YAAGPASNYA DPYRQLQYCP SVESPYSKSG PALPPEGTLA RSPSIDSIQK
     DPREFGWRDP ELPEVIQMLQ HQFPSVQSNA AAYLQHLCFG DNKIKAEIRR QGGIQLLVDL
     LDHRMTEVHR SACGALRNLV YGKANDDNKI ALKNCGGIPA LVRLLRKTTD LEIRELVTGV
     LWNLSSCDAL KMPIIQDALA VLTNAVIIPH SGWENSPLQD DRKIQLHSSQ VLRNATGCLR
     NVSSAGEEAR RRMRECDGLT DALLYVIQSA LGSSEIDSKT VENCVCILRN LSYRLAAETS
     QGQHMGTDEL DGLLCGEANG KDAESSGCWG KKKKKKKSQD QWDGVGPLPD CAEPPKGIQM
     LWHPSIVKPY LTLLSECSNP DTLEGAAGAL QNLAAGSWKW SVYIRAAVRK EKGLPILVEL
     LRIDNDRVVC AVATALRNMA LDVRNKELIG KYAMRDLVHR LPGGNNSNNT ASKAMSDDTV
     TAVCCTLHEV ITKNMENAKA LRDAGGIEKL VGISKSKGDK HSPKVVKAAS QVLNSMWQYR
     DLRSLYKKDG WSQYHFVASS STIERDRQRP YSSSRTPSIS PVRVSPNNRS ASAPASPREM
     ISLKERKTDY ECTGSNATYH GAKGEHTSRK DAMTAQNTGI STLYRNSYGA PAEDIKHNQV
     SAQPVPQEPS RKDYETYQPF QNSTRNYDES FFEDQVHHRP PASEYTMHLG LKSTGNYVDF
     YSAARPYSEL NYETSHYPAS PDSWV
//
ID   A4ZKH2_HUMAN            Unreviewed;        15 AA.
AC   A4ZKH2; A0A087WYR9; A0A0K0K1D3;
DT   29-MAY-2007, integrated into UniProtKB/TrEMBL.
DT   29-MAY-2007, sequence version 1.
DT   11-DEC-2019, entry version 43.
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant I {ECO:0000313|EMBL:ABO61874.1};
DE   Flags: Fragment;
GN   Name=CYSLTR2 {ECO:0000313|EMBL:ABO61874.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABO61874.1};
RN   [1] {ECO:0000313|EMBL:ABO61874.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=17404310;
RA   Woszczek G., Chen L.Y., Nagineni S., Alsaaty S., Harry A., Logun C.,
RA   Pawliczak R., Shelhamer J.H.;
RT   "IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances
RT   the responsiveness of human endothelial cells to cysteinyl leukotrienes.";
RL   J. Immunol. 178:5262-5270(2007).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF141523; ABO61874.1; -; mRNA.
DR   EMBL; EF141524; ABO61875.1; -; mRNA.
DR   EMBL; EF141525; ABO61876.1; -; mRNA.
DR   EMBL; EF141526; ABO61877.1; -; mRNA.
DR   EMBL; EF141527; ABO61878.1; -; mRNA.
DR   EMBL; EF141528; ABO61879.1; -; mRNA.
DR   EMBL; EF141529; ABO61880.1; -; mRNA.
DR   EMBL; EF141530; ABO61881.1; -; mRNA.
DR   RefSeq; NP_001295394.1; NM_001308465.2.
DR   RefSeq; NP_001295396.1; NM_001308467.2.
DR   RefSeq; NP_001295397.1; NM_001308468.2.
DR   RefSeq; NP_001295398.1; NM_001308469.2.
DR   RefSeq; NP_001295399.1; NM_001308470.2.
DR   RefSeq; NP_001295400.1; NM_001308471.2.
DR   RefSeq; NP_001295405.1; NM_001308476.2.
DR   GeneID; 57105; -.
DR   KEGG; hsa:57105; -.
DR   UCSC; uc058wyy.1; human.
DR   CTD; 57105; -.
DR   KO; K04323; -.
DR   OrthoDB; 930634at2759; -.
DR   GenomeRNAi; 57105; -.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:ABO61874.1}.
FT   NON_TER         15
FT                   /evidence="ECO:0000313|EMBL:ABO61874.1"
SQ   SEQUENCE   15 AA;  1740 MW;  5F22BA36A56838EE CRC64;
     MERKFMSLQP SISVS
//
ID   Q5KU17_HUMAN            Unreviewed;       346 AA.
AC   Q5KU17;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 121.
DE   SubName: Full=Cysteinyl leukotriene receptor 2 {ECO:0000313|EMBL:AAH96832.1};
DE   SubName: Full=G-protein coupled receptor protein {ECO:0000313|EMBL:BAD83598.1};
DE   SubName: Full=cDNA FLJ78284, highly similar to Homo sapiens cysteinyl leukotriene receptor 2 (CYSLTR2), mRNA {ECO:0000313|EMBL:BAF84428.1};
GN   Name=KPG_011 {ECO:0000313|EMBL:BAD83598.1};
GN   Synonyms=CYSLTR2 {ECO:0000313|EMBL:AAH96832.1};
GN   ORFNames=hCG_1647464 {ECO:0000313|EMBL:EAX08802.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD83598.1};
RN   [1] {ECO:0000313|EMBL:BAD83598.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ina K., Urakawa I., Mizutani S., Okazaki H.;
RT   "Probable G-protein coupled receptor.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAX08802.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAH96832.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000313|EMBL:AAW47925.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Fukai H., Ogasawara Y., Migita O., Koga M., Ichikawa K., Shibasaki M.,
RA   Arinami T., Noguchi E.;
RT   "Association between a polymorphism in cysteinyl leukotriene receptor 2 on
RT   chromosome 13q14 and atopic asthma.";
RL   Pharmacogenetics 10:683-690(2004).
RN   [5] {ECO:0000313|EMBL:EAX08802.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:BAF84428.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84428.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC096832; AAH96832.1; -; mRNA.
DR   EMBL; AY853711; AAW47925.1; -; mRNA.
DR   EMBL; AB041947; BAD83598.1; -; mRNA.
DR   EMBL; AK291739; BAF84428.1; -; mRNA.
DR   EMBL; CH471075; EAX08802.1; -; Genomic_DNA.
DR   RefSeq; NP_001295394.1; NM_001308465.2.
DR   RefSeq; NP_001295396.1; NM_001308467.2.
DR   RefSeq; NP_001295397.1; NM_001308468.2.
DR   RefSeq; NP_001295398.1; NM_001308469.2.
DR   RefSeq; NP_001295399.1; NM_001308470.2.
DR   RefSeq; NP_001295400.1; NM_001308471.2.
DR   RefSeq; NP_001295405.1; NM_001308476.2.
DR   RefSeq; NP_065110.1; NM_020377.4.
DR   Antibodypedia; 9403; 236 antibodies.
DR   DNASU; 57105; -.
DR   GeneID; 57105; -.
DR   KEGG; hsa:57105; -.
DR   CTD; 57105; -.
DR   EuPathDB; HostDB:ENSG00000152207.7; -.
DR   PharmGKB; PA38518; -.
DR   eggNOG; ENOG410IGJM; Eukaryota.
DR   eggNOG; ENOG410YDV0; LUCA.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   KO; K04323; -.
DR   OMA; HILRTLH; -.
DR   OrthoDB; 930634at2759; -.
DR   GenomeRNAi; 57105; -.
DR   Bgee; ENSG00000152207; Expressed in left adrenal gland cortex and 107 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004974; F:leukotriene receptor activity; IEA:InterPro.
DR   InterPro; IPR013311; CLT2_recept.
DR   InterPro; IPR004071; Cyst_leuk_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01903; CYSLT2RECPTR.
DR   PRINTS; PR01533; CYSLTRECPTR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:BAD83598.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        43..64
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        76..93
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        113..135
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        155..174
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        203..224
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        245..266
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        286..308
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          55..305
FT                   /note="G_PROTEIN_RECEP_F1_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50262"
SQ   SEQUENCE   346 AA;  39635 MW;  EB54A4A2DDCE5EE4 CRC64;
     MERKFMSLQP SISVSEMEPN GTFSNNNSRN CTIENFKREF FPIVYLIIFF WGVLGNGLSI
     YVFLQPYKKS TSVNVFMLNL AISDLLFIST LPFRADYYLR GSNWIFGDLA CRIMSYSLYV
     NMYSSIYFLT VLSVVRFLAM VHPFRLLHVT SIRSAWILCG IIWILIMASS IMLLDSGSEQ
     NGSVTSCLEL NLYKIAKLQT MNYIALVVGC LLPFFTLSIC YLLIIRVLLK VEVPESGLRV
     SHRKALTTII ITLIIFFLCF LPYHTLRTVH LTTWKVGLCK DRLHKALVIT LALAAANACF
     NPLLYYFAGE NFKDRLKSAL RKGHPQKAKT KCVFPVSVWL RKETRV
//
ID   CLTR2_HUMAN             Reviewed;         346 AA.
AC   Q9NS75; Q9HCQ2;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 162.
DE   RecName: Full=Cysteinyl leukotriene receptor 2;
DE            Short=CysLTR2;
DE   AltName: Full=G-protein coupled receptor GPCR21;
DE            Short=hGPCR21;
DE   AltName: Full=G-protein coupled receptor HG57;
DE   AltName: Full=HPN321;
GN   Name=CYSLTR2; Synonyms=CYSLT2, CYSLT2R; ORFNames=PSEC0146;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=10913337; DOI=10.1006/bbrc.2000.3140;
RA   Takasaki J., Kamohara M., Matsumoto M., Saito T., Sugimoto T., Ota T.,
RA   Nishikawa T., Kawai Y., Masuho Y., Isogai T., Suzuki Y., Sugano S.,
RA   Furuichi K.;
RT   "The molecular characterization and tissue distribution of the human
RT   cysteinyl leukotriene CysLT2 receptor.";
RL   Biochem. Biophys. Res. Commun. 274:316-322(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10851239; DOI=10.1074/jbc.m003490200;
RA   Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.-S.,
RA   Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R., Williams D.L. Jr.,
RA   Zeng Z., Liu Q., Ma L., Clements M.K., Coulombe N., Liu Y., Austin C.P.,
RA   George S.R., O'Neill G.P., Metters K.M., Lynch K.R., Evans J.F.;
RT   "Characterization of the human cysteinyl leukotriene 2 receptor.";
RL   J. Biol. Chem. 275:30531-30536(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11093801; DOI=10.1124/mol.58.6.1601;
RA   Nothacker H.-P., Wang Z., Zhu Y., Reinscheid R.K., Lin S.H.S., Civelli O.;
RT   "Molecular cloning and characterization of a second human cysteinyl
RT   leukotriene receptor: discovery of a subtype selective agonist.";
RL   Mol. Pharmacol. 58:1601-1608(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12044878; DOI=10.1016/s0014-5793(02)02775-8;
RA   Takeda S., Kadowaki S., Haga T., Takaesu H., Mitaku S.;
RT   "Identification of G protein-coupled receptor genes from the human genome
RT   sequence.";
RL   FEBS Lett. 520:97-101(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 17-346.
RA   Suga H.;
RT   "Homo sapiens cysteinyl leukotriene receptor 1 like receptor.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for cysteinyl leukotrienes. The response is mediated
CC       via a G-protein that activates a phosphatidylinositol-calcium second
CC       messenger system. Stimulation by BAY u9773, a partial agonist, induces
CC       specific contractions of pulmonary veins and might also have an
CC       indirect role in the relaxation of the pulmonary vascular endothelium.
CC       The rank order of affinities for the leukotrienes is LTC4 = LTD4 >>
CC       LTE4.
CC   -!- INTERACTION:
CC       Q9NS75; Q9Y271: CYSLTR1; NbExp=2; IntAct=EBI-3843579, EBI-9347754;
CC       Q9NS75; Q12959: DLG1; NbExp=7; IntAct=EBI-3843579, EBI-357481;
CC       Q9NS75; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-3843579, EBI-11959885;
CC       Q9NS75; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-3843579, EBI-739832;
CC       Q9NS75; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-3843579, EBI-11522433;
CC       Q9NS75; Q14160: SCRIB; NbExp=3; IntAct=EBI-3843579, EBI-357345;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in the heart,
CC       placenta, spleen, peripheral blood leukocytes and adrenal gland. In
CC       lung, expressed in the interstitial macrophages, and slightly in smooth
CC       muscle cells.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB038269; BAB03601.1; -; mRNA.
DR   EMBL; AF254664; AAG17281.1; -; Genomic_DNA.
DR   EMBL; AF279611; AAK69485.1; -; Genomic_DNA.
DR   EMBL; AB083603; BAB89316.1; -; Genomic_DNA.
DR   EMBL; AY389504; AAQ91330.1; -; Genomic_DNA.
DR   EMBL; AL137118; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069160; AAH69160.1; -; mRNA.
DR   EMBL; AB041644; BAB16379.1; -; Genomic_DNA.
DR   CCDS; CCDS9412.1; -.
DR   RefSeq; NP_001295394.1; NM_001308465.2.
DR   RefSeq; NP_001295396.1; NM_001308467.2.
DR   RefSeq; NP_001295397.1; NM_001308468.2.
DR   RefSeq; NP_001295398.1; NM_001308469.2.
DR   RefSeq; NP_001295399.1; NM_001308470.2.
DR   RefSeq; NP_001295400.1; NM_001308471.2.
DR   RefSeq; NP_001295405.1; NM_001308476.2.
DR   RefSeq; NP_065110.1; NM_020377.4.
DR   SMR; Q9NS75; -.
DR   BioGrid; 121371; 1.
DR   IntAct; Q9NS75; 34.
DR   MINT; Q9NS75; -.
DR   STRING; 9606.ENSP00000282018; -.
DR   BindingDB; Q9NS75; -.
DR   ChEMBL; CHEMBL4330; -.
DR   DrugBank; DB08855; Leukotriene C4.
DR   DrugBank; DB11858; Leukotriene D4.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugCentral; Q9NS75; -.
DR   GuidetoPHARMACOLOGY; 270; -.
DR   SwissLipids; SLP:000001584; -.
DR   iPTMnet; Q9NS75; -.
DR   PhosphoSitePlus; Q9NS75; -.
DR   BioMuta; CYSLTR2; -.
DR   DMDM; 20138034; -.
DR   PaxDb; Q9NS75; -.
DR   PeptideAtlas; Q9NS75; -.
DR   PRIDE; Q9NS75; -.
DR   ProteomicsDB; 82506; -.
DR   Antibodypedia; 9403; 236 antibodies.
DR   DNASU; 57105; -.
DR   Ensembl; ENST00000282018; ENSP00000282018; ENSG00000152207.
DR   Ensembl; ENST00000614739; ENSP00000477930; ENSG00000152207.
DR   GeneID; 57105; -.
DR   KEGG; hsa:57105; -.
DR   UCSC; uc010ada.2; human.
DR   CTD; 57105; -.
DR   DisGeNET; 57105; -.
DR   GeneCards; CYSLTR2; -.
DR   HGNC; HGNC:18274; CYSLTR2.
DR   HPA; ENSG00000152207; Tissue enhanced (blood, ductus deferens, placenta, seminal vesicle).
DR   MalaCards; CYSLTR2; -.
DR   MIM; 605666; gene.
DR   neXtProt; NX_Q9NS75; -.
DR   OpenTargets; ENSG00000152207; -.
DR   Orphanet; 39044; Uveal melanoma.
DR   PharmGKB; PA38518; -.
DR   eggNOG; ENOG410IGJM; Eukaryota.
DR   eggNOG; ENOG410YDV0; LUCA.
DR   GeneTree; ENSGT00980000198472; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; Q9NS75; -.
DR   KO; K04323; -.
DR   OMA; HILRTLH; -.
DR   OrthoDB; 930634at2759; -.
DR   PhylomeDB; Q9NS75; -.
DR   TreeFam; TF350009; -.
DR   Reactome; R-HSA-163359; Glucagon signaling in metabolic regulation.
DR   Reactome; R-HSA-391906; Leukotriene receptors.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-420092; Glucagon-type ligand receptors.
DR   SIGNOR; Q9NS75; -.
DR   GeneWiki; Cysteinyl_leukotriene_receptor_2; -.
DR   GenomeRNAi; 57105; -.
DR   Pharos; Q9NS75; Tchem.
DR   PRO; PR:Q9NS75; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9NS75; protein.
DR   Bgee; ENSG00000152207; Expressed in left adrenal gland cortex and 107 other tissues.
DR   ExpressionAtlas; Q9NS75; baseline and differential.
DR   Genevisible; Q9NS75; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0004966; F:galanin receptor activity; IBA:GO_Central.
DR   GO; GO:0004974; F:leukotriene receptor activity; NAS:UniProtKB.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   InterPro; IPR013311; CLT2_recept.
DR   InterPro; IPR004071; Cyst_leuk_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01903; CYSLT2RECPTR.
DR   PRINTS; PR01533; CYSLTRECPTR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..346
FT                   /note="Cysteinyl leukotriene receptor 2"
FT                   /id="PRO_0000069303"
FT   TOPO_DOM        1..42
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        43..63
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        64..72
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        73..93
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        94..123
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        124..144
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        145..153
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        154..174
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        175..204
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        205..225
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        226..245
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        246..266
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        267..286
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        287..307
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        308..346
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        20
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        26
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        30
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        181
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        111..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   346 AA;  39635 MW;  EB54A4A2DDCE5EE4 CRC64;
     MERKFMSLQP SISVSEMEPN GTFSNNNSRN CTIENFKREF FPIVYLIIFF WGVLGNGLSI
     YVFLQPYKKS TSVNVFMLNL AISDLLFIST LPFRADYYLR GSNWIFGDLA CRIMSYSLYV
     NMYSSIYFLT VLSVVRFLAM VHPFRLLHVT SIRSAWILCG IIWILIMASS IMLLDSGSEQ
     NGSVTSCLEL NLYKIAKLQT MNYIALVVGC LLPFFTLSIC YLLIIRVLLK VEVPESGLRV
     SHRKALTTII ITLIIFFLCF LPYHTLRTVH LTTWKVGLCK DRLHKALVIT LALAAANACF
     NPLLYYFAGE NFKDRLKSAL RKGHPQKAKT KCVFPVSVWL RKETRV
//
ID   DGCR8_HUMAN             Reviewed;         773 AA.
AC   Q8WYQ5; B2R8G1; Q6DCB2; Q6MZE9; Q6Y2L0; Q96G39; Q96GP8; Q9H6L8; Q9H6T7;
AC   Q9NRW2;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   22-APR-2020, entry version 178.
DE   RecName: Full=Microprocessor complex subunit DGCR8;
DE   AltName: Full=DiGeorge syndrome critical region 8;
GN   Name=DGCR8; Synonyms=C22orf12, DGCRK6; ORFNames=LP4941;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12705904; DOI=10.1016/s0006-291x(03)00554-0;
RA   Shiohama A., Sasaki T., Noda S., Minoshima S., Shimizu N.;
RT   "Molecular cloning and expression analysis of a novel gene DGCR8 located in
RT   the DiGeorge syndrome chromosomal region.";
RL   Biochem. Biophys. Res. Commun. 304:184-190(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 204-773 (ISOFORM 1).
RC   TISSUE=Hepatoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, Muscle, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-247.
RC   TISSUE=Heart;
RA   Gong L., Millas S., Jen J., Yeh E.T.H.;
RT   "Isolation and characterization of a novel human gene deleted in DiGeorge
RT   syndrome.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 282-773.
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 427-773.
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH DROSHA.
RX   PubMed=15589161; DOI=10.1016/j.cub.2004.11.001;
RA   Landthaler M., Yalcin A., Tuschl T.;
RT   "The human DiGeorge syndrome critical region gene 8 and its D. melanogaster
RT   homolog are required for miRNA biogenesis.";
RL   Curr. Biol. 14:2162-2167(2004).
RN   [10]
RP   FUNCTION, AND IDENTIFICATION IN THE MICROPROCESSOR COMPLEX.
RX   PubMed=15574589; DOI=10.1101/gad.1262504;
RA   Han J., Lee Y., Yeom K.-H., Kim Y.-K., Jin H., Kim V.N.;
RT   "The Drosha-DGCR8 complex in primary microRNA processing.";
RL   Genes Dev. 18:3016-3027(2004).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE MICROPROCESSOR COMPLEX.
RX   PubMed=15531877; DOI=10.1038/nature03120;
RA   Gregory R.I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B.,
RA   Cooch N., Shiekhattar R.;
RT   "The microprocessor complex mediates the genesis of microRNAs.";
RL   Nature 432:235-240(2004).
RN   [12]
RP   FUNCTION, IDENTIFICATION IN THE MICROPROCESSOR COMPLEX, AND RNA-BINDING.
RX   PubMed=16751099; DOI=10.1016/j.cell.2006.03.043;
RA   Han J., Lee Y., Yeom K.-H., Nam J.-W., Heo I., Rhee J.-K., Sohn S.Y.,
RA   Cho Y., Zhang B.-T., Kim V.N.;
RT   "Molecular basis for the recognition of primary microRNAs by the Drosha-
RT   DGCR8 complex.";
RL   Cell 125:887-901(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16906129; DOI=10.1038/sj.embor.7400783;
RA   Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J.,
RA   Chan E.K.L.;
RT   "Formation of GW bodies is a consequence of microRNA genesis.";
RL   EMBO Rep. 7:904-910(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH DROSHA, RNA-BINDING, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 568-ALA-ALA-569 AND 676-ALA-SER-677.
RX   PubMed=16963499; DOI=10.1093/nar/gkl458;
RA   Yeom K.-H., Lee Y., Han J., Suh M.R., Kim V.N.;
RT   "Characterization of DGCR8/Pasha, the essential cofactor for Drosha in
RT   primary miRNA processing.";
RL   Nucleic Acids Res. 34:4622-4629(2006).
RN   [16]
RP   INTERACTION WITH ILF3; NCL AND DROSHA, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17765891; DOI=10.1016/j.yexcr.2007.07.020;
RA   Shiohama A., Sasaki T., Noda S., Minoshima S., Shimizu N.;
RT   "Nucleolar localization of DGCR8 and identification of eleven DGCR8-
RT   associated proteins.";
RL   Exp. Cell Res. 313:4196-4207(2007).
RN   [17]
RP   FUNCTION, SUBUNIT, COFACTOR, AND MUTAGENESIS OF CYS-352 AND CYS-430.
RX   PubMed=17159994; DOI=10.1038/nsmb1182;
RA   Faller M., Matsunaga M., Yin S., Loo J.A., Guo F.;
RT   "Heme is involved in microRNA processing.";
RL   Nat. Struct. Mol. Biol. 14:23-29(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271; SER-275 AND SER-377, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   INTERACTION WITH DROSHA.
RX   PubMed=19135890; DOI=10.1016/j.cell.2008.10.053;
RA   Han J., Pedersen J.S., Kwon S.C., Belair C.D., Kim Y.-K., Yeom K.-H.,
RA   Yang W.-Y., Haussler D., Blelloch R., Kim V.N.;
RT   "Posttranscriptional crossregulation between Drosha and DGCR8.";
RL   Cell 136:75-84(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271 AND SER-275, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22118463; DOI=10.1016/j.cell.2011.10.039;
RA   Piskounova E., Polytarchou C., Thornton J.E., LaPierre R.J.,
RA   Pothoulakis C., Hagan J.P., Iliopoulos D., Gregory R.I.;
RT   "Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct
RT   mechanisms.";
RL   Cell 147:1066-1079(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; THR-371 AND SER-377, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-275; SER-373 AND
RP   SER-377, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-92, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-707, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [29]
RP   FUNCTION, INTERACTION WITH DROSHA, AND SUBUNIT.
RX   PubMed=26027739; DOI=10.1016/j.cell.2015.05.010;
RA   Nguyen T.A., Jo M.H., Choi Y.G., Park J., Kwon S.C., Hohng S., Kim V.N.,
RA   Woo J.S.;
RT   "Functional anatomy of the human microprocessor.";
RL   Cell 161:1374-1387(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-500 AND LYS-707, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [31]
RP   FUNCTION, AND RNA-BINDING.
RX   PubMed=25799998; DOI=10.1038/nature14281;
RA   Alarcon C.R., Lee H., Goodarzi H., Halberg N., Tavazoie S.F.;
RT   "N6-methyladenosine marks primary microRNAs for processing.";
RL   Nature 519:482-485(2015).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-424 AND LYS-500, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [33]
RP   INTERACTION WITH PUS10.
RX   PubMed=31819270; DOI=10.1038/s41589-019-0420-5;
RA   Song J., Zhuang Y., Zhu C., Meng H., Lu B., Xie B., Peng J., Li M., Yi C.;
RT   "Differential roles of human PUS10 in miRNA processing and tRNA
RT   pseudouridylation.";
RL   Nat. Chem. Biol. 0:0-0(2019).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 493-720, RNA-BINDING, AND
RP   MUTAGENESIS OF 561-LYS--LYS-565 AND 669-LYS--LYS-673.
RX   PubMed=17704815; DOI=10.1038/nsmb1294;
RA   Sohn S.Y., Bae W.J., Kim J.J., Yeom K.-H., Kim V.N., Cho Y.;
RT   "Crystal structure of human DGCR8 core.";
RL   Nat. Struct. Mol. Biol. 14:847-853(2007).
RN   [35]
RP   STRUCTURE BY NMR OF 502-586.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of DSRM domain in DGCR8 protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 728-750 IN COMPLEX WITH DROSHA,
RP   FUNCTION, INTERACTION WITH DROSHA, AND SUBUNIT.
RX   PubMed=26748718; DOI=10.1016/j.cell.2015.12.019;
RA   Kwon S.C., Nguyen T.A., Choi Y.G., Jo M.H., Hohng S., Kim V.N., Woo J.S.;
RT   "Structure of human DROSHA.";
RL   Cell 164:81-90(2016).
CC   -!- FUNCTION: Component of the microprocessor complex that acts as a
CC       RNA- and heme-binding protein that is involved in the initial step of
CC       microRNA (miRNA) biogenesis. Component of the microprocessor complex
CC       that is required to process primary miRNA transcripts (pri-miRNAs) to
CC       release precursor miRNA (pre-miRNA) in the nucleus. Within the
CC       microprocessor complex, DGCR8 function as a molecular anchor necessary
CC       for the recognition of pri-miRNA at dsRNA-ssRNA junction and directs
CC       DROSHA to cleave 11 bp away form the junction to release hairpin-shaped
CC       pre-miRNAs that are subsequently cut by the cytoplasmic DICER to
CC       generate mature miRNAs (PubMed:26027739, PubMed:26748718). The heme-
CC       bound DGCR8 dimer binds pri-miRNAs as a cooperative trimer (of dimers)
CC       and is active in triggering pri-miRNA cleavage, whereas the heme-free
CC       DGCR8 monomer binds pri-miRNAs as a dimer and is much less active. Both
CC       double-stranded and single-stranded regions of a pri-miRNA are required
CC       for its binding (PubMed:15531877, PubMed:15574589, PubMed:15589161,
CC       PubMed:16751099, PubMed:16906129, PubMed:16963499, PubMed:17159994).
CC       Specifically recognizes and binds N6-methyladenosine (m6A)-containing
CC       pri-miRNAs, a modification required for pri-miRNAs processing
CC       (PubMed:25799998). Involved in the silencing of embryonic stem cell
CC       self-renewal (By similarity). {ECO:0000250|UniProtKB:Q9EQM6,
CC       ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15574589,
CC       ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099,
CC       ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:16963499,
CC       ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:25799998,
CC       ECO:0000269|PubMed:26027739, ECO:0000269|PubMed:26748718}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:17159994};
CC       Note=Binds 1 heme group per homodimer. {ECO:0000269|PubMed:17159994};
CC   -!- SUBUNIT: Monomer; in absence of heme. Homodimer; the association with
CC       heme promotes its dimerization (PubMed:17159994). Component of the
CC       microprocessor complex, or pri-miRNA processing protein complex, which
CC       is composed of DROSHA and DGCR8 (PubMed:15589161, PubMed:15574589,
CC       PubMed:15531877, PubMed:16751099, PubMed:19135890, PubMed:26027739,
CC       PubMed:26748718). The microprocessor complex is a heterotrimer; each of
CC       the two DROSHA RNase III domains binds one DGCR8 (via C-terminal
CC       region) (PubMed:26027739, PubMed:26748718). Interacts with ILF3, NCL
CC       and DROSHA (PubMed:17765891). Interacts with CPSF3 and ISY1; this
CC       interaction is in an RNA dependent manner (By similarity). Interacts
CC       with PUS10; interaction promotes pri-miRNAs processing
CC       (PubMed:31819270). {ECO:0000250|UniProtKB:Q9EQM6,
CC       ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15574589,
CC       ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099,
CC       ECO:0000269|PubMed:16963499, ECO:0000269|PubMed:17159994,
CC       ECO:0000269|PubMed:17765891, ECO:0000269|PubMed:19135890,
CC       ECO:0000269|PubMed:26748718, ECO:0000269|PubMed:31819270}.
CC   -!- INTERACTION:
CC       Q8WYQ5; Q8WYQ5; NbExp=2; IntAct=EBI-528411, EBI-528411;
CC       Q8WYQ5; Q9NRR4: DROSHA; NbExp=13; IntAct=EBI-528411, EBI-528367;
CC       Q8WYQ5; P50222: MEOX2; NbExp=3; IntAct=EBI-528411, EBI-748397;
CC       Q8WYQ5; Q96SB4: SRPK1; NbExp=3; IntAct=EBI-528411, EBI-539478;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16906129,
CC       ECO:0000269|PubMed:16963499, ECO:0000269|PubMed:17159994,
CC       ECO:0000269|PubMed:22118463}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:17159994}. Note=Colocalizes with nucleolin and
CC       DROSHA in the nucleolus. Mostly detected in the nucleolus as electron-
CC       dense granular patches around the fibrillar center (FC) and granular
CC       component (GC). Also detected in the nucleoplasm as small foci adjacent
CC       to splicing speckles near the chromatin structure. Localized with
CC       DROSHA in GW bodies (GWBs), also known as P-bodies (PubMed:17159994).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8WYQ5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WYQ5-2; Sequence=VSP_003847, VSP_003848;
CC       Name=3;
CC         IsoId=Q8WYQ5-3; Sequence=VSP_012707;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:12705904}.
CC   -!- DOMAIN: Both DRBM domains are required for efficient binding to pri-
CC       miRNA. The region between residues 276 and 498 has an autoinhibitory
CC       function on pri-miRNA processing activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO86726.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15165.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15238.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB050770; BAB83032.1; -; Genomic_DNA.
DR   EMBL; CR456356; CAG30242.1; -; mRNA.
DR   EMBL; AK025539; BAB15165.1; ALT_INIT; mRNA.
DR   EMBL; AK025780; BAB15238.1; ALT_INIT; mRNA.
DR   EMBL; AK313357; BAG36158.1; -; mRNA.
DR   EMBL; AC006547; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009323; AAH09323.2; -; mRNA.
DR   EMBL; BC009984; AAH09984.1; -; mRNA.
DR   EMBL; BC078147; AAH78147.1; -; mRNA.
DR   EMBL; AF165527; AAF82263.1; -; mRNA.
DR   EMBL; BX649187; CAE46205.2; -; mRNA.
DR   EMBL; AY189282; AAO86726.1; ALT_INIT; mRNA.
DR   CCDS; CCDS13773.1; -. [Q8WYQ5-1]
DR   CCDS; CCDS54501.1; -. [Q8WYQ5-3]
DR   RefSeq; NP_001177255.1; NM_001190326.1. [Q8WYQ5-3]
DR   RefSeq; NP_073557.3; NM_022720.6. [Q8WYQ5-1]
DR   PDB; 1X47; NMR; -; A=502-586.
DR   PDB; 2YT4; X-ray; 2.60 A; A=493-720.
DR   PDB; 3LE4; X-ray; 1.70 A; A=275-353.
DR   PDB; 5B16; X-ray; 3.20 A; B/C=728-750.
DR   PDBsum; 1X47; -.
DR   PDBsum; 2YT4; -.
DR   PDBsum; 3LE4; -.
DR   PDBsum; 5B16; -.
DR   SMR; Q8WYQ5; -.
DR   BioGrid; 119986; 160.
DR   ComplexPortal; CPX-3080; Microprocessor complex.
DR   CORUM; Q8WYQ5; -.
DR   DIP; DIP-29261N; -.
DR   IntAct; Q8WYQ5; 118.
DR   MINT; Q8WYQ5; -.
DR   STRING; 9606.ENSP00000263209; -.
DR   iPTMnet; Q8WYQ5; -.
DR   PhosphoSitePlus; Q8WYQ5; -.
DR   BioMuta; DGCR8; -.
DR   DMDM; 23813990; -.
DR   EPD; Q8WYQ5; -.
DR   jPOST; Q8WYQ5; -.
DR   MassIVE; Q8WYQ5; -.
DR   MaxQB; Q8WYQ5; -.
DR   PaxDb; Q8WYQ5; -.
DR   PeptideAtlas; Q8WYQ5; -.
DR   PRIDE; Q8WYQ5; -.
DR   ProteomicsDB; 75188; -. [Q8WYQ5-1]
DR   ProteomicsDB; 75189; -. [Q8WYQ5-2]
DR   ProteomicsDB; 75190; -. [Q8WYQ5-3]
DR   Antibodypedia; 7887; 296 antibodies.
DR   DNASU; 54487; -.
DR   Ensembl; ENST00000351989; ENSP00000263209; ENSG00000128191. [Q8WYQ5-1]
DR   Ensembl; ENST00000383024; ENSP00000372488; ENSG00000128191. [Q8WYQ5-3]
DR   Ensembl; ENST00000407755; ENSP00000384726; ENSG00000128191. [Q8WYQ5-3]
DR   GeneID; 54487; -.
DR   KEGG; hsa:54487; -.
DR   UCSC; uc002zri.4; human. [Q8WYQ5-1]
DR   CTD; 54487; -.
DR   DisGeNET; 54487; -.
DR   GeneCards; DGCR8; -.
DR   GeneReviews; DGCR8; -.
DR   HGNC; HGNC:2847; DGCR8.
DR   HPA; ENSG00000128191; Low tissue specificity.
DR   MalaCards; DGCR8; -.
DR   MIM; 609030; gene.
DR   neXtProt; NX_Q8WYQ5; -.
DR   OpenTargets; ENSG00000128191; -.
DR   PharmGKB; PA27309; -.
DR   eggNOG; KOG4334; Eukaryota.
DR   eggNOG; ENOG410XS9I; LUCA.
DR   GeneTree; ENSGT00390000015977; -.
DR   HOGENOM; CLU_017211_3_0_1; -.
DR   InParanoid; Q8WYQ5; -.
DR   KO; K18419; -.
DR   OMA; MMENRAC; -.
DR   OrthoDB; 855874at2759; -.
DR   PhylomeDB; Q8WYQ5; -.
DR   TreeFam; TF324256; -.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-8986944; Transcriptional Regulation by MECP2.
DR   ChiTaRS; DGCR8; human.
DR   EvolutionaryTrace; Q8WYQ5; -.
DR   GeneWiki; DGCR8_(gene); -.
DR   GenomeRNAi; 54487; -.
DR   Pharos; Q8WYQ5; Tbio.
DR   PRO; PR:Q8WYQ5; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q8WYQ5; protein.
DR   Bgee; ENSG00000128191; Expressed in cerebellar hemisphere and 209 other tissues.
DR   ExpressionAtlas; Q8WYQ5; baseline and differential.
DR   Genevisible; Q8WYQ5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0070877; C:microprocessor complex; IDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070878; F:primary miRNA binding; IDA:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0010586; P:miRNA metabolic process; TAS:Reactome.
DR   GO; GO:0031053; P:primary miRNA processing; IDA:BHF-UCL.
DR   GO; GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IEA:GOC.
DR   CDD; cd00048; DSRM; 1.
DR   CDD; cd00201; WW; 1.
DR   InterPro; IPR040375; DGCR8.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   PANTHER; PTHR13482; PTHR13482; 1.
DR   Pfam; PF00035; dsrm; 2.
DR   SMART; SM00358; DSRM; 2.
DR   SMART; SM00456; WW; 1.
DR   SUPFAM; SSF51045; SSF51045; 1.
DR   PROSITE; PS50137; DS_RBD; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Heme; Iron; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN           1..773
FT                   /note="Microprocessor complex subunit DGCR8"
FT                   /id="PRO_0000079878"
FT   DOMAIN          301..334
FT                   /note="WW"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          511..578
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          620..685
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   REGION          1..342
FT                   /note="Necessary for interaction with NCL"
FT                   /evidence="ECO:0000269|PubMed:17765891"
FT   REGION          1..275
FT                   /note="Necessary for nuclear localization and retention"
FT   REGION          276..751
FT                   /note="Necessary for heme-binding and pri-miRNA processing"
FT   REGION          701..773
FT                   /note="Interaction with DROSHA"
FT                   /evidence="ECO:0000269|PubMed:26748718"
FT   METAL           352
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000305|PubMed:17159994"
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         95
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         279
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EQM6"
FT   MOD_RES         371
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   CROSSLNK        424
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        500
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        707
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297"
FT   VAR_SEQ         303..304
FT                   /note="LP -> VL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_003847"
FT   VAR_SEQ         305..773
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_003848"
FT   VAR_SEQ         536..568
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012707"
FT   VARIANT         174
FT                   /note="I -> V (in dbSNP:rs35987994)"
FT                   /id="VAR_050952"
FT   VARIANT         725
FT                   /note="N -> D (in dbSNP:rs11546015)"
FT                   /id="VAR_050953"
FT   MUTAGEN         352
FT                   /note="C->A,H: Inhibits heme-binding and dimerization."
FT                   /evidence="ECO:0000269|PubMed:17159994"
FT   MUTAGEN         430
FT                   /note="C->A: Does not inhibit heme-binding and
FT                   dimerization."
FT                   /evidence="ECO:0000269|PubMed:17159994"
FT   MUTAGEN         561..565
FT                   /note="KKLAK->AALAA: Strongly reduces pri-miRNA binding
FT                   affinity."
FT                   /evidence="ECO:0000269|PubMed:17704815"
FT   MUTAGEN         568..569
FT                   /note="AA->KK: Reduces pri-miRNA binding affinity and pri-
FT                   miRNA processing activity. Does not inhibit interaction
FT                   with DROSHA. When associated with A-676 and S-677, strongly
FT                   reduces binding affinity and pri-miRNA processing
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16963499"
FT   MUTAGEN         669..673
FT                   /note="KRVGK->AAVGA: Strongly reduces pri-miRNA binding
FT                   affinity."
FT                   /evidence="ECO:0000269|PubMed:17704815"
FT   MUTAGEN         676..677
FT                   /note="AS->KK: Reduces pri-miRNA binding affinity and pri-
FT                   miRNA processing activity. Slightly inhibits interaction
FT                   with DROSHA. When associated with A-568 and A-568, strongly
FT                   reduces binding affinity and pri-miRNA processing
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16963499"
FT   CONFLICT        241..247
FT                   /note="DDFDNDV -> VCWQPLL (in Ref. 6; AAF82263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        274
FT                   /note="P -> L (in Ref. 3; BAB15165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="H -> Y (in Ref. 3; BAB15165)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        706
FT                   /note="V -> A (in Ref. 3; BAB15165)"
FT                   /evidence="ECO:0000305"
FT   STRAND          307..311
FT                   /evidence="ECO:0000244|PDB:3LE4"
FT   STRAND          315..321
FT                   /evidence="ECO:0000244|PDB:3LE4"
FT   TURN            322..325
FT                   /evidence="ECO:0000244|PDB:3LE4"
FT   STRAND          326..330
FT                   /evidence="ECO:0000244|PDB:3LE4"
FT   TURN            340..342
FT                   /evidence="ECO:0000244|PDB:3LE4"
FT   HELIX           347..349
FT                   /evidence="ECO:0000244|PDB:3LE4"
FT   STRAND          493..495
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          502..505
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           512..522
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          529..534
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          536..539
FT                   /evidence="ECO:0000244|PDB:1X47"
FT   STRAND          542..548
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          551..560
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           561..576
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   TURN            578..582
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           594..600
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           608..615
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           620..629
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          631..633
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          637..640
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          651..657
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   STRAND          660..668
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           669..684
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           691..698
FT                   /evidence="ECO:0000244|PDB:2YT4"
FT   HELIX           728..749
FT                   /evidence="ECO:0000244|PDB:5B16"
SQ   SEQUENCE   773 AA;  86045 MW;  72D962BBE32890EC CRC64;
     METDESPSPL PCGPAGEAVM ESRARPFQAL PREQSPPPPL QTSSGAEVMD VGSGGDGQSE
     LPAEDPFNFY GASLLSKGSF SKGRLLIDPN CSGHSPRTAR HAPAVRKFSP DLKLLKDVKI
     SVSFTESCRS KDRKVLYTGA ERDVRAECGL LLSPVSGDVH ACPFGGSVGD GVGIGGESAD
     KKDEENELDQ EKRVEYAVLD ELEDFTDNLE LDEEGAGGFT AKAIVQRDRV DEEALNFPYE
     DDFDNDVDAL LEEGLCAPKK RRTEEKYGGD SDHPSDGETS VQPMMTKIKT VLKSRGRPPT
     EPLPDGWIMT FHNSGVPVYL HRESRVVTWS RPYFLGTGSI RKHDPPLSSI PCLHYKKMKD
     NEEREQSSDL TPSGDVSPVK PLSRSAELEF PLDEPDSMGA DPGPPDEKDP LGAEAAPGAL
     GQVKAKVEVC KDESVDLEEF RSYLEKRFDF EQVTVKKFRT WAERRQFNRE MKRKQAESER
     PILPANQKLI TLSVQDAPTK KEFVINPNGK SEVCILHEYM QRVLKVRPVY NFFECENPSE
     PFGASVTIDG VTYGSGTASS KKLAKNKAAR ATLEILIPDF VKQTSEEKPK DSEELEYFNH
     ISIEDSRVYE LTSKAGLLSP YQILHECLKR NHGMGDTSIK FEVVPGKNQK SEYVMACGKH
     TVRGWCKNKR VGKQLASQKI LQLLHPHVKN WGSLLRMYGR ESSKMVKQET SDKSVIELQQ
     YAKKNKPNLH ILSKLQEEMK RLAEEREETR KKPKMSIVAS AQPGGEPLCT VDV
//
ID   A4D1D0_HUMAN            Unreviewed;       879 AA.
AC   A4D1D0;
DT   03-APR-2007, integrated into UniProtKB/TrEMBL.
DT   03-APR-2007, sequence version 1.
DT   22-APR-2020, entry version 125.
DE   SubName: Full=Glutamate metabotropic receptor 3 {ECO:0000313|EMBL:ABY87922.1};
DE   SubName: Full=Glutamate receptor, metabotropic 3 {ECO:0000313|EMBL:EAL24182.1};
DE   SubName: Full=Glutamate receptor, metabotropic 3, isoform CRA_b {ECO:0000313|EMBL:EAW76972.1};
GN   Name=GRM3 {ECO:0000313|EMBL:EAL24182.1};
GN   ORFNames=hCG_17203 {ECO:0000313|EMBL:EAW76972.1},
GN   tcag7.244 {ECO:0000313|EMBL:EAL24182.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24182.1};
RN   [1] {ECO:0000313|EMBL:EAW76972.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24182.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J., Grzeschik K.H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H.,
RA   Dohner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:EAL24182.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F., Zeesman S., Teshima I.,
RA   Chitayat D., Shuman C., Weksberg R., Zackai E.H., Grebe T.A., Cox S.R.,
RA   Kirkpatrick S.J., Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.,
RA   Lococo F., Belloni E., Shaffer L.G., Morton C.C., Pober B., Gusella J.,
RA   Bruns G., Korf B.R., Quade B.J., Ligon A.H., Ferguson H., Higgins A.W.,
RA   Leach N.T., Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P.,
RA   Zlotorynski E., Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J.,
RA   Doehner H., Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW76972.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:ABY87922.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Whole brain {ECO:0000313|EMBL:ABY87922.1};
RA   Kaighin V.A., Martin A.L., Aronstam R.S.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|SAAS:SAAS00543559};
CC       Multi-pass membrane protein {ECO:0000256|SAAS:SAAS00543559}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family.
CC       {ECO:0000256|SAAS:SAAS00547813}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU432123; ABY87922.1; -; mRNA.
DR   EMBL; CH236949; EAL24182.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76972.1; -; Genomic_DNA.
DR   RefSeq; NP_000831.2; NM_000840.2.
DR   Antibodypedia; 15243; 357 antibodies.
DR   DNASU; 2913; -.
DR   GeneID; 2913; -.
DR   KEGG; hsa:2913; -.
DR   CTD; 2913; -.
DR   EuPathDB; HostDB:ENSG00000198822.10; -.
DR   PharmGKB; PA28992; -.
DR   eggNOG; KOG1056; Eukaryota.
DR   eggNOG; ENOG410XR6W; LUCA.
DR   HOGENOM; CLU_005389_0_0_1; -.
DR   KO; K04606; -.
DR   OMA; KWEDAWA; -.
DR   OrthoDB; 1154468at2759; -.
DR   ChiTaRS; GRM3; human.
DR   GenomeRNAi; 2913; -.
DR   Bgee; ENSG00000198822; Expressed in caudate nucleus and 97 other tissues.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005246; F:calcium channel regulator activity; IEA:Ensembl.
DR   GO; GO:0001641; F:group II metabotropic glutamate receptor activity; IEA:Ensembl.
DR   Gene3D; 2.10.50.30; -; 1.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR000337; GPCR_3.
DR   InterPro; IPR011500; GPCR_3_9-Cys_dom.
DR   InterPro; IPR038550; GPCR_3_9-Cys_sf.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR017979; GPCR_3_CS.
DR   InterPro; IPR000162; GPCR_3_mtglu_rcpt.
DR   InterPro; IPR001234; GPCR_3_mtglu_rcpt_3.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF07562; NCD3G; 1.
DR   PRINTS; PR00248; GPCRMGR.
DR   PRINTS; PR01053; MTABOTROPC3R.
DR   PRINTS; PR00593; MTABOTROPICR.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   PROSITE; PS00979; G_PROTEIN_RECEP_F3_1; 1.
DR   PROSITE; PS00980; G_PROTEIN_RECEP_F3_2; 1.
DR   PROSITE; PS00981; G_PROTEIN_RECEP_F3_3; 1.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane {ECO:0000256|SAAS:SAAS00138752};
KW   G-protein coupled receptor {ECO:0000256|SAAS:SAAS00148552};
KW   Membrane {ECO:0000256|SAAS:SAAS00138752, ECO:0000256|SAAS:SAAS00283606,
KW   ECO:0000256|SAM:Phobius}; Receptor {ECO:0000256|SAAS:SAAS00148552};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transducer {ECO:0000256|SAAS:SAAS00148552};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00283606, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00283606,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           25..879
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014296875"
FT   TRANSMEM        575..599
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        614..634
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        688..709
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        737..756
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        768..790
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        796..820
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          576..842
FT                   /note="G_PROTEIN_RECEP_F3_4"
FT                   /evidence="ECO:0000259|PROSITE:PS50259"
SQ   SEQUENCE   879 AA;  98879 MW;  7EB84521676E8304 CRC64;
     MKMLTRLQVL TLALFSKGFL LSLGDHNFLR REIKIEGDLV LGGLFPINEK GTGTEECGRI
     NEDRGIQRLE AMLFAIDEIN KDDYLLPGVK LGVHILDTCS RDTYALEQSL EFVRASLTKV
     DEAEYMCPDG SYAIQENIPL LIAGVIGGSY SSVSIQVANL LRLFQIPQIS YASTSAKLSD
     KSRYDYFART VPPDFYQAKA MAEILRFFNW TYVSTVASEG DYGETGIEAF EQEARLRNIC
     IATAEKVGRS NIRKSYDSVI RELLQKPNAR VVVLFMRSDD SRELIAAASR ANASFTWVAS
     DGWGAQESII KGSEHVAYGA ITLELASQPV RQFDRYFQSL NPYNNHRNPW FRDFWEQKFQ
     CSLQNKRNHR RVCDKHLAID SSNYEQESKI MFVVNAVYAM AHALHKMQRT LCPNTTKLCD
     AMKILDGKKL YKDYLLKINF TAPFNPNKDA DSIVKFDTFG DGMGRYNVFN FQNVGGKYSY
     LKVGHWAETL SLDVNSIHWS RNSVPTSQCS DPCAPNEMKN MQPGDVCCWI CIPCEPYEYL
     ADEFTCMDCG SGQWPTADLT GCYDLPEDYI RWEDAWAIGP VTIACLGFMC TCMVVTVFIK
     HNNTPLVKAS GRELCYILLF GVGLSYCMTF FFIAKPSPVI CALRRLGLGS SFAICYSALL
     TKTNCIARIF DGVKNGAQRP KFISPSSQVF ICLGLILVQI VMVSVWLILE APGTRRYTLA
     EKRETVILKC NVKDSSMLIS LTYDVILVIL CTVYAFKTRK CPENFNEAKF IGFTMYTTCI
     IWLAFLPIFY VTSSDYRVQT TTMCISVSLS GFVVLGCLFA PKVHIILFQP QKNVVTHRLH
     LNRFSVSGTG TTYSQSSAST YVPTVCNGRE VLDSTTSSL
//
ID   GRM3_HUMAN              Reviewed;         879 AA.
AC   Q14832; Q2PNZ6; Q75MV4; Q75N17; Q86YG6; Q8TBH9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   22-APR-2020, entry version 176.
DE   RecName: Full=Metabotropic glutamate receptor 3;
DE            Short=mGluR3;
DE   Flags: Precursor;
GN   Name=GRM3; Synonyms=GPRC1C, MGLUR3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8840013; DOI=10.1016/0169-328x(96)00037-x;
RA   Makoff A., Volpe F., Lelchuk R., Harrington K., Emson P.;
RT   "Molecular characterization and localization of human metabotropic
RT   glutamate receptor type 3.";
RL   Brain Res. Mol. Brain Res. 40:55-63(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Lymphoblast;
RX   PubMed=16417579; DOI=10.1111/j.1471-4159.2005.03609.x;
RA   Sartorius L.J., Nagappan G., Lipska B.K., Lu B., Sei Y., Ren-Patterson R.,
RA   Li Z., Weinberger D.R., Harrison P.J.;
RT   "Alternative splicing of human metabotropic glutamate receptor 3.";
RL   J. Neurochem. 96:1139-1148(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.26 ANGSTROMS) OF 26-504 OF MUTANT SER-240, AND
RP   DISULFIDE BONDS.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of metabotropic glutamate receptor 3 precursor in
RT   presence of LY341495 antagonist.";
RL   Submitted (JUL-2011) to the PDB data bank.
CC   -!- FUNCTION: G-protein coupled receptor for glutamate. Ligand binding
CC       causes a conformation change that triggers signaling via guanine
CC       nucleotide-binding proteins (G proteins) and modulates the activity of
CC       down-stream effectors. Signaling inhibits adenylate cyclase activity.
CC       {ECO:0000269|PubMed:8840013}.
CC   -!- SUBUNIT: Interacts with GRASP. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8840013};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:8840013}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14832-1; Sequence=Displayed;
CC       Name=2; Synonyms=GRM3Delta4;
CC         IsoId=Q14832-2; Sequence=VSP_047679, VSP_047680;
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, thalamus, subthalamic
CC       nucleus, substantia nigra, hypothalamus, hippocampus, corpus callosum,
CC       caudate nucleus and amygdala. {ECO:0000269|PubMed:8840013}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Appears to be membrane-associated, despite
CC       the absence of the seven-transmembrane domain. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD15616.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=ABC47402.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA54796.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X77748; CAA54796.1; ALT_INIT; mRNA.
DR   EMBL; DQ315361; ABC47402.1; ALT_INIT; mRNA.
DR   EMBL; AC004829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005009; AAD15616.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC002081; AAC60379.2; -; Genomic_DNA.
DR   EMBL; BC022496; AAH22496.2; -; mRNA.
DR   EMBL; BC041407; AAH41407.1; -; mRNA.
DR   CCDS; CCDS5600.1; -. [Q14832-1]
DR   CCDS; CCDS87515.1; -. [Q14832-2]
DR   RefSeq; NP_000831.2; NM_000840.2. [Q14832-1]
DR   RefSeq; XP_011514390.1; XM_011516088.1.
DR   PDB; 1S8M; Model; -; A=30-499.
DR   PDB; 3SM9; X-ray; 2.26 A; A=26-504.
DR   PDB; 4XAR; X-ray; 2.26 A; A=2-508.
DR   PDB; 5CNK; X-ray; 3.15 A; A/B/C=2-507.
DR   PDB; 5CNM; X-ray; 2.84 A; A=2-507.
DR   PDB; 6B7H; X-ray; 2.82 A; A=2-507.
DR   PDBsum; 1S8M; -.
DR   PDBsum; 3SM9; -.
DR   PDBsum; 4XAR; -.
DR   PDBsum; 5CNK; -.
DR   PDBsum; 5CNM; -.
DR   PDBsum; 6B7H; -.
DR   SMR; Q14832; -.
DR   BioGrid; 109170; 5.
DR   CORUM; Q14832; -.
DR   IntAct; Q14832; 1.
DR   STRING; 9606.ENSP00000355316; -.
DR   BindingDB; Q14832; -.
DR   ChEMBL; CHEMBL2888; -.
DR   DrugBank; DB05096; LY2140023.
DR   DrugCentral; Q14832; -.
DR   GuidetoPHARMACOLOGY; 291; -.
DR   iPTMnet; Q14832; -.
DR   PhosphoSitePlus; Q14832; -.
DR   BioMuta; GRM3; -.
DR   DMDM; 76803803; -.
DR   MassIVE; Q14832; -.
DR   PaxDb; Q14832; -.
DR   PeptideAtlas; Q14832; -.
DR   PRIDE; Q14832; -.
DR   ProteomicsDB; 60202; -. [Q14832-1]
DR   ProteomicsDB; 61428; -.
DR   Antibodypedia; 15243; 357 antibodies.
DR   DNASU; 2913; -.
DR   Ensembl; ENST00000361669; ENSP00000355316; ENSG00000198822. [Q14832-1]
DR   Ensembl; ENST00000439827; ENSP00000398767; ENSG00000198822. [Q14832-2]
DR   GeneID; 2913; -.
DR   KEGG; hsa:2913; -.
DR   UCSC; uc003uid.4; human. [Q14832-1]
DR   CTD; 2913; -.
DR   DisGeNET; 2913; -.
DR   GeneCards; GRM3; -.
DR   HGNC; HGNC:4595; GRM3.
DR   HPA; ENSG00000198822; Tissue enriched (brain).
DR   MIM; 601115; gene.
DR   neXtProt; NX_Q14832; -.
DR   OpenTargets; ENSG00000198822; -.
DR   PharmGKB; PA28992; -.
DR   eggNOG; KOG1056; Eukaryota.
DR   eggNOG; ENOG410XR6W; LUCA.
DR   GeneTree; ENSGT00950000182807; -.
DR   HOGENOM; CLU_005389_0_0_1; -.
DR   InParanoid; Q14832; -.
DR   KO; K04606; -.
DR   OMA; KWEDAWA; -.
DR   PhylomeDB; Q14832; -.
DR   TreeFam; TF313240; -.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-420499; Class C/3 (Metabotropic glutamate/pheromone receptors).
DR   SignaLink; Q14832; -.
DR   SIGNOR; Q14832; -.
DR   ChiTaRS; GRM3; human.
DR   GeneWiki; Metabotropic_glutamate_receptor_3; -.
DR   GenomeRNAi; 2913; -.
DR   Pharos; Q14832; Tchem.
DR   PRO; PR:Q14832; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q14832; protein.
DR   Bgee; ENSG00000198822; Expressed in caudate nucleus and 97 other tissues.
DR   ExpressionAtlas; Q14832; baseline and differential.
DR   Genevisible; Q14832; HS.
DR   GO; GO:0097449; C:astrocyte projection; ISS:ARUK-UCL.
DR   GO; GO:0030424; C:axon; ISS:ARUK-UCL.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005246; F:calcium channel regulator activity; IEA:Ensembl.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; TAS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; IBA:GO_Central.
DR   GO; GO:0001641; F:group II metabotropic glutamate receptor activity; IBA:GO_Central.
DR   GO; GO:0097110; F:scaffold protein binding; ISS:ARUK-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0007216; P:G protein-coupled glutamate receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:GO_Central.
DR   Gene3D; 2.10.50.30; -; 1.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR000337; GPCR_3.
DR   InterPro; IPR011500; GPCR_3_9-Cys_dom.
DR   InterPro; IPR038550; GPCR_3_9-Cys_sf.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR017979; GPCR_3_CS.
DR   InterPro; IPR000162; GPCR_3_mtglu_rcpt.
DR   InterPro; IPR001234; GPCR_3_mtglu_rcpt_3.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF07562; NCD3G; 1.
DR   PRINTS; PR00248; GPCRMGR.
DR   PRINTS; PR01053; MTABOTROPC3R.
DR   PRINTS; PR00593; MTABOTROPICR.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   PROSITE; PS00979; G_PROTEIN_RECEP_F3_1; 1.
DR   PROSITE; PS00980; G_PROTEIN_RECEP_F3_2; 1.
DR   PROSITE; PS00981; G_PROTEIN_RECEP_F3_3; 1.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..879
FT                   /note="Metabotropic glutamate receptor 3"
FT                   /id="PRO_0000012927"
FT   TOPO_DOM        23..576
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        577..599
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        600..613
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        614..634
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        635..645
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        646..664
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        665..688
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        689..709
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        710..734
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        735..756
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        757..769
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        770..792
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        793..802
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        803..828
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        829..879
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          172..174
FT                   /note="Glutamate binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         151
FT                   /note="Glutamate"
FT                   /evidence="ECO:0000250"
FT   BINDING         222
FT                   /note="Glutamate"
FT                   /evidence="ECO:0000250"
FT   BINDING         301
FT                   /note="Glutamate"
FT                   /evidence="ECO:0000250"
FT   BINDING         389
FT                   /note="Glutamate"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        209
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        414
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        439
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..99
FT                   /evidence="ECO:0000269|Ref.5"
FT   DISULFID        240..527
FT                   /evidence="ECO:0000250"
FT   DISULFID        361..373
FT                   /evidence="ECO:0000269|Ref.5"
FT   DISULFID        412..419
FT                   /evidence="ECO:0000269|Ref.5"
FT   DISULFID        509..528
FT                   /evidence="ECO:0000250"
FT   DISULFID        513..531
FT                   /evidence="ECO:0000250"
FT   DISULFID        534..546
FT                   /evidence="ECO:0000250"
FT   DISULFID        549..562
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         442..537
FT                   /note="APFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLD
FT                   VNSIHWSRNSVPTSQCSDPCAPNEMKNMQPGDVCCWICIPCEPY -> GADDNHVHLCQ
FT                   PEWLCGLGLFVCTQGSHHPVSTPEECCHTQTAPQQVQCQWNWDHILSVLCKHVCANGVQ
FT                   WAGSPRLHHLISVIVNCSSVLVFLDC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16417579"
FT                   /id="VSP_047679"
FT   VAR_SEQ         538..879
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16417579"
FT                   /id="VSP_047680"
FT   VARIANT         475
FT                   /note="G -> D (in dbSNP:rs17161026)"
FT                   /id="VAR_049274"
FT   CONFLICT        96
FT                   /note="L -> F (in Ref. 4; AAH41407)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        446
FT                   /note="P -> T (in Ref. 4; AAH22496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        512
FT                   /note="P -> A (in Ref. 4; AAH22496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        856
FT                   /note="S -> Y (in Ref. 4; AAH22496)"
FT                   /evidence="ECO:0000305"
FT   STRAND          33..35
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          38..45
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          48..50
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          56..60
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            62..65
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           66..81
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          83..86
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          91..97
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           102..114
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          142..146
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           151..161
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           162..164
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          168..172
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           176..179
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            181..186
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          187..191
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           195..207
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          212..220
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           221..235
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            236..238
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          240..247
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           253..264
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          271..275
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           278..290
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          296..299
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            301..305
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           307..310
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            314..319
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          321..325
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           331..338
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            342..344
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           351..359
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   TURN            381..383
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           390..411
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           420..423
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           427..433
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           435..437
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          438..440
FT                   /evidence="ECO:0000244|PDB:4XAR"
FT   HELIX           450..452
FT                   /evidence="ECO:0000244|PDB:5CNM"
FT   STRAND          453..455
FT                   /evidence="ECO:0000244|PDB:4XAR"
FT   STRAND          466..476
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   STRAND          478..492
FT                   /evidence="ECO:0000244|PDB:3SM9"
FT   HELIX           494..496
FT                   /evidence="ECO:0000244|PDB:3SM9"
SQ   SEQUENCE   879 AA;  98879 MW;  7EB84521676E8304 CRC64;
     MKMLTRLQVL TLALFSKGFL LSLGDHNFLR REIKIEGDLV LGGLFPINEK GTGTEECGRI
     NEDRGIQRLE AMLFAIDEIN KDDYLLPGVK LGVHILDTCS RDTYALEQSL EFVRASLTKV
     DEAEYMCPDG SYAIQENIPL LIAGVIGGSY SSVSIQVANL LRLFQIPQIS YASTSAKLSD
     KSRYDYFART VPPDFYQAKA MAEILRFFNW TYVSTVASEG DYGETGIEAF EQEARLRNIC
     IATAEKVGRS NIRKSYDSVI RELLQKPNAR VVVLFMRSDD SRELIAAASR ANASFTWVAS
     DGWGAQESII KGSEHVAYGA ITLELASQPV RQFDRYFQSL NPYNNHRNPW FRDFWEQKFQ
     CSLQNKRNHR RVCDKHLAID SSNYEQESKI MFVVNAVYAM AHALHKMQRT LCPNTTKLCD
     AMKILDGKKL YKDYLLKINF TAPFNPNKDA DSIVKFDTFG DGMGRYNVFN FQNVGGKYSY
     LKVGHWAETL SLDVNSIHWS RNSVPTSQCS DPCAPNEMKN MQPGDVCCWI CIPCEPYEYL
     ADEFTCMDCG SGQWPTADLT GCYDLPEDYI RWEDAWAIGP VTIACLGFMC TCMVVTVFIK
     HNNTPLVKAS GRELCYILLF GVGLSYCMTF FFIAKPSPVI CALRRLGLGS SFAICYSALL
     TKTNCIARIF DGVKNGAQRP KFISPSSQVF ICLGLILVQI VMVSVWLILE APGTRRYTLA
     EKRETVILKC NVKDSSMLIS LTYDVILVIL CTVYAFKTRK CPENFNEAKF IGFTMYTTCI
     IWLAFLPIFY VTSSDYRVQT TTMCISVSLS GFVVLGCLFA PKVHIILFQP QKNVVTHRLH
     LNRFSVSGTG TTYSQSSAST YVPTVCNGRE VLDSTTSSL
//
ID   KAT7_HUMAN              Reviewed;         611 AA.
AC   O95251; B3KN74; B4DF85; B4DFB4; B4DFE0; B4DGY4; E7ER15; G5E9K7;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=Histone acetyltransferase KAT7 {ECO:0000305};
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:17954561, ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551, ECO:0000269|PubMed:31827282};
DE   AltName: Full=Histone acetyltransferase binding to ORC1 {ECO:0000303|PubMed:10438470, ECO:0000303|PubMed:10930412};
DE   AltName: Full=Lysine acetyltransferase 7 {ECO:0000303|PubMed:31767635};
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2 {ECO:0000303|Ref.4};
DE            Short=MYST-2 {ECO:0000303|Ref.4};
GN   Name=KAT7 {ECO:0000303|PubMed:31767635, ECO:0000312|HGNC:HGNC:17016};
GN   Synonyms=HBO1 {ECO:0000303|PubMed:10438470, ECO:0000303|PubMed:10930412},
GN   HBOa {ECO:0000303|Ref.3}, MYST2 {ECO:0000303|Ref.4};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH ORC1, FUNCTION,
RP   CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Epithelium;
RX   PubMed=10438470; DOI=10.1074/jbc.274.33.23027;
RA   Iizuka M., Stillman B.;
RT   "Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the
RT   human initiator protein.";
RL   J. Biol. Chem. 274:23027-23034(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH AR.
RC   TISSUE=Prostate;
RX   PubMed=10930412; DOI=10.1074/jbc.m004838200;
RA   Sharma M., Zarnegar M., Li X., Lim B., Sun Z.;
RT   "Androgen receptor interacts with a novel MYST protein, HBO1.";
RL   J. Biol. Chem. 275:35200-35208(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Jian J., Guangtao L., Guangwei D., Yan Z., Jianhe C., Jiangang Y.,
RA   Boqin Q.;
RT   "Cloning and identifying histone acetyltransferase HBOa.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Borrow J., Housman D.E.;
RT   "Structure and function of the human MYST family: MOZ2, MYST1 and MYST2.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RC   TISSUE=Brain, Cerebellum, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH MCM2 AND ORC1, DOMAIN, SUBCELLULAR LOCATION, FUNCTION, AND
RP   MUTAGENESIS OF CYS-371.
RX   PubMed=11278932; DOI=10.1074/jbc.m011556200;
RA   Burke T.W., Cook J.G., Asano M., Nevins J.R.;
RT   "Replication factors MCM2 and ORC1 interact with the histone
RT   acetyltransferase HBO1.";
RL   J. Biol. Chem. 276:15397-15408(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=16997280; DOI=10.1016/j.bbrc.2006.09.030;
RA   Contzler R., Regamey A., Favre B., Roger T., Hohl D., Huber M.;
RT   "Histone acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator
RT   sequestration.";
RL   Biochem. Biophys. Res. Commun. 350:208-213(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   FUNCTION IN HISTONE ACETYLATION, IDENTIFICATION IN THE HBO1 COMPLEX,
RP   INTERACTION WITH MCM2, AND SUBCELLULAR LOCATION.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-88, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   INTERACTION WITH CDT1, AND SUBCELLULAR LOCATION.
RX   PubMed=18832067; DOI=10.1101/gad.1674108;
RA   Miotto B., Struhl K.;
RT   "HBO1 histone acetylase is a coactivator of the replication licensing
RT   factor Cdt1.";
RL   Genes Dev. 22:2633-2638(2008).
RN   [16]
RP   CATALYTIC ACTIVITY, INTERACTION WITH TP53, AND MUTAGENESIS OF GLY-485.
RX   PubMed=17954561; DOI=10.1128/mcb.00662-07;
RA   Iizuka M., Sarmento O.F., Sekiya T., Scrable H., Allis C.D., Smith M.M.;
RT   "Hbo1 Links p53-dependent stress signaling to DNA replication licensing.";
RL   Mol. Cell. Biol. 28:140-153(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-57; THR-85; THR-88
RP   AND SER-102, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION AT SER-57 BY PLK1, PHOSPHORYLATION AT THR-85 AND THR-88 BY
RP   CDK1, AND MUTAGENESIS OF SER-57.
RX   PubMed=18250300; DOI=10.1073/pnas.0712063105;
RA   Wu Z.Q., Liu X.;
RT   "Role for Plk1 phosphorylation of Hbo1 in regulation of replication
RT   licensing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1919-1924(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   FUNCTION, IDENTIFICATION IN THE HBO1 COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=19187766; DOI=10.1016/j.molcel.2009.01.007;
RA   Saksouk N., Avvakumov N., Champagne K.S., Hung T., Doyon Y., Cayrou C.,
RA   Paquet E., Ullah M., Landry A.J., Cote V., Yang X.J., Gozani O.,
RA   Kutateladze T.G., Cote J.;
RT   "HBO1 HAT complexes target chromatin throughout gene coding regions via
RT   multiple PHD finger interactions with histone H3 tail.";
RL   Mol. Cell 33:257-265(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-85; THR-88 AND
RP   SER-102, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   FUNCTION, ACTIVITY REGULATION, IDENTIFICATION IN THE HBO1 COMPLEX,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLY-485.
RX   PubMed=20129055; DOI=10.1016/j.molcel.2009.12.012;
RA   Miotto B., Struhl K.;
RT   "HBO1 histone acetylase activity is essential for DNA replication licensing
RT   and inhibited by Geminin.";
RL   Mol. Cell 37:57-66(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE HBO1 COMPLEX.
RX   PubMed=21753189; DOI=10.1182/blood-2011-01-331892;
RA   Mishima Y., Miyagi S., Saraya A., Negishi M., Endoh M., Endo T.A.,
RA   Toyoda T., Shinga J., Katsumoto T., Chiba T., Yamaguchi N., Kitabayashi I.,
RA   Koseki H., Iwama A.;
RT   "The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14
RT   and required for fetal liver erythropoiesis.";
RL   Blood 118:2443-2453(2011).
RN   [26]
RP   FUNCTION.
RX   PubMed=21856198; DOI=10.1016/j.molcel.2011.06.021;
RA   Miotto B., Struhl K.;
RT   "JNK1 phosphorylation of Cdt1 inhibits recruitment of HBO1 histone
RT   acetylase and blocks replication licensing in response to stress.";
RL   Mol. Cell 44:62-71(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-88; SER-102; SER-124;
RP   SER-162 AND SER-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   FUNCTION, CATALYTIC ACTIVITY, IDENTIFICATION IN THE HBO1 COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24065767; DOI=10.1101/gad.223396.113;
RA   Lalonde M.E., Avvakumov N., Glass K.C., Joncas F.H., Saksouk N.,
RA   Holliday M., Paquet E., Yan K., Tong Q., Klein B.J., Tan S., Yang X.J.,
RA   Kutateladze T.G., Cote J.;
RT   "Exchange of associated factors directs a switch in HBO1 acetyltransferase
RT   histone tail specificity.";
RL   Genes Dev. 27:2009-2024(2013).
RN   [29]
RP   MUTAGENESIS OF LYS-338, AND UBIQUITINATION AT LYS-338.
RX   PubMed=23319590; DOI=10.1074/jbc.m112.426882;
RA   Zou C., Chen Y., Smith R.M., Snavely C., Li J., Coon T.A., Chen B.B.,
RA   Zhao Y., Mallampalli R.K.;
RT   "SCF(Fbxw15) mediates histone acetyltransferase binding to origin
RT   recognition complex (HBO1) ubiquitin-proteasomal degradation to regulate
RT   cell proliferation.";
RL   J. Biol. Chem. 288:6306-6316(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-50; SER-57; SER-64;
RP   SER-102; SER-111; SER-162; SER-164; SER-178 AND SER-506, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MIS18BP1.
RX   PubMed=27270040; DOI=10.1016/j.devcel.2016.05.006;
RA   Ohzeki J., Shono N., Otake K., Martins N.M., Kugou K., Kimura H.,
RA   Nagase T., Larionov V., Earnshaw W.C., Masumoto H.;
RT   "KAT7/HBO1/MYST2 regulates CENP-A chromatin assembly by antagonizing
RT   Suv39h1-mediated centromere inactivation.";
RL   Dev. Cell 37:413-427(2016).
RN   [33]
RP   FUNCTION, CATALYTIC ACTIVITY, AND IDENTIFICATION IN THE HBO1 COMPLEX.
RX   PubMed=26620551; DOI=10.15252/embj.201Fphers591293;
RA   Feng Y., Vlassis A., Roques C., Lalonde M.E., Gonzalez-Aguilera C.,
RA   Lambert J.P., Lee S.B., Zhao X., Alabert C., Johansen J.V., Paquet E.,
RA   Yang X.J., Gingras A.C., Cote J., Groth A.;
RT   "BRPF3-HBO1 regulates replication origin activation and histone H3K14
RT   acetylation.";
RL   EMBO J. 35:176-192(2016).
RN   [34]
RP   PHOSPHORYLATION AT SER-50 AND SER-53, UBIQUITINATION, AND MUTAGENESIS OF
RP   50-SER--SER-53.
RX   PubMed=26572825; DOI=10.1128/mcb.00809-15;
RA   Matsunuma R., Niida H., Ohhata T., Kitagawa K., Sakai S., Uchida C.,
RA   Shiotani B., Matsumoto M., Nakayama K.I., Ogura H., Shiiya N., Kitagawa M.;
RT   "UV damage-induced phosphorylation of HBO1 triggers CRL4DDB2-mediated
RT   degradation to regulate cell proliferation.";
RL   Mol. Cell. Biol. 36:394-406(2016).
RN   [35]
RP   FUNCTION, PHOSPHORYLATION AT SER-50 AND SER-53, AND SUBCELLULAR LOCATION.
RX   PubMed=28719581; DOI=10.1038/ncomms16102;
RA   Niida H., Matsunuma R., Horiguchi R., Uchida C., Nakazawa Y., Motegi A.,
RA   Nishimoto K., Sakai S., Ohhata T., Kitagawa K., Moriwaki S., Nishitani H.,
RA   Ui A., Ogi T., Kitagawa M.;
RT   "Phosphorylated HBO1 at UV irradiated sites is essential for nucleotide
RT   excision repair.";
RL   Nat. Commun. 8:16102-16102(2017).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-323, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [37]
RP   INTERACTION WITH JADE1.
RX   PubMed=29382722; DOI=10.1074/jbc.ra117.000677;
RA   Han J., Lachance C., Ricketts M.D., McCullough C.E., Gerace M., Black B.E.,
RA   Cote J., Marmorstein R.;
RT   "The scaffolding protein JADE1 physically links the acetyltransferase
RT   subunit HBO1 with its histone H3-H4 substrate.";
RL   J. Biol. Chem. 293:4498-4509(2018).
RN   [38]
RP   FUNCTION.
RX   PubMed=31767635; DOI=10.1128/mcb.00506-19;
RA   Kueh A.J., Eccles S., Tang L., Garnham A.L., May R.E., Herold M.J.,
RA   Smyth G.K., Voss A.K., Thomas T.;
RT   "HBO1(KAT7) does not have an essential role in cell proliferation, DNA
RT   replication or histone 4 acetylation in human cells.";
RL   Mol. Cell. Biol. 0:0-0(2019).
RN   [39] {ECO:0000244|PDB:5GK9}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 336-611 IN COMPLEX WITH BRD1;
RP   ZINC AND ACETYL-COA.
RX   PubMed=28334966; DOI=10.1093/nar/gkx142;
RA   Tao Y., Zhong C., Zhu J., Xu S., Ding J.;
RT   "Structural and mechanistic insights into regulation of HBO1 histone
RT   acetyltransferase activity by BRPF2.";
RL   Nucleic Acids Res. 45:5707-5719(2017).
RN   [40] {ECO:0000244|PDB:6MAJ, ECO:0000244|PDB:6MAK}
RP   X-RAY CRYSTALLOGRAPHY (2.13 ANGSTROMS) OF 336-609 IN COMPLEX WITH BRD1;
RP   ZINC; WM-3835 INHIBITOR AND ACETYL-COA, FUNCTION, CATALYTIC ACTIVITY,
RP   ACTIVITY REGULATION, AND MUTAGENESIS OF GLU-508.
RX   PubMed=31827282; DOI=10.1038/s41586-019-1835-6;
RA   MacPherson L., Anokye J., Yeung M.M., Lam E.Y.N., Chan Y.C., Weng C.F.,
RA   Yeh P., Knezevic K., Butler M.S., Hoegl A., Chan K.L., Burr M.L.,
RA   Gearing L.J., Willson T., Liu J., Choi J., Yang Y., Bilardi R.A., Falk H.,
RA   Nguyen N., Stupple P.A., Peat T.S., Zhang M., de Silva M.,
RA   Carrasco-Pozo C., Avery V.M., Khoo P.S., Dolezal O., Dennis M.L.,
RA   Nuttall S., Surjadi R., Newman J., Ren B., Leaver D.J., Sun Y., Baell J.B.,
RA   Dovey O., Vassiliou G.S., Grebien F., Dawson S.J., Street I.P.,
RA   Monahan B.J., Burns C.J., Choudhary C., Blewitt M.E., Voss A.K., Thomas T.,
RA   Dawson M.A.;
RT   "HBO1 is required for the maintenance of leukaemia stem cells.";
RL   Nature 0:0-0(2019).
CC   -!- FUNCTION: Catalytic subunit of histone acetyltransferase HBO1
CC       complexes, which specifically mediate acetylation of histone H3 at
CC       'Lys-14' (H3K14ac), thereby regulating various processes, such as gene
CC       transcription, protein ubiquitination, immune regulation, stem cell
CC       pluripotent and self-renewal maintenance and embryonic development
CC       (PubMed:16387653, PubMed:21753189, PubMed:24065767, PubMed:26620551,
CC       PubMed:31767635, PubMed:31827282). Some complexes also catalyze
CC       acetylation of histone H4 at 'Lys-5', 'Lys-8' and 'Lys-12' (H4K5ac,
CC       H4K8ac and H4K12ac, respectively), regulating DNA replication
CC       initiation, regulating DNA replication initiation (PubMed:10438470,
CC       PubMed:19187766, PubMed:20129055, PubMed:24065767). Specificity of the
CC       HBO1 complexes is determined by the scaffold subunit: complexes
CC       containing BRPF scaffold (BRPF1, BRD1/BRPF2 or BRPF3) direct KAT7/HBO1
CC       specificity towards H3K14ac, while complexes containing JADE (JADE1,
CC       JADE2 and JADE3) scaffold direct KAT7/HBO1 specificity towards histone
CC       H4 (PubMed:19187766, PubMed:20129055, PubMed:24065767,
CC       PubMed:26620551). H3K14ac promotes transcriptional elongation by
CC       facilitating the processivity of RNA polymerase II (PubMed:31827282).
CC       Acts as a key regulator of hematopoiesis by forming a complex with
CC       BRD1/BRPF2, directing KAT7/HBO1 specificity towards H3K14ac and
CC       promoting erythroid differentiation (PubMed:21753189). H3K14ac is also
CC       required for T-cell development (By similarity). KAT7/HBO1-mediated
CC       acetylation facilitates two consecutive steps, licensing and
CC       activation, in DNA replication initiation: H3K14ac facilitates the
CC       activation of replication origins, and histone H4 acetylation (H4K5ac,
CC       H4K8ac and H4K12ac) facilitates chromatin loading of MCM complexes,
CC       promoting DNA replication licensing (PubMed:10438470, PubMed:11278932,
CC       PubMed:18832067, PubMed:19187766, PubMed:20129055, PubMed:21856198,
CC       PubMed:24065767, PubMed:26620551). Acts as a positive regulator of
CC       centromeric CENPA assembly: recruited to centromeres and mediates
CC       histone acetylation, thereby preventing centromere inactivation
CC       mediated by SUV39H1, possibly by increasing histone turnover/exchange
CC       (PubMed:27270040). Involved in nucleotide excision repair:
CC       phosphorylation by ATR in response to ultraviolet irradiation promotes
CC       its localization to DNA damage sites, where it mediates histone
CC       acetylation to facilitate recruitment of XPC at the damaged DNA sites
CC       (PubMed:28719581). Acts as an inhibitor of NF-kappa-B independently of
CC       its histone acetyltransferase activity (PubMed:16997280).
CC       {ECO:0000250|UniProtKB:Q5SVQ0, ECO:0000269|PubMed:10438470,
CC       ECO:0000269|PubMed:11278932, ECO:0000269|PubMed:16387653,
CC       ECO:0000269|PubMed:16997280, ECO:0000269|PubMed:18832067,
CC       ECO:0000269|PubMed:19187766, ECO:0000269|PubMed:20129055,
CC       ECO:0000269|PubMed:21753189, ECO:0000269|PubMed:21856198,
CC       ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551,
CC       ECO:0000269|PubMed:27270040, ECO:0000269|PubMed:28719581,
CC       ECO:0000269|PubMed:31767635, ECO:0000269|PubMed:31827282}.
CC   -!- FUNCTION: Plays a central role in the maintenance of leukemia stem
CC       cells in acute myeloid leukemia (AML) (PubMed:31827282). Acts by
CC       mediating acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby
CC       facilitating the processivity of RNA polymerase II to maintain the high
CC       expression of key genes, such as HOXA9 and HOXA10 that help to sustain
CC       the functional properties of leukemia stem cells (PubMed:31827282).
CC       {ECO:0000269|PubMed:31827282}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[histone] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[histone]; Xref=Rhea:RHEA:21992, Rhea:RHEA-COMP:9845,
CC         Rhea:RHEA-COMP:11338, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:17954561,
CC         ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551,
CC         ECO:0000269|PubMed:31827282};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21993;
CC         Evidence={ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:17954561,
CC         ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551,
CC         ECO:0000269|PubMed:31827282};
CC   -!- ACTIVITY REGULATION: Histone acetyltransferase activity is inhibited by
CC       GMNN in the context of a complex with CDT1, inhibiting histone H4
CC       acetylation and DNA replication licensing (PubMed:20129055).
CC       Selectively inhibited by WM-3835 (N'-(4-fluoro-5-methyl-[1,1'-
CC       biphenyl]-3-carbonyl)-3- hydroxybenzenesulfonohydrazide) inhibitor
CC       (PubMed:31827282). {ECO:0000269|PubMed:20129055,
CC       ECO:0000269|PubMed:31827282}.
CC   -!- SUBUNIT: Component of the HBO1 complex composed of KAT7/HBO1, MEAF6,
CC       ING4 or ING5, and one scaffold subunit: complexes containing BRPF
CC       scaffold (BRPF1, BRD1/BRPF2 or BRPF3) direct KAT7/HBO1 specificity
CC       towards H3K14ac, while complexes containing JADE scaffold (JADE1, JADE2
CC       and JADE3) mediate acetylation of histone H4 (PubMed:16387653,
CC       PubMed:19187766, PubMed:20129055, PubMed:21753189, PubMed:24065767,
CC       PubMed:26620551, PubMed:29382722). Interacts with MCM2 and ORC1
CC       (PubMed:10438470, PubMed:11278932, PubMed:16387653). Interacts with the
CC       androgen receptor (AR); in the presence of dihydrotestosterone
CC       (PubMed:10930412). Interacts with CDT1 (PubMed:18832067). Interacts
CC       with MAP2K1 and CUL1 (By similarity). Interacts with p53/TP53; leading
CC       to inhibit histone acetyltransferase activity (PubMed:17954561).
CC       Interacts with MIS18BP1 (PubMed:27270040).
CC       {ECO:0000250|UniProtKB:Q5SVQ0, ECO:0000269|PubMed:10438470,
CC       ECO:0000269|PubMed:10930412, ECO:0000269|PubMed:11278932,
CC       ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:17954561,
CC       ECO:0000269|PubMed:18832067, ECO:0000269|PubMed:19187766,
CC       ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:21753189,
CC       ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551,
CC       ECO:0000269|PubMed:27270040, ECO:0000269|PubMed:29382722}.
CC   -!- INTERACTION:
CC       O95251; P10275: AR; NbExp=5; IntAct=EBI-473199, EBI-608057;
CC       O95251; Q99728: BARD1; NbExp=2; IntAct=EBI-473199, EBI-473181;
CC       O95251; Q9P2H0: CEP126; NbExp=2; IntAct=EBI-473199, EBI-473176;
CC       O95251; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-473199, EBI-348259;
CC       O95251; P53350: PLK1; NbExp=6; IntAct=EBI-473199, EBI-476768;
CC       O95251; P08670: VIM; NbExp=4; IntAct=EBI-473199, EBI-353844;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10930412,
CC       ECO:0000269|PubMed:11278932, ECO:0000269|PubMed:16387653,
CC       ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:28719581}. Chromosome
CC       {ECO:0000269|PubMed:18832067, ECO:0000269|PubMed:19187766,
CC       ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:21753189,
CC       ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:28719581}. Chromosome,
CC       centromere {ECO:0000269|PubMed:27270040}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q5SVQ0}. Note=Associates with replication
CC       origins specifically during the G1 phase of the cell cycle
CC       (PubMed:18832067, PubMed:20129055). Localizes to transcription start
CC       sites (PubMed:21753189, PubMed:24065767). Localizes to ultraviolet-
CC       induced DNA damage sites following phosphorylation by ATR
CC       (PubMed:28719581). Localizes to centromeres in G1 phase
CC       (PubMed:27270040). {ECO:0000269|PubMed:18832067,
CC       ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:21753189,
CC       ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:27270040,
CC       ECO:0000269|PubMed:28719581}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O95251-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95251-2; Sequence=VSP_042553, VSP_042554;
CC       Name=3;
CC         IsoId=O95251-3; Sequence=VSP_042552, VSP_042553, VSP_042554;
CC       Name=4;
CC         IsoId=O95251-4; Sequence=VSP_042554;
CC       Name=5;
CC         IsoId=O95251-5; Sequence=VSP_042552, VSP_042553;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in
CC       testis. {ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:10930412}.
CC   -!- DOMAIN: The C2HC MYST-type zinc finger is required for interaction with
CC       MCM2 and ORC1. {ECO:0000269|PubMed:11278932}.
CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression, while
CC       the C-terminus mediates AR-interaction. {ECO:0000269|PubMed:10930412}.
CC   -!- PTM: Phosphorylated at Ser-50 and Ser-53 by ATR in response to DNA
CC       damage, promoting its ubiquitination by the CRL4(DDB2) complex and
CC       subsequent degradation (PubMed:26572825). Phosphorylation at Ser-50 and
CC       Ser-53 by ATR in response to ultraviolet-induced DNA, promotes
CC       localization to DNA damage sites (PubMed:28719581). Phosphorylation at
CC       Ser-57 by PLK1 during mitosis seems important for prereplicative
CC       complex formation and DNA replication licensing, and requires prior
CC       phosphorylation at Thr-85 and Thr-88 by CDK1 (PubMed:18250300).
CC       Phosphorylated by MAP2K1, which accelerates its degradation (By
CC       similarity). {ECO:0000250|UniProtKB:Q5SVQ0,
CC       ECO:0000269|PubMed:18250300, ECO:0000269|PubMed:26572825,
CC       ECO:0000269|PubMed:28719581}.
CC   -!- PTM: Ubiquitinated at Lys-338, leading to proteasomal degradation
CC       (PubMed:23319590). Ubiquitinated by the CRL4(DDB2) complex following
CC       phosphorylation by ATR, leading to its subsequent degradation
CC       (PubMed:26572825). {ECO:0000269|PubMed:23319590,
CC       ECO:0000269|PubMed:26572825}.
CC   -!- PTM: Autoacetylation at Lys-432 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF074606; AAC99368.1; -; mRNA.
DR   EMBL; AF140360; AAD42348.1; -; mRNA.
DR   EMBL; AF217502; AAL56649.1; -; mRNA.
DR   EMBL; AK023890; BAG51236.1; -; mRNA.
DR   EMBL; AK293976; BAG57346.1; -; mRNA.
DR   EMBL; AK294014; BAG57375.1; -; mRNA.
DR   EMBL; AK294052; BAG57401.1; -; mRNA.
DR   EMBL; AK294836; BAG57945.1; -; mRNA.
DR   EMBL; AC015795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94658.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94659.1; -; Genomic_DNA.
DR   EMBL; BC032640; AAH32640.1; -; mRNA.
DR   CCDS; CCDS11554.1; -. [O95251-1]
DR   CCDS; CCDS56035.1; -. [O95251-4]
DR   CCDS; CCDS56036.1; -. [O95251-2]
DR   CCDS; CCDS56037.1; -. [O95251-5]
DR   CCDS; CCDS56038.1; -. [O95251-3]
DR   RefSeq; NP_001186084.1; NM_001199155.1. [O95251-4]
DR   RefSeq; NP_001186085.1; NM_001199156.1. [O95251-5]
DR   RefSeq; NP_001186086.1; NM_001199157.1. [O95251-2]
DR   RefSeq; NP_001186087.1; NM_001199158.1. [O95251-3]
DR   RefSeq; NP_008998.1; NM_007067.4. [O95251-1]
DR   PDB; 5GK9; X-ray; 2.40 A; A=336-611.
DR   PDB; 6MAJ; X-ray; 2.14 A; A=336-609.
DR   PDB; 6MAK; X-ray; 2.13 A; A=336-609.
DR   PDBsum; 5GK9; -.
DR   PDBsum; 6MAJ; -.
DR   PDBsum; 6MAK; -.
DR   SMR; O95251; -.
DR   BioGrid; 116315; 82.
DR   ComplexPortal; CPX-718; HBO1-4.1 histone acetyltransferase complex.
DR   ComplexPortal; CPX-719; HBO1-4.2 histone acetyltransferase complex.
DR   ComplexPortal; CPX-720; HBO1-4.3 histone acetyltransferase complex.
DR   ComplexPortal; CPX-721; HBO1-5.1 histone acetyltransferase complex.
DR   ComplexPortal; CPX-722; HBO1-5.2 histone acetyltransferase complex.
DR   ComplexPortal; CPX-723; HBO1-5.3 histone acetyltransferase complex.
DR   CORUM; O95251; -.
DR   DIP; DIP-29697N; -.
DR   IntAct; O95251; 62.
DR   MINT; O95251; -.
DR   STRING; 9606.ENSP00000259021; -.
DR   ChEMBL; CHEMBL3774299; -.
DR   iPTMnet; O95251; -.
DR   MetOSite; O95251; -.
DR   PhosphoSitePlus; O95251; -.
DR   SwissPalm; O95251; -.
DR   BioMuta; KAT7; -.
DR   EPD; O95251; -.
DR   jPOST; O95251; -.
DR   MassIVE; O95251; -.
DR   MaxQB; O95251; -.
DR   PaxDb; O95251; -.
DR   PeptideAtlas; O95251; -.
DR   PRIDE; O95251; -.
DR   ProteomicsDB; 17693; -.
DR   ProteomicsDB; 33968; -.
DR   ProteomicsDB; 50746; -. [O95251-1]
DR   ProteomicsDB; 50747; -. [O95251-2]
DR   ProteomicsDB; 50748; -. [O95251-3]
DR   Antibodypedia; 17983; 350 antibodies.
DR   DNASU; 11143; -.
DR   Ensembl; ENST00000259021; ENSP00000259021; ENSG00000136504. [O95251-1]
DR   Ensembl; ENST00000424009; ENSP00000398961; ENSG00000136504. [O95251-4]
DR   Ensembl; ENST00000454930; ENSP00000413415; ENSG00000136504. [O95251-5]
DR   Ensembl; ENST00000509773; ENSP00000424577; ENSG00000136504. [O95251-2]
DR   Ensembl; ENST00000510819; ENSP00000423385; ENSG00000136504. [O95251-3]
DR   GeneID; 11143; -.
DR   KEGG; hsa:11143; -.
DR   UCSC; uc002ipl.3; human. [O95251-1]
DR   CTD; 11143; -.
DR   DisGeNET; 11143; -.
DR   GeneCards; KAT7; -.
DR   HGNC; HGNC:17016; KAT7.
DR   HPA; ENSG00000136504; Low tissue specificity.
DR   MIM; 609880; gene.
DR   neXtProt; NX_O95251; -.
DR   OpenTargets; ENSG00000136504; -.
DR   PharmGKB; PA134886407; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00940000157744; -.
DR   HOGENOM; CLU_011815_6_1_1; -.
DR   InParanoid; O95251; -.
DR   KO; K11307; -.
DR   OMA; VYSTRRV; -.
DR   OrthoDB; 629545at2759; -.
DR   PhylomeDB; O95251; -.
DR   TreeFam; TF317619; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SIGNOR; O95251; -.
DR   ChiTaRS; KAT7; human.
DR   GeneWiki; MYST2; -.
DR   GenomeRNAi; 11143; -.
DR   Pharos; O95251; Tbio.
DR   PRO; PR:O95251; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; O95251; protein.
DR   Bgee; ENSG00000136504; Expressed in testis and 223 other tissues.
DR   ExpressionAtlas; O95251; baseline and differential.
DR   Genevisible; O95251; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0003688; F:DNA replication origin binding; IMP:CAFA.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IDA:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB.
DR   GO; GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB.
DR   GO; GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0090240; P:positive regulation of histone H4 acetylation; IMP:CAFA.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IDA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:CAFA.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0072716; P:response to actinomycin D; IMP:CAFA.
DR   GO; GO:0072739; P:response to anisomycin; IMP:CAFA.
DR   GO; GO:0072720; P:response to dithiothreitol; IMP:CAFA.
DR   GO; GO:0072710; P:response to hydroxyurea; IMP:CAFA.
DR   GO; GO:0072708; P:response to sorbitol; IMP:CAFA.
DR   GO; GO:0031098; P:stress-activated protein kinase signaling cascade; IDA:CAFA.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   InterPro; IPR002515; Znf_C2H2C.
DR   InterPro; IPR036060; Znf_C2H2C_sf.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF01530; zf-C2HC; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SUPFAM; SSF103637; SSF103637; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS51802; ZF_CCHHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Centromere; Chromatin regulator; Chromosome; Cytoplasm; DNA damage;
KW   DNA repair; DNA replication; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..611
FT                   /note="Histone acetyltransferase KAT7"
FT                   /id="PRO_0000051569"
FT   DOMAIN          332..607
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   ZN_FING         176..219
FT                   /note="CCHHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   ZN_FING         365..390
FT                   /note="C2HC MYST-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   REGION          475..477
FT                   /note="acetyl-CoA binding"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAK,
FT                   ECO:0000269|PubMed:28334966, ECO:0000269|PubMed:31827282"
FT   REGION          483..488
FT                   /note="acetyl-CoA binding"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAK,
FT                   ECO:0000269|PubMed:28334966, ECO:0000269|PubMed:31827282"
FT   REGION          483..488
FT                   /note="WM-3835 inhibitor binding"
FT                   /evidence="ECO:0000244|PDB:6MAJ,
FT                   ECO:0000269|PubMed:31827282"
FT   COMPBIAS        10..57
FT                   /note="Ser-rich"
FT   ACT_SITE        508
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000305|PubMed:31827282"
FT   METAL           368
FT                   /note="Zinc"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAJ,
FT                   ECO:0000244|PDB:6MAK, ECO:0000269|PubMed:28334966,
FT                   ECO:0000269|PubMed:31827282"
FT   METAL           371
FT                   /note="Zinc"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAJ,
FT                   ECO:0000244|PDB:6MAK, ECO:0000269|PubMed:28334966,
FT                   ECO:0000269|PubMed:31827282"
FT   METAL           384
FT                   /note="Zinc"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAJ,
FT                   ECO:0000244|PDB:6MAK, ECO:0000269|PubMed:28334966,
FT                   ECO:0000269|PubMed:31827282"
FT   METAL           388
FT                   /note="Zinc"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAJ,
FT                   ECO:0000244|PDB:6MAK, ECO:0000269|PubMed:28334966,
FT                   ECO:0000269|PubMed:31827282"
FT   BINDING         512
FT                   /note="acetyl-CoA"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAK,
FT                   ECO:0000269|PubMed:28334966, ECO:0000269|PubMed:31827282"
FT   BINDING         518
FT                   /note="WM-3835 inhibitor"
FT                   /evidence="ECO:0000244|PDB:6MAJ,
FT                   ECO:0000269|PubMed:31827282"
FT   BINDING         521
FT                   /note="acetyl-CoA"
FT                   /evidence="ECO:0000244|PDB:5GK9, ECO:0000244|PDB:6MAK,
FT                   ECO:0000269|PubMed:28334966, ECO:0000269|PubMed:31827282"
FT   BINDING         525
FT                   /note="WM-3835 inhibitor"
FT                   /evidence="ECO:0000244|PDB:6MAJ,
FT                   ECO:0000269|PubMed:31827282"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         50
FT                   /note="Phosphoserine; by ATR"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:26572825,
FT                   ECO:0000269|PubMed:28719581"
FT   MOD_RES         53
FT                   /note="Phosphoserine; by ATR"
FT                   /evidence="ECO:0000269|PubMed:26572825,
FT                   ECO:0000269|PubMed:28719581"
FT   MOD_RES         57
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:18250300"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         85
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000269|PubMed:18250300"
FT   MOD_RES         88
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:18250300"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         104
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SVQ0"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         124
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         128
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SVQ0"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         277
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SVQ0"
FT   MOD_RES         432
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         506
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        323
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        338
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:23319590"
FT   VAR_SEQ         55..113
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042552"
FT   VAR_SEQ         114..193
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042553"
FT   VAR_SEQ         222..251
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042554"
FT   MUTAGEN         50..53
FT                   /note="SQSS->AQSA: Impaired phosphorylation by ATR, leading
FT                   to decreased ubiquitination and increased stability in
FT                   response to DNA damage."
FT                   /evidence="ECO:0000269|PubMed:26572825"
FT   MUTAGEN         57
FT                   /note="S->A: Leads to cell cycle arrest in the G1/S phase."
FT                   /evidence="ECO:0000269|PubMed:18250300"
FT   MUTAGEN         338
FT                   /note="K->R: Decreases ubiquitination."
FT                   /evidence="ECO:0000269|PubMed:23319590"
FT   MUTAGEN         371
FT                   /note="C->A: No interaction with MCM2 and ORC1."
FT                   /evidence="ECO:0000269|PubMed:11278932"
FT   MUTAGEN         485
FT                   /note="G->A: Abolishes histone acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:17954561,
FT                   ECO:0000269|PubMed:20129055"
FT   MUTAGEN         508
FT                   /note="E->A: Abolished histone acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:31827282"
FT   CONFLICT        38..44
FT                   /note="Missing (in Ref. 5; BAG57945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        41
FT                   /note="R -> Q (in Ref. 5; BAG57346)"
FT                   /evidence="ECO:0000305"
FT   STRAND          339..342
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          345..348
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           357..360
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          362..367
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   TURN            369..371
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          374..376
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           378..387
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          394..401
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          404..410
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   TURN            411..414
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           415..426
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          441..450
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          453..465
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          470..477
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           479..481
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           486..500
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          505..507
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           513..533
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          536..539
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           541..548
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           552..561
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          565..568
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   STRAND          571..575
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           578..583
FT                   /evidence="ECO:0000244|PDB:5GK9"
FT   HELIX           600..602
FT                   /evidence="ECO:0000244|PDB:5GK9"
SQ   SEQUENCE   611 AA;  70642 MW;  8368E7C4F07D8D7C CRC64;
     MPRRKRNAGS SSDGTEDSDF STDLEHTDSS ESDGTSRRSA RVTRSSARLS QSSQDSSPVR
     NLQSFGTEEP AYSTRRVTRS QQQPTPVTPK KYPLRQTRSS GSETEQVVDF SDRETKNTAD
     HDESPPRTPT GNAPSSESDI DISSPNVSHD ESIAKDMSLK DSGSDLSHRP KRRRFHESYN
     FNMKCPTPGC NSLGHLTGKH ERHFSISGCP LYHNLSADEC KVRAQSRDKQ IEERMLSHRQ
     DDNNRHATRH QAPTERQLRY KEKVAELRKK RNSGLSKEQK EKYMEHRQTY GNTREPLLEN
     LTSEYDLDLF RRAQARASED LEKLRLQGQI TEGSNMIKTI AFGRYELDTW YHSPYPEEYA
     RLGRLYMCEF CLKYMKSQTI LRRHMAKCVW KHPPGDEIYR KGSISVFEVD GKKNKIYCQN
     LCLLAKLFLD HKTLYYDVEP FLFYVMTEAD NTGCHLIGYF SKEKNSFLNY NVSCILTMPQ
     YMRQGYGKML IDFSYLLSKV EEKVGSPERP LSDLGLISYR SYWKEVLLRY LHNFQGKEIS
     IKEISQETAV NPVDIVSTLQ ALQMLKYWKG KHLVLKRQDL IDEWIAKEAK RSNSNKTMDP
     SCLKWTPPKG T
//
ID   SKAP_HUMAN              Reviewed;         316 AA.
AC   Q9Y448; B4DXA7; Q147U5; Q32Q57; Q5ISJ0; Q6P2S5; Q6PJM0; Q86XB4;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   22-APR-2020, entry version 126.
DE   RecName: Full=Small kinetochore-associated protein {ECO:0000303|PubMed:19667759};
DE            Short=SKAP {ECO:0000303|PubMed:19667759};
DE   AltName: Full=Kinetochore-localized astrin-binding protein {ECO:0000303|PubMed:21402792};
DE            Short=Kinastrin {ECO:0000303|PubMed:21402792};
DE   AltName: Full=Kinetochore-localized astrin/SPAG5-binding protein;
DE   AltName: Full=TRAF4-associated factor 1;
GN   Name=KNSTRN {ECO:0000312|HGNC:HGNC:30767};
GN   Synonyms=C15orf23 {ECO:0000312|HGNC:HGNC:30767},
GN   SKAP {ECO:0000303|PubMed:19667759}, TRAF4AF1; ORFNames=HSD11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Cai C.L., Liu N., Lin W., Miao S.Y., Wang L.F.;
RT   "A spermatogenesis related gene expressed in nucleus.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLU-40;
RP   LEU-75 AND SER-92.
RC   TISSUE=Kidney, Ovary, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 39-316 (ISOFORM 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 55-316 (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 44-316 (ISOFORM 1).
RA   Touji S., Yano M., Kobayasi A., Tamai K.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INDUCTION BY NITRIC OXIDE.
RX   PubMed=15855057; DOI=10.1016/j.freeradbiomed.2005.02.002;
RA   Turpaev K., Bouton C., Diet A., Glatigny A., Drapier J.-C.;
RT   "Analysis of differentially expressed genes in nitric oxide-exposed human
RT   monocytic cells.";
RL   Free Radic. Biol. Med. 38:1392-1400(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19667759; DOI=10.4161/cc.8.17.9514;
RA   Fang L., Seki A., Fang G.;
RT   "SKAP associates with kinetochores and promotes the metaphase-to-anaphase
RT   transition.";
RL   Cell Cycle 8:2819-2827(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN A COMPLEX WITH SPAG5;
RP   PLK1; DYNLL1 AND SGO2, AND INTERACTION WITH SPAG5.
RX   PubMed=21402792; DOI=10.1083/jcb.201008023;
RA   Dunsch A.K., Linnane E., Barr F.A., Gruneberg U.;
RT   "The astrin-kinastrin/SKAP complex localizes to microtubule plus ends and
RT   facilitates chromosome alignment.";
RL   J. Cell Biol. 192:959-968(2011).
RN   [12]
RP   FUNCTION, INTERACTION WITH CENPE, BINDING TO MICROTUBULES, SUBCELLULAR
RP   LOCATION, AND INDUCTION.
RX   PubMed=22110139; DOI=10.1074/jbc.m111.277194;
RA   Huang Y., Wang W., Yao P., Wang X., Liu X., Zhuang X., Yan F., Zhou J.,
RA   Du J., Ward T., Zou H., Zhang J., Fang G., Ding X., Dou Z., Yao X.;
RT   "CENP-E kinesin interacts with SKAP protein to orchestrate accurate
RT   chromosome segregation in mitosis.";
RL   J. Biol. Chem. 287:1500-1509(2012).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DSN1 AND MAPRE1.
RX   PubMed=23035123; DOI=10.1074/jbc.m112.406652;
RA   Wang X., Zhuang X., Cao D., Chu Y., Yao P., Liu W., Liu L., Adams G.,
RA   Fang G., Dou Z., Ding X., Huang Y., Wang D., Yao X.;
RT   "Mitotic regulator SKAP forms a link between kinetochore core complex KMN
RT   and dynamic spindle microtubules.";
RL   J. Biol. Chem. 287:39380-39390(2012).
RN   [14]
RP   INVOLVEMENT IN SCC, VARIANT SCC PHE-24, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=25194279; DOI=10.1038/ng.3091;
RA   Lee C.S., Bhaduri A., Mah A., Johnson W.L., Ungewickell A., Aros C.J.,
RA   Nguyen C.B., Rios E.J., Siprashvili Z., Straight A., Kim J., Aasi S.Z.,
RA   Khavari P.A.;
RT   "Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous
RT   squamous cell carcinoma.";
RL   Nat. Genet. 46:1060-1062(2014).
RN   [15]
RP   INTERACTION WITH PRPF19, AND SUBCELLULAR LOCATION.
RX   PubMed=24718257; DOI=10.1371/journal.pone.0092712;
RA   Lu S., Wang R., Cai C., Liang J., Xu L., Miao S., Wang L., Song W.;
RT   "Small kinetochore associated protein (SKAP) promotes UV-induced cell
RT   apoptosis through negatively regulating pre-mRNA processing factor 19
RT   (Prp19).";
RL   PLoS ONE 9:E92712-E92712(2014).
CC   -!- FUNCTION: Essential component of the mitotic spindle required for
CC       faithful chromosome segregation and progression into anaphase
CC       (PubMed:19667759). Promotes the metaphase-to-anaphase transition and is
CC       required for chromosome alignment, normal timing of sister chromatid
CC       segregation, and maintenance of spindle pole architecture
CC       (PubMed:19667759, PubMed:22110139). The astrin (SPAG5)-kinastrin (SKAP)
CC       complex promotes stable microtubule-kinetochore attachments
CC       (PubMed:21402792). Required for kinetochore oscillations and dynamics
CC       of microtubule plus-ends during live cell mitosis, possibly by forming
CC       a link between spindle microtubule plus-ends and mitotic chromosomes to
CC       achieve faithful cell division (PubMed:23035123). May be involved in
CC       UV-induced apoptosis via its interaction with PRPF19; however, these
CC       results need additional evidences (PubMed:24718257).
CC       {ECO:0000269|PubMed:19667759, ECO:0000269|PubMed:21402792,
CC       ECO:0000269|PubMed:22110139, ECO:0000269|PubMed:23035123,
CC       ECO:0000305|PubMed:24718257}.
CC   -!- SUBUNIT: Part of an astrin (SPAG5)-kinastrin (SKAP) complex containing
CC       KNSTRN, SPAG5, PLK1, DYNLL1 and SGO2. Interacts with SPAG5. Directly
CC       binds to microtubules, although at relatively low affinity. Interacts
CC       with CENPE; this interaction greatly favors microtubule-binding.
CC       Interacts with DSN1/MIS13; leading to localization to kinetochores.
CC       Interacts with MAPRE1/EB1; leading to localization to the microtubule
CC       plus ends. Interacts with PRPF19. {ECO:0000269|PubMed:21402792,
CC       ECO:0000269|PubMed:22110139, ECO:0000269|PubMed:23035123}.
CC   -!- INTERACTION:
CC       Q9Y448; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-373334, EBI-11096309;
CC       Q9Y448; Q9BXY8: BEX2; NbExp=3; IntAct=EBI-373334, EBI-745073;
CC       Q9Y448; Q8IY31-3: IFT20; NbExp=3; IntAct=EBI-373334, EBI-9091197;
CC       Q9Y448; Q15691: MAPRE1; NbExp=4; IntAct=EBI-373334, EBI-1004115;
CC       Q9Y448; Q9UPY8: MAPRE3; NbExp=3; IntAct=EBI-373334, EBI-726739;
CC       Q9Y448; O43482: OIP5; NbExp=3; IntAct=EBI-373334, EBI-536879;
CC       Q9Y448; O60437: PPL; NbExp=3; IntAct=EBI-373334, EBI-368321;
CC       Q9Y448; Q96ES7: SGF29; NbExp=5; IntAct=EBI-373334, EBI-743117;
CC       Q9Y448; Q9Y3C0: WASHC3; NbExp=6; IntAct=EBI-373334, EBI-712969;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24718257}.
CC       Chromosome, centromere, kinetochore {ECO:0000269|PubMed:19667759,
CC       ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:22110139,
CC       ECO:0000269|PubMed:23035123}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:19667759}. Note=Colocalizes with microtubules
CC       around centrosomes in prophase and with the mitotic spindle at
CC       prometaphase and metaphase. From late prometaphase to anaphase, is
CC       highly concentrated on kinetochores. Located at the kinetochore-
CC       microtubule interface. The astrin (SPAG5)-kinastrin (SKAP) complex
CC       localizes to the microtubule plus ends (PubMed:23035123).
CC       {ECO:0000269|PubMed:19667759, ECO:0000269|PubMed:21402792,
CC       ECO:0000269|PubMed:22110139, ECO:0000269|PubMed:23035123}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y448-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y448-2; Sequence=VSP_041070;
CC       Name=3;
CC         IsoId=Q9Y448-3; Sequence=VSP_041069;
CC   -!- TISSUE SPECIFICITY: Widely expressed, including in skin.
CC       {ECO:0000269|PubMed:25194279}.
CC   -!- INDUCTION: Degraded at the end of mitosis. Down-regulated upon exposure
CC       to nitric oxide. {ECO:0000269|PubMed:15855057,
CC       ECO:0000269|PubMed:22110139}.
CC   -!- DOMAIN: The coiled coil regions mediate binding to kinetochores.
CC       {ECO:0000269|PubMed:23035123}.
CC   -!- DISEASE: Note=Cutaneous squamous cell carcinomas (SCC): A malignancy of
CC       the skin. The hallmark of cutaneous SCC is malignant transformation of
CC       normal epidermal keratinocytes. Disease susceptibility is associated
CC       with variations affecting the gene represented in this entry. Variant
CC       Phe-24 appears specific for UV-associated malignancies
CC       (PubMed:25194279). {ECO:0000269|PubMed:25194279}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04543.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH14060.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI07803.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY652615; AAT66172.1; -; mRNA.
DR   EMBL; AK301887; BAG63319.1; -; mRNA.
DR   EMBL; AC013356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004543; AAH04543.1; ALT_TERM; mRNA.
DR   EMBL; BC014060; AAH14060.1; ALT_TERM; mRNA.
DR   EMBL; BC045739; AAH45739.1; -; mRNA.
DR   EMBL; BC064344; AAH64344.1; -; mRNA.
DR   EMBL; BC107802; AAI07803.1; ALT_INIT; mRNA.
DR   EMBL; BC118559; AAI18560.1; -; mRNA.
DR   EMBL; BC118639; AAI18640.1; -; mRNA.
DR   EMBL; CR602848; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CR611451; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U81002; AAD24201.1; -; mRNA.
DR   CCDS; CCDS42021.1; -. [Q9Y448-1]
DR   CCDS; CCDS45226.1; -. [Q9Y448-2]
DR   CCDS; CCDS45227.1; -. [Q9Y448-3]
DR   RefSeq; NP_001136233.1; NM_001142761.1. [Q9Y448-2]
DR   RefSeq; NP_001136234.1; NM_001142762.1. [Q9Y448-3]
DR   RefSeq; NP_150628.3; NM_033286.3. [Q9Y448-1]
DR   SMR; Q9Y448; -.
DR   BioGrid; 124714; 49.
DR   CORUM; Q9Y448; -.
DR   DIP; DIP-31247N; -.
DR   IntAct; Q9Y448; 46.
DR   MINT; Q9Y448; -.
DR   STRING; 9606.ENSP00000249776; -.
DR   GlyConnect; 2078; -.
DR   iPTMnet; Q9Y448; -.
DR   MetOSite; Q9Y448; -.
DR   PhosphoSitePlus; Q9Y448; -.
DR   BioMuta; KNSTRN; -.
DR   DMDM; 125991199; -.
DR   EPD; Q9Y448; -.
DR   jPOST; Q9Y448; -.
DR   MassIVE; Q9Y448; -.
DR   PaxDb; Q9Y448; -.
DR   PeptideAtlas; Q9Y448; -.
DR   PRIDE; Q9Y448; -.
DR   ProteomicsDB; 86099; -. [Q9Y448-1]
DR   ProteomicsDB; 86100; -. [Q9Y448-2]
DR   ProteomicsDB; 86101; -. [Q9Y448-3]
DR   Antibodypedia; 52276; 48 antibodies.
DR   Ensembl; ENST00000249776; ENSP00000249776; ENSG00000128944. [Q9Y448-1]
DR   Ensembl; ENST00000416151; ENSP00000391233; ENSG00000128944. [Q9Y448-2]
DR   Ensembl; ENST00000448395; ENSP00000393001; ENSG00000128944. [Q9Y448-3]
DR   GeneID; 90417; -.
DR   KEGG; hsa:90417; -.
DR   UCSC; uc001zll.4; human. [Q9Y448-1]
DR   CTD; 90417; -.
DR   DisGeNET; 90417; -.
DR   GeneCards; KNSTRN; -.
DR   HGNC; HGNC:30767; KNSTRN.
DR   HPA; ENSG00000128944; Group enriched (blood, lymphoid tissue, testis, thyroid gland).
DR   MalaCards; KNSTRN; -.
DR   MIM; 614718; gene.
DR   neXtProt; NX_Q9Y448; -.
DR   OpenTargets; ENSG00000128944; -.
DR   Orphanet; 221139; Combined immunodeficiency with faciooculoskeletal anomalies.
DR   PharmGKB; PA134895025; -.
DR   eggNOG; ENOG410IKUT; Eukaryota.
DR   eggNOG; ENOG4111DW5; LUCA.
DR   GeneTree; ENSGT00390000010376; -.
DR   InParanoid; Q9Y448; -.
DR   OrthoDB; 1460326at2759; -.
DR   PhylomeDB; Q9Y448; -.
DR   TreeFam; TF336302; -.
DR   SIGNOR; Q9Y448; -.
DR   GenomeRNAi; 90417; -.
DR   Pharos; Q9Y448; Tbio.
DR   PRO; PR:Q9Y448; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9Y448; protein.
DR   Bgee; ENSG00000128944; Expressed in testis and 177 other tissues.
DR   ExpressionAtlas; Q9Y448; baseline and differential.
DR   Genevisible; Q9Y448; HS.
DR   GO; GO:0034451; C:centriolar satellite; IDA:HPA.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB.
DR   GO; GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB.
DR   GO; GO:0007051; P:spindle organization; IMP:UniProtKB.
DR   InterPro; IPR033373; SKAP.
DR   PANTHER; PTHR31940; PTHR31940; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Centromere; Chromosome;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Disease mutation; Kinetochore;
KW   Microtubule; Mitosis; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..316
FT                   /note="Small kinetochore-associated protein"
FT                   /id="PRO_0000274512"
FT   REGION          159..316
FT                   /note="Interaction with SPAG5"
FT                   /evidence="ECO:0000269|PubMed:21402792"
FT   COILED          166..216
FT                   /evidence="ECO:0000255"
FT   COILED          248..316
FT                   /evidence="ECO:0000255"
FT   MOD_RES         128
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976"
FT   VAR_SEQ         229..316
FT                   /note="ALGSETLASRQESTTDHMDSMLLLETLQEELKLFNETAKKQMEELQALKVKL
FT                   EMKEERVRFLEQQTLCNNQVNDLTTALKEMEQLLEM -> VAVRNFARGAEAF (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_041069"
FT   VAR_SEQ         275..316
FT                   /note="ALKVKLEMKEERVRFLEQQTLCNNQVNDLTTALKEMEQLLEM -> IAWMNH
FT                   GILHQM (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_041070"
FT   VARIANT         24
FT                   /note="S -> F (in SCC; impaired chromatid cohesion;
FT                   dbSNP:rs868438023)"
FT                   /evidence="ECO:0000269|PubMed:25194279"
FT                   /id="VAR_071857"
FT   VARIANT         40
FT                   /note="A -> E (in dbSNP:rs7164132)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030304"
FT   VARIANT         75
FT                   /note="R -> L (in dbSNP:rs7169404)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030305"
FT   VARIANT         92
FT                   /note="P -> S (in dbSNP:rs7169262)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030306"
FT   CONFLICT        47
FT                   /note="T -> K (in Ref. 4; AAH45739)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        232
FT                   /note="S -> G (in Ref. 4; AAI18640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        236
FT                   /note="A -> S (in Ref. 6; AAD24201)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   316 AA;  35438 MW;  6FC6745DBA6B70D8 CRC64;
     MAAPEAPPLD RVFRTTWLST ECDSHPLPPS YRKFLFETQA ADLAGGTTVA AGNLLNESEK
     DCGQDRRAPG VQPCRLVTMT SVVKTVYSLQ PPSALSGGQP ADTQTRATSK SLLPVRSKEV
     DVSKQLHSGG PENDVTKITK LRRENGQMKA TDTATRRNVR KGYKPLSKQK SEEELKDKNQ
     LLEAVNKQLH QKLTETQGEL KDLTQKVELL EKFRDNCLAI LESKGLDPAL GSETLASRQE
     STTDHMDSML LLETLQEELK LFNETAKKQM EELQALKVKL EMKEERVRFL EQQTLCNNQV
     NDLTTALKEM EQLLEM
//
ID   MACC1_HUMAN             Reviewed;         852 AA.
AC   Q6ZN28; A8MUS5; B2RNR9; Q6ZQN8; Q7Z5A5;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 2.
DT   22-APR-2020, entry version 120.
DE   RecName: Full=Metastasis-associated in colon cancer protein 1;
DE   AltName: Full=SH3 domain-containing protein 7a5;
GN   Name=MACC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Colon carcinoma, and Trachea;
RX   PubMed=19098908; DOI=10.1038/nm.1889;
RA   Stein U., Walther W., Arlt F., Schwabe H., Smith J., Fichtner I.,
RA   Birchmeier W., Schlag P.M.;
RT   "MACC1, a newly identified key regulator of HGF-MET signaling, predicts
RT   colon cancer metastasis.";
RL   Nat. Med. 15:59-67(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-31; LEU-515 AND
RP   THR-804.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Acts as a transcription activator for MET and as a key
CC       regulator of HGF-MET signaling. Promotes cell motility, proliferation
CC       and hepatocyte growth factor (HGF)-dependent scattering in vitro and
CC       tumor growth and metastasis in vivo. {ECO:0000269|PubMed:19098908}.
CC   -!- SUBUNIT: Interacts with FASLG. {ECO:0000269|PubMed:19807924}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19098908}. Nucleus
CC       {ECO:0000269|PubMed:19098908}. Note=Mainly found in the cytoplasm in
CC       non-metastasizing tumors.
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in metastasizing tumors.
CC       {ECO:0000269|PubMed:19098908}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC87646.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=EAW93719.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ313524; CAC86408.1; -; mRNA.
DR   EMBL; AK128850; BAC87646.1; ALT_INIT; mRNA.
DR   EMBL; AK131400; BAD18547.1; -; mRNA.
DR   EMBL; CH236948; EAL24276.1; -; Genomic_DNA.
DR   EMBL; AC007001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93719.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC137090; AAI37091.1; -; mRNA.
DR   CCDS; CCDS5369.1; -.
DR   RefSeq; NP_877439.3; NM_182762.3.
DR   SMR; Q6ZN28; -.
DR   BioGrid; 131381; 8.
DR   IntAct; Q6ZN28; 3.
DR   STRING; 9606.ENSP00000383185; -.
DR   iPTMnet; Q6ZN28; -.
DR   PhosphoSitePlus; Q6ZN28; -.
DR   BioMuta; MACC1; -.
DR   DMDM; 182627616; -.
DR   EPD; Q6ZN28; -.
DR   jPOST; Q6ZN28; -.
DR   MassIVE; Q6ZN28; -.
DR   MaxQB; Q6ZN28; -.
DR   PaxDb; Q6ZN28; -.
DR   PeptideAtlas; Q6ZN28; -.
DR   PRIDE; Q6ZN28; -.
DR   ProteomicsDB; 67968; -.
DR   Antibodypedia; 11924; 151 antibodies.
DR   Ensembl; ENST00000332878; ENSP00000328410; ENSG00000183742.
DR   Ensembl; ENST00000400331; ENSP00000383185; ENSG00000183742.
DR   Ensembl; ENST00000589011; ENSP00000466864; ENSG00000183742.
DR   GeneID; 346389; -.
DR   KEGG; hsa:346389; -.
DR   UCSC; uc003sus.5; human.
DR   CTD; 346389; -.
DR   DisGeNET; 346389; -.
DR   GeneCards; MACC1; -.
DR   HGNC; HGNC:30215; MACC1.
DR   HPA; ENSG00000183742; Tissue enhanced (intestine, kidney).
DR   MIM; 612646; gene.
DR   neXtProt; NX_Q6ZN28; -.
DR   OpenTargets; ENSG00000183742; -.
DR   PharmGKB; PA164722150; -.
DR   eggNOG; ENOG410IHUQ; Eukaryota.
DR   eggNOG; ENOG410YRKQ; LUCA.
DR   GeneTree; ENSGT00390000013151; -.
DR   HOGENOM; CLU_013080_1_0_1; -.
DR   InParanoid; Q6ZN28; -.
DR   KO; K23702; -.
DR   OMA; DMIQDLH; -.
DR   OrthoDB; 140316at2759; -.
DR   PhylomeDB; Q6ZN28; -.
DR   TreeFam; TF105572; -.
DR   ChiTaRS; MACC1; human.
DR   GenomeRNAi; 346389; -.
DR   Pharos; Q6ZN28; Tbio.
DR   PRO; PR:Q6ZN28; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q6ZN28; protein.
DR   Bgee; ENSG00000183742; Expressed in intestine and 98 other tissues.
DR   Genevisible; Q6ZN28; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000906; ZU5_dom.
DR   Pfam; PF00791; ZU5; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51145; ZU5; 1.
PE   1: Evidence at protein level;
KW   Activator; Cytoplasm; Growth factor; Mitogen; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; SH3 domain; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..852
FT                   /note="Metastasis-associated in colon cancer protein 1"
FT                   /id="PRO_0000329032"
FT   DOMAIN          212..349
FT                   /note="ZU5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          549..619
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VARIANT         31
FT                   /note="L -> V (in dbSNP:rs4721888)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_042620"
FT   VARIANT         50
FT                   /note="P -> L (in dbSNP:rs17142503)"
FT                   /id="VAR_042621"
FT   VARIANT         515
FT                   /note="S -> L (in dbSNP:rs975263)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_042622"
FT   VARIANT         728
FT                   /note="E -> A (in dbSNP:rs12671170)"
FT                   /id="VAR_042623"
FT   VARIANT         804
FT                   /note="R -> T (in dbSNP:rs3735615)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_042624"
FT   CONFLICT        171
FT                   /note="L -> P (in Ref. 2; BAD18547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        264
FT                   /note="D -> N (in Ref. 2; BAD18547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        383
FT                   /note="S -> N (in Ref. 2; BAD18547)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   852 AA;  96639 MW;  9272110E1F91489A CRC64;
     MLITERKHFR SGRIAQSMSE ANLIDMEAGK LSKSCNITEC QDPDLLHNWP DAFTLRGNNA
     SKVANPFWNQ LSASNPFLDD ITQLRNNRKR NNISILKEDP FLFCREIENG NSFDSSGDEL
     DVHQLLRQTS SRNSGRSKSV SELLDILDDT AHAHQSIHNS DQILLHDLEW LKNDREAYKM
     AWLSQRQLAR SCLDLNTISQ SPGWAQTQLA EVTIACKVNH QGGSVQLPES DITVHVPQGH
     VAVGEFQEVS LRAFLDPPHM LNHDLSCTVS PLLEIMLGNL NTMEALLLEM KIGAEVRKDP
     FSQVMTEMVC LHSLGKEGPF KVLSNCYIYK DTIQVKLIDL SQVMYLVVAA QAKALPSPAA
     TIWDYIHKTT SIGIYGPKYI HPSFTVVLTV CGHNYMPGQL TISDIKKGGK NISPVVFQLW
     GKQSFLLDKP QDLSISIFSC DPDFEVKTEG ERKEIKQKQL EAGEVVHQQF LFSLVEHREM
     HLFDFCVQVE PPNGEPVAQF SITTPDPTPN LKRLSNLPGY LQKKEEIKSA PLSPKILVKY
     PTFQDKTLNF SNYGVTLKAV LRQSKIDYFL EYFKGDTIAL LGEGKVKAIG QSKVKEWYVG
     VLRGKIGLVH CKNVKVISKE QVMFMSDSVF TTRNLLEQIV LPLKKLTYIY SVVLTLVSEK
     VYDWKVLADV LGYSHLSLED FDQIQADKES EKVSYVIKKL KEDCHTERNT RKFLYELIVA
     LLKMDCQELV ARLIQEAAVL TSAVKLGKGW RELAEKLVRL TKQQMEAYEI PHRGNTGDVA
     VEMMWKPAYD FLYTWSAHYG NNYRDVLQDL QSALDRMKNP VTKHWRELTG VLILVNSLEV
     LRVTAFSTSE EV
//
ID   B3KY81_HUMAN            Unreviewed;      1647 AA.
AC   B3KY81;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 45.
DE   SubName: Full=cDNA FLJ46662 fis, clone TRACH3006800, highly similar to Homo sapiens mucin 16, cell surface associated (MUC16), mRNA {ECO:0000313|EMBL:BAG54743.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54743.1};
RN   [1] {ECO:0000313|EMBL:BAG54743.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG54743.1};
RA   Ninomiya K., Wagatsuma M., Kanda K., Kondo H., Yokoi T., Kodaira H.,
RA   Furuya T., Takahashi M., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Ota T., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H., Matsuo K.,
RA   Nakamura Y., Sekine M., Kikuchi H., Murakawa K., Kanehori K.,
RA   Takahashi-Fujii A., Oshima A., Sugiyama A., Kawakami B., Suzuki Y.,
RA   Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK128857; BAG54743.1; -; mRNA.
DR   RefSeq; NP_078966.2; NM_024690.2.
DR   PeptideAtlas; B3KY81; -.
DR   PRIDE; B3KY81; -.
DR   GeneID; 94025; -.
DR   KEGG; hsa:94025; -.
DR   CTD; 94025; -.
DR   KO; K16145; -.
DR   OrthoDB; 98at2759; -.
DR   GenomeRNAi; 94025; -.
DR   Genevisible; B3KY81; HS.
DR   Gene3D; 3.30.70.960; -; 12.
DR   InterPro; IPR028850; MUC16.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   PANTHER; PTHR14672; PTHR14672; 5.
DR   Pfam; PF01390; SEA; 12.
DR   SUPFAM; SSF82671; SSF82671; 12.
DR   PROSITE; PS50024; SEA; 12.
PE   2: Evidence at transcript level;
FT   DOMAIN          1..103
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          138..259
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          294..415
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          428..549
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          584..705
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          740..861
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          896..1017
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          1030..1150
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          1163..1284
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          1314..1434
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          1439..1550
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   DOMAIN          1560..1647
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          554..580
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          866..888
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        554..578
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1647 AA;  182991 MW;  D09D2739F82B4899 CRC64;
     MQHPGSRKFN TTERVLQGLL KPLFKSTSVG PLYSGCRLTL LRPEKHGAAT GVDAICTLRL
     DPTGPGLDRE WLYWELSQLT NSVTELGPYT LDRDSLYVNG FTHRSSVPTT SIPGTSAVHL
     ETSGTPASLP GHTAPGPLLV PFTLNFTITN LQYEEDMRHP GSRKFNTTER VLQGLLKPLF
     KSTSVGPLYS GCRLTLLRPE KRGAATGVDT ICTHRLDPLN PGLDREQLYW ELSKLTHGII
     ELGPYLLDRG SLYVNGFTHR NFVPITSTPG TSTVHLGTSE TPSSLPRPIV PGPLLVPFTL
     NFTITNLQYE EAMRHPGSRK FNTTERVLQG LLRPLFKNTS IGPLYSSCRL TLLRPEKDKA
     ATRVDAICTH HPDPQSPGLN REQLYWELSQ LTHGITELGP YTLDRDSLYV DGFTHWSPIP
     TTSTTGPLLM PFTLNFTITN LQYEENMGHP GSRKFNITES VLQGLLKPLF KSTSVGPLYS
     GCRLTLLRPE KDGVATRVDA ICTHRPDPKI PGLDRQQLYW ELSQLTHSIT ELGPYTLDRD
     SLYVNGFTQR SSVPTTSTPG TFTVQPETSE TPSSLPGPTA TGPVLLPFTL NFTITNLQYE
     EDMHRPGSRK FNTTERVLQG LLMPLFKNTS VSSLYSGCRL TLLRPEKDGA ATRVDAVCTH
     RPDPKSPGLD RERLYWKLSQ LTHGITELGP YTLDRHSLYV NGFTHQSSMT TTRTPDTSTM
     HLATSRTPAS LSGPTTASPL LVLFTINFTI TNLRYEENMH HPGSRKFNTT ERVLQGLLRP
     VFKNTSVGPL YSGCRLTLLR PKKDGAATKV DAICTYRPDP KSPGLDREQL YWELSQLTHS
     ITELGPYTLD RDSLYVNGFT QRSSVPTTSI PGTPTVDLGT SGTPVSKPGP SAASPLLVLF
     TLNFTITNLR YEENMQHPGS RKFNTTERVL QGLLRSLFKS TSVGPLYSGC RLTLLRPEKD
     GTATGVDAIC THHPDPKSPR LDREQLYWEL SQLTHNITEL GPYALDNDSL FVNGFTHRSS
     VSTTSTASHL LILFTLNFTI TNLRYEENMW PGSRKFNTTE RVLQGLLRPL FKNTSVGPLY
     SGCRLTLLRP EKDGEATGVD AICTHRPDPT GPGLDREQLY LELSQLTHSI TELGPYTLDR
     DSLYVNGFTH RSSVPTTSTG VVSEEPFTLN FTINNLRYMA DMGQPGSLKF NITDNVMKHL
     LSPLFQRSSL GARYTGCRVI ALRSVKNGAE TRVDLLCTYL QPLSGPGLPI KQVFHELSQQ
     THGITRLGPY SLDKDSLYLN GYNEPGPDEP PTTPKPATTF LPPLSEATTA MGYHLKTLTL
     NFTISNLQYS PDMGKGSATF NSTEGVLQHL LRPLFQKSSM GPFYLGCQLI SLRPEKDGAA
     TGVDTTCTYH PDPVGPGLDI QQLYWELSQL THGVTQLGFY VLDRDSLFIN GYAPQNLSIR
     GEYQINFHIV NWNLSNPDPT SSEYITLLRD IQDKVTTLYK GSQLHDTFRF CLVTNLTMDS
     VLVTVKALFS SNLDPSLVEQ VFLDKTLNAS FHWLGSTYQL VDIHVTEMES SVYQPTSSSS
     TQHFYLNFTI TNLPYSQDKA QPGTTNYQRN KRNIEDAVRR GCSTNSSETA ASRVIFLTVK
     FQHSGLSPTG TTPGWTPCVT SRHWLGE
//
ID   MUC16_HUMAN             Reviewed;       14507 AA.
AC   Q8WXI7; B5ME49; Q6ZQW5; Q96RK2;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-MAY-2016, sequence version 3.
DT   22-APR-2020, entry version 134.
DE   RecName: Full=Mucin-16 {ECO:0000305};
DE            Short=MUC-16;
DE   AltName: Full=Ovarian cancer-related tumor marker CA125 {ECO:0000303|PubMed:12218296};
DE            Short=CA-125 {ECO:0000303|PubMed:12218296};
DE   AltName: Full=Ovarian carcinoma antigen CA125 {ECO:0000303|PubMed:11369781};
GN   Name=MUC16 {ECO:0000312|HGNC:HGNC:15582};
GN   Synonyms=CA125 {ECO:0000303|PubMed:11786729};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-10429, SEQUENCE REVISION TO N-TERMINUS,
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=12218296; DOI=10.1159/000064032;
RA   O'Brien T.J., Beard J.B., Underwood L.J., Shigemasa K.;
RT   "The CA 125 gene: a newly discovered extension of the glycosylated N-
RT   terminal domain doubles the size of this extracellular superstructure.";
RL   Tumor Biol. 23:154-169(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10430-14507, REGION, AND POLYMORPHISM.
RX   PubMed=11786729; DOI=10.1159/000050638;
RA   O'Brien T.J., Beard J.B., Underwood L.J., Dennis R.A., Santin A.D.,
RA   York L.;
RT   "The CA 125 gene: an extracellular superstructure dominated by repeat
RT   sequences.";
RL   Tumor Biol. 22:348-366(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8295-14507, PROTEIN SEQUENCE OF 13715-13720
RP   AND 14338-14350, AND TISSUE SPECIFICITY.
RX   PubMed=11369781; DOI=10.1074/jbc.m103554200;
RA   Yin B.W.T., Lloyd K.O.;
RT   "Molecular cloning of the CA125 ovarian cancer antigen: identification as a
RT   new mucin, MUC16.";
RL   J. Biol. Chem. 276:27371-27375(2001).
RN   [5]
RP   SEQUENCE REVISION.
RA   Lloyd K.O., Yin B.W.T.;
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 12828-14050.
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   PHOSPHORYLATION.
RX   PubMed=9276028; DOI=10.1159/000218041;
RA   Fendrick J.L., Konishi I., Geary S.M., Parmley T.H., Quirk J.G. Jr.,
RA   O'Brien T.J.;
RT   "CA125 phosphorylation is associated with its secretion from the WISH human
RT   amnion cell line.";
RL   Tumor Biol. 18:278-289(1997).
RN   [8]
RP   GLYCOSYLATION.
RX   PubMed=12734200; DOI=10.1074/jbc.m302741200;
RA   Kui Wong N., Easton R.L., Panico M., Sutton-Smith M., Morrison J.C.,
RA   Lattanzio F.A., Morris H.R., Clark G.F., Dell A., Patankar M.S.;
RT   "Characterization of the oligosaccharides associated with the human ovarian
RT   tumor marker CA125.";
RL   J. Biol. Chem. 278:28619-28634(2003).
RN   [9]
RP   INTERACTION WITH MSLN.
RX   PubMed=14676194; DOI=10.1074/jbc.m312372200;
RA   Rump A., Morikawa Y., Tanaka M., Minami S., Umesaki N., Takeuchi M.,
RA   Miyajima A.;
RT   "Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell
RT   adhesion.";
RL   J. Biol. Chem. 279:9190-9198(2004).
RN   [10]
RP   REVIEW, AND POLYMORPHISM.
RX   PubMed=15788735; DOI=10.1177/1099800404274445;
RA   McLemore M.R., Aouizerat B.;
RT   "Introducing the MUC16 gene: implications for prevention and early
RT   detection in epithelial ovarian cancer.";
RL   Biol. Res. Nurs. 6:262-267(2005).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=16384952; DOI=10.1167/iovs.05-0735;
RA   Argueso P., Tisdale A., Spurr-Michaud S., Sumiyoshi M., Gipson I.K.;
RT   "Mucin characteristics of human corneal-limbal epithelial cells that
RT   exclude the rose bengal anionic dye.";
RL   Invest. Ophthalmol. Vis. Sci. 47:113-119(2006).
CC   -!- FUNCTION: Thought to provide a protective, lubricating barrier against
CC       particles and infectious agents at mucosal surfaces. {ECO:0000250}.
CC   -!- SUBUNIT: Binds to MSLN. Binding to MSLN mediates heterotypic cell
CC       adhesion. This may contribute to the metastasis of ovarian cancer to
CC       the peritoneum by initiating cell attachment to the mesothelial
CC       epithelium via binding to MSLN.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Secreted, extracellular space. Note=May be liberated into the
CC       extracellular space following the phosphorylation of the intracellular
CC       C-terminus which induces the proteolytic cleavage and liberation of the
CC       extracellular domain.
CC   -!- TISSUE SPECIFICITY: Expressed in corneal and conjunctival epithelia (at
CC       protein level). Overexpressed in ovarian carcinomas and ovarian low
CC       malignant potential (LMP) tumors as compared to the expression in
CC       normal ovarian tissue and ovarian adenomas.
CC       {ECO:0000269|PubMed:11369781, ECO:0000269|PubMed:12218296,
CC       ECO:0000269|PubMed:16384952}.
CC   -!- INDUCTION: Up-regulated in ovarian cancer cells.
CC       {ECO:0000269|PubMed:12218296}.
CC   -!- DOMAIN: Composed of three domains, a Ser-, Thr-rich N-terminal domain,
CC       a repeated domain containing between 12 and 60 partially conserved
CC       tandem repeats of 156 amino acids and a C-terminal transmembrane
CC       contain domain with a short cytoplasmic tail.
CC       {ECO:0000269|PubMed:11786729}.
CC   -!- PTM: Heavily O-glycosylated; expresses both type 1 and type 2 core
CC       glycans. {ECO:0000269|PubMed:12734200}.
CC   -!- PTM: Heavily N-glycosylated; expresses primarily high mannose and
CC       complex bisecting type N-linked glycans. {ECO:0000269|PubMed:12734200}.
CC   -!- PTM: May be phosphorylated. Phosphorylation of the intracellular C-
CC       terminal domain may induce proteolytic cleavage and the liberation of
CC       the extracellular domain into the extracellular space.
CC       {ECO:0000269|PubMed:9276028}.
CC   -!- PTM: May contain numerous disulfide bridges. Association of several
CC       molecules of the secreted form may occur through interchain disulfide
CC       bridges providing an extraordinarily large gel-like matrix in the
CC       extracellular space or in the lumen of secretory ducts.
CC   -!- POLYMORPHISM: The number of repeats is highly polymorphic and can be
CC       composed between 12 and 60 extracellular mucin repeats.
CC       {ECO:0000305|PubMed:11786729}.
CC   -!- MISCELLANEOUS: Antigen that is the basis for a widely used serum assay
CC       for the monitoring of patients with ovarian epithelial cancer. Due to
CC       lack of sensitivity for stage I disease and lack of specificity, it is
CC       of little value in the detection of early ovarian cancer. Due to its
CC       similarly elevated levels in some nonmalignant conditions, it is not
CC       specific enough to be used for population screening.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL65133.2; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAC87568.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MUC16ID41455ch19q13.html";
CC   -!- WEB RESOURCE: Name=Mucin database;
CC       URL="http://www.medkem.gu.se/mucinbiology/databases/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC008734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF414442; AAL65133.2; ALT_FRAME; mRNA.
DR   EMBL; AF361486; AAK74120.3; -; mRNA.
DR   EMBL; AK128681; BAC87568.1; ALT_INIT; mRNA.
DR   CCDS; CCDS54212.1; -.
DR   RefSeq; NP_078966.2; NM_024690.2.
DR   SMR; Q8WXI7; -.
DR   BioGrid; 125094; 11.
DR   IntAct; Q8WXI7; 2.
DR   STRING; 9606.ENSP00000381008; -.
DR   ChEMBL; CHEMBL3580482; -.
DR   DrugBank; DB04964; Oregovomab.
DR   iPTMnet; Q8WXI7; -.
DR   PhosphoSitePlus; Q8WXI7; -.
DR   SwissPalm; Q8WXI7; -.
DR   BioMuta; MUC16; -.
DR   CPTAC; CPTAC-2227; -.
DR   EPD; Q8WXI7; -.
DR   jPOST; Q8WXI7; -.
DR   MassIVE; Q8WXI7; -.
DR   MaxQB; Q8WXI7; -.
DR   PaxDb; Q8WXI7; -.
DR   PeptideAtlas; Q8WXI7; -.
DR   PRIDE; Q8WXI7; -.
DR   ProteomicsDB; 6210; -.
DR   ProteomicsDB; 75068; -.
DR   ABCD; Q8WXI7; -.
DR   Antibodypedia; 3492; 961 antibodies.
DR   Ensembl; ENST00000397910; ENSP00000381008; ENSG00000181143.
DR   GeneID; 94025; -.
DR   KEGG; hsa:94025; -.
DR   UCSC; uc002mkp.3; human.
DR   CTD; 94025; -.
DR   DisGeNET; 94025; -.
DR   GeneCards; MUC16; -.
DR   HGNC; HGNC:15582; MUC16.
DR   HPA; ENSG00000181143; Group enriched (adipose tissue, cervix, uterine, fallopian tube, salivary gland).
DR   MIM; 606154; gene.
DR   neXtProt; NX_Q8WXI7; -.
DR   OpenTargets; ENSG00000181143; -.
DR   PharmGKB; PA31314; -.
DR   eggNOG; ENOG410IEHG; Eukaryota.
DR   eggNOG; ENOG4111B0P; LUCA.
DR   GeneTree; ENSGT00440000039287; -.
DR   KO; K16145; -.
DR   OrthoDB; 98at2759; -.
DR   PhylomeDB; Q8WXI7; -.
DR   TreeFam; TF335600; -.
DR   Reactome; R-HSA-5083625; Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC).
DR   Reactome; R-HSA-5083632; Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS).
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes colorectal cancer 1 (CRCS1).
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   ChiTaRS; MUC16; human.
DR   GeneWiki; CA-125; -.
DR   GenomeRNAi; 94025; -.
DR   Pharos; Q8WXI7; Tbio.
DR   PRO; PR:Q8WXI7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8WXI7; protein.
DR   Bgee; ENSG00000181143; Expressed in nasal cavity epithelium and 65 other tissues.
DR   ExpressionAtlas; Q8WXI7; baseline and differential.
DR   Genevisible; B5ME49; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; NAS:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   Gene3D; 3.30.70.960; -; 16.
DR   InterPro; IPR028850; MUC16.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   PANTHER; PTHR14672; PTHR14672; 18.
DR   Pfam; PF01390; SEA; 16.
DR   SMART; SM00200; SEA; 7.
DR   SUPFAM; SSF82671; SSF82671; 16.
DR   PROSITE; PS50024; SEA; 16.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Secreted; Transmembrane; Transmembrane helix.
FT   CHAIN           1..14507
FT                   /note="Mucin-16"
FT                   /id="PRO_0000436078"
FT   TOPO_DOM        1..14451
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        14452..14472
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        14473..14507
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          12067..12223
FT                   /note="1"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          12072..12193
FT                   /note="SEA 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          12224..12381
FT                   /note="2"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          12228..12349
FT                   /note="SEA 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          12382..12537
FT                   /note="3"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          12386..12507
FT                   /note="SEA 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          12538..12692
FT                   /note="4"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          12542..12663
FT                   /note="SEA 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          12693..12848
FT                   /note="5"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          12697..12818
FT                   /note="SEA 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          12849..13004
FT                   /note="6"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          12853..12974
FT                   /note="SEA 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          13005..13160
FT                   /note="7"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          13009..13130
FT                   /note="SEA 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          13161..13316
FT                   /note="8"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          13165..13286
FT                   /note="SEA 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          13317..13472
FT                   /note="9"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          13321..13442
FT                   /note="SEA 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          13473..13628
FT                   /note="10"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          13477..13598
FT                   /note="SEA 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          13629..13784
FT                   /note="11"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          13633..13754
FT                   /note="SEA 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REPEAT          13785..13939
FT                   /note="12"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   DOMAIN          13789..13909
FT                   /note="SEA 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   DOMAIN          13922..14043
FT                   /note="SEA 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   DOMAIN          14073..14193
FT                   /note="SEA 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   DOMAIN          14198..14309
FT                   /note="SEA 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   DOMAIN          14319..14438
FT                   /note="SEA 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REGION          12067..13939
FT                   /note="12 X approximate tandem repeats"
FT                   /evidence="ECO:0000269|PubMed:11786729"
FT   COMPBIAS        14..12083
FT                   /note="Thr-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00017"
FT   COMPBIAS        1638..3054
FT                   /note="Ser-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00016"
FT   COMPBIAS        2365..2371
FT                   /note="Poly-Ser"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        3899..4383
FT                   /note="Ser-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00016"
FT   COMPBIAS        4743..4953
FT                   /note="Ser-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00016"
FT   COMPBIAS        7083..10394
FT                   /note="Ser-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00016"
FT   CARBOHYD        139
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        434
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        787
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        930
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        957
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1375
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1633
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1840
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1877
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1890
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2375
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2737
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3085
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3178
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3501
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4220
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4498
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4606
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4613
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4624
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4861
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5096
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5131
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5228
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5320
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5470
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5689
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        5863
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        6088
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        6732
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        6859
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        6961
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        8029
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        8055
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        8324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        8618
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        8684
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        8913
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        9202
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        9493
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        9785
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10075
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10173
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10510
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10700
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10749
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        11053
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        11224
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        11263
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        11367
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        11594
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12079
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12235
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12393
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12414
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12430
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12549
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12570
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12586
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12704
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12725
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12741
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12824
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12860
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12881
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        12897
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13016
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13037
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13053
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13193
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13328
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13349
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13365
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13484
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13505
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13521
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13640
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13661
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13733
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13744
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13796
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13816
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13832
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13929
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13950
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14080
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14195
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14212
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14254
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14326
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14363
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14423
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        12126..12146
FT                   /evidence="ECO:0000255"
FT   DISULFID        12282..12302
FT                   /evidence="ECO:0000255"
FT   DISULFID        12440..12460
FT                   /evidence="ECO:0000255"
FT   DISULFID        12596..12616
FT                   /evidence="ECO:0000255"
FT   DISULFID        12751..12771
FT                   /evidence="ECO:0000255"
FT   DISULFID        12907..12927
FT                   /evidence="ECO:0000255"
FT   DISULFID        13063..13083
FT                   /evidence="ECO:0000255"
FT   DISULFID        13219..13239
FT                   /evidence="ECO:0000255"
FT   DISULFID        13375..13395
FT                   /evidence="ECO:0000255"
FT   DISULFID        13531..13551
FT                   /evidence="ECO:0000255"
FT   DISULFID        13687..13707
FT                   /evidence="ECO:0000255"
FT   DISULFID        13976..13996
FT                   /evidence="ECO:0000255"
FT   DISULFID        14126..14146
FT                   /evidence="ECO:0000255"
FT   DISULFID        14373..14393
FT                   /evidence="ECO:0000255"
FT   VARIANT         545
FT                   /note="T -> A (in dbSNP:rs17000957)"
FT                   /id="VAR_056592"
FT   VARIANT         1015
FT                   /note="R -> G (in dbSNP:rs17000950)"
FT                   /id="VAR_056593"
FT   VARIANT         1032
FT                   /note="S -> T (in dbSNP:rs10411228)"
FT                   /id="VAR_056594"
FT   VARIANT         1041
FT                   /note="P -> S (in dbSNP:rs10406202)"
FT                   /id="VAR_056595"
FT   VARIANT         1162
FT                   /note="T -> I (in dbSNP:rs17000947)"
FT                   /id="VAR_056596"
FT   VARIANT         1266
FT                   /note="K -> N (in dbSNP:rs1596797)"
FT                   /id="VAR_056597"
FT   VARIANT         1353
FT                   /note="H -> Y (in dbSNP:rs12611293)"
FT                   /id="VAR_056598"
FT   VARIANT         1400
FT                   /note="K -> N (in dbSNP:rs1596798)"
FT                   /id="VAR_056599"
FT   VARIANT         1833
FT                   /note="L -> F (in dbSNP:rs4520945)"
FT                   /id="VAR_056600"
FT   VARIANT         1953
FT                   /note="S -> P (in dbSNP:rs1108380)"
FT                   /id="VAR_056601"
FT   VARIANT         2058
FT                   /note="S -> P (in dbSNP:rs1574479)"
FT                   /id="VAR_056602"
FT   VARIANT         2150
FT                   /note="I -> V (in dbSNP:rs10407633)"
FT                   /id="VAR_056603"
FT   VARIANT         2271
FT                   /note="T -> A (in dbSNP:rs11085805)"
FT                   /id="VAR_056604"
FT   VARIANT         2288
FT                   /note="V -> L (in dbSNP:rs10410933)"
FT                   /id="VAR_056605"
FT   VARIANT         2356
FT                   /note="D -> E (in dbSNP:rs10416013)"
FT                   /id="VAR_056606"
FT   VARIANT         2747
FT                   /note="A -> T (in dbSNP:rs10402538)"
FT                   /id="VAR_056607"
FT   VARIANT         2786
FT                   /note="M -> I (in dbSNP:rs17000886)"
FT                   /id="VAR_056608"
FT   VARIANT         2834
FT                   /note="T -> M (in dbSNP:rs10407623)"
FT                   /id="VAR_056609"
FT   VARIANT         3573
FT                   /note="R -> H (in dbSNP:rs2591594)"
FT                   /id="VAR_056610"
FT   VARIANT         5741
FT                   /note="H -> D (in dbSNP:rs1559172)"
FT                   /id="VAR_056611"
FT   VARIANT         5754
FT                   /note="A -> T (in dbSNP:rs1559171)"
FT                   /id="VAR_056612"
FT   VARIANT         5852
FT                   /note="F -> V (in dbSNP:rs1862460)"
FT                   /id="VAR_056613"
FT   VARIANT         7063
FT                   /note="T -> A (in dbSNP:rs17000770)"
FT                   /id="VAR_056614"
FT   VARIANT         7272
FT                   /note="I -> V (in dbSNP:rs1867691)"
FT                   /id="VAR_056615"
FT   VARIANT         10507
FT                   /note="T -> N (in dbSNP:rs11670461)"
FT                   /id="VAR_056616"
FT   CONFLICT        1898
FT                   /note="Y -> D (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2506
FT                   /note="T -> A (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3190
FT                   /note="S -> T (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3202
FT                   /note="M -> V (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3932
FT                   /note="I -> V (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4440
FT                   /note="S -> T (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        5682
FT                   /note="P -> T (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6303
FT                   /note="V -> M (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6655
FT                   /note="L -> V (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6866
FT                   /note="E -> V (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6895
FT                   /note="S -> C (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6906
FT                   /note="A -> T (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7191
FT                   /note="S -> F (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7425
FT                   /note="L -> P (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7475
FT                   /note="S -> P (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7923
FT                   /note="D -> A (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8301
FT                   /note="N -> T (in Ref. 2; AAL65133 and 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8344
FT                   /note="D -> A (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8578
FT                   /note="T -> A (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9059
FT                   /note="T -> S (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9072
FT                   /note="T -> A (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9129
FT                   /note="D -> E (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9213
FT                   /note="I -> T (in Ref. 2; AAL65133 and 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9405
FT                   /note="Q -> R (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9502
FT                   /note="A -> T (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9608
FT                   /note="P -> S (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9850
FT                   /note="D -> E (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9899
FT                   /note="Y -> F (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9920
FT                   /note="I -> T (in Ref. 2; AAL65133 and 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10013
FT                   /note="L -> P (in Ref. 2; AAL65133 and 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10169
FT                   /note="F -> L (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10394
FT                   /note="S -> T (in Ref. 2; AAL65133)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10828
FT                   /note="P -> S (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11154
FT                   /note="S -> F (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11199
FT                   /note="A -> G (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11455
FT                   /note="G -> D (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12514
FT                   /note="S -> T (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12580
FT                   /note="L -> V (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12692
FT                   /note="T -> TSA (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12832
FT                   /note="T -> A (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12834
FT                   /note="D -> H (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12836
FT                   /note="G -> E (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12842
FT                   /note="S -> A (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12846..12847
FT                   /note="SP -> GH (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12849..12850
FT                   /note="SA -> AP (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12873
FT                   /note="H -> R (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12892..12894
FT                   /note="GPM -> KPL (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12897
FT                   /note="N -> S (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12902
FT                   /note="L -> P (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12917
FT                   /note="N -> R (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12923..12925
FT                   /note="MDA -> VDT (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12928
FT                   /note="S -> T (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12934..12935
FT                   /note="KS -> LN (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12939
FT                   /note="N -> D (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12949
FT                   /note="Q -> K (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12952
FT                   /note="H -> R (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12955
FT                   /note="K -> I (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12961
FT                   /note="T -> L (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12965
FT                   /note="N -> G (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12976..12977
FT                   /note="SS -> NF (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12979..12980
FT                   /note="AP -> PI (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12990
FT                   /note="D -> H (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12995
FT                   /note="G -> E (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13002..13007
FT                   /note="SPTTAV -> RPIVPG (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13025..13027
FT                   /note="GED -> EEA (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13048
FT                   /note="G -> R (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13054..13056
FT                   /note="SSV -> TSI (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13062
FT                   /note="G -> S (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13332
FT                   /note="T -> I (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13341
FT                   /note="R -> H (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13386
FT                   /note="G -> K (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13394
FT                   /note="V -> I (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13398
FT                   /note="R -> H (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13402
FT                   /note="K -> Q (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13407
FT                   /note="D -> N (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13410
FT                   /note="R -> Q (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13414
FT                   /note="K -> E (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13472
FT                   /note="M -> T (in Ref. 6; BAC87568 and 4; AAK74120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        14041..14050
FT                   /note="YNEPGPDEPP -> HHTLQRQSTT (in Ref. 6; BAC87568)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        14466
FT                   /note="V -> L (in Ref. 4; AAK74120)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   14507 AA;  1519175 MW;  7D5E9A14F70EB90A CRC64;
     MLKPSGLPGS SSPTRSLMTG SRSTKATPEM DSGLTGATLS PKTSTGAIVV TEHTLPFTSP
     DKTLASPTSS VVGRTTQSLG VMSSALPEST SRGMTHSEQR TSPSLSPQVN GTPSRNYPAT
     SMVSGLSSPR TRTSSTEGNF TKEASTYTLT VETTSGPVTE KYTVPTETST TEGDSTETPW
     DTRYIPVKIT SPMKTFADST ASKENAPVSM TPAETTVTDS HTPGRTNPSF GTLYSSFLDL
     SPKGTPNSRG ETSLELILST TGYPFSSPEP GSAGHSRIST SAPLSSSASV LDNKISETSI
     FSGQSLTSPL SPGVPEARAS TMPNSAIPFS MTLSNAETSA ERVRSTISSL GTPSISTKQT
     AETILTFHAF AETMDIPSTH IAKTLASEWL GSPGTLGGTS TSALTTTSPS TTLVSEETNT
     HHSTSGKETE GTLNTSMTPL ETSAPGEESE MTATLVPTLG FTTLDSKIRS PSQVSSSHPT
     RELRTTGSTS GRQSSSTAAH GSSDILRATT SSTSKASSWT SESTAQQFSE PQHTQWVETS
     PSMKTERPPA STSVAAPITT SVPSVVSGFT TLKTSSTKGI WLEETSADTL IGESTAGPTT
     HQFAVPTGIS MTGGSSTRGS QGTTHLLTRA TASSETSADL TLATNGVPVS VSPAVSKTAA
     GSSPPGGTKP SYTMVSSVIP ETSSLQSSAF REGTSLGLTP LNTRHPFSSP EPDSAGHTKI
     STSIPLLSSA SVLEDKVSAT STFSHHKATS SITTGTPEIS TKTKPSSAVL SSMTLSNAAT
     SPERVRNATS PLTHPSPSGE ETAGSVLTLS TSAETTDSPN IHPTGTLTSE SSESPSTLSL
     PSVSGVKTTF SSSTPSTHLF TSGEETEETS NPSVSQPETS VSRVRTTLAS TSVPTPVFPT
     MDTWPTRSAQ FSSSHLVSEL RATSSTSVTN STGSALPKIS HLTGTATMSQ TNRDTFNDSA
     APQSTTWPET SPRFKTGLPS ATTTVSTSAT SLSATVMVSK FTSPATSSME ATSIREPSTT
     ILTTETTNGP GSMAVASTNI PIGKGYITEG RLDTSHLPIG TTASSETSMD FTMAKESVSM
     SVSPSQSMDA AGSSTPGRTS QFVDTFSDDV YHLTSREITI PRDGTSSALT PQMTATHPPS
     PDPGSARSTW LGILSSSPSS PTPKVTMSST FSTQRVTTSM IMDTVETSRW NMPNLPSTTS
     LTPSNIPTSG AIGKSTLVPL DTPSPATSLE ASEGGLPTLS TYPESTNTPS IHLGAHASSE
     SPSTIKLTMA SVVKPGSYTP LTFPSIETHI HVSTARMAYS SGSSPEMTAP GETNTGSTWD
     PTTYITTTDP KDTSSAQVST PHSVRTLRTT ENHPKTESAT PAAYSGSPKI SSSPNLTSPA
     TKAWTITDTT EHSTQLHYTK LAEKSSGFET QSAPGPVSVV IPTSPTIGSS TLELTSDVPG
     EPLVLAPSEQ TTITLPMATW LSTSLTEEMA STDLDISSPS SPMSTFAIFP PMSTPSHELS
     KSEADTSAIR NTDSTTLDQH LGIRSLGRTG DLTTVPITPL TTTWTSVIEH STQAQDTLSA
     TMSPTHVTQS LKDQTSIPAS ASPSHLTEVY PELGTQGRSS SEATTFWKPS TDTLSREIET
     GPTNIQSTPP MDNTTTGSSS SGVTLGIAHL PIGTSSPAET STNMALERRS STATVSMAGT
     MGLLVTSAPG RSISQSLGRV SSVLSESTTE GVTDSSKGSS PRLNTQGNTA LSSSLEPSYA
     EGSQMSTSIP LTSSPTTPDV EFIGGSTFWT KEVTTVMTSD ISKSSARTES SSATLMSTAL
     GSTENTGKEK LRTASMDLPS PTPSMEVTPW ISLTLSNAPN TTDSLDLSHG VHTSSAGTLA
     TDRSLNTGVT RASRLENGSD TSSKSLSMGN STHTSMTYTE KSEVSSSIHP RPETSAPGAE
     TTLTSTPGNR AISLTLPFSS IPVEEVISTG ITSGPDINSA PMTHSPITPP TIVWTSTGTI
     EQSTQPLHAV SSEKVSVQTQ STPYVNSVAV SASPTHENSV SSGSSTSSPY SSASLESLDS
     TISRRNAITS WLWDLTTSLP TTTWPSTSLS EALSSGHSGV SNPSSTTTEF PLFSAASTSA
     AKQRNPETET HGPQNTAAST LNTDASSVTG LSETPVGASI SSEVPLPMAI TSRSDVSGLT
     SESTANPSLG TASSAGTKLT RTISLPTSES LVSFRMNKDP WTVSIPLGSH PTTNTETSIP
     VNSAGPPGLS TVASDVIDTP SDGAESIPTV SFSPSPDTEV TTISHFPEKT THSFRTISSL
     THELTSRVTP IPGDWMSSAM STKPTGASPS ITLGERRTIT SAAPTTSPIV LTASFTETST
     VSLDNETTVK TSDILDARKT NELPSDSSSS SDLINTSIAS STMDVTKTAS ISPTSISGMT
     ASSSPSLFSS DRPQVPTSTT ETNTATSPSV SSNTYSLDGG SNVGGTPSTL PPFTITHPVE
     TSSALLAWSR PVRTFSTMVS TDTASGENPT SSNSVVTSVP APGTWTSVGS TTDLPAMGFL
     KTSPAGEAHS LLASTIEPAT AFTPHLSAAV VTGSSATSEA SLLTTSESKA IHSSPQTPTT
     PTSGANWETS ATPESLLVVT ETSDTTLTSK ILVTDTILFS TVSTPPSKFP STGTLSGASF
     PTLLPDTPAI PLTATEPTSS LATSFDSTPL VTIASDSLGT VPETTLTMSE TSNGDALVLK
     TVSNPDRSIP GITIQGVTES PLHPSSTSPS KIVAPRNTTY EGSITVALST LPAGTTGSLV
     FSQSSENSET TALVDSSAGL ERASVMPLTT GSQGMASSGG IRSGSTHSTG TKTFSSLPLT
     MNPGEVTAMS EITTNRLTAT QSTAPKGIPV KPTSAESGLL TPVSASSSPS KAFASLTTAP
     PTWGIPQSTL TFEFSEVPSL DTKSASLPTP GQSLNTIPDS DASTASSSLS KSPEKNPRAR
     MMTSTKAISA SSFQSTGFTE TPEGSASPSM AGHEPRVPTS GTGDPRYASE SMSYPDPSKA
     SSAMTSTSLA SKLTTLFSTG QAARSGSSSS PISLSTEKET SFLSPTASTS RKTSLFLGPS
     MARQPNILVH LQTSALTLSP TSTLNMSQEE PPELTSSQTI AEEEGTTAET QTLTFTPSET
     PTSLLPVSSP TEPTARRKSS PETWASSISV PAKTSLVETT DGTLVTTIKM SSQAAQGNST
     WPAPAEETGS SPAGTSPGSP EMSTTLKIMS SKEPSISPEI RSTVRNSPWK TPETTVPMET
     TVEPVTLQST ALGSGSTSIS HLPTGTTSPT KSPTENMLAT ERVSLSPSPP EAWTNLYSGT
     PGGTRQSLAT MSSVSLESPT ARSITGTGQQ SSPELVSKTT GMEFSMWHGS TGGTTGDTHV
     SLSTSSNILE DPVTSPNSVS SLTDKSKHKT ETWVSTTAIP STVLNNKIMA AEQQTSRSVD
     EAYSSTSSWS DQTSGSDITL GASPDVTNTL YITSTAQTTS LVSLPSGDQG ITSLTNPSGG
     KTSSASSVTS PSIGLETLRA NVSAVKSDIA PTAGHLSQTS SPAEVSILDV TTAPTPGIST
     TITTMGTNSI STTTPNPEVG MSTMDSTPAT ERRTTSTEHP STWSSTAASD SWTVTDMTSN
     LKVARSPGTI STMHTTSFLA SSTELDSMST PHGRITVIGT SLVTPSSDAS AVKTETSTSE
     RTLSPSDTTA STPISTFSRV QRMSISVPDI LSTSWTPSST EAEDVPVSMV STDHASTKTD
     PNTPLSTFLF DSLSTLDWDT GRSLSSATAT TSAPQGATTP QELTLETMIS PATSQLPFSI
     GHITSAVTPA AMARSSGVTF SRPDPTSKKA EQTSTQLPTT TSAHPGQVPR SAATTLDVIP
     HTAKTPDATF QRQGQTALTT EARATSDSWN EKEKSTPSAP WITEMMNSVS EDTIKEVTSS
     SSVLRTLNTL DINLESGTTS SPSWKSSPYE RIAPSESTTD KEAIHPSTNT VETTGWVTSS
     EHASHSTIPA HSASSKLTSP VVTTSTREQA IVSMSTTTWP ESTRARTEPN SFLTIELRDV
     SPYMDTSSTT QTSIISSPGS TAITKGPRTE ITSSKRISSS FLAQSMRSSD SPSEAITRLS
     NFPAMTESGG MILAMQTSPP GATSLSAPTL DTSATASWTG TPLATTQRFT YSEKTTLFSK
     GPEDTSQPSP PSVEETSSSS SLVPIHATTS PSNILLTSQG HSPSSTPPVT SVFLSETSGL
     GKTTDMSRIS LEPGTSLPPN LSSTAGEALS TYEASRDTKA IHHSADTAVT NMEATSSEYS
     PIPGHTKPSK ATSPLVTSHI MGDITSSTSV FGSSETTEIE TVSSVNQGLQ ERSTSQVASS
     ATETSTVITH VSSGDATTHV TKTQATFSSG TSISSPHQFI TSTNTFTDVS TNPSTSLIMT
     ESSGVTITTQ TGPTGAATQG PYLLDTSTMP YLTETPLAVT PDFMQSEKTT LISKGPKDVS
     WTSPPSVAET SYPSSLTPFL VTTIPPATST LQGQHTSSPV SATSVLTSGL VKTTDMLNTS
     MEPVTNSPQN LNNPSNEILA TLAATTDIET IHPSINKAVT NMGTASSAHV LHSTLPVSSE
     PSTATSPMVP ASSMGDALAS ISIPGSETTD IEGEPTSSLT AGRKENSTLQ EMNSTTESNI
     ILSNVSVGAI TEATKMEVPS FDATFIPTPA QSTKFPDIFS VASSRLSNSP PMTISTHMTT
     TQTGSSGATS KIPLALDTST LETSAGTPSV VTEGFAHSKI TTAMNNDVKD VSQTNPPFQD
     EASSPSSQAP VLVTTLPSSV AFTPQWHSTS SPVSMSSVLT SSLVKTAGKV DTSLETVTSS
     PQSMSNTLDD ISVTSAATTD IETTHPSINT VVTNVGTTGS AFESHSTVSA YPEPSKVTSP
     NVTTSTMEDT TISRSIPKSS KTTRTETETT SSLTPKLRET SISQEITSST ETSTVPYKEL
     TGATTEVSRT DVTSSSSTSF PGPDQSTVSL DISTETNTRL STSPIMTESA EITITTQTGP
     HGATSQDTFT MDPSNTTPQA GIHSAMTHGF SQLDVTTLMS RIPQDVSWTS PPSVDKTSSP
     SSFLSSPAMT TPSLISSTLP EDKLSSPMTS LLTSGLVKIT DILRTRLEPV TSSLPNFSST
     SDKILATSKD SKDTKEIFPS INTEETNVKA NNSGHESHSP ALADSETPKA TTQMVITTTV
     GDPAPSTSMP VHGSSETTNI KREPTYFLTP RLRETSTSQE SSFPTDTSFL LSKVPTGTIT
     EVSSTGVNSS SKISTPDHDK STVPPDTFTG EIPRVFTSSI KTKSAEMTIT TQASPPESAS
     HSTLPLDTST TLSQGGTHST VTQGFPYSEV TTLMGMGPGN VSWMTTPPVE ETSSVSSLMS
     SPAMTSPSPV SSTSPQSIPS SPLPVTALPT SVLVTTTDVL GTTSPESVTS SPPNLSSITH
     ERPATYKDTA HTEAAMHHST NTAVTNVGTS GSGHKSQSSV LADSETSKAT PLMSTTSTLG
     DTSVSTSTPN ISQTNQIQTE PTASLSPRLR ESSTSEKTSS TTETNTAFSY VPTGAITQAS
     RTEISSSRTS ISDLDRPTIA PDISTGMITR LFTSPIMTKS AEMTVTTQTT TPGATSQGIL
     PWDTSTTLFQ GGTHSTVSQG FPHSEITTLR SRTPGDVSWM TTPPVEETSS GFSLMSPSMT
     SPSPVSSTSP ESIPSSPLPV TALLTSVLVT TTNVLGTTSP EPVTSSPPNL SSPTQERLTT
     YKDTAHTEAM HASMHTNTAV ANVGTSISGH ESQSSVPADS HTSKATSPMG ITFAMGDTSV
     STSTPAFFET RIQTESTSSL IPGLRDTRTS EEINTVTETS TVLSEVPTTT TTEVSRTEVI
     TSSRTTISGP DHSKMSPYIS TETITRLSTF PFVTGSTEMA ITNQTGPIGT ISQATLTLDT
     SSTASWEGTH SPVTQRFPHS EETTTMSRST KGVSWQSPPS VEETSSPSSP VPLPAITSHS
     SLYSAVSGSS PTSALPVTSL LTSGRRKTID MLDTHSELVT SSLPSASSFS GEILTSEAST
     NTETIHFSEN TAETNMGTTN SMHKLHSSVS IHSQPSGHTP PKVTGSMMED AIVSTSTPGS
     PETKNVDRDS TSPLTPELKE DSTALVMNST TESNTVFSSV SLDAATEVSR AEVTYYDPTF
     MPASAQSTKS PDISPEASSS HSNSPPLTIS THKTIATQTG PSGVTSLGQL TLDTSTIATS
     AGTPSARTQD FVDSETTSVM NNDLNDVLKT SPFSAEEANS LSSQAPLLVT TSPSPVTSTL
     QEHSTSSLVS VTSVPTPTLA KITDMDTNLE PVTRSPQNLR NTLATSEATT DTHTMHPSIN
     TAVANVGTTS SPNEFYFTVS PDSDPYKATS AVVITSTSGD SIVSTSMPRS SAMKKIESET
     TFSLIFRLRE TSTSQKIGSS SDTSTVFDKA FTAATTEVSR TELTSSSRTS IQGTEKPTMS
     PDTSTRSVTM LSTFAGLTKS EERTIATQTG PHRATSQGTL TWDTSITTSQ AGTHSAMTHG
     FSQLDLSTLT SRVPEYISGT SPPSVEKTSS SSSLLSLPAI TSPSPVPTTL PESRPSSPVH
     LTSLPTSGLV KTTDMLASVA SLPPNLGSTS HKIPTTSEDI KDTEKMYPST NIAVTNVGTT
     TSEKESYSSV PAYSEPPKVT SPMVTSFNIR DTIVSTSMPG SSEITRIEME STFSLAHGLK
     GTSTSQDPIV STEKSAVLHK LTTGATETSR TEVASSRRTS IPGPDHSTES PDISTEVIPS
     LPISLGITES SNMTIITRTG PPLGSTSQGT FTLDTPTTSS RAGTHSMATQ EFPHSEMTTV
     MNKDPEILSW TIPPSIEKTS FSSSLMPSPA MTSPPVSSTL PKTIHTTPSP MTSLLTPSLV
     MTTDTLGTSP EPTTSSPPNL SSTSHEILTT DEDTTAIEAM HPSTSTAATN VETTSSGHGS
     QSSVLADSEK TKATAPMDTT STMGHTTVST SMSVSSETTK IKRESTYSLT PGLRETSISQ
     NASFSTDTSI VLSEVPTGTT AEVSRTEVTS SGRTSIPGPS QSTVLPEIST RTMTRLFASP
     TMTESAEMTI PTQTGPSGST SQDTLTLDTS TTKSQAKTHS TLTQRFPHSE MTTLMSRGPG
     DMSWQSSPSL ENPSSLPSLL SLPATTSPPP ISSTLPVTIS SSPLPVTSLL TSSPVTTTDM
     LHTSPELVTS SPPKLSHTSD ERLTTGKDTT NTEAVHPSTN TAASNVEIPS SGHESPSSAL
     ADSETSKATS PMFITSTQED TTVAISTPHF LETSRIQKES ISSLSPKLRE TGSSVETSSA
     IETSAVLSEV SIGATTEISR TEVTSSSRTS ISGSAESTML PEISTTRKII KFPTSPILAE
     SSEMTIKTQT SPPGSTSEST FTLDTSTTPS LVITHSTMTQ RLPHSEITTL VSRGAGDVPR
     PSSLPVEETS PPSSQLSLSA MISPSPVSST LPASSHSSSA SVTSLLTPGQ VKTTEVLDAS
     AEPETSSPPS LSSTSVEILA TSEVTTDTEK IHPFSNTAVT KVGTSSSGHE SPSSVLPDSE
     TTKATSAMGT ISIMGDTSVS TLTPALSNTR KIQSEPASSL TTRLRETSTS EETSLATEAN
     TVLSKVSTGA TTEVSRTEAI SFSRTSMSGP EQSTMSQDIS IGTIPRISAS SVLTESAKMT
     ITTQTGPSES TLESTLNLNT ATTPSWVETH SIVIQGFPHP EMTTSMGRGP GGVSWPSPPF
     VKETSPPSSP LSLPAVTSPH PVSTTFLAHI PPSPLPVTSL LTSGPATTTD ILGTSTEPGT
     SSSSSLSTTS HERLTTYKDT AHTEAVHPST NTGGTNVATT SSGYKSQSSV LADSSPMCTT
     STMGDTSVLT STPAFLETRR IQTELASSLT PGLRESSGSE GTSSGTKMST VLSKVPTGAT
     TEISKEDVTS IPGPAQSTIS PDISTRTVSW FSTSPVMTES AEITMNTHTS PLGATTQGTS
     TLDTSSTTSL TMTHSTISQG FSHSQMSTLM RRGPEDVSWM SPPLLEKTRP SFSLMSSPAT
     TSPSPVSSTL PESISSSPLP VTSLLTSGLA KTTDMLHKSS EPVTNSPANL SSTSVEILAT
     SEVTTDTEKT HPSSNRTVTD VGTSSSGHES TSFVLADSQT SKVTSPMVIT STMEDTSVST
     STPGFFETSR IQTEPTSSLT LGLRKTSSSE GTSLATEMST VLSGVPTGAT AEVSRTEVTS
     SSRTSISGFA QLTVSPETST ETITRLPTSS IMTESAEMMI KTQTDPPGST PESTHTVDIS
     TTPNWVETHS TVTQRFSHSE MTTLVSRSPG DMLWPSQSSV EETSSASSLL SLPATTSPSP
     VSSTLVEDFP SASLPVTSLL NPGLVITTDR MGISREPGTS STSNLSSTSH ERLTTLEDTV
     DTEDMQPSTH TAVTNVRTSI SGHESQSSVL SDSETPKATS PMGTTYTMGE TSVSISTSDF
     FETSRIQIEP TSSLTSGLRE TSSSERISSA TEGSTVLSEV PSGATTEVSR TEVISSRGTS
     MSGPDQFTIS PDISTEAITR LSTSPIMTES AESAITIETG SPGATSEGTL TLDTSTTTFW
     SGTHSTASPG FSHSEMTTLM SRTPGDVPWP SLPSVEEASS VSSSLSSPAM TSTSFFSTLP
     ESISSSPHPV TALLTLGPVK TTDMLRTSSE PETSSPPNLS STSAEILATS EVTKDREKIH
     PSSNTPVVNV GTVIYKHLSP SSVLADLVTT KPTSPMATTS TLGNTSVSTS TPAFPETMMT
     QPTSSLTSGL REISTSQETS SATERSASLS GMPTGATTKV SRTEALSLGR TSTPGPAQST
     ISPEISTETI TRISTPLTTT GSAEMTITPK TGHSGASSQG TFTLDTSSRA SWPGTHSAAT
     HRSPHSGMTT PMSRGPEDVS WPSRPSVEKT SPPSSLVSLS AVTSPSPLYS TPSESSHSSP
     LRVTSLFTPV MMKTTDMLDT SLEPVTTSPP SMNITSDESL ATSKATMETE AIQLSENTAV
     TQMGTISARQ EFYSSYPGLP EPSKVTSPVV TSSTIKDIVS TTIPASSEIT RIEMESTSTL
     TPTPRETSTS QEIHSATKPS TVPYKALTSA TIEDSMTQVM SSSRGPSPDQ STMSQDISTE
     VITRLSTSPI KTESTEMTIT TQTGSPGATS RGTLTLDTST TFMSGTHSTA SQGFSHSQMT
     ALMSRTPGDV PWLSHPSVEE ASSASFSLSS PVMTSSSPVS STLPDSIHSS SLPVTSLLTS
     GLVKTTELLG TSSEPETSSP PNLSSTSAEI LAITEVTTDT EKLEMTNVVT SGYTHESPSS
     VLADSVTTKA TSSMGITYPT GDTNVLTSTP AFSDTSRIQT KSKLSLTPGL METSISEETS
     SATEKSTVLS SVPTGATTEV SRTEAISSSR TSIPGPAQST MSSDTSMETI TRISTPLTRK
     ESTDMAITPK TGPSGATSQG TFTLDSSSTA SWPGTHSATT QRFPQSVVTT PMSRGPEDVS
     WPSPLSVEKN SPPSSLVSSS SVTSPSPLYS TPSGSSHSSP VPVTSLFTSI MMKATDMLDA
     SLEPETTSAP NMNITSDESL AASKATTETE AIHVFENTAA SHVETTSATE ELYSSSPGFS
     EPTKVISPVV TSSSIRDNMV STTMPGSSGI TRIEIESMSS LTPGLRETRT SQDITSSTET
     STVLYKMPSG ATPEVSRTEV MPSSRTSIPG PAQSTMSLDI SDEVVTRLST SPIMTESAEI
     TITTQTGYSL ATSQVTLPLG TSMTFLSGTH STMSQGLSHS EMTNLMSRGP ESLSWTSPRF
     VETTRSSSSL TSLPLTTSLS PVSSTLLDSS PSSPLPVTSL ILPGLVKTTE VLDTSSEPKT
     SSSPNLSSTS VEIPATSEIM TDTEKIHPSS NTAVAKVRTS SSVHESHSSV LADSETTITI
     PSMGITSAVD DTTVFTSNPA FSETRRIPTE PTFSLTPGFR ETSTSEETTS ITETSAVLYG
     VPTSATTEVS MTEIMSSNRI HIPDSDQSTM SPDIITEVIT RLSSSSMMSE STQMTITTQK
     SSPGATAQST LTLATTTAPL ARTHSTVPPR FLHSEMTTLM SRSPENPSWK SSLFVEKTSS
     SSSLLSLPVT TSPSVSSTLP QSIPSSSFSV TSLLTPGMVK TTDTSTEPGT SLSPNLSGTS
     VEILAASEVT TDTEKIHPSS SMAVTNVGTT SSGHELYSSV SIHSEPSKAT YPVGTPSSMA
     ETSISTSMPA NFETTGFEAE PFSHLTSGFR KTNMSLDTSS VTPTNTPSSP GSTHLLQSSK
     TDFTSSAKTS SPDWPPASQY TEIPVDIITP FNASPSITES TGITSFPESR FTMSVTESTH
     HLSTDLLPSA ETISTGTVMP SLSEAMTSFA TTGVPRAISG SGSPFSRTES GPGDATLSTI
     AESLPSSTPV PFSSSTFTTT DSSTIPALHE ITSSSATPYR VDTSLGTESS TTEGRLVMVS
     TLDTSSQPGR TSSSPILDTR MTESVELGTV TSAYQVPSLS TRLTRTDGIM EHITKIPNEA
     AHRGTIRPVK GPQTSTSPAS PKGLHTGGTK RMETTTTALK TTTTALKTTS RATLTTSVYT
     PTLGTLTPLN ASMQMASTIP TEMMITTPYV FPDVPETTSS LATSLGAETS TALPRTTPSV
     FNRESETTAS LVSRSGAERS PVIQTLDVSS SEPDTTASWV IHPAETIPTV SKTTPNFFHS
     ELDTVSSTAT SHGADVSSAI PTNISPSELD ALTPLVTISG TDTSTTFPTL TKSPHETETR
     TTWLTHPAET SSTIPRTIPN FSHHESDATP SIATSPGAET SSAIPIMTVS PGAEDLVTSQ
     VTSSGTDRNM TIPTLTLSPG EPKTIASLVT HPEAQTSSAI PTSTISPAVS RLVTSMVTSL
     AAKTSTTNRA LTNSPGEPAT TVSLVTHPAQ TSPTVPWTTS IFFHSKSDTT PSMTTSHGAE
     SSSAVPTPTV STEVPGVVTP LVTSSRAVIS TTIPILTLSP GEPETTPSMA TSHGEEASSA
     IPTPTVSPGV PGVVTSLVTS SRAVTSTTIP ILTFSLGEPE TTPSMATSHG TEAGSAVPTV
     LPEVPGMVTS LVASSRAVTS TTLPTLTLSP GEPETTPSMA TSHGAEASST VPTVSPEVPG
     VVTSLVTSSS GVNSTSIPTL ILSPGELETT PSMATSHGAE ASSAVPTPTV SPGVSGVVTP
     LVTSSRAVTS TTIPILTLSS SEPETTPSMA TSHGVEASSA VLTVSPEVPG MVTSLVTSSR
     AVTSTTIPTL TISSDEPETT TSLVTHSEAK MISAIPTLAV SPTVQGLVTS LVTSSGSETS
     AFSNLTVASS QPETIDSWVA HPGTEASSVV PTLTVSTGEP FTNISLVTHP AESSSTLPRT
     TSRFSHSELD TMPSTVTSPE AESSSAISTT ISPGIPGVLT SLVTSSGRDI SATFPTVPES
     PHESEATASW VTHPAVTSTT VPRTTPNYSH SEPDTTPSIA TSPGAEATSD FPTITVSPDV
     PDMVTSQVTS SGTDTSITIP TLTLSSGEPE TTTSFITYSE THTSSAIPTL PVSPGASKML
     TSLVISSGTD STTTFPTLTE TPYEPETTAI QLIHPAETNT MVPRTTPKFS HSKSDTTLPV
     AITSPGPEAS SAVSTTTISP DMSDLVTSLV PSSGTDTSTT FPTLSETPYE PETTATWLTH
     PAETSTTVSG TIPNFSHRGS DTAPSMVTSP GVDTRSGVPT TTIPPSIPGV VTSQVTSSAT
     DTSTAIPTLT PSPGEPETTA SSATHPGTQT GFTVPIRTVP SSEPDTMASW VTHPPQTSTP
     VSRTTSSFSH SSPDATPVMA TSPRTEASSA VLTTISPGAP EMVTSQITSS GAATSTTVPT
     LTHSPGMPET TALLSTHPRT ETSKTFPAST VFPQVSETTA SLTIRPGAET STALPTQTTS
     SLFTLLVTGT SRVDLSPTAS PGVSAKTAPL STHPGTETST MIPTSTLSLG LLETTGLLAT
     SSSAETSTST LTLTVSPAVS GLSSASITTD KPQTVTSWNT ETSPSVTSVG PPEFSRTVTG
     TTMTLIPSEM PTPPKTSHGE GVSPTTILRT TMVEATNLAT TGSSPTVAKT TTTFNTLAGS
     LFTPLTTPGM STLASESVTS RTSYNHRSWI STTSSYNRRY WTPATSTPVT STFSPGISTS
     SIPSSTAATV PFMVPFTLNF TITNLQYEED MRHPGSRKFN ATERELQGLL KPLFRNSSLE
     YLYSGCRLAS LRPEKDSSAT AVDAICTHRP DPEDLGLDRE RLYWELSNLT NGIQELGPYT
     LDRNSLYVNG FTHRSSMPTT STPGTSTVDV GTSGTPSSSP SPTTAGPLLM PFTLNFTITN
     LQYEEDMRRT GSRKFNTMES VLQGLLKPLF KNTSVGPLYS GCRLTLLRPE KDGAATGVDA
     ICTHRLDPKS PGLNREQLYW ELSKLTNDIE ELGPYTLDRN SLYVNGFTHQ SSVSTTSTPG
     TSTVDLRTSG TPSSLSSPTI MAAGPLLVPF TLNFTITNLQ YGEDMGHPGS RKFNTTERVL
     QGLLGPIFKN TSVGPLYSGC RLTSLRSEKD GAATGVDAIC IHHLDPKSPG LNRERLYWEL
     SQLTNGIKEL GPYTLDRNSL YVNGFTHRTS VPTSSTPGTS TVDLGTSGTP FSLPSPATAG
     PLLVLFTLNF TITNLKYEED MHRPGSRKFN TTERVLQTLL GPMFKNTSVG LLYSGCRLTL
     LRSEKDGAAT GVDAICTHRL DPKSPGVDRE QLYWELSQLT NGIKELGPYT LDRNSLYVNG
     FTHWIPVPTS STPGTSTVDL GSGTPSSLPS PTTAGPLLVP FTLNFTITNL KYEEDMHCPG
     SRKFNTTERV LQSLLGPMFK NTSVGPLYSG CRLTLLRSEK DGAATGVDAI CTHRLDPKSP
     GVDREQLYWE LSQLTNGIKE LGPYTLDRNS LYVNGFTHQT SAPNTSTPGT STVDLGTSGT
     PSSLPSPTSA GPLLVPFTLN FTITNLQYEE DMHHPGSRKF NTTERVLQGL LGPMFKNTSV
     GLLYSGCRLT LLRPEKNGAA TGMDAICSHR LDPKSPGLNR EQLYWELSQL THGIKELGPY
     TLDRNSLYVN GFTHRSSVAP TSTPGTSTVD LGTSGTPSSL PSPTTAVPLL VPFTLNFTIT
     NLQYGEDMRH PGSRKFNTTE RVLQGLLGPL FKNSSVGPLY SGCRLISLRS EKDGAATGVD
     AICTHHLNPQ SPGLDREQLY WQLSQMTNGI KELGPYTLDR NSLYVNGFTH RSSGLTTSTP
     WTSTVDLGTS GTPSPVPSPT TTGPLLVPFT LNFTITNLQY EENMGHPGSR KFNITESVLQ
     GLLKPLFKST SVGPLYSGCR LTLLRPEKDG VATRVDAICT HRPDPKIPGL DRQQLYWELS
     QLTHSITELG PYTLDRDSLY VNGFTQRSSV PTTSTPGTFT VQPETSETPS SLPGPTATGP
     VLLPFTLNFT ITNLQYEEDM RRPGSRKFNT TERVLQGLLM PLFKNTSVSS LYSGCRLTLL
     RPEKDGAATR VDAVCTHRPD PKSPGLDRER LYWKLSQLTH GITELGPYTL DRHSLYVNGF
     THQSSMTTTR TPDTSTMHLA TSRTPASLSG PMTASPLLVL FTINFTITNL RYEENMHHPG
     SRKFNTTERV LQGLLRPVFK NTSVGPLYSG CRLTLLRPKK DGAATKVDAI CTYRPDPKSP
     GLDREQLYWE LSQLTHSITE LGPYTLDRDS LYVNGFTQRS SVPTTSIPGT PTVDLGTSGT
     PVSKPGPSAA SPLLVLFTLN FTITNLRYEE NMQHPGSRKF NTTERVLQGL LRSLFKSTSV
     GPLYSGCRLT LLRPEKDGTA TGVDAICTHH PDPKSPRLDR EQLYWELSQL THNITELGPY
     ALDNDSLFVN GFTHRSSVST TSTPGTPTVY LGASKTPASI FGPSAASHLL ILFTLNFTIT
     NLRYEENMWP GSRKFNTTER VLQGLLRPLF KNTSVGPLYS GCRLTLLRPE KDGEATGVDA
     ICTHRPDPTG PGLDREQLYL ELSQLTHSIT ELGPYTLDRD SLYVNGFTHR SSVPTTSTGV
     VSEEPFTLNF TINNLRYMAD MGQPGSLKFN ITDNVMQHLL SPLFQRSSLG ARYTGCRVIA
     LRSVKNGAET RVDLLCTYLQ PLSGPGLPIK QVFHELSQQT HGITRLGPYS LDKDSLYLNG
     YNEPGPDEPP TTPKPATTFL PPLSEATTAM GYHLKTLTLN FTISNLQYSP DMGKGSATFN
     STEGVLQHLL RPLFQKSSMG PFYLGCQLIS LRPEKDGAAT GVDTTCTYHP DPVGPGLDIQ
     QLYWELSQLT HGVTQLGFYV LDRDSLFING YAPQNLSIRG EYQINFHIVN WNLSNPDPTS
     SEYITLLRDI QDKVTTLYKG SQLHDTFRFC LVTNLTMDSV LVTVKALFSS NLDPSLVEQV
     FLDKTLNASF HWLGSTYQLV DIHVTEMESS VYQPTSSSST QHFYLNFTIT NLPYSQDKAQ
     PGTTNYQRNK RNIEDALNQL FRNSSIKSYF SDCQVSTFRS VPNRHHTGVD SLCNFSPLAR
     RVDRVAIYEE FLRMTRNGTQ LQNFTLDRSS VLVDGYSPNR NEPLTGNSDL PFWAVILIGL
     AGLLGVITCL ICGVLVTTRR RKKEGEYNVQ QQCPGYYQSH LDLEDLQ
//
ID   A0A0G2JS65_HUMAN        Unreviewed;      7418 AA.
AC   A0A0G2JS65;
DT   22-JUL-2015, integrated into UniProtKB/TrEMBL.
DT   22-JUL-2015, sequence version 1.
DT   11-DEC-2019, entry version 25.
DE   SubName: Full=Mucin-4 {ECO:0000313|Ensembl:ENSP00000487383};
GN   Name=MUC4 {ECO:0000313|Ensembl:ENSP00000487383};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000487383, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000487383, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000487383}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC069513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239646; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001309397.1; NM_001322468.1.
DR   jPOST; A0A0G2JS65; -.
DR   PeptideAtlas; A0A0G2JS65; -.
DR   Ensembl; ENST00000626947; ENSP00000487383; ENSG00000277585.
DR   GeneID; 4585; -.
DR   CTD; 4585; -.
DR   HGNC; HGNC:7514; MUC4.
DR   OrthoDB; 668024at2759; -.
DR   ChiTaRS; MUC4; human.
DR   GenomeRNAi; 4585; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; IEA:InterPro.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IEA:InterPro.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR039898; Mucin_4.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   PANTHER; PTHR13802:SF53; PTHR13802:SF53; 1.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A0G2JS65,
KW   ECO:0000213|PeptideAtlas:A0A0G2JS65, ECO:0000213|ProteomicsDB:A0A0G2JS65};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           29..7418
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002546446"
FT   TRANSMEM        7374..7400
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          6403..6558
FT                   /note="NIDO"
FT                   /evidence="ECO:0000259|PROSITE:PS51220"
FT   DOMAIN          6559..6674
FT                   /note="AMOP"
FT                   /evidence="ECO:0000259|PROSITE:PS50856"
FT   DOMAIN          6687..6922
FT                   /note="VWFD"
FT                   /evidence="ECO:0000259|PROSITE:PS51233"
FT   DOMAIN          7124..7163
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          7327..7366
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          34..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          147..254
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          272..291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          309..333
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          359..386
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          443..478
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          493..585
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          597..858
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          873..968
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          988..1261
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1275..1475
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1514..2035
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2058..3025
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3037..3374
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3387..3917
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3931..4557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4571..4802
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4843..4930
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4942..6002
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          6014..6294
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        493..532
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        548..585
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        7153..7162
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   7418 AA;  734618 MW;  E9A9AE68920B0159 CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT PAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METVTQETAP
     PDEMTTSFPS SVTNTLMMTS KTITMTTSTD STLGNTEETS TAGTESSTPV TSAVSITAGQ
     EGQSRTTSWR TSIQDTSASS QNHWTRSTQT TRESQTSTLT HRTTSTPSFS PSVHNVTGTV
     SQKTSPSGET ATSSLCSVTN TSMMTSEKIT VTTSTGSTLG NPGETSSVPV TGSLMPVTSA
     ALVTVDPEGQ SPVTFSRTST QDTTAFSKNH QTQSVETTRV SQINTLNTLT PVTTSTVLSS
     PSGFNPSGTV SQETFPSGET TISSPSSVSN TFLVTSKVFR MPISRDSTLG NTEETSLSVS
     GTISAITSKV STIWWSDTLS TALSPSSLPP KISTAFHTQQ SEGAETTGRP HERSSFSPGV
     SQEIFTLHET TTWPSSFSSK GHTTWSQTEL PSTSTGAATR LVTGNPSTGA AGTIPRVPSK
     VSAIGEPGEP TTYSSHSTTL PKTTGAGAQT QWTQETGTTG EALLSSPSYS VTQMIKTATS
     PSSSPMLDRH TSQQITTAPS TNHSTIHSTS TSPQESPAVS QRGHTQAPQT TQESQTTRSV
     SPMTDTKTVT TPGSSFTASG HSPSEIVPQD APTISAATTF APAPTGDGHT TQAPTTALQA
     APSSHDATLG PSGGTSLSKT GALTLANSVV STPGGPEGQW TSASASTSPD TAAAMTHTHQ
     AESTEASGQT QTSEPASSGS RTTSAGTATP SSSGASGTTP SGSEGISTSG ETTRFSSNPS
     RDSHTTQSTT ELLSASASHG AIPVSTGMAS SIVPGTFHPT LSEASTAGRP TGQSSPTSPS
     ASPQETAAIS RMAQTQRTRT SRGSDTISLA SQATDTFSTV PPTPPSITSS GLTSPQTQTH
     TLSPSGSGKT FTTALISNAT PLPVTYASSA STGHTTPLHV TDASSVSTGH ATPLPVTDTS
     SESTGHATPL PVTSPSSVST GHTTPLPVTD TSSESTGHVT PLPVTSLSSA STGDSTPLPV
     TDTSSASTGH VTPLPVTSLS SASTGDTTPL PVTDTSSAST GHATSLPVTD TSSVSTGHTT
     PLPVTDTSSA STGHATSLPV TDTSSVSTAH ATPLPVTGLS SASTDDTTRL PVTDVSSAST
     GQAIPLPVTS PSSASTGDTT PLPVTDASSA STGDTTSLPV TIPSSASSGH TTSLPVTDAS
     SVSTGHATSL LVTDASSVST GDTTPLPVTD TNSASTGDTT PLHVTDASSV STGHATSLPV
     TSLSSASTGD TTPLPVTSPS SASSGHTTPL PVTDASSVPT GHATSLPVTD ASSVSTGHAT
     PLPVTDASSV STGHATPLPV TDTSSVSTGQ ATPLPVTSLS SASTGDTTPL PVTDTSSAST
     GQDTPLPVTS LSSVSTGDTT PLPVTSPSSA STGHATPLLV TDASSVSTGH ATSLLVTDAS
     SVSTGHATAL HVTDASSLST GDTTPLPVTS PSSASTGDTT PLPVTDTSSA STGHATSLPV
     TDTSSASTGH ATPLPVTDTS SASTGQATPL PVTGPSSAST GHAIPLLVTD TSSASTGQAT
     PLPVTSLSSA STGDTTPLPV TDASSVSTGH ATSLPVTSLS SVSTGDTTPL PVTSPSSASS
     GHTTPLPVTD ASSVSTGDTT PLPVTSPSSA SSGHTTPLPV TSPSSASSGH TTPLPVTDAS
     SASTGDTTPL PVTDTSSAST GHATHLPVTG LSSASTGDTT RLPVTNVSSA STGHATPLPV
     TSTSSASTGD TTPLPGTDTS SVSTGHTTPL LVTDASSVST GDTTRLPVTS PSSASTGHTT
     PLPVTDTPSA STGDTTPLPV TNASSLSTRH TTSLHVTSPS SASTGHATSL PVTDTSSVST
     GHATPLHVTS PSSASTGDTT PLPVTDTYSA STGQATPLPV TDTSSASTGD TTPLPVTDTS
     SASTGHATPL PVTNTSSVST GHATPLHVTS PSSASTGHTT PLPVTDASSV STGHATSLPV
     TDASSVFTGH ATSLPVTIPS SASSGHTTPL PVTDASSVST GHATSLPVTD ASSVSTGHAT
     PLPVTDASSV STGHATPLPV TDTSSVSTGH ATPLPLTSLS SVSTGDTTPL PVTDTSSAST
     GQATPLPVTS LSSVSTGDTT PLPVTDTSSA STGHATSLPV TDTSSASTGH ATPLPDTDTS
     SASTGHATPL PVTDTSSAST GHATLLPVTD TSSASIGHAT PLPVTDTSSI STGHATPLHV
     TSPSSASTGH ATPLPVTDTS SASTGHANPL HVTSPSSAST GHATPLPVTD TSSASTGHAT
     PLPVTSLSSV STGDTTPLPV TSPSSASTGH TTPLPVTDTS SASTGQATAL PVTSTSSAST
     GDTTPLPVTD TSSASTGQAT PLPVTSLSSV STGDTTPLPV TSPSSASTGH ATPLLVTDAS
     SASTGQATPL PVTDTSSAYT GDTTSLPVTD TSSSSTGDTT PLLVTETSSA STGHATPLHV
     TSPSSASTGD TTPVPVTDTS SVSTGHATPL PVTGLSSAST GDTTRLPVTD ISSASTGQAT
     PLPVTNTSSA STGHATPLPV TGLSSASTGD TTRLPVTDIS SASTGQATPL PVTNTSSVST
     GDTMPLPVTS PSSASTGHAT PLPVTSTSSA STGHATPVPV TSTSSASTGH TTPLPVTDTS
     SASTGDTTPL PVTSPSSAST GHTTPLHVTI PSSASTGDTS TLPVTGASSA STGHATPLPV
     TDTSSVSTGH ATPLPVTSFS SVSTGDTTPL PVTDTSSVST GHATPLPVTS FSSVSTGDTT
     PLPVTDASSA STGHATPLPV TDTSSVSTGH ATPLPLTSLS SVSTGDTTTL PVTDTSSVST
     GHATPLPVTS FSSVSTGDTT PLPVTDASSA STGHATPLPV TDTSSVSTGH ATPLPVTSLS
     SVSTGDTTPL PVTDASSAST GQATPLPVTS LSSVSTGDTT PLPVTIPSSA SSGHTTSLPV
     TDTSSASTGQ ATPLPVTSLS SVSTGDTTPL LVTDASSVST GHATPLPVTD TSSASTGDTT
     RLPVTDTSSA STGQATPLPV TSLSSVSTGD TTPLLVTNTS SVSRGHATSL PVTIPSSSSS
     GHTTPLPVTS TSSVSTGHVT PLPVTSTSSA STGHATSLPV TDTSSVSTGH ATSLPVTDTS
     SVSTGHATPL PVTDASSVST GHATPLPVTD ASSASTGDTT PLPVTNTSSA STGQATPLPV
     TSLSSVSTGD TMPLPVTSPS SASTGHATPL PVTGLSSAST GDTTPLPVTD TSSASTGHVT
     PLPVTSLSSA STGDSTPLPV TDTSSASTGH VTPLPVTSLS SASTGDTTPL PVTDTSSAST
     GHATPLHVTD ASSASTGQAT LLPVTSLSSV STGDTTPLPV TSPSSASTGH ATPLLVTDTS
     SASTGHATPL PVTDASSVST GHATSLPVTI RSSGSTGHTT PLPVTDTSSA STGQATSLLV
     TDTSSVSTGD TTPLPVTSTS SASTGHVTPL HVTSPSSAST GHATPLPVTS LSSASTGDTM
     PLPVTSPSSA STGDTTPLPV TDASSVSTGH TTPLPVTSPS SASTGHTTPL PVTDTTSASK
     GDTTPLPVTS PSSASTGHTT PLPVTDTSSA STGDTTPLPV TSPSSASTGH ATPLPVTNAS
     SLSTGHATPL HVTSPSSAST GHATPLPVTS TSSASTGHAT SLPVTSTSSA STGHATPLPV
     TDNSSVSTGH ATPLPVTGLS SATTDDTTRL PVTDVSSAST GQATPLPVTS LSSVSTGDTT
     PLPVTSPSSA STGHASPLLV TDASSASTGQ ATPLPVTDTS SVSTAHATPL PVTGLSSAST
     DDTTRLPVTD VSSASTGQAI PLPVTSPSSA STGDTTPLPV TDASSASTGD TTSLPVTIPS
     SASSGHTTSL PVTDASSVST GHATSLLVTD ASSVSTGDTT PLPVTDTNSA STGDTTPLHV
     TDASSVSTGH ATSLPVTSLS SASTGDTTPL PVTSPSSASS GDTTPLPVTD TSSASTGHAT
     HLPVTGLSSA STGDTTRLPV TNVSSASTGH ATPLPVTSTS SASTGDTTPL PGTDTSSVST
     GHTTPLLVTD ASSVSTGDTT RLPVTSPSSA STGHTTPLHV TDASSVSTGH TTPLPVTDTS
     SASTGQATSL LVTDTSSVST GDTTPLPVTS TSSASTGHVT PLHVTSPSSA STGHATPLPV
     TSLSSASTGD TTPLPVTDTS SVSTGHTTPL PVTSPSSAST GHTTPLPVTD TSSASKGDTT
     PLPVTSPSSA STGHTTPLPV TDTSSASTGD TTPLPVTNAS SLSTGHATPL HVTSPSSAST
     GHATPLPVTS TSSASTGHAT PLPVTSTSSA STGHATPLPV TDNSSVSTGH ATPLPVTGLS
     SATTDDTTRL PVTDVSSAST GQATPLPVTS LSSVSTGDTT PLPVTSPSSA STGHASPLLV
     TDASSASTGQ ATPLPVTDTS SVSTAHATPL PVTGLSSAST DDTTRLPVTD VSSASTGQAI
     PLPVTSPSSA STGDTTPLPV TDASSASTGD TTSLPVTIPS SASSGHTTSL PVTDASSVST
     GHATSLLVTD ASSVSTGDTT PLPVTDTNSA STGDTTPLHV TDASSVSTGH ATSLPVTSLS
     SASTGDTTPL PVTSPSSASS GHTTSLPVTD ASSVSTGHAT SLPVTIPSSA SSGHTTPLPV
     TDASSVPTGH ATSLPVTDAS SVSTGHATPL PVTDASSVST GHATPLPVTD TSSVSTGQAT
     PLPVTSLSSA SSTGDTTPLP VTDTSSASTG QDTPLPVTSL FSVSTGDTTP LPVTSPSSAS
     TGHATHLLVT DASSVSTGHA TSLLVTDASS VSTGHATALH VTDASSLSTG DTTPLPVTSP
     SSASTGDTTP LPVTDTSSVS TGHATSLPVT DTSSASTGHA TSLPVTDTSS ASTGQATPLP
     VTSPSSASTG HAIPLLVTDT SSASTGQATP LPVTSLSSAS TGDTTPLPVT DASSVSTGHA
     TSLPVTSLSS VSTGDTTPLP VTSPSSASTG HATPLHVTSP SSASTGHATP LPVTSLSSAS
     TGDTTPLPVT SPSSASTGHA TPLHVTDASS VSTGDTTPLP VTSPSSASSG HTTPLPVTDA
     SSASTGDTTP LPVTDTSSAS TGHATHLPVT GLSSASTGDT TRLPVTDVSS ASTGHATPLP
     VTSTSSASTG DTTPLPGTDT SSVSTGHTTP LLVTDASSVS TGDTTRLPVT SPSSASTGHT
     TPLPVTDTPS ASTGDTTPLP VTNASSLSTR HATSLHVTSP SSASTGHATP LPVTDTSAAS
     TGHATPLPVT STSSASTGDT TPLPVTDTSS ASTGHATPLP VTNTSSVSTG HATPLHVTSP
     SSASTGHTTP LPVTDASSVS TGHATSLPVT DASSVSTGHA TPLPVTDASS VSTGHATPLP
     LTSLSSVSTG DTTPLPVTDT SSASTGQATP LPVTSLSSVS TGDTTPLPVT DTSSASTGHA
     TSLPVTDTSS ASTGHATPLP VTDTSSISTG HATPLHVTSP SSASTGHATP LPVTDTSSAS
     TGHATPLPVT SLSSVSTGDT TPLPVTSPSS ASTGHATPLL VTDASSASTG QATPLPVTSL
     SSVSTGDTTP LPVTSPSSAS TGHATSLPVT DTSSASTGDT TSLPVTDTSS AYTGDTTSLP
     VTDTSSSSTG DTTPLLVTET SSASTGDTTP VPVTDTSSVS TGHATPLPVT GLSSASTGDT
     TRLPVTDISS ASTGQATPLP VTNTSSVSTG DTMPLPVTSP SSASTGHATP LPVTSTSSAS
     TGHATPVPVT STSLASTGHT TPLPVTSPSS ASTGHTTPLP VTDTSSASTG DTTPLPVTNA
     SSLSTGHTTP LHVTIPSSAS TGDTSTLPVT GASSASTGHA TPLPVTDTSS VSTGHATPLP
     VTSFSSVSTG DTTPLPVTDA SSASTGHATP LPVTDTSSAS TGDTTPLPVT DASSASTGQA
     TPLPVTSLSS VSTGDTTPLP VTIPSSASSG HTTSLPVSDT SSASTGQATP LPVTSLSSVS
     TGDTTPLLVT DASSVSTGHA TPLPVTDTSS ASTGDTTRLP VTDTSSASTG QATPLPVTSL
     SSVSTGDTTP LLVTNTSSVS TGHATSLPVT IPSSSSSGHT TPLPVTSTSS VSTGHVTPLH
     VTSPSSSSTG QATPLPVTST SSVSTGHVTP LHVTSPSSAS TGHATPLPVT STSSASTGHA
     TPLPVTDASS VSTGHATPLP VTDTSSASTG DTTPLPVTDT SSASTGQATP LPVTSLSSVS
     TGHATPLAVS SATSASTVSS DSPLKMETSG MTTPSLKTDG GRRTATSPPP TTSQTIISTI
     PSTAMHTRST AAPIPILPER GVSLFPYGAD AGDLEFVRRT VDFTSPLFKP ATGFPLGSSL
     RDSLYFTDNG QIIFPESDYQ IFSYPNPLPT GFTGRDPVAL VAPFWDDADF STGRGTTFYQ
     EYETFYGEHS LLVQQAESWI RKMTNNGGYK ARWALKVTWV NAHAYPAQWT LGSNTYQAIL
     STDGSRSYAL FLYQSGGMQW DVAQRSGNPV LMGFSSGDGY FENSPLMSQP VWERYRPDRF
     LNSNSGLQGL QFYRLHREER PNYRLECLQW LKSQPRWPSW GWNQVSCPCS WQQGRRDLRF
     QPVSIGRWGL GSRQLCSFTS WRGGVCCSYG PWGEFREGWH VQRPWQLAQE LEPQSWCCRW
     NDKPYLCALY QQRRPHVGCA TYRPPQPAWM FGDPHITTLD GVSYTFNGLG DFLLVGAQDG
     NSSFLLQGRT AQTGSAQATN FIAFAAQYRS SSLGPVTVQW LLEPHDAIRV LLDNQTVTFQ
     PDHEDGGGQE TFNATGVLLS RNGSEVSASF DGWATVSVIA LSNILHASAS LPPEYQNRTE
     GLLGVWNNNP EDDFRMPNGS TIPPGSPEEM LFHFGMTWQI NGTGLLGKRN DQLPSNFTPV
     FYSQLQKNSS WAEHLISNCD GDSSCIYDTL ALRNASIGLH TREVSKNYEQ ANATLNQYPP
     SINGGRVIEA YKGQTTLIQY TSNAEDANFT LRDSCTDLEL FENGTLLWTP KSLEPFTLEI
     LARSAKIGLA SALQPRTVVC HCNAESQCLY NQTSRVGNSS LEVAGCKCDG GTFGRYCEGS
     EDACEEPCFP SVHCVPGKGC EACPPNLTGD GRHCAALGSS FLCQNQSCPV NYCYNQGHCY
     ISQTLGCQPM CTCPPAFTDS RCFLAGNNFS PTVNLELPLR VIQLLLSEEE NASMAEVNAS
     VAYRLGTLDM RAFLRNSQVE RIDSAAPASG SPIQHWMVIS EFQYRPRGPV IDFLNNQLLA
     AVVEAFLYHV PRRSEEPRND VVFQPISGED VRDVTALNVS TLKAYFRCDG YKGYDLVYSP
     QSGFTCVSPC SRGYCDHGGQ CQHLPSGPRC SCVSFSIYTA WGEHCEHLSM KLDAFFGIFF
     GALGGLLLLG VGTFVVLRFW GCSGARFSYF LNSAEALP
//
ID   A0T3F4_HUMAN            Unreviewed;      1437 AA.
AC   A0T3F4;
DT   09-JAN-2007, integrated into UniProtKB/TrEMBL.
DT   09-JAN-2007, sequence version 1.
DT   22-APR-2020, entry version 64.
DE   SubName: Full=Mucin 4 {ECO:0000313|EMBL:ABK78776.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABK78776.1};
RN   [1] {ECO:0000313|EMBL:ABK78776.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wei J., Miao Y., Gao W.;
RT   "A New Splicing Variant of the Human Pancreatic Tumor-Associated Mucin MUC4
RT   cDNA.";
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF091824; ABK78776.1; -; mRNA.
DR   RefSeq; NP_004523.3; NM_004532.5.
DR   RefSeq; NP_612154.2; NM_138297.4.
DR   PeptideAtlas; A0T3F4; -.
DR   PRIDE; A0T3F4; -.
DR   GeneID; 4585; -.
DR   KEGG; hsa:4585; -.
DR   CTD; 4585; -.
DR   PharmGKB; PA31319; -.
DR   eggNOG; ENOG410IHUZ; Eukaryota.
DR   eggNOG; ENOG4111F6U; LUCA.
DR   KO; K22017; -.
DR   GenomeRNAi; 4585; -.
DR   Genevisible; A0T3F4; HS.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; IEA:InterPro.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IEA:InterPro.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR039898; Mucin_4.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   PANTHER; PTHR13802:SF53; PTHR13802:SF53; 1.
DR   Pfam; PF06119; NIDO; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00539; NIDO; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           29..1437
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002630483"
FT   DOMAIN          1132..1287
FT                   /note="NIDO"
FT                   /evidence="ECO:0000259|PROSITE:PS51220"
FT   DOMAIN          1288..1403
FT                   /note="AMOP"
FT                   /evidence="ECO:0000259|PROSITE:PS50856"
FT   DOMAIN          1416..1437
FT                   /note="VWFD"
FT                   /evidence="ECO:0000259|PROSITE:PS51233"
FT   REGION          34..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          147..254
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          272..291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          308..333
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          359..386
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          443..478
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          493..585
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          597..858
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          873..1025
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        309..333
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        493..532
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        548..585
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1437
FT                   /evidence="ECO:0000313|EMBL:ABK78776.1"
SQ   SEQUENCE   1437 AA;  151953 MW;  CE57979138FC3A4B CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT PAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METVTQETAP
     PDEMTTSFPS SVTNTLMMTS KTITMTTSTD STLGNTEETS TAGTESSTPV TSAVSITAGQ
     EGQSRTTSWR TSIQDTSASS QNHWTRSTQT TRESQTSTLT HRTTSTPSFS PSVHNVTGTV
     SQKTSPSGET ATSSLCSVTN TSMMTSEKIT VTTSTGSTLG NPGETSSVPV TGSLMPVTSA
     ALVTVDPEGQ SPATFSRTST QDTTAFSKNH QTQSVETTRV SQINTLNTLT PVTTSTVLSS
     PSGFNPSGTV SQETFPSGET TISSPSSVSN TFLVTSKVFR MPISRDSTLG NTEETSLSVS
     GTISAITSKV STIWWSDTLS TALSPSSLPP KISTAFHTQQ SEGAETTGRP HERSSFSPGV
     SQEIFTLHET TTWPSSFSSK GHTTWSQTEL PSTSTGAATR LVTGNPSTGA AGTIPRVPSK
     VSAIGEPGEP TTYSSHSTTL PKTTGAGAQT QWTQETGTTG EALLSSPSYS VTQMIKTATS
     PSSSPMLDRH TSQQITTAPS TNHSTIHSTS TSPQESPAVS QRGHTQAPQT TQESQTTRSV
     SPMTDTKTVT TPGSSFTASG HSPSEIVPQD APTISAATTF APAPTGDGHT TQAPTTALQA
     APSSHDATLG PSGGTSLSKT GALTLANSVV STPGGPEGQW TSASASTSPD TAAAMTHTHQ
     AESTEASGQT QTSEPASSGS RTTSAGTATP SSSGASGTTP SGSEGISTSG ETTRFSSNPS
     RDSHTTQSTT ELLSASASHG AIPVSTGMAS SIVPGTFHPT LSEASTAGRP TGQSSPTSPS
     ASPQETAAIS RMAQTQRTRT SRGSDTISLA SQATDTFSTV PPTPPSITSS GLTSPQTQTH
     TLSPSGSVST GHATPLAVSS ATSASTVSSD SPLKMETSGM TTPSLKTDGG RRTATSPPPT
     TSQTIISTIP STAMHTRSTA APIPILPERG VSLFPYGAGA GDLEFVRRTV DFTSPLFKPA
     TGFPLGSSLR DSLYFTDNGQ IIFPESDYQI FSYPNPLPTG FTGRDPVALV APFWDDADFS
     TGRGTTFYQE YETFYGEHSL LVQQAESWIR KITNNGGYKA RWALKVTWVN AHAYPAQWTL
     GSNTYQAILS TDGSRSYALF LYQSGGMQWD VAQRSGNPVL MGFSSGDGYF ENSPLMSQPV
     WERYRPDRFL NSNSGLQGLQ FYRLHREERP NYRLECLQWL KSQPRWPSWG WNQVSCPCSW
     QQGRRDLRFQ PVSIGRWGLG SRQLCSFTSW RGGVCCSYGP WGEFREGWHV QRPWQLAQEL
     EPQSWCCRWN DKPYLCALYQ QRRPHVGCAT YRPPQPAWMF GDPHITTLDG VSYTFNG
//
ID   E9PDY6_HUMAN            Unreviewed;      5412 AA.
AC   E9PDY6;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   22-APR-2020, entry version 64.
DE   SubName: Full=Mucin-4 {ECO:0000313|Ensembl:ENSP00000417498};
GN   Name=MUC4 {ECO:0000313|Ensembl:ENSP00000417498};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000417498, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000417498, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000417498}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC069513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_060876.5; NM_018406.6.
DR   iPTMnet; E9PDY6; -.
DR   jPOST; E9PDY6; -.
DR   MaxQB; E9PDY6; -.
DR   PRIDE; E9PDY6; -.
DR   ProteomicsDB; 19774; -.
DR   Antibodypedia; 1457; 336 antibodies.
DR   Ensembl; ENST00000463781; ENSP00000417498; ENSG00000145113.
DR   GeneID; 4585; -.
DR   UCSC; uc021xjp.3; human.
DR   CTD; 4585; -.
DR   EuPathDB; HostDB:ENSG00000145113.21; -.
DR   HGNC; HGNC:7514; MUC4.
DR   OpenTargets; ENSG00000145113; -.
DR   eggNOG; ENOG410IHUZ; Eukaryota.
DR   eggNOG; ENOG4111F6U; LUCA.
DR   GeneTree; ENSGT00730000110943; -.
DR   HOGENOM; CLU_223685_0_0_1; -.
DR   OMA; ITSTHKL; -.
DR   OrthoDB; 668024at2759; -.
DR   TreeFam; TF330652; -.
DR   ChiTaRS; MUC4; human.
DR   GenomeRNAi; 4585; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000145113; Expressed in nasal cavity epithelium and 133 other tissues.
DR   ExpressionAtlas; E9PDY6; baseline and differential.
DR   Genevisible; E9PDY6; HS.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; IEA:InterPro.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IEA:InterPro.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR039898; Mucin_4.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   PANTHER; PTHR13802:SF53; PTHR13802:SF53; 1.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PDY6,
KW   ECO:0000213|PeptideAtlas:E9PDY6, ECO:0000213|ProteomicsDB:E9PDY6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           29..5412
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003242818"
FT   TRANSMEM        5368..5394
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          4397..4552
FT                   /note="NIDO"
FT                   /evidence="ECO:0000259|PROSITE:PS51220"
FT   DOMAIN          4553..4668
FT                   /note="AMOP"
FT                   /evidence="ECO:0000259|PROSITE:PS50856"
FT   DOMAIN          4681..4916
FT                   /note="VWFD"
FT                   /evidence="ECO:0000259|PROSITE:PS51233"
FT   DOMAIN          5118..5157
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          5321..5360
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          40..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..249
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          267..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          303..328
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          353..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          438..473
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          488..580
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          592..853
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          868..963
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          983..1864
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1878..2078
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2111..2220
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2232..2814
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2837..3306
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3320..3580
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3592..3644
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3656..3756
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3769..4223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4242..4288
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        304..328
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        488..530
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        543..580
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        5147..5156
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   5412 AA;  542307 MW;  CA70610C2C0FC5B0 CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT AAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METAPPDEMT
     TSFPSSVTNT LMMTSKTITM TTSTDSTLGN TEETSTAGTE SSTPVTSAVS ITAGQEGQSR
     TTSWRTSIQD TSASSQNHWT RSTQTTRESQ TSTLTHRTTS TPSFSPSVHN VTGTVSQKTS
     PSGETATSSL CSVTNTSMMT SEKITVTTST GSTLGNPGET SSVPVTGSLM PVTSAALVTF
     DPEGQSPATF SRTSTQDTTA FSKNHQTQSV ETTRVSQINT LNTLTPVTTS TVLSSPSGFN
     PSGTVSQETF PSGETTTSSP SSVSNTFLVT SKVFRMPTSR DSTLGNTEET SLSVSGTISA
     ITSKVSTIWW SDTLSTALSP SSLPPKISTA FHTQQSEGAE TTGRPHERSS FSPGVSQEIF
     TLHETTTWPS SFSSKGHTTW SQTELPSTST GAATRLVTGN PSTGTAGTIP RVPSKVSAIG
     EPGEPTTYSS HSTTLPKTTG AGAQTQWTQE TGTTGEALLS SPSYSVTQMI KTATSPSSSP
     MLDRHTSQQI TTAPSTNHST IHSTSTSPQE SPAVSQRGHT QAPQTTQESQ TTRSVSPMTD
     TKTVTTPGSS FTASGHSPSE IVPQDAPTIS AATTFAPAPT GDGHTTQAPT TALQAAPSSH
     DATLGPSGGT SLSKTGALTL ANSVVSTPGG PEGQWTSASA STSPDTAAAM THTHQAESTE
     ASGQTQTSEP ASSGSRTTSA GTATPSSSGA SGTTPSGSEG ISTSGETTRF SSNPSRDSHT
     TQSTTELLSA SASHGAIPVS TGMASSIVPG TFHPTLSEAS TAGRPTGQSS PTSPSASPQE
     TAAISRMAQT QRTRTSRGSD TISLASQATD TFSTVPPTPP SITSTGLTSP QTETHTLSPS
     GSGKTFTTAL ISNATPLPVT YASSASTGHT TPLHVTDASS VSTGHATPLP VTSPSSVSTG
     HTTPLPVTDT SSESTGHVTP LPVTSFSSAS TGDSTPLPVT DTSSASTGHV TPLPVTSLSS
     ASTGDTTPLP VTDTSSASTG HATSLPVTDT SSVSTGHTTP LPVTDTSSAS TGHATSLPVT
     DTSSVSTGHT TPLHVTDASS ASTGQATPLP VTSLSSVSTG DTTPLPVTSP SSASTGHATP
     LLVTDTSSAS TGHATPLPVT DASSVSTDHA TSLPVTIPSA ASTGHTTPLP VTDTSSASTG
     QATSLLVTDT SSVSTGDTTP LPVTSTSSAS TGHVTPLHVT SPSSASTGHA TPLPVTSLSS
     ASTGDTMPLP VTSPSSASTG DTTPLPVTDA SSVSTGHTTP LHVTDASSAS TGQATPLPVT
     SLSSVSTGDT TPLPVTSPSS ASTGHATPLL VTDTSSASTG HATPLPVTDA SSVSTDHATS
     LPVTIPSAAS TGHTTPLPVT DTSSASTGQA TSLLVTDTSS VSTGDTTPLP VTSTSSASTG
     HVTPLHVTSP SSASTGHATP LPVTSLSSAS TGDTMPLPVT SPSSASTGDT TPLPVTDASS
     VSTGHTTPLP VTSPSSASTG HTTPLPVTDT SSASKGDTTP LPVTSPSSAS TGHTTPLPVT
     DTSSASTGDT TPLPVTNASS LSTGHATPLH VTSPSSASTG HATPLPVTST SSASTGHATP
     LPVTGLSSAT TDDTTRLPVT DVSSASTGQA TPLPVTSLSS VSTGDTTPLP VTSPSSASTG
     HASPLLVTDA SSASTGQATP LPVTDTSSVS TAHATPLPVT GLSSASTDDT TRLPVTDVSS
     ASTGQAIPLP VTSPSSASTG DTTPLPVTDA SSASTGDTTS LPVTIPSSAS SGHTTSLPVT
     DASSVSTGHA TSLLVTDASS VSTGDTTPLP VTDTNSASTG DTTPLHVTDA SSVSTGHATS
     LPVTSLSSAS TGDTTPLPVT SPSSASSGHT TPLPVTDASS VPTGHATSLP VTDASSVSTG
     HATPLPVTDA SSVSTGHATP LPVTDTSSVS TGQATPLPVT SLSSASTGDT TPLPVTDTSS
     ASTGQDTPLP VTSLSSVSTG DTTPLPVTNP SSASTGHATP LLVTDASSIS TGHATSLLVT
     DASSVSTGHA TALHDTDASS LSTGDTTPLP VTSPSSTSTG DTTPLPVTET SSVSTGHATS
     LPVTDTSSAS TGHATSLPVT DTSSASTGHA TPLPVTDTSS ASTGQATPLP VTSPSSASTG
     HAIPLLVTDT SSASTGQATP LPVTSLSSAS TGDTTPLPVT DASSVSTGHA TSLPVTSLSS
     VSTGDTTPLP VTSPSSASTG HATPLHVTDA SSASTGHATP LPVTSLSSAS TGDTTPLPVT
     SPSSASTGHA TPLHVTDASS VSTGDTTPLP VTSSSSASSG HTTPLPVTDA SSASTGDTTP
     LPVTDTSSAS TGHATHLPVT GLSSASTGDT TRLPVTNVSS ASTGHATPLP VTSTSSASTG
     DTTPLPGTDT SSVSTGHTTP LLVTDASSVS TGDTTRLPVT SPSSASTGHT TPLPVTDTPS
     ASTGDTTPLP VTNASSLSTR HATSLHVTSP SSASTGHATS LPVTDTSAAS TGHATPLPVT
     STSSASTGDT TPLPVTDTYS ASTGQATPLP VTSLSSVSTG DTTPLPVTSP SSASTGHATP
     LLVTDASSAS TGQATPLPVT SLSSVSTGDT TPLPVTSPSS ASTGHATSLP VTDTSSASTG
     DTTSLPVTDT SSAYTGDTTS LPVTDTSSSS TGDTTPLLVT ETSSVSTGDT TPLPVTDTSS
     ASTGHATPLP VTNTSSVSTG HATPLHVTSP SSASTGHTTP LPVTDASSVS TGHATSLPVT
     DASSVFTGHA TSLPVTIPSS ASSGHTTPLP VTDASSVSTG HATSLPVTDA SSVSTGHATP
     LPVTDASSVS TGHATPLPLT SLSSVSTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG
     DTTPLPVTDT SSASTGHATS LPVTDTSSAS TGHATPLPDT DTSSASTGHA TLLPVTDTSS
     ASIGHATSLP VTDTSSISTG HATPLHVTSP SSASTGHATP LPVTDTSSAS TGHANPLHVT
     SPSSASTGHA TPLPVTDTSS ASTGHATPLP VTSLSSVSTG DTTPLPVTSP SSASTGHTTP
     LPVTDTSSAS TGQATALPVT STSSASTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG
     DTTPLPVTSP SSASTGHATP LLVTDASSAS TGQATPLPVT SLSSVSTGDT TPLPVTSPSS
     ASTGHATSLP VTDTSSASTG DTTSLPVTDT SSAYTGDTTS LPVTDTSSSS TGDTTPLLVT
     ETSSVSTGHA TPLLVTDASS ASTGHATPLH VTSPSSASTG DTTPVPVTDT SSVSTGHATP
     LPVTGLSSAS TGDTTRLPVT DISSASTGQA TPLPVTNTSS VSTGDTMPLP VTSPSSASTG
     HATPLPVTST SSASTGHATP VPVTSTSSAS TGHTTPLPVT DTSSASTGDT TPLPVTSPSS
     ASTGHTTPLH VTIPSSASTG DTSTLPVTGA SSASTGHATP LPVTDTSSVS TGHATPLPVT
     SLSSVSTGDT TPLPVTDASS ASTGQATPLP VTSLSSVSTG DTTPLLVTDA SSVSTGHATP
     LPVTDTSSAS TGDTTRLPVT DTSSASTGQA TPLPVTSLSS VSTGDTTPLL VTDASSVSTG
     HATPLPVTDT SSASTGDTTR LPVTDTSSAS TGQATPLPVT IPSSSSSGHT TPLPVTSTSS
     VSTGHVTPLH VTSPSSASTG HVTPLPVTST SSASTGHATP LLVTDASSVS TGHATPLPVT
     DASSASTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG DTTPLPVTDA SSASTGHATP
     LPVTIPSSVS TGDTMPLPVT SPSSASTGHA TPLPVTGLSS ASTGDTTPLP VTDTSSASTR
     HATPLPVTDT SSASTDDTTR LPVTDVSSAS TGHATPLPVT STSSASTGDT TPLPVTDTSS
     VSTGHATSLP VTSRSSASTG HATPLPVTDT SSVSTGHATP LPVTSTSSVS TGHATPLPVT
     SPSSASTGHA TPVPVTSTSS ASTGDTTPLP VTNASSLSTG HATPLHVTSP SSASRGDTST
     LPVTDASSAS TGHATPLPLT SLSSVSTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG
     DTTPLPVTIP SSASSGHTTS LPVTDASSVS TGHGTPLPVT STSSASTGDT TPLPVTDTSS
     ASTGHATPLP VTDTSSASTG HATPLPVTSL SSVSTGHATP LAVSSATSAS TVSSDSPLKM
     ETPGMTTPSL KTDGGRRTAT SPPPTTSQTI ISTIPSTAMH TRSTAAPIPI LPERGVSLFP
     YGAGAGDLEF VRRTVDFTSP LFKPATGFPL GSSLRDSLYF TDNGQIIFPE SDYQIFSYPN
     PLPTGFTGRD PVALVAPFWD DADFSTGRGT TFYQEYETFY GEHSLLVQQA ESWIRKMTNN
     GGYKARWALK VTWVNAHAYP AQWTLGSNTY QAILSTDGSR SYALFLYQSG GMQWDVAQRS
     GNPVLMGFSS GDGYFENSPL MSQPVWERYR PDRFLNSNSG LQGLQFYRLH REERPNYRLE
     CLQWLKSQPR WPSWGWNQVS CPCSWQQGRR DLRFQPVSIG RWGLGSRQLC SFTSWRGGVC
     CSYGPWGEFR EGWHVQRPWQ LAQELEPQSW CCRWNDKPYL CALYQQRRPH VGCATYRPPQ
     PAWMFGDPHI TTLDGVSYTF NGLGDFLLVG AQDGNSSFLL QGRTAQTGSA QATNFIAFAA
     QYRSSSLGPV TVQWLLEPHD AIRVLLDNQT VTFQPDHEDG GGQETFNATG VLLSRNGSEV
     SASFDGWATV SVIALSNILH ASASLPPEYQ NRTEGLLGVW NNNPEDDFRM PNGSTIPPGS
     PEEMLFHFGM TWQINGTGLL GKRNDQLPSN FTPVFYSQLQ KNSSWAEHLI SNCDGDSSCI
     YDTLALRNAS IGLHTREVSK NYEQANATLN QYPPSINGGR VIEAYKGQTT LIQYTSNAED
     ANFTLRDSCT DLELFENGTL LWTPKSLEPF TLEILARSAK IGLASALQPR TVVCHCNAES
     QCLYNQTSRV GNSSLEVAGC KCDGGTFGRY CEGSEDACEE PCFPSVHCVP GKGCEACPPN
     LTGDGRHCAA LGSSFLCQNQ SCPVNYCYNQ GHCYISQTLG CQPMCTCPPA FTDSRCFLAG
     NNFSPTVNLE LPLRVIQLLL SEEENASMAE VNASVAYRLG TLDMRAFLRN SQVERIDSAA
     PASGSPIQHW MVISEFQYRP RGPVIDFLNN QLLAAVVEAF LYHVPRRSEE PRNDVVFQPI
     SGEDVRDVTA LNVSTLKAYF RCDGYKGYDL VYSPQSGFTC VSPCSRGYCD HGGQCQHLPS
     GPRCSCVSFS IYTAWGEHCE HLSMKLDAFF GIFFGALGGL LLLGVGTFVV LRFWGCSGAR
     FSYFLNSAEA LP
//
ID   MUC4_HUMAN              Reviewed;        2169 AA.
AC   Q99102; O95938; Q9GZM2; Q9GZV6; Q9H481; Q9H482; Q9H483; Q9H484; Q9H485;
AC   Q9H486; Q9H487; Q9H4D6; Q9H4D8; Q9NPJ0; Q9NY09; Q9NY75; Q9NY76; Q9NY77;
AC   Q9NY78; Q9NY79; Q9NY80; Q9NY81;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 4.
DT   22-APR-2020, entry version 158.
DE   RecName: Full=Mucin-4;
DE            Short=MUC-4;
DE   AltName: Full=Ascites sialoglycoprotein;
DE            Short=ASGP;
DE   AltName: Full=Pancreatic adenocarcinoma mucin;
DE   AltName: Full=Testis mucin;
DE   AltName: Full=Tracheobronchial mucin;
DE   Contains:
DE     RecName: Full=Mucin-4 alpha chain;
DE     AltName: Full=Ascites sialoglycoprotein 1;
DE              Short=ASGP-1;
DE   Contains:
DE     RecName: Full=Mucin-4 beta chain;
DE     AltName: Full=Ascites sialoglycoprotein 2;
DE              Short=ASGP-2;
DE   Flags: Precursor;
GN   Name=MUC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 12 AND 13), PARTIAL NUCLEOTIDE
RP   SEQUENCE [MRNA] (ISOFORMS 2; 3; 11; 15; 16 AND 17), TISSUE SPECIFICITY, AND
RP   VARIANT ASP-1081.
RC   TISSUE=Lung, and Testis;
RX   PubMed=10880978; DOI=10.1046/j.1432-1327.2000.01504.x;
RA   Moniaux N., Escande F., Batra S.K., Porchet N., Laine A., Aubert J.-P.;
RT   "Alternative splicing generates a family of putative secreted and membrane-
RT   associated MUC4 mucins.";
RL   Eur. J. Biochem. 267:4536-4544(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 5; 7; 8; 9; 10 AND 11),
RP   TISSUE SPECIFICITY, AND VARIANTS PRO-41 AND ASP-1081.
RC   TISSUE=Pancreatic tumor;
RX   PubMed=10920259; DOI=10.1093/oxfordjournals.jbchem.a022746;
RA   Choudhury A., Moniaux N., Winpenny J.P., Hollingsworth M.A., Aubert J.-P.,
RA   Batra S.K.;
RT   "Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.";
RL   J. Biochem. 128:233-243(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-41; ASP-1081 AND
RP   SER-1578.
RX   PubMed=12084055; DOI=10.1046/j.1432-1033.2002.02988.x;
RA   Desseyn J.-L., Clavereau I., Laine A.;
RT   "Cloning, chromosomal localization and characterization of the murine mucin
RT   gene orthologous to human MUC4.";
RL   Eur. J. Biochem. 269:3150-3159(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1014-2169 (ISOFORM 1), TISSUE SPECIFICITY,
RP   AND VARIANT ASP-1081.
RC   TISSUE=Colon mucosa;
RX   PubMed=10024507; DOI=10.1042/bj3380325;
RA   Moniaux N., Nollet S., Porchet N., Degand P., Laine A., Aubert J.-P.;
RT   "Complete sequence of the human mucin MUC4: a putative cell membrane-
RT   associated mucin.";
RL   Biochem. J. 338:325-333(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1014-2169, AND VARIANT ASP-1081.
RX   PubMed=12153560; DOI=10.1046/j.1432-1033.2002.03032.x;
RA   Escande F., Lemaitre L., Moniaux N., Batra S.K., Aubert J.-P.,
RA   Buisine M.P.;
RT   "Genomic organization of MUC4 mucin gene: towards the characterization of
RT   splice variants.";
RL   Eur. J. Biochem. 269:3637-3644(2002).
RN   [6]
RP   PRELIMINARY PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1673336; DOI=10.1016/0006-291x(91)91580-6;
RA   Porchet N., van Cong N., Dufosse J., Audie J.P., Guyonnet-Duperat V.,
RA   Gross M.S., Denis C., Degand P., Bernheim A., Aubert J.-P.;
RT   "Molecular cloning and chromosomal localization of a novel human tracheo-
RT   bronchial mucin cDNA containing tandemly repeated sequences of 48 base
RT   pairs.";
RL   Biochem. Biophys. Res. Commun. 175:414-422(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12102554; DOI=10.1016/s0079-6603(02)71043-x;
RA   Carraway K.L., Perez A., Idris N., Jepson S., Arango M.E., Komatsu M.,
RA   Haq B., Price-Schiavi S.A., Zhang J., Carraway C.A.;
RT   "Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and
RT   epithelia: to protect and to survive.";
RL   Prog. Nucleic Acid Res. Mol. Biol. 71:149-185(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=16049287; DOI=10.1136/jcp.2004.023572;
RA   Saitou M., Goto M., Horinouchi M., Tamada S., Nagata K., Hamada T.,
RA   Osako M., Takao S., Batra S.K., Aikou T., Imai K., Yonezawa S.;
RT   "MUC4 expression is a novel prognostic factor in patients with invasive
RT   ductal carcinoma of the pancreas.";
RL   J. Clin. Pathol. 58:845-852(2005).
RN   [10]
RP   TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=16814944; DOI=10.1016/j.prp.2006.04.002;
RA   Karg A., Dinc Z.A., Basok O., Ucvet A.;
RT   "MUC4 expression and its relation to ErbB2 expression, apoptosis,
RT   proliferation, differentiation, and tumor stage in non-small cell lung
RT   cancer (NSCLC).";
RL   Pathol. Res. Pract. 202:577-583(2006).
RN   [11]
RP   DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=16914178; DOI=10.1016/j.tice.2006.06.004;
RA   Zhang J., Yasin M., Carraway C.A., Carraway K.L.;
RT   "MUC4 expression and localization in gastrointestinal tract and skin of
RT   human embryos.";
RL   Tissue Cell 38:271-275(2006).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1809.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
CC   -!- FUNCTION: May play a role in tumor progression. Ability to promote
CC       tumor growth may be mainly due to repression of apoptosis as opposed to
CC       proliferation. Has anti-adhesive properties. Seems to alter cellular
CC       behavior through both anti-adhesive effects on cell-cell and cell-
CC       extracellular matrix interactions and in its ability to act as an
CC       intramembrane ligand for ERBB2. Plays an important role in cell
CC       proliferation and differentiation of epithelial cells by inducing
CC       specific phosphorylation of ERBB2. The MUC4-ERBB2 complex causes site-
CC       specific phosphorylation of the ERBB2 'Tyr-1248'. In polarized
CC       epithelial cells segregates ERBB2 and other ERBB receptors and prevents
CC       ERBB2 from acting as a coreceptor. The interaction with ERBB2 leads to
CC       enhanced expression of CDKN1B. The formation of a MUC4-ERBB2-ERBB3-NRG1
CC       complex leads to down-regulation of CDKN1B, resulting in repression of
CC       apoptosis and stimulation of proliferation.
CC       {ECO:0000269|PubMed:12102554, ECO:0000269|PubMed:16049287,
CC       ECO:0000269|PubMed:16814944, ECO:0000269|PubMed:16914178}.
CC   -!- SUBUNIT: A heterodimeric complex, composed of a mucin-4 alpha chain and
CC       a cysteine-rich transmembrane mucin-4 beta chain. Mucin-4 beta chain
CC       interacts with ERBB2 via the EGF-like domain 1. In nonpolarized cells,
CC       associates with ERBB2 and ERBB3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}. Secreted {ECO:0000269|PubMed:12102554}.
CC       Note=Isoforms lacking the Cys-rich region, EGF-like domains and
CC       transmembrane region are secreted. Secretion occurs by splicing or
CC       proteolytic processing.
CC   -!- SUBCELLULAR LOCATION: [Mucin-4 beta chain]: Cell membrane; Single-pass
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Mucin-4 alpha chain]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell membrane; Single-pass membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 11]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform 15]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform 17]: Cell membrane; Single-pass membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=14;
CC         Comment=Additional isoforms exist.;
CC       Name=1;
CC         IsoId=Q99102-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sv12, Sv13;
CC         IsoId=Q99102-2; Sequence=VSP_022658, VSP_022659;
CC       Name=3; Synonyms=Sv20;
CC         IsoId=Q99102-3; Sequence=VSP_022674, VSP_022675;
CC       Name=5; Synonyms=Sv18, Sv19;
CC         IsoId=Q99102-5; Sequence=VSP_022661, VSP_022669, VSP_022670;
CC       Name=7; Synonyms=Sv16;
CC         IsoId=Q99102-7; Sequence=VSP_022656, VSP_022665;
CC       Name=8; Synonyms=Sv15;
CC         IsoId=Q99102-8; Sequence=VSP_022657, VSP_022664;
CC       Name=9; Synonyms=Sv11;
CC         IsoId=Q99102-9; Sequence=VSP_022652, VSP_022655;
CC       Name=10; Synonyms=Sv3, Sv17;
CC         IsoId=Q99102-10; Sequence=VSP_022661;
CC       Name=11; Synonyms=Sv2;
CC         IsoId=Q99102-11; Sequence=VSP_022653, VSP_022663;
CC       Name=12; Synonyms=SvX;
CC         IsoId=Q99102-12; Sequence=VSP_022650;
CC       Name=13; Synonyms=SvY;
CC         IsoId=Q99102-13; Sequence=VSP_022651;
CC       Name=15; Synonyms=Sv1;
CC         IsoId=Q99102-15; Sequence=VSP_022654, VSP_022662;
CC       Name=16; Synonyms=Sv6;
CC         IsoId=Q99102-16; Sequence=VSP_022671, VSP_022673;
CC       Name=17; Synonyms=Sv8;
CC         IsoId=Q99102-17; Sequence=VSP_022672;
CC   -!- TISSUE SPECIFICITY: Expressed in the thymus, thyroid, lung, trachea,
CC       esophagus, stomach, small intestine, colon, testis, prostate, ovary,
CC       uterus, placenta, and mammary and salivary glands. Expressed in
CC       carcinomas arising from some of these epithelia, such as lung cancers,
CC       squamous cell carcinomas of the upper aerodigestive tract, mammary
CC       carcinomas, biliary tract, colon, and cervix cancers. Minimally or not
CC       expressed in the normal pancreas or chronic pancreatitis, but is highly
CC       expressed in pancreatic tumors and pancreatic tumor cell lines.
CC       {ECO:0000269|PubMed:10024507, ECO:0000269|PubMed:10880978,
CC       ECO:0000269|PubMed:10920259, ECO:0000269|PubMed:16814944}.
CC   -!- DEVELOPMENTAL STAGE: Expressed early in the primitive gut before
CC       respiratory and digestive epithelial cells have acquired their tissue
CC       and cell specificity. Expressed at the basal surface of the epithelium
CC       from week 14 to 26 weeks and then predominantly localized in only
CC       parietal cells. Immediately before birth, found in the cytoplasm of the
CC       mucous columnar epithelial cells. In the embryo expressed in skin, then
CC       disappears late in gestation. {ECO:0000269|PubMed:16914178}.
CC   -!- PTM: Proteolytically cleaved into 2 chains, mucin-4 alpha chain and
CC       mucin-4 beta chain.
CC   -!- PTM: mucrnin-4 alpha chain is highly O-glycosylated.
CC       {ECO:0000269|PubMed:18780401}.
CC   -!- PTM: mucin-4 beta chain is predominantly N-glycosylated.
CC       {ECO:0000269|PubMed:18780401}.
CC   -!- MISCELLANEOUS: Expression is a very useful predictor of poor prognosis
CC       in patients with invasive ductal carcinoma and intrahepatic
CC       cholangiocarcinoma, mass forming type (IDC,ICC-MF). Patients with IDC
CC       or ICC-MF who have high MUC4 expression had a worse survival rate than
CC       those with low MUC4 expression.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 7]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 8]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 9]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 11]: May be produced at very low levels due to
CC       a premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 12]: May be preferentially expressed in tumor
CC       tissues. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 13]: May be preferentially expressed in tumor
CC       tissues. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 15]: May be produced at very low levels due to
CC       a premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 16]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 17]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA63230.1; Type=Miscellaneous discrepancy; Note=May be derived from an intron translation.; Evidence={ECO:0000305};
CC       Sequence=CAC14139.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAC14141.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mucin database;
CC       URL="http://www.medkem.gu.se/mucinbiology/databases/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MUC4ID41459ch3q29.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ242541; CAB85597.1; -; mRNA.
DR   EMBL; AJ242542; CAB85598.1; -; mRNA.
DR   EMBL; AJ242543; CAB85599.1; -; mRNA.
DR   EMBL; AJ242544; CAB85600.1; -; mRNA.
DR   EMBL; AJ242545; CAB85601.1; -; mRNA.
DR   EMBL; AJ242546; CAB85602.1; -; mRNA.
DR   EMBL; AJ242547; CAB85603.1; -; mRNA.
DR   EMBL; AJ242548; CAB85604.1; -; mRNA.
DR   EMBL; AJ242549; CAB85605.1; -; mRNA.
DR   EMBL; AJ242550; CAB85606.1; -; mRNA.
DR   EMBL; AJ276359; CAB81773.1; -; mRNA.
DR   EMBL; AJ277412; CAC10061.1; -; mRNA.
DR   EMBL; AJ277505; CAC14585.1; -; mRNA.
DR   EMBL; AJ400633; CAC10062.1; -; mRNA.
DR   EMBL; AJ400849; CAC14134.1; -; mRNA.
DR   EMBL; AJ400850; CAC14135.1; -; mRNA.
DR   EMBL; AJ400851; CAC14136.1; -; mRNA.
DR   EMBL; AJ400852; CAC14137.1; -; mRNA.
DR   EMBL; AJ400855; CAC14140.1; -; mRNA.
DR   EMBL; AJ400853; CAC14138.1; -; mRNA.
DR   EMBL; AJ400854; CAC14139.1; ALT_FRAME; mRNA.
DR   EMBL; AJ400856; CAC14141.1; ALT_FRAME; mRNA.
DR   EMBL; AJ400857; CAC14142.1; -; mRNA.
DR   EMBL; AJ400858; CAC14143.1; -; mRNA.
DR   EMBL; AF522055; AAM66747.1; -; Genomic_DNA.
DR   EMBL; AF522031; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522032; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522033; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522034; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522035; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522036; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522037; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522038; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522039; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522040; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522041; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522042; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522043; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522044; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522045; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522046; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522047; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522048; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522049; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522050; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522051; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522052; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522053; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522054; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010901; CAB38059.1; -; mRNA.
DR   EMBL; AJ430032; CAD22550.1; -; Genomic_DNA.
DR   EMBL; AJ430033; CAD22550.1; JOINED; Genomic_DNA.
DR   EMBL; AJ430034; CAD22550.1; JOINED; Genomic_DNA.
DR   EMBL; M64594; AAA63230.1; ALT_SEQ; mRNA.
DR   EMBL; AC069513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3310.1; -. [Q99102-13]
DR   CCDS; CCDS3311.1; -. [Q99102-12]
DR   PIR; PN0012; PN0012.
DR   RefSeq; NP_004523.3; NM_004532.5. [Q99102-13]
DR   RefSeq; NP_060876.5; NM_018406.6.
DR   RefSeq; NP_612154.2; NM_138297.4. [Q99102-12]
DR   SMR; Q99102; -.
DR   BioGrid; 110672; 7.
DR   IntAct; Q99102; 1.
DR   STRING; 9606.ENSP00000417498; -.
DR   GlyConnect; 374; -.
DR   iPTMnet; Q99102; -.
DR   PhosphoSitePlus; Q99102; -.
DR   UniCarbKB; Q99102; -.
DR   BioMuta; MUC4; -.
DR   DMDM; 338817990; -.
DR   jPOST; Q99102; -.
DR   MassIVE; Q99102; -.
DR   MaxQB; Q99102; -.
DR   PaxDb; Q99102; -.
DR   PeptideAtlas; Q99102; -.
DR   PRIDE; Q99102; -.
DR   ProteomicsDB; 78234; -. [Q99102-1]
DR   ProteomicsDB; 78235; -. [Q99102-10]
DR   ProteomicsDB; 78236; -. [Q99102-11]
DR   ProteomicsDB; 78237; -. [Q99102-12]
DR   ProteomicsDB; 78238; -. [Q99102-13]
DR   ProteomicsDB; 78239; -. [Q99102-15]
DR   ProteomicsDB; 78240; -. [Q99102-16]
DR   ProteomicsDB; 78241; -. [Q99102-17]
DR   ProteomicsDB; 78242; -. [Q99102-2]
DR   ProteomicsDB; 78243; -. [Q99102-3]
DR   ProteomicsDB; 78244; -. [Q99102-5]
DR   ProteomicsDB; 78245; -. [Q99102-7]
DR   ProteomicsDB; 78246; -. [Q99102-8]
DR   ProteomicsDB; 78247; -. [Q99102-9]
DR   TopDownProteomics; Q99102-3; -. [Q99102-3]
DR   Antibodypedia; 1457; 336 antibodies.
DR   Ensembl; ENST00000346145; ENSP00000304207; ENSG00000145113. [Q99102-13]
DR   Ensembl; ENST00000349607; ENSP00000338109; ENSG00000145113. [Q99102-12]
DR   GeneID; 4585; -.
DR   KEGG; hsa:4585; -.
DR   UCSC; uc003fvo.5; human. [Q99102-1]
DR   CTD; 4585; -.
DR   DisGeNET; 4585; -.
DR   GeneCards; MUC4; -.
DR   HGNC; HGNC:7514; MUC4.
DR   HPA; ENSG00000145113; Tissue enhanced (intestine, lymphoid tissue).
DR   MIM; 158372; gene.
DR   neXtProt; NX_Q99102; -.
DR   OpenTargets; ENSG00000145113; -.
DR   PharmGKB; PA31319; -.
DR   eggNOG; ENOG410IHUZ; Eukaryota.
DR   eggNOG; ENOG4111F6U; LUCA.
DR   GeneTree; ENSGT00730000110943; -.
DR   HOGENOM; CLU_001484_0_0_1; -.
DR   InParanoid; Q99102; -.
DR   KO; K22017; -.
DR   OrthoDB; 668024at2759; -.
DR   Reactome; R-HSA-5083625; Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC).
DR   Reactome; R-HSA-5083632; Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS).
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes colorectal cancer 1 (CRCS1).
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   SIGNOR; Q99102; -.
DR   ChiTaRS; MUC4; human.
DR   GeneWiki; MUC4; -.
DR   GenomeRNAi; 4585; -.
DR   Pharos; Q99102; Tbio.
DR   PRO; PR:Q99102; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q99102; protein.
DR   Bgee; ENSG00000145113; Expressed in nasal cavity epithelium and 133 other tissues.
DR   ExpressionAtlas; Q99102; baseline and differential.
DR   Genevisible; Q99102; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; NAS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; TAS:ProtInc.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IEA:InterPro.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR039898; Mucin_4.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   PANTHER; PTHR13802:SF53; PTHR13802:SF53; 1.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..2169
FT                   /note="Mucin-4"
FT                   /id="PRO_0000158956"
FT   CHAIN           29..1444
FT                   /note="Mucin-4 alpha chain"
FT                   /id="PRO_0000274225"
FT   CHAIN           1445..2169
FT                   /note="Mucin-4 beta chain"
FT                   /id="PRO_0000274226"
FT   TRANSMEM        2126..2146
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1154..1309
FT                   /note="NIDO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00570"
FT   DOMAIN          1310..1425
FT                   /note="AMOP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00347"
FT   DOMAIN          1438..1673
FT                   /note="VWFD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00580"
FT   DOMAIN          1875..1914
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          2078..2117
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          1002..1038
FT                   /note="Repeat"
FT   COMPBIAS        793..1013
FT                   /note="Ser-rich"
FT   SITE            1444..1445
FT                   /note="Cleavage"
FT   CARBOHYD        161
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        235
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        260
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        622
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1472
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1525
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1544
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1553
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1588
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1609
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1632
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1659
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1685
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1703
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1739
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1754
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1802
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1809
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401"
FT   CARBOHYD        1857
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1876
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1942
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1949
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2049
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        1879..1890
FT                   /evidence="ECO:0000250"
FT   DISULFID        1884..1902
FT                   /evidence="ECO:0000250"
FT   DISULFID        1904..1913
FT                   /evidence="ECO:0000250"
FT   DISULFID        2081..2092
FT                   /evidence="ECO:0000250"
FT   DISULFID        2086..2101
FT                   /evidence="ECO:0000250"
FT   DISULFID        2103..2116
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         29..1072
FT                   /note="Missing (in isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:10880978"
FT                   /id="VSP_022650"
FT   VAR_SEQ         29..1021
FT                   /note="Missing (in isoform 13)"
FT                   /evidence="ECO:0000303|PubMed:10880978"
FT                   /id="VSP_022651"
FT   VAR_SEQ         1071..1107
FT                   /note="RGVSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPL -> SPLWGRRRGPG
FT                   VRQEDRGLHLPTLQAGDWLPP (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022652"
FT   VAR_SEQ         1073..1187
FT                   /note="VSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPLGSSLRDSLYFTDNGQII
FT                   FPESDYQIFSYPNPLPTGFTGRDPVALVAPFWDDADFSTGRGTTFYQEYETFYGEHSLL
FT                   VQQA -> EAIQEFPSSPMGQTPGTWSSSGGPWTSPPHSSSRRLASPLAPLSVIPSTSQ
FT                   TMARSSSQSQTTRFSPTPTHSQQASQAGTLWPWWLRSGTMLTSPLVGGPHFIRNTRRSM
FT                   VNTAC (in isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022653"
FT   VAR_SEQ         1073..1177
FT                   /note="VSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPLGSSLRDSLYFTDNGQII
FT                   FPESDYQIFSYPNPLPTGFTGRDPVALVAPFWDDADFSTGRGTTFYQEYETFY -> AI
FT                   QEFPSSPMGQTPGTWSSSGGPWTSPPHSSSRRLASPLAPLSVIPSTSQTMARSSSQSQT
FT                   TRFSPTPTHSQQASQAGTLWPWWLRSGTMLTSPLVGGPHFIRL (in isoform
FT                   15)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022654"
FT   VAR_SEQ         1108..2169
FT                   /note="Missing (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022655"
FT   VAR_SEQ         1117..1201
FT                   /note="FTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWDDADFSTGRGTT
FT                   FYQEYETFYGEHSLLVQQAESWIRKMTNNGGYK -> ASQAGTLWPWWLRSGTMLTSPL
FT                   VGGPHFIRATPTKPSSPRTGAGPMPCFSTRAVGCSGTWPSAQWRWLFRKQPTDVPASVG
FT                   EVSP (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022656"
FT   VAR_SEQ         1117..1199
FT                   /note="FTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWDDADFSTGRGTT
FT                   FYQEYETFYGEHSLLVQQAESWIRKMTNNGG -> ASQAGTLWPWWLRSGTMLTSPLVG
FT                   GPHFIRATPTKPSSPRTGAGPMPCFSTRAVGCSGTWPSAQASRCSWASLVEMAFSKTAH
FT                   (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022657"
FT   VAR_SEQ         1117..1157
FT                   /note="FTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWD -> ASQAGTL
FT                   WPWWLRSGTMLTSPLVGGPHFIRNTRRSMVNTAC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022658"
FT   VAR_SEQ         1158..2169
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022659"
FT   VAR_SEQ         1172..1223
FT                   /note="Missing (in isoform 5 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022661"
FT   VAR_SEQ         1178..2169
FT                   /note="Missing (in isoform 15)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022662"
FT   VAR_SEQ         1188..2169
FT                   /note="Missing (in isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022663"
FT   VAR_SEQ         1200..2169
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022664"
FT   VAR_SEQ         1202..2169
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022665"
FT   VAR_SEQ         1258..1267
FT                   /note="GNPVLMGFSS -> VEMAFSKTAH (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022669"
FT   VAR_SEQ         1268..2169
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022670"
FT   VAR_SEQ         1336..1384
FT                   /note="VSCPCSWQQGRRDLRFQPVSIGRWGLGSRQLCSFTSWRGGVCCSYGPWG ->
FT                   AAPPRLAQPRPPTSSPLRLSTAPAAWAPSRSNGSLSLTTQSVSCWITRL (in
FT                   isoform 16)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022671"
FT   VAR_SEQ         1354..1579
FT                   /note="Missing (in isoform 17)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022672"
FT   VAR_SEQ         1385..2169
FT                   /note="Missing (in isoform 16)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022673"
FT   VAR_SEQ         1814..1827
FT                   /note="VAGCKCDGGTFGRY -> LWGALSCVRTSPAL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022674"
FT   VAR_SEQ         1828..2169
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10920259"
FT                   /id="VSP_022675"
FT   VARIANT         37
FT                   /note="G -> D (in dbSNP:rs2259292)"
FT                   /id="VAR_030211"
FT   VARIANT         41
FT                   /note="A -> P (in dbSNP:rs3107764)"
FT                   /evidence="ECO:0000269|PubMed:10920259,
FT                   ECO:0000269|PubMed:12084055"
FT                   /id="VAR_065261"
FT   VARIANT         161
FT                   /note="T -> A (in dbSNP:rs2293232)"
FT                   /id="VAR_030212"
FT   VARIANT         585
FT                   /note="S -> A (in dbSNP:rs2246901)"
FT                   /id="VAR_030213"
FT   VARIANT         721
FT                   /note="A -> T (in dbSNP:rs3749331)"
FT                   /id="VAR_056585"
FT   VARIANT         1081
FT                   /note="G -> D (in dbSNP:rs2259292)"
FT                   /evidence="ECO:0000269|PubMed:10024507,
FT                   ECO:0000269|PubMed:10880978, ECO:0000269|PubMed:10920259,
FT                   ECO:0000269|PubMed:12084055, ECO:0000269|PubMed:12153560"
FT                   /id="VAR_065262"
FT   VARIANT         1205
FT                   /note="A -> T (in dbSNP:rs2293232)"
FT                   /id="VAR_056586"
FT   VARIANT         1578
FT                   /note="A -> S (in dbSNP:rs2246901)"
FT                   /evidence="ECO:0000269|PubMed:12084055"
FT                   /id="VAR_056587"
FT   CONFLICT        1194
FT                   /note="M -> I (in Ref. 1; CAB85602/CAB85603/CAB85604/
FT                   CAB85605/CAB85606, 2; CAB81773/CAC14141/CAC14142/CAC14143,
FT                   3; AAM66747, 4; CAD22550 and 5; CAB38059)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1259
FT                   /note="N -> K (in Ref. 2; CAB81773/CAC14143/CAC10061 and 3;
FT                   AAM66747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1271
FT                   /note="Y -> F (in Ref. 2; CAB81773/CAC14143/CAC10061 and 3;
FT                   AAM66747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1305
FT                   /note="R -> G (in Ref. 2; CAB81773/CAC14143/CAC10061 and 3;
FT                   AAM66747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1557
FT                   /note="V -> A (in Ref. 2; CAB81773/CAC14143/CAC10061 and 3;
FT                   AAM66747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1920..1921
FT                   /note="Missing (in Ref. 2; CAC14143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2039
FT                   /note="G -> E (in Ref. 1; CAB85604/CAB85605/CAB85606, 4;
FT                   CAD22550 and 5; CAB38059)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2169 AA;  231518 MW;  53615AF8DD416957 CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT AAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METVTQETAP
     PDEMTTSFPS SVTNTLMMTS KTITMTTSTD STLGNTEETS TAGTESSTPV TSAVSITAGQ
     EGQSRTTSWR TSIQDTSASS QNHWTRSTQT TRESQTSTLT HRTTSTPSFS PSVHNVTGTV
     SQKTSPSGET ATSSLCSVTN TSMMTSEKIT VTTSTGSTLG NPGETSSVPV TGSLMPVTSA
     ALVTVDPEGQ SPATFSRTST QDTTAFSKNH QTQSVETTRV SQINTLNTLT PVTTSTVLSS
     PSGFNPSGTV SQETFPSGET TISSPSSVSN TFLVTSKVFR MPISRDSTLG NTEETSLSVS
     GTISAITSKV STIWWSDTLS TALSPSSLPP KISTAFHTQQ SEGAETTGRP HERSSFSPGV
     SQEIFTLHET TTWPSSFSSK GHTTWSQTEL PSTSTGAATR LVTGNPSTRA AGTIPRVPSK
     VSAIGEPGEP TTYSSHSTTL PKTTGAGAQT QWTQETGTTG EALLSSPSYS VIQMIKTATS
     PSSSPMLDRH TSQQITTAPS TNHSTIHSTS TSPQESPAVS QRGHTRAPQT TQESQTTRSV
     SPMTDTKTVT TPGSSFTASG HSPSEIVPQD APTISAATTF APAPTGNGHT TQAPTTALQA
     APSSHDATLG PSGGTSLSKT GALTLANSVV STPGGPEGQW TSASASTSPD TAAAMTHTHQ
     AESTEASGQT QTSEPASSGS RTTSAGTATP SSSGASGTTP SGSEGISTSG ETTRFSSNPS
     RDSHTTQSTT ELLSASASHG AIPVSTGMAS SIVPGTFHPT LSEASTAGRP TGQSSPTSPS
     ASPQETAAIS RMAQTQRTGT SRGSDTISLA SQATDTFSTV PPTPPSITSS GLTSPQTQTH
     TLSPSGSGKT FTTALISNAT PLPVTSTSSA STGHATPLAV SSATSASTVS SDSPLKMETS
     GMTTPSLKTD GGRRTATSPP PTTSQTIIST IPSTAMHTRS TAAPIPILPE RGVSLFPYGA
     GAGDLEFVRR TVDFTSPLFK PATGFPLGSS LRDSLYFTDN GQIIFPESDY QIFSYPNPLP
     TGFTGRDPVA LVAPFWDDAD FSTGRGTTFY QEYETFYGEH SLLVQQAESW IRKMTNNGGY
     KARWALKVTW VNAHAYPAQW TLGSNTYQAI LSTDGSRSYA LFLYQSGGMQ WDVAQRSGNP
     VLMGFSSGDG YFENSPLMSQ PVWERYRPDR FLNSNSGLQG LQFYRLHREE RPNYRLECLQ
     WLKSQPRWPS WGWNQVSCPC SWQQGRRDLR FQPVSIGRWG LGSRQLCSFT SWRGGVCCSY
     GPWGEFREGW HVQRPWQLAQ ELEPQSWCCR WNDKPYLCAL YQQRRPHVGC ATYRPPQPAW
     MFGDPHITTL DGVSYTFNGL GDFLLVGAQD GNSSFLLQGR TAQTGSAQAT NFIAFAAQYR
     SSSLGPVTVQ WLLEPHDAIR VLLDNQTVTF QPDHEDGGGQ ETFNATGVLL SRNGSEVSAS
     FDGWATVSVI ALSNILHASA SLPPEYQNRT EGLLGVWNNN PEDDFRMPNG STIPPGSPEE
     MLFHFGMTWQ INGTGLLGKR NDQLPSNFTP VFYSQLQKNS SWAEHLISNC DGDSSCIYDT
     LALRNASIGL HTREVSKNYE QANATLNQYP PSINGGRVIE AYKGQTTLIQ YTSNAEDANF
     TLRDSCTDLE LFENGTLLWT PKSLEPFTLE ILARSAKIGL ASALQPRTVV CHCNAESQCL
     YNQTSRVGNS SLEVAGCKCD GGTFGRYCEG SEDACEEPCF PSVHCVPGKG CEACPPNLTG
     DGRHCAALGS SFLCQNQSCP VNYCYNQGHC YISQTLGCQP MCTCPPAFTD SRCFLAGNNF
     SPTVNLELPL RVIQLLLSEE ENASMAEVNA SVAYRLGTLD MRAFLRNSQV ERIDSAAPAS
     GSPIQHWMVI SEFQYRPRGP VIDFLNNQLL AAVVEAFLYH VPRRSEEPRN DVVFQPISGE
     DVRDVTALNV STLKAYFRCD GYKGYDLVYS PQSGFTCVSP CSRGYCDHGG QCQHLPSGPR
     CSCVSFSIYT AWGEHCEHLS MKLDAFFGIF FGALGGLLLL GVGTFVVLRF WGCSGARFSY
     FLNSAEALP
//
ID   SETB1_HUMAN             Reviewed;        1291 AA.
AC   Q15047; A6NEW2; Q5SZD8; Q5SZD9; Q5SZE0; Q5SZE7; Q96GM9;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 214.
DE   RecName: Full=Histone-lysine N-methyltransferase SETDB1 {ECO:0000305};
DE            EC=2.1.1.- {ECO:0000269|PubMed:14536086};
DE   AltName: Full=ERG-associated protein with SET domain;
DE            Short=ESET {ECO:0000303|PubMed:14536086};
DE   AltName: Full=Histone H3-K9 methyltransferase 4;
DE            Short=H3-K9-HMTase 4;
DE   AltName: Full=Lysine N-methyltransferase 1E;
DE   AltName: Full=SET domain bifurcated 1;
GN   Name=SETDB1 {ECO:0000312|HGNC:HGNC:10761};
GN   Synonyms=ESET {ECO:0000303|PubMed:14536086}, KIAA0067, KMT1E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S., Seki N.,
RA   Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II. The
RT   coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT
RP   SER-506.
RC   TISSUE=Muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CHARACTERIZATION, MUTAGENESIS OF 729-CYS--CYS-731; HIS-1224; CYS-1226 AND
RP   CYS-1279, AND INTERACTION WITH TRIM28.
RX   PubMed=11959841; DOI=10.1101/gad.973302;
RA   Schultz D.C., Ayyanathan K., Negorev D., Maul G.G., Rauscher F.J. III;
RT   "SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific
RT   methyltransferase that contributes to HP1-mediated silencing of euchromatic
RT   genes by KRAB zinc-finger proteins.";
RL   Genes Dev. 16:919-932(2002).
RN   [6]
RP   FUNCTION.
RX   PubMed=12869583; DOI=10.1101/gad.1102803;
RA   Ayyanathan K., Lechner M.S., Bell P., Maul G.G., Schultz D.C., Yamada Y.,
RA   Tanaka K., Torigoe K., Rauscher F.J. III;
RT   "Regulated recruitment of HP1 to a euchromatic gene induces mitotically
RT   heritable, epigenetic gene silencing: a mammalian cell culture model of
RT   gene variegation.";
RL   Genes Dev. 17:1855-1869(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH ATF7IP,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND CATALYTIC ACTIVITY.
RX   PubMed=14536086; DOI=10.1016/j.molcel.2003.08.007;
RA   Wang H., An W., Cao R., Xia L., Erdjument-Bromage H., Chatton B.,
RA   Tempst P., Roeder R.G., Zhang Y.;
RT   "mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of
RT   histone H3 to cause transcriptional repression.";
RL   Mol. Cell 12:475-487(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MBD1 AND CHAF1A.
RX   PubMed=15327775; DOI=10.1016/j.molcel.2004.06.043;
RA   Sarraf S.A., Stancheva I.;
RT   "Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9
RT   by SETDB1 to DNA replication and chromatin assembly.";
RL   Mol. Cell 15:595-605(2004).
RN   [9]
RP   INTERACTION WITH CBX1 AND CBX5.
RX   PubMed=15899859; DOI=10.1128/mcb.25.11.4552-4564.2005;
RA   Verschure P.J., van der Kraan I., de Leeuw W., van der Vlag J.,
RA   Carpenter A.E., Belmont A.S., van Driel R.;
RT   "In vivo HP1 targeting causes large-scale chromatin condensation and
RT   enhanced histone lysine methylation.";
RL   Mol. Cell. Biol. 25:4552-4564(2005).
RN   [10]
RP   INTERACTION WITH MBD1.
RX   PubMed=17066076; DOI=10.1038/sj.emboj.7601404;
RA   Lyst M.J., Nan X., Stancheva I.;
RT   "Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS
RT   proteins.";
RL   EMBO J. 25:5317-5328(2006).
RN   [11]
RP   INTERACTION WITH ATF7IP AND ATF7IP2.
RX   PubMed=15691849; DOI=10.1074/jbc.m413654200;
RA   Ichimura T., Watanabe S., Sakamoto Y., Aoto T., Fujita N., Nakao M.;
RT   "Transcriptional repression and heterochromatin formation by MBD1 and
RT   MCAF/AM family proteins.";
RL   J. Biol. Chem. 280:13928-13935(2005).
RN   [12]
RP   INTERACTION WITH DNMT3A AND DNMT3B.
RX   PubMed=16682412; DOI=10.1074/jbc.m513249200;
RA   Li H., Rauch T., Chen Z.-X., Szabo P.E., Riggs A.D., Pfeifer G.P.;
RT   "The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A
RT   interact directly and localize to promoters silenced in cancer cells.";
RL   J. Biol. Chem. 281:19489-19500(2006).
RN   [13]
RP   INTERACTION WITH SUMO2.
RX   PubMed=16567619; DOI=10.1073/pnas.0601066103;
RA   Rosendorff A., Sakakibara S., Lu S., Kieff E., Xuan Y., DiBacco A., Shi Y.,
RA   Shi Y., Gill G.;
RT   "NXP-2 association with SUMO-2 depends on lysines required for
RT   transcriptional repression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5308-5313(2006).
RN   [14]
RP   EXPRESSION IN HUNTINGTON DISEASE.
RX   PubMed=17142323; DOI=10.1073/pnas.0606373103;
RA   Ryu H., Lee J., Hagerty S.W., Soh B.Y., McAlpin S.E., Cormier K.A.,
RA   Smith K.M., Ferrante R.J.;
RT   "ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in
RT   Huntington's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:19176-19181(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH CHD7; NLK1 AND PPARG, PHOSPHORYLATION AT
RP   THR-976, AND MUTAGENESIS OF THR-976.
RX   PubMed=17952062; DOI=10.1038/ncb1647;
RA   Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M.,
RA   Youn M.Y., Takeyama K., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y.,
RA   Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K.,
RA   Kato S.;
RT   "A histone lysine methyltransferase activated by non-canonical Wnt
RT   signalling suppresses PPAR-gamma transactivation.";
RL   Nat. Cell Biol. 9:1273-1285(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1066, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   IDENTIFICATION IN A COMPLEX WITH REST; CDYL; WIZ; EHMT1 AND EHMT2.
RX   PubMed=19061646; DOI=10.1016/j.molcel.2008.10.025;
RA   Mulligan P., Westbrook T.F., Ottinger M., Pavlova N., Chang B., Macia E.,
RA   Shi Y.J., Barretina J., Liu J., Howley P.M., Elledge S.J., Shi Y.;
RT   "CDYL bridges REST and histone methyltransferases for gene repression and
RT   suppression of cellular transformation.";
RL   Mol. Cell 32:718-726(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1066, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   INTERACTION WITH MPHOSPH8.
RX   PubMed=20871592; DOI=10.1038/emboj.2010.239;
RA   Kokura K., Sun L., Bedford M.T., Fang J.;
RT   "Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and
RT   promotes tumour cell motility and invasion.";
RL   EMBO J. 29:3673-3687(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1066, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22939622; DOI=10.1016/j.cell.2012.06.048;
RA   Pinheiro I., Margueron R., Shukeir N., Eisold M., Fritzsch C.,
RA   Richter F.M., Mittler G., Genoud C., Goyama S., Kurokawa M., Son J.,
RA   Reinberg D., Lachner M., Jenuwein T.;
RT   "Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian
RT   heterochromatin integrity.";
RL   Cell 150:948-960(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1025 AND SER-1066, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   FUNCTION, POSSIBLE IDENTIFICATION IN A COREPRESSOR COMPLEX, AND
RP   CHROMATIN-BINDING.
RX   PubMed=24623306; DOI=10.7554/elife.02313;
RA   Serra R.W., Fang M., Park S.M., Hutchinson L., Green M.R.;
RT   "A KRAS-directed transcriptional silencing pathway that mediates the CpG
RT   island methylator phenotype.";
RL   Elife 3:E02313-E02313(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-1170 AND LYS-1178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1032 AND LYS-1069, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1032, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1032 AND LYS-1069, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1032 AND LYS-1069, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [31]
RP   FUNCTION, INTERACTION WITH ATRX, AND FORMATION OF A COMPLEX WITH ATRX;
RP   TRIM28 AND ZNF274.
RX   PubMed=27029610; DOI=10.1080/15592294.2016.1169351;
RA   Valle-Garcia D., Qadeer Z.A., McHugh D.S., Ghiraldini F.G., Chowdhury A.H.,
RA   Hasson D., Dyer M.A., Recillas-Targa F., Bernstein E.;
RT   "ATRX binds to atypical chromatin domains at the 3' exons of zinc finger
RT   genes to preserve H3K9me3 enrichment.";
RL   Epigenetics 11:398-414(2016).
RN   [32]
RP   FUNCTION, INTERACTION WITH ATF7IP, DEGRADATION, AND SUBCELLULAR LOCATION.
RX   PubMed=27732843; DOI=10.1016/j.celrep.2016.09.050;
RA   Timms R.T., Tchasovnikarova I.A., Antrobus R., Dougan G., Lehner P.J.;
RT   "ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is
RT   Essential for Heterochromatin Formation by the HUSH Complex.";
RL   Cell Rep. 17:653-659(2016).
RN   [33]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182; LYS-1032; LYS-1038; LYS-1069
RP   AND LYS-1149, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [34]
RP   INTERACTION WITH ZNF638.
RX   PubMed=30487602; DOI=10.1038/s41586-018-0750-6;
RA   Zhu Y., Wang G.Z., Cingoez O., Goff S.P.;
RT   "NP220 mediates silencing of unintegrated retroviral DNA.";
RL   Nature 564:278-282(2018).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 196-402.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of Tudor domain of human histone-lysine N-
RT   methyltransferase SETDB1.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Histone methyltransferase that specifically trimethylates
CC       'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific
CC       tag for epigenetic transcriptional repression by recruiting HP1 (CBX1,
CC       CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in
CC       euchromatin regions, thereby playing a central role in the silencing of
CC       euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA
CC       methylation (PubMed:12869583, PubMed:17952062). Required for HUSH-
CC       mediated heterochromatin formation and gene silencing. Forms a complex
CC       with MBD1 and ATF7IP that represses transcription and couples DNA
CC       methylation and histone 'Lys-9' trimethylation (PubMed:27732843,
CC       PubMed:14536086). Its activity is dependent on MBD1 and is heritably
CC       maintained through DNA replication by being recruited by CAF-1
CC       (PubMed:14536086, PubMed:15327775). SETDB1 is targeted to histone H3 by
CC       TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably
CC       forms a corepressor complex required for activated KRAS-mediated
CC       promoter hypermethylation and transcriptional silencing of tumor
CC       suppressor genes (TSGs) or other tumor-related genes in colorectal
CC       cancer (CRC) cells (PubMed:24623306). Required to maintain a
CC       transcriptionally repressive state of genes in undifferentiated
CC       embryonic stem cells (ESCs) (PubMed:24623306). In ESCs, in
CC       collaboration with TRIM28, is also required for H3K9me3 and silencing
CC       of endogenous and introduced retroviruses in a DNA-methylation
CC       independent-pathway (By similarity). Associates at promoter regions of
CC       tumor suppressor genes (TSGs) leading to their gene silencing
CC       (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in
CC       recruiting ATRX to the 3'-exons of zinc-finger coding genes with
CC       atypical chromatin signatures to establish or maintain/protect H3K9me3
CC       at these transcriptionally active regions (PubMed:27029610).
CC       {ECO:0000250|UniProtKB:O88974, ECO:0000269|PubMed:12869583,
CC       ECO:0000269|PubMed:14536086, ECO:0000269|PubMed:15327775,
CC       ECO:0000269|PubMed:17952062, ECO:0000269|PubMed:24623306,
CC       ECO:0000269|PubMed:27029610, ECO:0000269|PubMed:27732843}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6),N(6)-dimethyl-L-lysyl(9)-[histone H3] + S-adenosyl-L-
CC         methionine = H(+) + N(6),N(6),N(6)-trimethyl-L-lysyl(9)-[histone H3]
CC         + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:60288, Rhea:RHEA-
CC         COMP:15538, Rhea:RHEA-COMP:15541, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961,
CC         ChEBI:CHEBI:61976; Evidence={ECO:0000255|PROSITE-ProRule:PRU00906,
CC         ECO:0000269|PubMed:14536086};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60289;
CC         Evidence={ECO:0000269|PubMed:14536086};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.78 uM for S-adenosyl-L-methionine {ECO:0000269|PubMed:14536086};
CC   -!- SUBUNIT: Part of a complex containing at least CDYL, REST, WIZ, SETDB1,
CC       EHMT1 and EHMT2 (PubMed:19061646). During DNA replication, it is
CC       recruited by SETDB1 to form a S phase-specific complex that facilitates
CC       methylation of H3 'Lys-9' during replication-coupled chromatin assembly
CC       and is at least composed of the CAF-1 subunit CHAF1A, MBD1 and SETDB1
CC       (PubMed:15327775). Probably part of a corepressor complex containing
CC       ZNF304, TRIM28, SETDB1 and DNMT1 (PubMed:24623306). Interacts with
CC       TRIM28/TIF1B (PubMed:11959841). Interacts with ATF7IP and ATF7IP2; the
CC       interaction with ATF7IP protects SETDB1 from proteasomal degradation
CC       and is required to stimulate histone methyltransferase activity and
CC       facilitate the conversion of dimethylated to trimethylated H3 'Lys-9'
CC       (PubMed:14536086, PubMed:15691849). Interacts with MBD1; interaction is
CC       abolished when MBD1 is sumoylated (PubMed:15327775, PubMed:17066076).
CC       Interacts with CBX1 and CBX5 (PubMed:15899859). Interacts with DNMT3A
CC       and DNMT3B (PubMed:16682412). Interacts with SUMO2. Interacts with
CC       CHD7, NLK1 and PPARG (PubMed:17952062). Interacts with MPHOSPH8
CC       (PubMed:20871592). Interacts with ERG (By similarity). Interacts with
CC       HDAC1, HDAC2, SIN3A and SIN3B (By similarity). Interacts with ATRX.
CC       Forms a complex with ATRX, TRIM28 and ZNF274 (PubMed:27029610).
CC       Interacts with RESF1 (By similarity). Interacts with ZNF638
CC       (PubMed:30487602). {ECO:0000250|UniProtKB:O88974,
CC       ECO:0000269|PubMed:11959841, ECO:0000269|PubMed:14536086,
CC       ECO:0000269|PubMed:15327775, ECO:0000269|PubMed:15691849,
CC       ECO:0000269|PubMed:15899859, ECO:0000269|PubMed:16567619,
CC       ECO:0000269|PubMed:16682412, ECO:0000269|PubMed:17066076,
CC       ECO:0000269|PubMed:17952062, ECO:0000269|PubMed:19061646,
CC       ECO:0000269|PubMed:20871592, ECO:0000269|PubMed:24623306,
CC       ECO:0000269|PubMed:27029610, ECO:0000269|PubMed:30487602}.
CC   -!- INTERACTION:
CC       Q15047; P31749: AKT1; NbExp=9; IntAct=EBI-79691, EBI-296087;
CC       Q15047; Q6P1J9: CDC73; NbExp=3; IntAct=EBI-79691, EBI-930143;
CC       Q15047; Q9Y6K1: DNMT3A; NbExp=7; IntAct=EBI-79691, EBI-923653;
CC       Q15047-3; O75031: HSF2BP; NbExp=3; IntAct=EBI-11149962, EBI-7116203;
CC       Q15047; Q9UIS9: MBD1; NbExp=3; IntAct=EBI-79691, EBI-867196;
CC       Q15047; Q99549: MPHOSPH8; NbExp=3; IntAct=EBI-79691, EBI-2653928;
CC       Q15047-3; Q15654: TRIP6; NbExp=3; IntAct=EBI-11149962, EBI-742327;
CC       Q15047-2; Q8IUH5: ZDHHC17; NbExp=3; IntAct=EBI-9090795, EBI-524753;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27732843}. Cytoplasm
CC       {ECO:0000269|PubMed:27732843}. Chromosome. Note=Associated with non-
CC       pericentromeric regions of chromatin. Excluded from nucleoli and
CC       islands of condensed chromatin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15047-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15047-2; Sequence=VSP_002217, VSP_002218;
CC       Name=3;
CC         IsoId=Q15047-3; Sequence=VSP_034600;
CC   -!- TISSUE SPECIFICITY: Widely expressed. High expression in testis.
CC   -!- DOMAIN: The pre-SET, SET and post-SET domains are all required for
CC       methyltransferase activity. The 347-amino-acid insertion in the SET
CC       domain has no effect on the catalytic activity.
CC   -!- DOMAIN: Isoform 2 lacks all domains required for histone
CC       methyltransferase activity.
CC   -!- DOMAIN: In the pre-SET domain, Cys residues bind 3 zinc ions that are
CC       arranged in a triangular cluster; some of these Cys residues contribute
CC       to the binding of two zinc ions within the cluster. {ECO:0000250}.
CC   -!- PTM: Degraded by the proteasome, shielded by interaction with ATF7IP.
CC       {ECO:0000269|PubMed:27732843}.
CC   -!- MISCELLANEOUS: Highly up-regulated in Huntington disease patients,
CC       suggesting that participates in the altered chromatin modulation and
CC       transcription dysfunction observed in Huntington disease. Its down-
CC       regulation has salubrious effects on patients, suggesting that it may
CC       be a promising treatment in Huntington disease patients.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. Histone-lysine methyltransferase family. Suvar3-9
CC       subfamily. {ECO:0000255|PROSITE-ProRule:PRU00906}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA06689.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D31891; BAA06689.2; ALT_INIT; mRNA.
DR   EMBL; AL590133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53506.1; -; Genomic_DNA.
DR   EMBL; BC009362; AAH09362.1; -; mRNA.
DR   EMBL; BC028671; AAH28671.1; -; mRNA.
DR   CCDS; CCDS44217.1; -. [Q15047-1]
DR   CCDS; CCDS58026.1; -. [Q15047-2]
DR   CCDS; CCDS972.1; -. [Q15047-3]
DR   RefSeq; NP_001138887.1; NM_001145415.1. [Q15047-1]
DR   RefSeq; NP_001230420.1; NM_001243491.1. [Q15047-2]
DR   RefSeq; NP_036564.3; NM_012432.3. [Q15047-3]
DR   RefSeq; XP_016858444.1; XM_017002955.1. [Q15047-2]
DR   PDB; 3DLM; X-ray; 1.77 A; A=196-402.
DR   PDB; 4X3S; X-ray; 1.60 A; C/D=1165-1174.
DR   PDB; 5KCH; X-ray; 1.70 A; A=196-403.
DR   PDB; 5KCO; X-ray; 1.47 A; A=196-403.
DR   PDB; 5KE2; X-ray; 1.56 A; A=196-402.
DR   PDB; 5KE3; X-ray; 1.70 A; A=196-402.
DR   PDB; 5KH6; X-ray; 2.05 A; A=196-400.
DR   PDB; 5QT1; X-ray; 1.58 A; A=196-397.
DR   PDB; 5QT2; X-ray; 1.59 A; A=196-397.
DR   PDB; 6AU2; X-ray; 1.63 A; A=196-402.
DR   PDB; 6AU3; X-ray; 1.80 A; A=196-402.
DR   PDB; 6BHD; X-ray; 1.25 A; A=190-410.
DR   PDB; 6BHE; X-ray; 1.35 A; A=190-410.
DR   PDB; 6BHG; X-ray; 1.45 A; A=190-410.
DR   PDB; 6BHH; X-ray; 1.85 A; A=190-410.
DR   PDB; 6BHI; X-ray; 1.40 A; A=190-410.
DR   PDB; 6BPI; X-ray; 1.64 A; A=196-402.
DR   PDBsum; 3DLM; -.
DR   PDBsum; 4X3S; -.
DR   PDBsum; 5KCH; -.
DR   PDBsum; 5KCO; -.
DR   PDBsum; 5KE2; -.
DR   PDBsum; 5KE3; -.
DR   PDBsum; 5KH6; -.
DR   PDBsum; 5QT1; -.
DR   PDBsum; 5QT2; -.
DR   PDBsum; 6AU2; -.
DR   PDBsum; 6AU3; -.
DR   PDBsum; 6BHD; -.
DR   PDBsum; 6BHE; -.
DR   PDBsum; 6BHG; -.
DR   PDBsum; 6BHH; -.
DR   PDBsum; 6BHI; -.
DR   PDBsum; 6BPI; -.
DR   SMR; Q15047; -.
DR   BioGrid; 115202; 144.
DR   CORUM; Q15047; -.
DR   DIP; DIP-31029N; -.
DR   IntAct; Q15047; 142.
DR   MINT; Q15047; -.
DR   STRING; 9606.ENSP00000271640; -.
DR   BindingDB; Q15047; -.
DR   ChEMBL; CHEMBL2321646; -.
DR   iPTMnet; Q15047; -.
DR   PhosphoSitePlus; Q15047; -.
DR   BioMuta; SETDB1; -.
DR   DMDM; 25091210; -.
DR   EPD; Q15047; -.
DR   jPOST; Q15047; -.
DR   MassIVE; Q15047; -.
DR   MaxQB; Q15047; -.
DR   PaxDb; Q15047; -.
DR   PeptideAtlas; Q15047; -.
DR   PRIDE; Q15047; -.
DR   ProteomicsDB; 60397; -. [Q15047-1]
DR   ProteomicsDB; 60398; -. [Q15047-2]
DR   ProteomicsDB; 60399; -. [Q15047-3]
DR   Antibodypedia; 20300; 380 antibodies.
DR   Ensembl; ENST00000271640; ENSP00000271640; ENSG00000143379. [Q15047-1]
DR   Ensembl; ENST00000368962; ENSP00000357958; ENSG00000143379. [Q15047-2]
DR   Ensembl; ENST00000368969; ENSP00000357965; ENSG00000143379. [Q15047-3]
DR   GeneID; 9869; -.
DR   KEGG; hsa:9869; -.
DR   UCSC; uc001evu.3; human. [Q15047-1]
DR   CTD; 9869; -.
DR   DisGeNET; 9869; -.
DR   GeneCards; SETDB1; -.
DR   HGNC; HGNC:10761; SETDB1.
DR   HPA; ENSG00000143379; Low tissue specificity.
DR   MIM; 604396; gene.
DR   neXtProt; NX_Q15047; -.
DR   OpenTargets; ENSG00000143379; -.
DR   PharmGKB; PA35679; -.
DR   eggNOG; KOG1141; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00940000157471; -.
DR   HOGENOM; CLU_003279_1_0_1; -.
DR   InParanoid; Q15047; -.
DR   KO; K11421; -.
DR   OMA; KNMSGPM; -.
DR   OrthoDB; 183716at2759; -.
DR   PhylomeDB; Q15047; -.
DR   TreeFam; TF106411; -.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   SIGNOR; Q15047; -.
DR   ChiTaRS; SETDB1; human.
DR   EvolutionaryTrace; Q15047; -.
DR   GeneWiki; SETDB1; -.
DR   GenomeRNAi; 9869; -.
DR   Pharos; Q15047; Tbio.
DR   PRO; PR:Q15047; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q15047; protein.
DR   Bgee; ENSG00000143379; Expressed in testis and 214 other tissues.
DR   ExpressionAtlas; Q15047; baseline and differential.
DR   Genevisible; Q15047; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IMP:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IMP:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0046974; F:histone methyltransferase activity (H3-K9 specific); IDA:UniProtKB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0070828; P:heterochromatin organization; IBA:GO_Central.
DR   GO; GO:0051567; P:histone H3-K9 methylation; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; ISS:UniProtKB.
DR   GO; GO:0090309; P:positive regulation of methylation-dependent chromatin silencing; IMP:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0033273; P:response to vitamin; IEA:Ensembl.
DR   InterPro; IPR016177; DNA-bd_dom_sf.
DR   InterPro; IPR040880; DUF5604.
DR   InterPro; IPR025796; Hist-Lys_N-MeTrfase_SETDB1.
DR   InterPro; IPR001739; Methyl_CpG_DNA-bd.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR007728; Pre-SET_dom.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR002999; Tudor.
DR   InterPro; IPR041292; Tudor_4.
DR   InterPro; IPR041291; TUDOR_5.
DR   Pfam; PF18300; DUF5604; 1.
DR   Pfam; PF01429; MBD; 1.
DR   Pfam; PF05033; Pre-SET; 1.
DR   Pfam; PF00856; SET; 1.
DR   Pfam; PF18358; Tudor_4; 1.
DR   Pfam; PF18359; TUDOR_5; 1.
DR   SMART; SM00391; MBD; 1.
DR   SMART; SM00468; PreSET; 1.
DR   SMART; SM00317; SET; 1.
DR   SMART; SM00333; TUDOR; 2.
DR   SUPFAM; SSF54171; SSF54171; 1.
DR   PROSITE; PS50982; MBD; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50867; PRE_SET; 1.
DR   PROSITE; PS51573; SAM_MT43_SUVAR39_1; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator; Chromosome;
KW   Coiled coil; Cytoplasm; Isopeptide bond; Metal-binding; Methylation;
KW   Methyltransferase; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; S-adenosyl-L-methionine;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW   Zinc.
FT   CHAIN           1..1291
FT                   /note="Histone-lysine N-methyltransferase SETDB1"
FT                   /id="PRO_0000186064"
FT   DOMAIN          257..320
FT                   /note="Tudor 1"
FT   DOMAIN          347..403
FT                   /note="Tudor 2"
FT   DOMAIN          594..665
FT                   /note="MBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00338"
FT   DOMAIN          727..800
FT                   /note="Pre-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00157"
FT   DOMAIN          803..1266
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   DOMAIN          1275..1291
FT                   /note="Post-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00155"
FT   REGION          813..815
FT                   /note="S-adenosyl-L-methionine binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1223..1224
FT                   /note="S-adenosyl-L-methionine binding"
FT                   /evidence="ECO:0000250"
FT   COILED          18..64
FT                   /evidence="ECO:0000255"
FT   METAL           729
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           729
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           731
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           735
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           735
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           741
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           743
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           781
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           781
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           785
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           787
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           792
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           1226
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   METAL           1279
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   METAL           1281
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   METAL           1286
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   BINDING         851
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   BINDING         853
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   BINDING         1220
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88974"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88974"
FT   MOD_RES         120
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O88974"
FT   MOD_RES         976
FT                   /note="Phosphothreonine; by NLK"
FT                   /evidence="ECO:0000305|PubMed:17952062"
FT   MOD_RES         1025
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1066
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1170
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         1170
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         1178
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         1178
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        182
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT   CROSSLNK        1032
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        1032
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1038
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1069
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1149
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         381..397
FT                   /note="DDKRCEWIYRGSTRLEP -> VLFFSTILEAEVGGGGT (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_002217"
FT   VAR_SEQ         398..1291
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_002218"
FT   VAR_SEQ         1254
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034600"
FT   VARIANT         236
FT                   /note="N -> S (in dbSNP:rs2271075)"
FT                   /id="VAR_014284"
FT   VARIANT         506
FT                   /note="P -> S (in dbSNP:rs17852587)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031281"
FT   VARIANT         824
FT                   /note="A -> G (in dbSNP:rs2691551)"
FT                   /id="VAR_014286"
FT   VARIANT         824
FT                   /note="A -> P (in dbSNP:rs2814054)"
FT                   /id="VAR_014285"
FT   MUTAGEN         729..731
FT                   /note="CDC->LDP: Abolishes methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:11959841"
FT   MUTAGEN         976
FT                   /note="T->A: Abrogates interaction with CHD7, NLK and
FT                   PPARG. Reduces phosphorylation by NLK. Reduces
FT                   transcriptional repression."
FT                   /evidence="ECO:0000269|PubMed:17952062"
FT   MUTAGEN         1224
FT                   /note="H->K: Abolishes methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:11959841"
FT   MUTAGEN         1226
FT                   /note="C->A: Abolishes methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:11959841"
FT   MUTAGEN         1279
FT                   /note="C->Y: Abolishes methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:11959841"
FT   STRAND          191..195
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          203..207
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          213..224
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          227..237
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          239..242
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   HELIX           244..246
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          247..251
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   HELIX           255..257
FT                   /evidence="ECO:0000244|PDB:6BHE"
FT   STRAND          263..269
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          274..283
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   TURN            287..290
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          293..297
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          302..305
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   HELIX           307..309
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          310..315
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   HELIX           320..323
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   HELIX           327..339
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          353..358
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          361..371
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          374..379
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   TURN            380..383
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          384..389
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   HELIX           396..403
FT                   /evidence="ECO:0000244|PDB:6BHD"
FT   STRAND          1167..1172
FT                   /evidence="ECO:0000244|PDB:4X3S"
SQ   SEQUENCE   1291 AA;  143157 MW;  D8841B4C41B911C5 CRC64;
     MSSLPGCIGL DAATATVESE EIAELQQAVV EELGISMEEL RHFIDEELEK MDCVQQRKKQ
     LAELETWVIQ KESEVAHVDQ LFDDASRAVT NCESLVKDFY SKLGLQYRDS SSEDESSRPT
     EIIEIPDEDD DVLSIDSGDA GSRTPKDQKL REAMAALRKS AQDVQKFMDA VNKKSSSQDL
     HKGTLSQMSG ELSKDGDLIV SMRILGKKRT KTWHKGTLIA IQTVGPGKKY KVKFDNKGKS
     LLSGNHIAYD YHPPADKLYV GSRVVAKYKD GNQVWLYAGI VAETPNVKNK LRFLIFFDDG
     YASYVTQSEL YPICRPLKKT WEDIEDISCR DFIEEYVTAY PNRPMVLLKS GQLIKTEWEG
     TWWKSRVEEV DGSLVRILFL DDKRCEWIYR GSTRLEPMFS MKTSSASALE KKQGQLRTRP
     NMGAVRSKGP VVQYTQDLTG TGTQFKPVEP PQPTAPPAPP FPPAPPLSPQ AGDSDLESQL
     AQSRKQVAKK STSFRPGSVG SGHSSPTSPA LSENVSGGKP GINQTYRSPL GSTASAPAPS
     ALPAPPAPPV FHGMLERAPA EPSYRAPMEK LFYLPHVCSY TCLSRVRPMR NEQYRGKNPL
     LVPLLYDFRR MTARRRVNRK MGFHVIYKTP CGLCLRTMQE IERYLFETGC DFLFLEMFCL
     DPYVLVDRKF QPYKPFYYIL DITYGKEDVP LSCVNEIDTT PPPQVAYSKE RIPGKGVFIN
     TGPEFLVGCD CKDGCRDKSK CACHQLTIQA TACTPGGQIN PNSGYQYKRL EECLPTGVYE
     CNKRCKCDPN MCTNRLVQHG LQVRLQLFKT QNKGWGIRCL DDIAKGSFVC IYAGKILTDD
     FADKEGLEMG DEYFANLDHI ESVENFKEGY ESDAPCSSDS SGVDLKDQED GNSGTEDPEE
     SNDDSSDDNF CKDEDFSTSS VWRSYATRRQ TRGQKENGLS ETTSKDSHPP DLGPPHIPVP
     PSIPVGGCNP PSSEETPKNK VASWLSCNSV SEGGFADSDS HSSFKTNEGG EGRAGGSRME
     AEKASTSGLG IKDEGDIKQA KKEDTDDRNK MSVVTESSRN YGYNPSPVKP EGLRRPPSKT
     SMHQSRRLMA SAQSNPDDVL TLSSSTESEG ESGTSRKPTA GQTSATAVDS DDIQTISSGS
     EGDDFEDKKN MTGPMKRQVA VKSTRGFALK STHGIAIKST NMASVDKGES APVRKNTRQF
     YDGEESCYII DAKLEGNLGR YLNHSCSPNL FVQNVFVDTH DLRFPWVAFF ASKRIRAGTE
     LTWDYNYEVG SVEGKELLCC CGAIECRGRL L
//
ID   B7Z325_HUMAN            Unreviewed;       387 AA.
AC   B7Z325;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   22-APR-2020, entry version 52.
DE   RecName: Full=Non-specific serine/threonine protein kinase {ECO:0000256|SAAS:SAAS01060667};
DE            EC=2.7.11.1 {ECO:0000256|SAAS:SAAS01060667};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12061.1};
RN   [1] {ECO:0000313|EMBL:BAH12061.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Corpus callosum {ECO:0000313|EMBL:BAH12061.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000256|SAAS:SAAS01127769};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000256|SAAS:SAAS01127730};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000256|RuleBase:RU000304}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK295422; BAH12061.1; -; mRNA.
DR   RefSeq; NP_001278924.1; NM_001291995.1.
DR   PeptideAtlas; B7Z325; -.
DR   PRIDE; B7Z325; -.
DR   GeneID; 6446; -.
DR   CTD; 6446; -.
DR   SignaLink; B7Z325; -.
DR   GenomeRNAi; 6446; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593399};
KW   Kinase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Serine/threonine-protein kinase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706};
KW   Transferase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706}.
FT   DOMAIN          1..311
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   DOMAIN          312..387
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51285"
FT   REGION          66..92
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   387 AA;  43783 MW;  34775AE1248702D7 CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEL FYHLQRERCF LEPRARFYAA EIASALGYLH SLNIVYRDLK
     PENILLDSQG HIVLTDFGLC KENIEHNSTT STFCGTPEYL APEVLHKQPY DRTVDWWCLG
     AVLYEMLYGL PPFYSRNTAE MYDNILNKPL QLKPNITNSA RHLLEGLLQK DRTKRLGAKD
     DFMEIKSHVF FSLINWDDLI NKKITPPFNP NVSGPNDLRH FDPEFTEEPV PNSIGKSPDS
     VLVTASAKEA AEAFLGFSYA PPTDSFL
//
ID   E9PR89_HUMAN            Unreviewed;       387 AA.
AC   E9PR89;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   22-APR-2020, entry version 75.
DE   RecName: Full=Non-specific serine/threonine protein kinase {ECO:0000256|SAAS:SAAS01060667};
DE            EC=2.7.11.1 {ECO:0000256|SAAS:SAAS01060667};
GN   Name=SGK1 {ECO:0000313|Ensembl:ENSP00000434302};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434302, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000434302, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [3] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5] {ECO:0000313|Ensembl:ENSP00000434302}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000256|SAAS:SAAS01127769};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000256|SAAS:SAAS01127730};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000256|RuleBase:RU000304}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL135839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458297; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278924.1; NM_001291995.1.
DR   jPOST; E9PR89; -.
DR   MaxQB; E9PR89; -.
DR   PeptideAtlas; E9PR89; -.
DR   PRIDE; E9PR89; -.
DR   ProteomicsDB; 23244; -.
DR   Antibodypedia; 19734; 854 antibodies.
DR   Ensembl; ENST00000475719; ENSP00000434302; ENSG00000118515.
DR   GeneID; 6446; -.
DR   UCSC; uc011ecu.3; human.
DR   CTD; 6446; -.
DR   EuPathDB; HostDB:ENSG00000118515.11; -.
DR   HGNC; HGNC:10810; SGK1.
DR   OpenTargets; ENSG00000118515; -.
DR   GeneTree; ENSGT00940000155726; -.
DR   SignaLink; E9PR89; -.
DR   ChiTaRS; SGK1; human.
DR   GenomeRNAi; 6446; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000118515; Expressed in female gonad and 232 other tissues.
DR   ExpressionAtlas; E9PR89; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593399};
KW   Kinase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PR89,
KW   ECO:0000213|PeptideAtlas:E9PR89, ECO:0000213|ProteomicsDB:E9PR89};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Serine/threonine-protein kinase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706};
KW   Transferase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706}.
FT   DOMAIN          1..311
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   DOMAIN          312..387
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51285"
FT   REGION          66..92
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   387 AA;  43811 MW;  34775AE13C3052D7 CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEL FYHLQRERCF LEPRARFYAA EIASALGYLH SLNIVYRDLK
     PENILLDSQG HIVLTDFGLC KENIEHNSTT STFCGTPEYL APEVLHKQPY DRTVDWWCLG
     AVLYEMLYGL PPFYSRNTAE MYDNILNKPL QLKPNITNSA RHLLEGLLQK DRTKRLGAKD
     DFMEIKSHVF FSLINWDDLI NKKITPPFNP NVSGPNDLRH FDPEFTEEPV PNSIGKSPDS
     VLVTASVKEA AEAFLGFSYA PPTDSFL
//
ID   SGK1_HUMAN              Reviewed;         431 AA.
AC   O00141; B7UUP7; B7UUP8; B7UUP9; B7Z5B2; E1P583; Q5TCN2; Q5TCN3; Q5TCN4;
AC   Q5VY65; Q9UN56;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   22-APR-2020, entry version 200.
DE   RecName: Full=Serine/threonine-protein kinase Sgk1;
DE            EC=2.7.11.1;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 1;
GN   Name=SGK1; Synonyms=SGK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9114008; DOI=10.1073/pnas.94.9.4440;
RA   Waldegger S., Barth P., Raber G., Lang F.;
RT   "Cloning and characterization of a putative human serine/threonine protein
RT   kinase transcriptionally modified during anisotonic and isotonic
RT   alterations of cell volume.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4440-4445(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM 1).
RX   PubMed=9722955; DOI=10.1006/geno.1998.5258;
RA   Waldegger S., Erdel M., Nagl U.O., Barth P., Raber G., Steuer S.,
RA   Utermann G., Paulmichl M., Lang F.;
RT   "Genomic organization and chromosomal localization of the human SGK protein
RT   kinase gene.";
RL   Genomics 51:299-302(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ALTERNATIVE PROMOTER
RP   USAGE, INDUCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=18753299; DOI=10.1152/ajprenal.90239.2008;
RA   Raikwar N.S., Snyder P.M., Thomas C.P.;
RT   "An evolutionarily conserved N-terminal Sgk1 variant with enhanced
RT   stability and improved function.";
RL   Am. J. Physiol. 295:F1440-F1448(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), AND ALTERNATIVE
RP   PROMOTER USAGE.
RC   TISSUE=Glioblastoma, Hippocampus, and Skin;
RA   Hall B.A., Blakeley S., Daniels N.A., Jamieson D., Brickley D.,
RA   Reynolds N.J., Conzen S.D., Jackson T.R.;
RT   "Transcriptional variants of serum/glucocorticoid regulated kinase 1 show
RT   differential localisation and regulation.";
RL   Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RA   Kim M.K., Kim Y.H., Seo J.M., Lee H.M., Chung H.J., Sohn M.Y., Hwang S.Y.,
RA   Im S.U., Jung E.J., Lee J.H., Kim J.C.;
RT   "A catalogue of genes in the human dermal papilla cells as identified by
RT   expressed sequence tags.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=10548550; DOI=10.1042/bj3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel isoforms of
RT   serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [11]
RP   PHOSPHORYLATION AT THR-256 AND SER-422, AND MUTAGENESIS OF THR-256 AND
RP   SER-422.
RC   TISSUE=Brain;
RX   PubMed=10191262; DOI=10.1042/bj3390319;
RA   Kobayashi T., Cohen P.;
RT   "Activation of serum- and glucocorticoid-regulated protein kinase by
RT   agonists that activate phosphatidylinositide 3-kinase is mediated by 3-
RT   phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.";
RL   Biochem. J. 339:319-328(1999).
RN   [12]
RP   CHARACTERIZATION.
RX   PubMed=10884438; DOI=10.1073/pnas.97.14.8157;
RA   Lang F., Klingel K., Wagner C.A., Stegen C., Waerntges S., Friedrich B.,
RA   Lanzendoerfer M., Melzig J., Moschen I., Steuer S., Waldegger S.,
RA   Sauter M., Paulmichl M., Gerke V., Risler T., Gamba G., Capasso G.,
RA   Kandolf R., Hebert S.C., Massry S.G., Broer S.;
RT   "Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK
RT   in diabetic nephropathy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8157-8162(2000).
RN   [13]
RP   PHOSPHORYLATION AT SER-78 BY MAPK7, AND INTERACTION WITH MAPK7.
RX   PubMed=11254654; DOI=10.1074/jbc.c000838200;
RA   Hayashi M., Tapping R.I., Chao T.H., Lo J.F., King C.C., Yang Y., Lee J.D.;
RT   "BMK1 mediates growth factor-induced cell proliferation through direct
RT   cellular activation of serum and glucocorticoid-inducible kinase.";
RL   J. Biol. Chem. 276:8631-8634(2001).
RN   [14]
RP   PHOSPHORYLATION AT THR-369 BY PKA.
RX   PubMed=11096081; DOI=10.1074/jbc.m007052200;
RA   Perrotti N., He R.A., Phillips S.A., Haft C.R., Taylor S.I.;
RT   "Activation of serum- and glucocorticoid-induced protein kinase (Sgk) by
RT   cyclic AMP and insulin.";
RL   J. Biol. Chem. 276:9406-9412(2001).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF BRAF.
RX   PubMed=11410590; DOI=10.1074/jbc.m102808200;
RA   Zhang B.H., Tang E.D., Zhu T., Greenberg M.E., Vojtek A.B., Guan K.L.;
RT   "Serum- and glucocorticoid-inducible kinase SGK phosphorylates and
RT   negatively regulates B-Raf.";
RL   J. Biol. Chem. 276:31620-31626(2001).
RN   [16]
RP   FUNCTION.
RX   PubMed=11154281; DOI=10.1128/mcb.21.3.952-965.2001;
RA   Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E.;
RT   "Protein kinase SGK mediates survival signals by phosphorylating the
RT   forkhead transcription factor FKHRL1 (FOXO3a).";
RL   Mol. Cell. Biol. 21:952-965(2001).
RN   [17]
RP   INTERACTION WITH NEDD4 AND NEDD4L, MUTAGENESIS OF LYS-127; TYR-298 AND
RP   SER-422, AND FUNCTION.
RX   PubMed=11696533; DOI=10.1074/jbc.c100623200;
RA   Snyder P.M., Olson D.R., Thomas B.C.;
RT   "Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated
RT   inhibition of the epithelial Na+ channel.";
RL   J. Biol. Chem. 277:5-8(2002).
RN   [18]
RP   FUNCTION IN REGULATION OF NA(+)/K(+) ATPASE.
RX   PubMed=12590200; DOI=10.1159/000068699;
RA   Henke G., Setiawan I., Boehmer C., Lang F.;
RT   "Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent
RT   kinase isoforms.";
RL   Kidney Blood Press. Res. 25:370-374(2002).
RN   [19]
RP   FUNCTION.
RX   PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH SLC9A3R2/NHERF2 AND KCNJ1/ROMK1.
RX   PubMed=14623317; DOI=10.1016/j.bbrc.2003.10.037;
RA   Palmada M., Embark H.M., Yun C., Bohmer C., Lang F.;
RT   "Molecular requirements for the regulation of the renal outer medullary
RT   K(+) channel ROMK1 by the serum- and glucocorticoid-inducible kinase
RT   SGK1.";
RL   Biochem. Biophys. Res. Commun. 311:629-634(2003).
RN   [21]
RP   FUNCTION IN REGULATION OF SCN5A.
RX   PubMed=12650886; DOI=10.1016/s0008-6363(02)00837-4;
RA   Boehmer C., Wilhelm V., Palmada M., Wallisch S., Henke G., Brinkmeier H.,
RA   Cohen P., Pieske B., Lang F.;
RT   "Serum and glucocorticoid inducible kinases in the regulation of the
RT   cardiac sodium channel SCN5A.";
RL   Cardiovasc. Res. 57:1079-1084(2003).
RN   [22]
RP   FUNCTION IN PHOSPHORYLATION OF MAP3K3/MEKK3.
RX   PubMed=12761204; DOI=10.1093/jb/mvg010;
RA   Chun J., Kwon T., Kim D.J., Park I., Chung G., Lee E.J., Hong S.K.,
RA   Chang S.I., Kim H.Y., Kang S.S.;
RT   "Inhibition of mitogen-activated kinase kinase kinase 3 activity through
RT   phosphorylation by the serum- and glucocorticoid-induced kinase 1.";
RL   J. Biochem. 133:103-108(2003).
RN   [23]
RP   FUNCTION IN REGULATION OF KCNA3/KV1.3, AND MUTAGENESIS OF LYS-127 AND
RP   SER-422.
RX   PubMed=12911626; DOI=10.1046/j.1471-4159.2003.01937.x;
RA   Boehmer C., Henke G., Schniepp R., Palmada M., Rothstein J.D., Broeer S.,
RA   Lang F.;
RT   "Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase
RT   Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms SGK1/3
RT   and protein kinase B.";
RL   J. Neurochem. 86:1181-1188(2003).
RN   [24]
RP   NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=12631736; DOI=10.1091/mbc.e02-03-0170;
RA   Maiyar A.C., Leong M.L., Firestone G.L.;
RT   "Importin-alpha mediates the regulated nuclear targeting of serum- and
RT   glucocorticoid-inducible protein kinase (Sgk) by recognition of a nuclear
RT   localization signal in the kinase central domain.";
RL   Mol. Biol. Cell 14:1221-1239(2003).
RN   [25]
RP   FUNCTION IN REGULATION OF KCNE1 AND KCNQ1.
RX   PubMed=12634932; DOI=10.1007/s00424-002-0982-y;
RA   Embark H.M., Boehmer C., Vallon V., Luft F., Lang F.;
RT   "Regulation of KCNE1-dependent K(+) current by the serum and
RT   glucocorticoid-inducible kinase (SGK) isoforms.";
RL   Pflugers Arch. 445:601-606(2003).
RN   [26]
RP   FUNCTION IN REGULATION OF SLC34A2/NAPI-2B, AND FUNCTION IN PHOSPHORYLATION
RP   OF NEDD4L.
RX   PubMed=15044175; DOI=10.1152/ajpgi.00121.2003;
RA   Palmada M., Dieter M., Speil A., Boehmer C., Mack A.F., Wagner H.J.,
RA   Klingel K., Kandolf R., Murer H., Biber J., Closs E.I., Lang F.;
RT   "Regulation of intestinal phosphate cotransporter NaPi IIb by ubiquitin
RT   ligase Nedd4-2 and by serum- and glucocorticoid-dependent kinase 1.";
RL   Am. J. Physiol. 287:G143-G150(2004).
RN   [27]
RP   FUNCTION IN REGULATION OF SLC13A2/NADC1.
RX   PubMed=14706641; DOI=10.1016/j.bbrc.2003.12.011;
RA   Boehmer C., Embark H.M., Bauer A., Palmada M., Yun C.H., Weinman E.J.,
RA   Endou H., Cohen P., Lahme S., Bichler K.H., Lang F.;
RT   "Stimulation of renal Na+ dicarboxylate cotransporter 1 by Na+/H+ exchanger
RT   regulating factor 2, serum and glucocorticoid inducible kinase isoforms,
RT   and protein kinase B.";
RL   Biochem. Biophys. Res. Commun. 313:998-1003(2004).
RN   [28]
RP   FUNCTION IN REGULATION OF TRPV5.
RX   PubMed=15319523; DOI=10.1159/000080329;
RA   Embark H.M., Setiawan I., Poppendieck S., van de Graaf S.F., Boehmer C.,
RA   Palmada M., Wieder T., Gerstberger R., Cohen P., Yun C.C., Bindels R.J.,
RA   Lang F.;
RT   "Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating
RT   factor NHERF2 and the serum and glucocorticoid inducible kinase isoforms
RT   SGK1 and SGK3 expressed in Xenopus oocytes.";
RL   Cell. Physiol. Biochem. 14:203-212(2004).
RN   [29]
RP   FUNCTION.
RX   PubMed=15234985; DOI=10.1074/jbc.m403260200;
RA   Diakov A., Korbmacher C.;
RT   "A novel pathway of epithelial sodium channel activation involves a
RT   serum- and glucocorticoid-inducible kinase consensus motif in the C
RT   terminus of the channel's alpha-subunit.";
RL   J. Biol. Chem. 279:38134-38142(2004).
RN   [30]
RP   FUNCTION, AND MUTAGENESIS OF LYS-127 AND SER-422.
RX   PubMed=15040001; DOI=10.1002/jcp.10430;
RA   Henke G., Maier G., Wallisch S., Boehmer C., Lang F.;
RT   "Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase
RT   Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1.";
RL   J. Cell. Physiol. 199:194-199(2004).
RN   [31]
RP   FUNCTION IN REGULATION OF BSND.
RX   PubMed=15496163; DOI=10.1111/j.1523-1755.2004.00966.x;
RA   Embark H.M., Boehmer C., Palmada M., Rajamanickam J., Wyatt A.W.,
RA   Wallisch S., Capasso G., Waldegger P., Seyberth H.W., Waldegger S.,
RA   Lang F.;
RT   "Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the
RT   serum- and glucocorticoid-dependent kinases.";
RL   Kidney Int. 66:1918-1925(2004).
RN   [32]
RP   FUNCTION IN PHOSPHORYLATION OF SLC9A3/NHE3.
RX   PubMed=15888551; DOI=10.1152/ajpcell.00597.2004;
RA   Wang D., Sun H., Lang F., Yun C.C.;
RT   "Activation of NHE3 by dexamethasone requires phosphorylation of NHE3 at
RT   Ser663 by SGK1.";
RL   Am. J. Physiol. 289:C802-C810(2005).
RN   [33]
RP   FUNCTION IN REGULATION OF SLC1A5/ASCT2.
RX   PubMed=15845389; DOI=10.1016/j.bbrc.2005.03.159;
RA   Palmada M., Speil A., Jeyaraj S., Boehmer C., Lang F.;
RT   "The serine/threonine kinases SGK1, 3 and PKB stimulate the amino acid
RT   transporter ASCT2.";
RL   Biochem. Biophys. Res. Commun. 331:272-277(2005).
RN   [34]
RP   FUNCTION IN REGULATION OF SLC1A7/EAAT5.
RX   PubMed=15737648; DOI=10.1016/j.bbrc.2005.02.035;
RA   Boehmer C., Rajamanickam J., Schniepp R., Kohler K., Wulff P., Kuhl D.,
RA   Palmada M., Lang F.;
RT   "Regulation of the excitatory amino acid transporter EAAT5 by the serum and
RT   glucocorticoid dependent kinases SGK1 and SGK3.";
RL   Biochem. Biophys. Res. Commun. 329:738-742(2005).
RN   [35]
RP   FUNCTION IN REGULATION OF SLC6A8.
RX   PubMed=16036218; DOI=10.1016/j.bbrc.2005.06.164;
RA   Shojaiefard M., Christie D.L., Lang F.;
RT   "Stimulation of the creatine transporter SLC6A8 by the protein kinases SGK1
RT   and SGK3.";
RL   Biochem. Biophys. Res. Commun. 334:742-746(2005).
RN   [36]
RP   FUNCTION IN PHOSPHORYLATION OF CREB1, AND INTERACTION WITH CREB1.
RX   PubMed=15733869; DOI=10.1016/j.febslet.2005.01.040;
RA   David S., Kalb R.G.;
RT   "Serum/glucocorticoid-inducible kinase can phosphorylate the cyclic AMP
RT   response element binding protein, CREB.";
RL   FEBS Lett. 579:1534-1538(2005).
RN   [37]
RP   UBIQUITINATION.
RX   PubMed=15576372; DOI=10.1074/jbc.m411053200;
RA   Zhou R., Snyder P.M.;
RT   "Nedd4-2 phosphorylation induces serum and glucocorticoid-regulated kinase
RT   (SGK) ubiquitination and degradation.";
RL   J. Biol. Chem. 280:4518-4523(2005).
RN   [38]
RP   FUNCTION IN REGULATION OF SLC2A1/GLUT1.
RX   PubMed=16443776; DOI=10.2337/diabetes.55.02.06.db05-0720;
RA   Palmada M., Boehmer C., Akel A., Rajamanickam J., Jeyaraj S., Keller K.,
RA   Lang F.;
RT   "SGK1 kinase upregulates GLUT1 activity and plasma membrane expression.";
RL   Diabetes 55:421-427(2006).
RN   [39]
RP   FUNCTION IN PHOSPHORYLATION OF MAPT/TAU, AND INTERACTION WITH MAPT/TAU.
RX   PubMed=16982696; DOI=10.1128/mcb.01017-06;
RA   Yang Y.C., Lin C.H., Lee E.H.;
RT   "Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite
RT   formation through microtubule depolymerization by SGK1 and by SGK1
RT   phosphorylation of tau.";
RL   Mol. Cell. Biol. 26:8357-8370(2006).
RN   [40]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17202226; DOI=10.1152/ajpcell.00399.2006;
RA   Cordas E., Naray-Fejes-Toth A., Fejes-Toth G.;
RT   "Subcellular location of serum- and glucocorticoid-induced kinase-1 in
RT   renal and mammary epithelial cells.";
RL   Am. J. Physiol. 292:C1971-C1981(2007).
RN   [41]
RP   FUNCTION IN PHOSPHORYLATION OF SLC2A4/GLUT4.
RX   PubMed=17382906; DOI=10.1016/j.bbrc.2007.03.029;
RA   Jeyaraj S., Boehmer C., Lang F., Palmada M.;
RT   "Role of SGK1 kinase in regulating glucose transport via glucose
RT   transporter GLUT4.";
RL   Biochem. Biophys. Res. Commun. 356:629-635(2007).
RN   [42]
RP   FUNCTION IN REGULATION OF TRPV6.
RX   PubMed=18005662; DOI=10.1016/j.febslet.2007.11.006;
RA   Boehmer C., Palmada M., Kenngott C., Lindner R., Klaus F., Laufer J.,
RA   Lang F.;
RT   "Regulation of the epithelial calcium channel TRPV6 by the serum and
RT   glucocorticoid-inducible kinase isoforms SGK1 and SGK3.";
RL   FEBS Lett. 581:5586-5590(2007).
RN   [43]
RP   FUNCTION IN PHOSPHORYLATION OF APBB1/FE65.
RX   PubMed=18304449; DOI=10.5483/bmbrep.2008.41.1.041;
RA   Lee E.J., Chun J., Hyun S., Ahn H.R., Jeong J.M., Hong S.K., Hong J.T.,
RA   Chang I.K., Jeon H.Y., Han Y.S., Auh C.K., Park J.I., Kang S.S.;
RT   "Regulation Fe65 localization to the nucleus by SGK1 phosphorylation of its
RT   Ser566 residue.";
RL   BMB Rep. 41:41-47(2008).
RN   [44]
RP   PHOSPHORYLATION AT SER-422 BY MTORC2.
RX   PubMed=18925875; DOI=10.1042/bj20081668;
RA   Garcia-Martinez J.M., Alessi D.R.;
RT   "mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and
RT   activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).";
RL   Biochem. J. 416:375-385(2008).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-397 AND SER-401, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [46]
RP   ALTERNATIVE PROMOTER USAGE (ISOFORMS 2 AND 3).
RX   PubMed=18334630; DOI=10.1073/pnas.0800958105;
RA   Arteaga M.F., Coric T., Straub C., Canessa C.M.;
RT   "A brain-specific SGK1 splice isoform regulates expression of ASIC1 in
RT   neurons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:4459-4464(2008).
RN   [47]
RP   PHOSPHORYLATION AT SER-397 AND SER-401.
RX   PubMed=19068477; DOI=10.1074/jbc.m807502200;
RA   Chen W., Chen Y., Xu B.E., Juang Y.C., Stippec S., Zhao Y., Cobb M.H.;
RT   "Regulation of a third conserved phosphorylation site in SGK1.";
RL   J. Biol. Chem. 284:3453-3460(2009).
RN   [48]
RP   FUNCTION IN PHOSPHORYLATION OF MAPK1/ERK2, AND INTERACTION WITH MAPK3/ERK1;
RP   MAPK1/ERK2; MAP2K1/MEK1 AND MAP2K2/MEK2.
RX   PubMed=19447520; DOI=10.1016/j.jhep.2009.02.027;
RA   Won M., Park K.A., Byun H.S., Kim Y.R., Choi B.L., Hong J.H., Park J.,
RA   Seok J.H., Lee Y.H., Cho C.H., Song I.S., Kim Y.K., Shen H.M., Hur G.M.;
RT   "Protein kinase SGK1 enhances MEK/ERK complex formation through the
RT   phosphorylation of ERK2: implication for the positive regulatory role of
RT   SGK1 on the ERK function during liver regeneration.";
RL   J. Hepatol. 51:67-76(2009).
RN   [49]
RP   FUNCTION IN PHOSPHORYLATION OF MDM2.
RX   PubMed=19756449; DOI=10.1007/s00109-009-0525-5;
RA   Amato R., D'Antona L., Porciatti G., Agosti V., Menniti M., Rinaldo C.,
RA   Costa N., Bellacchio E., Mattarocci S., Fuiano G., Soddu S., Paggi M.G.,
RA   Lang F., Perrotti N.;
RT   "Sgk1 activates MDM2-dependent p53 degradation and affects cell
RT   proliferation, survival, and differentiation.";
RL   J. Mol. Med. 87:1221-1239(2009).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-397 AND SER-401, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [51]
RP   FUNCTION IN REGULATION OF SLC6A19.
RX   PubMed=20511718; DOI=10.1159/000315092;
RA   Boehmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S.,
RA   Lang F., Palmada M.;
RT   "The serum and glucocorticoid inducible kinases SGK1-3 stimulate the
RT   neutral amino acid transporter SLC6A19.";
RL   Cell. Physiol. Biochem. 25:723-732(2010).
RN   [52]
RP   PHOSPHORYLATION AT SER-422 BY MTORC2, AND INTERACTION WITH MTORC2.
RX   PubMed=20338997; DOI=10.1681/asn.2009111168;
RA   Lu M., Wang J., Jones K.T., Ives H.E., Feldman M.E., Yao L.J., Shokat K.M.,
RA   Ashrafi K., Pearce D.;
RT   "mTOR complex-2 activates ENaC by phosphorylating SGK1.";
RL   J. Am. Soc. Nephrol. 21:811-818(2010).
RN   [53]
RP   FUNCTION.
RX   PubMed=20730100; DOI=10.1371/journal.pone.0012163;
RA   Wiemuth D., Lott J.S., Ly K., Ke Y., Teesdale-Spittle P., Snyder P.M.,
RA   McDonald F.J.;
RT   "Interaction of serum- and glucocorticoid regulated kinase 1 (SGK1) with
RT   the WW-domains of Nedd4-2 is required for epithelial sodium channel
RT   regulation.";
RL   PLoS ONE 5:E12163-E12163(2010).
RN   [54]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [55]
RP   FUNCTION IN REGULATION OF SLC9A3/NHE3, AND SUBCELLULAR LOCATION.
RX   PubMed=21865597; DOI=10.1091/mbc.e11-04-0328;
RA   He P., Lee S.J., Lin S., Seidler U., Lang F., Fejes-Toth G.,
RA   Naray-Fejes-Toth A., Yun C.C.;
RT   "Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates
RT   acute activation of Na+/H+ exchanger NHE3 by glucocorticoids.";
RL   Mol. Biol. Cell 22:3812-3825(2011).
RN   [56]
RP   REVIEW.
RX   PubMed=12649597; DOI=10.1159/000070244;
RA   Firestone G.L., Giampaolo J.R., O'Keeffe B.A.;
RT   "Stimulus-dependent regulation of serum and glucocorticoid inducible
RT   protein kinase (SGK) transcription, subcellular localization and enzymatic
RT   activity.";
RL   Cell. Physiol. Biochem. 13:1-12(2003).
RN   [57]
RP   REVIEW.
RX   PubMed=16460280; DOI=10.1146/annurev.physiol.68.040104.131654;
RA   Loffing J., Flores S.Y., Staub O.;
RT   "Sgk kinases and their role in epithelial transport.";
RL   Annu. Rev. Physiol. 68:461-490(2006).
RN   [58]
RP   REVIEW ON FUNCTION.
RX   PubMed=20919962; DOI=10.3109/08977194.2010.518616;
RA   Bruhn M.A., Pearson R.B., Hannan R.D., Sheppard K.E.;
RT   "Second AKT: the rise of SGK in cancer signalling.";
RL   Growth Factors 28:394-408(2010).
RN   [59]
RP   REVIEW ON FUNCTION.
RX   PubMed=20530112; DOI=10.1113/jphysiol.2010.190926;
RA   Lang F., Strutz-Seebohm N., Seebohm G., Lang U.E.;
RT   "Significance of SGK1 in the regulation of neuronal function.";
RL   J. Physiol. (Lond.) 588:3349-3354(2010).
RN   [60]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 60-431, SUBUNIT, AND DISULFIDE
RP   BOND.
RX   PubMed=17965184; DOI=10.1110/ps.073161707;
RA   Zhao B., Lehr R., Smallwood A.M., Ho T.F., Maley K., Randall T., Head M.S.,
RA   Koretke K.K., Schnackenberg C.G.;
RT   "Crystal structure of the kinase domain of serum and glucocorticoid-
RT   regulated kinase 1 in complex with AMP PNP.";
RL   Protein Sci. 16:2761-2769(2007).
RN   [61]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-219 AND VAL-342.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase which is involved in the
CC       regulation of a wide variety of ion channels, membrane transporters,
CC       cellular enzymes, transcription factors, neuronal excitability, cell
CC       growth, proliferation, survival, migration and apoptosis. Plays an
CC       important role in cellular stress response. Contributes to regulation
CC       of renal Na(+) retention, renal K(+) elimination, salt appetite,
CC       gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient
CC       transport, insulin-dependent salt sensitivity of blood pressure, salt
CC       sensitivity of peripheral glucose uptake, cardiac repolarization and
CC       memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A
CC       and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and
CC       KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels:
CC       BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2
CC       /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid
CC       transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine
CC       transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1,
CC       Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate
CC       receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3,
CC       SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and
CC       SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase,
CC       and transcription factors: CTNNB1 and nuclear factor NF-kappa-B.
CC       Stimulates sodium transport into epithelial cells by enhancing the
CC       stability and expression of SCNN1A/ENAC. This is achieved by
CC       phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its
CC       interaction with 14-3-3 proteins, thereby preventing it from binding to
CC       SCNN1A/ENAC and targeting it for degradation. Regulates store-operated
CC       Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates
CC       KCNJ1/ROMK1 directly via its phosphorylation or indirectly via
CC       increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and
CC       activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates
CC       MAPT/TAU and mediates microtubule depolymerization and neurite
CC       formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-
CC       regulates its activity. Phosphorylates APBB1/FE65 and promotes its
CC       localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it
CC       by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2.
CC       Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1
CC       signaling. Phosphorylates FOXO1 resulting in its relocalization from
CC       the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit
CC       from the nucleus and interference with FOXO3-dependent transcription.
CC       Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity.
CC       Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in
CC       its activation and increased localization at the cell membrane.
CC       Phosphorylates CREB1. Necessary for vascular remodeling during
CC       angiogenesis. Sustained high levels and activity may contribute to
CC       conditions such as hypertension and diabetic nephropathy. Isoform 2
CC       exhibited a greater effect on cell plasma membrane expression of
CC       SCNN1A/ENAC and Na(+) transport than isoform 1.
CC       {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590,
CC       ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388,
CC       ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932,
CC       ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204,
CC       ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317,
CC       ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001,
CC       ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985,
CC       ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163,
CC       ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648,
CC       ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551,
CC       ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776,
CC       ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906,
CC       ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449,
CC       ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520,
CC       ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718,
CC       ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Two specific sites, one in the kinase domain (Thr-
CC       256) and the other in the C-terminal regulatory region (Ser-422), need
CC       to be phosphorylated for its full activation. Phosphorylation at Ser-
CC       397 and Ser-401 are also essential for its activity. Activated by WNK1,
CC       WNK2, WNK3 and WNK4.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Forms a trimeric complex with
CC       FBXW7 and NOTCH1. Interacts with MAPK3/ERK1, MAPK1/ERK2, MAP2K1/MEK1,
CC       MAP2K2/MEK2, NEDD4, NEDD4L, MAPT/TAU, MAPK7, CREB1, SLC9A3R2/NHERF2 and
CC       KCNJ1/ROMK1. Associates with the mammalian target of rapamycin complex
CC       2 (mTORC2) via an interaction with MAPKAP1/SIN1.
CC       {ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11696533,
CC       ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:15733869,
CC       ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17965184,
CC       ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:20338997}.
CC   -!- INTERACTION:
CC       O00141; O15182: CETN3; NbExp=3; IntAct=EBI-1042854, EBI-712959;
CC       O00141; Q969L2: MAL2; NbExp=3; IntAct=EBI-1042854, EBI-944295;
CC       O00141; Q9ULP0-2: NDRG4; NbExp=3; IntAct=EBI-1042854, EBI-11978907;
CC       O00141; P49815: TSC2; NbExp=4; IntAct=EBI-1042854, EBI-396587;
CC       O00141; Q80UE6: Wnk4; Xeno; NbExp=2; IntAct=EBI-1042854, EBI-295378;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Endoplasmic reticulum
CC       membrane. Cell membrane. Mitochondrion. Note=The subcellular
CC       localization is controlled by the cell cycle, as well as by exposure to
CC       specific hormones and environmental stress stimuli. In proliferating
CC       cells, it shuttles between the nucleus and cytoplasm in synchrony with
CC       the cell cycle, and in serum/growth factor-stimulated cells it resides
CC       in the nucleus. In contrast, after exposure to environmental stress or
CC       treatment with glucocorticoids, it is detected in the cytoplasm and
CC       with certain stress conditions is associated with the mitochondria. In
CC       osmoregulation through the epithelial sodium channel, it can be
CC       localized to the cytoplasmic surface of the cell membrane. Nuclear,
CC       upon phosphorylation.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O00141-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sgk1.1, Sgk1_v2;
CC         IsoId=O00141-2; Sequence=VSP_037784;
CC       Name=3; Synonyms=Sgk1.2;
CC         IsoId=O00141-3; Sequence=VSP_037785;
CC       Name=4;
CC         IsoId=O00141-4; Sequence=VSP_037786;
CC       Name=5;
CC         IsoId=O00141-5; Sequence=VSP_037787;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues with highest levels in
CC       the pancreas, followed by placenta, kidney and lung. Isoform 2 is
CC       strongly expressed in brain and pancreas, weaker in heart, placenta,
CC       lung, liver and skeletal muscle. {ECO:0000269|PubMed:10548550,
CC       ECO:0000269|PubMed:18753299}.
CC   -!- INDUCTION: Induced by a very large spectrum of stimuli distinct from
CC       glucocorticoids and serum. These include aldosterone, cell shrinkage,
CC       cell swelling, TGF-beta, ischemic injury of the brain, neuronal
CC       excitotoxicity memory consolidation, chronic viral hepatitis, DNA-
CC       damaging agents, vitamin D3 psychophysiological stress, iron, glucose,
CC       EDN1, CSF2, fibroblast growth factor, platelet-derived growth factor,
CC       phorbolesters, follicle-stimulating hormone, sorbitol, heat shock,
CC       oxidative stress, UV irradiation, and p53/TP53. Many of these stimuli
CC       are highly cell-specific, as is the case, for example for aldosterone,
CC       which has been found to stimulate its expression only in cells derived
CC       from aldosterone-responsive epithelia. Isoform 2 is not induced by
CC       glucocorticoids but by excessive extracellular glucose and by TGFB1, in
CC       cultured cells. {ECO:0000269|PubMed:18753299}.
CC   -!- DOMAIN: Isoform 2 subcellular localization at the cell membrane and
CC       resistance to proteasomal degradation is mediated by the sequences
CC       within the first 120 amino acids.
CC   -!- PTM: Regulated by phosphorylation. Activated by phosphorylation on Ser-
CC       422 by mTORC2, transforming it into a substrate for PDPK1 which
CC       phosphorylates it on Thr-256. Phosphorylation on Ser-397 and Ser-401
CC       are also essential for its activity. Phosphorylation on Ser-78 by MAPK7
CC       is required for growth factor-induced cell cycle progression.
CC       {ECO:0000269|PubMed:10191262, ECO:0000269|PubMed:11096081,
CC       ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:18925875,
CC       ECO:0000269|PubMed:19068477, ECO:0000269|PubMed:20338997}.
CC   -!- PTM: Ubiquitinated by NEDD4L; which promotes proteasomal degradation.
CC       Ubiquitinated by SYVN1 at the endoplasmic reticulum; which promotes
CC       rapid proteasomal degradation and maintains a high turnover rate in
CC       resting cells. Isoform 2 shows enhanced stability.
CC       {ECO:0000269|PubMed:15576372}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative splicing of isoform
CC       1. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y10032; CAA71138.1; -; mRNA.
DR   EMBL; AJ000512; CAA04146.1; -; Genomic_DNA.
DR   EMBL; EU518415; ACD35864.1; -; mRNA.
DR   EMBL; FM205707; CAR58095.1; -; mRNA.
DR   EMBL; FM205708; CAR58096.1; -; mRNA.
DR   EMBL; FM205709; CAR58097.1; -; mRNA.
DR   EMBL; FM205710; CAR58098.1; -; mRNA.
DR   EMBL; AF153609; AAD41091.1; -; mRNA.
DR   EMBL; AK055077; BAG51463.1; -; mRNA.
DR   EMBL; AK298688; BAH12848.1; -; mRNA.
DR   EMBL; AL355881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL135839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47991.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47992.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47993.1; -; Genomic_DNA.
DR   EMBL; BC001263; AAH01263.1; -; mRNA.
DR   CCDS; CCDS47476.1; -. [O00141-2]
DR   CCDS; CCDS47477.1; -. [O00141-5]
DR   CCDS; CCDS47478.1; -. [O00141-3]
DR   CCDS; CCDS5170.1; -. [O00141-1]
DR   RefSeq; NP_001137148.1; NM_001143676.1. [O00141-2]
DR   RefSeq; NP_001137149.1; NM_001143677.1. [O00141-5]
DR   RefSeq; NP_001137150.1; NM_001143678.1. [O00141-3]
DR   RefSeq; NP_001278924.1; NM_001291995.1.
DR   RefSeq; NP_005618.2; NM_005627.3. [O00141-1]
DR   RefSeq; XP_011534373.1; XM_011536071.1. [O00141-2]
DR   PDB; 2R5T; X-ray; 1.90 A; A=60-431.
DR   PDB; 3HDM; X-ray; 2.60 A; A=60-431.
DR   PDB; 3HDN; X-ray; 3.10 A; A=60-431.
DR   PDBsum; 2R5T; -.
DR   PDBsum; 3HDM; -.
DR   PDBsum; 3HDN; -.
DR   SMR; O00141; -.
DR   BioGrid; 112344; 63.
DR   CORUM; O00141; -.
DR   DIP; DIP-42464N; -.
DR   ELM; O00141; -.
DR   IntAct; O00141; 20.
DR   MINT; O00141; -.
DR   STRING; 9606.ENSP00000356832; -.
DR   BindingDB; O00141; -.
DR   ChEMBL; CHEMBL2343; -.
DR   DrugBank; DB08191; 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid.
DR   DrugBank; DB07837; [4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid.
DR   DrugBank; DB03247; Flavin mononucleotide.
DR   GuidetoPHARMACOLOGY; 1534; -.
DR   iPTMnet; O00141; -.
DR   PhosphoSitePlus; O00141; -.
DR   BioMuta; SGK1; -.
DR   jPOST; O00141; -.
DR   MassIVE; O00141; -.
DR   MaxQB; O00141; -.
DR   PaxDb; O00141; -.
DR   PeptideAtlas; O00141; -.
DR   PRIDE; O00141; -.
DR   ProteomicsDB; 47726; -. [O00141-1]
DR   ProteomicsDB; 47727; -. [O00141-2]
DR   ProteomicsDB; 47728; -. [O00141-3]
DR   ProteomicsDB; 47729; -. [O00141-4]
DR   ProteomicsDB; 47730; -. [O00141-5]
DR   Antibodypedia; 19734; 854 antibodies.
DR   DNASU; 6446; -.
DR   Ensembl; ENST00000237305; ENSP00000237305; ENSG00000118515. [O00141-1]
DR   Ensembl; ENST00000367857; ENSP00000356831; ENSG00000118515. [O00141-4]
DR   Ensembl; ENST00000367858; ENSP00000356832; ENSG00000118515. [O00141-2]
DR   Ensembl; ENST00000413996; ENSP00000396242; ENSG00000118515. [O00141-3]
DR   Ensembl; ENST00000528577; ENSP00000434450; ENSG00000118515. [O00141-5]
DR   GeneID; 6446; -.
DR   KEGG; hsa:6446; -.
DR   UCSC; uc003qen.5; human. [O00141-1]
DR   CTD; 6446; -.
DR   DisGeNET; 6446; -.
DR   GeneCards; SGK1; -.
DR   HGNC; HGNC:10810; SGK1.
DR   HPA; ENSG00000118515; Tissue enhanced (parathyroid).
DR   MIM; 602958; gene.
DR   neXtProt; NX_O00141; -.
DR   OpenTargets; ENSG00000118515; -.
DR   PharmGKB; PA162403013; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00940000155726; -.
DR   HOGENOM; CLU_000288_63_5_1; -.
DR   InParanoid; O00141; -.
DR   KO; K13302; -.
DR   OMA; GKDCTAN; -.
DR   OrthoDB; 614710at2759; -.
DR   PhylomeDB; O00141; -.
DR   TreeFam; TF320906; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-8986944; Transcriptional Regulation by MECP2.
DR   SignaLink; O00141; -.
DR   SIGNOR; O00141; -.
DR   ChiTaRS; SGK1; human.
DR   EvolutionaryTrace; O00141; -.
DR   GeneWiki; SGK; -.
DR   GenomeRNAi; 6446; -.
DR   Pharos; O00141; Tchem.
DR   PRO; PR:O00141; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O00141; protein.
DR   Bgee; ENSG00000118515; Expressed in female gonad and 232 other tissues.
DR   ExpressionAtlas; O00141; baseline and differential.
DR   Genevisible; O00141; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005246; F:calcium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0017081; F:chloride channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; IBA:GO_Central.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007616; P:long-term memory; TAS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032411; P:positive regulation of transporter activity; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; TAS:UniProtKB.
DR   GO; GO:0050790; P:regulation of catalytic activity; TAS:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; TAS:UniProtKB.
DR   GO; GO:0051090; P:regulation of DNA-binding transcription factor activity; TAS:UniProtKB.
DR   GO; GO:0060453; P:regulation of gastric acid secretion; TAS:UniProtKB.
DR   GO; GO:0070294; P:renal sodium ion absorption; TAS:UniProtKB.
DR   GO; GO:0006814; P:sodium ion transport; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing; Apoptosis;
KW   ATP-binding; Cell membrane; Cytoplasm; Disulfide bond;
KW   Endoplasmic reticulum; Kinase; Membrane; Mitochondrion; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Ubl conjugation.
FT   CHAIN           1..431
FT                   /note="Serine/threonine-protein kinase Sgk1"
FT                   /id="PRO_0000086642"
FT   DOMAIN          98..355
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          356..431
FT                   /note="AGC-kinase C-terminal"
FT   NP_BIND         104..112
FT                   /note="ATP"
FT   REGION          1..60
FT                   /note="Necessary for localization to the mitochondria"
FT   MOTIF           131..141
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:12631736"
FT   COMPBIAS        131..141
FT                   /note="Glu/Lys-rich"
FT   ACT_SITE        222
FT                   /note="Proton acceptor"
FT   BINDING         127
FT                   /note="ATP"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19369195"
FT   MOD_RES         78
FT                   /note="Phosphoserine; by MAPK7"
FT                   /evidence="ECO:0000269|PubMed:11254654"
FT   MOD_RES         256
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000269|PubMed:10191262"
FT   MOD_RES         369
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:11096081"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231,
FT                   ECO:0000269|PubMed:19068477"
FT   MOD_RES         401
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19369195, ECO:0000269|PubMed:19068477"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10191262,
FT                   ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:20338997"
FT   DISULFID        193
FT                   /note="Interchain (with C-258)"
FT                   /evidence="ECO:0000269|PubMed:17965184"
FT   DISULFID        258
FT                   /note="Interchain (with C-193)"
FT                   /evidence="ECO:0000269|PubMed:17965184"
FT   VAR_SEQ         1..25
FT                   /note="MTVKTEAAKGTLTYSRMRGMVAILI -> MVNKDMNGFPVKKCSAFQFFKKR
FT                   VRRWIKSPMVSVDKHQSPSLKYTGSSMVHIPPGEPDFESSLCQTCLGEHAFQRGVLPQE
FT                   NESCSWETQSGCEVREPCNHANILTKPDPRTFWTNDDP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:18753299, ECO:0000303|Ref.4"
FT                   /id="VSP_037784"
FT   VAR_SEQ         1..25
FT                   /note="MTVKTEAAKGTLTYSRMRGMVAILI -> MGEMQGALARARLESLLRPRHKK
FT                   RAEAQKRSESFLLSGL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.4"
FT                   /id="VSP_037785"
FT   VAR_SEQ         1..25
FT                   /note="MTVKTEAAKGTLTYSRMRGMVAILI -> MKPSKRFFISPPSST (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_037786"
FT   VAR_SEQ         1..25
FT                   /note="MTVKTEAAKGTLTYSRMRGMVAILI -> MSSQSSSLSEACSREAYSSHNWA
FT                   LPPASRSNPQPAYPWATRRMKEEAIKPPLK (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_037787"
FT   VARIANT         219
FT                   /note="V -> I (in dbSNP:rs34133418)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041071"
FT   VARIANT         342
FT                   /note="A -> V (in dbSNP:rs55932330)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041072"
FT   MUTAGEN         127
FT                   /note="K->M: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:11696533,
FT                   ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001"
FT   MUTAGEN         256
FT                   /note="T->A: Low activity."
FT                   /evidence="ECO:0000269|PubMed:10191262"
FT   MUTAGEN         256
FT                   /note="T->D: Low activity."
FT                   /evidence="ECO:0000269|PubMed:10191262"
FT   MUTAGEN         256
FT                   /note="T->E: Low activity."
FT                   /evidence="ECO:0000269|PubMed:10191262"
FT   MUTAGEN         298
FT                   /note="Y->A: Abolishes interaction with NEDD4 and NEDD4L."
FT                   /evidence="ECO:0000269|PubMed:11696533"
FT   MUTAGEN         422
FT                   /note="S->A: Low activity."
FT                   /evidence="ECO:0000269|PubMed:10191262,
FT                   ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626,
FT                   ECO:0000269|PubMed:15040001"
FT   MUTAGEN         422
FT                   /note="S->D: 10-fold activation."
FT                   /evidence="ECO:0000269|PubMed:10191262,
FT                   ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12911626,
FT                   ECO:0000269|PubMed:15040001"
FT   CONFLICT        62
FT                   /note="Q -> E (in Ref. 4; CAR58097)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        152
FT                   /note="K -> R (in Ref. 4; CAR58096)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        196
FT                   /note="E -> G (in Ref. 4; CAR58095)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="I -> V (in Ref. 6; BAH12848)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="P -> R (in Ref. 4; CAR58097)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        381
FT                   /note="D -> E (in Ref. 1; CAA71138 and 2; CAA04146)"
FT                   /evidence="ECO:0000305"
FT   HELIX           95..97
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          98..105
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          111..117
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   TURN            118..120
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          123..130
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           131..133
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          162..167
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          169..177
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           184..191
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           196..215
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           225..227
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          228..230
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          232..234
FT                   /evidence="ECO:0000244|PDB:3HDN"
FT   STRAND          236..238
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           245..247
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          256..258
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           266..269
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           277..292
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           302..311
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   STRAND          318..320
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           322..331
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           336..338
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   TURN            340..345
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           346..350
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           353..355
FT                   /evidence="ECO:0000244|PDB:2R5T"
FT   HELIX           360..364
FT                   /evidence="ECO:0000244|PDB:2R5T"
SQ   SEQUENCE   431 AA;  48942 MW;  F3697C63AB1F499D CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEE KHIMSERNVL LKNVKHPFLV GLHFSFQTAD KLYFVLDYIN
     GGELFYHLQR ERCFLEPRAR FYAAEIASAL GYLHSLNIVY RDLKPENILL DSQGHIVLTD
     FGLCKENIEH NSTTSTFCGT PEYLAPEVLH KQPYDRTVDW WCLGAVLYEM LYGLPPFYSR
     NTAEMYDNIL NKPLQLKPNI TNSARHLLEG LLQKDRTKRL GAKDDFMEIK SHVFFSLINW
     DDLINKKITP PFNPNVSGPN DLRHFDPEFT EEPVPNSIGK SPDSVLVTAS VKEAAEAFLG
     FSYAPPTDSF L
//
ID   Q8TBA2_HUMAN            Unreviewed;       291 AA.
AC   Q8TBA2;
DT   01-JUN-2002, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2002, sequence version 1.
DT   11-DEC-2019, entry version 103.
DE   SubName: Full=SIX homeobox 2 {ECO:0000313|EMBL:AAH24033.1};
GN   Name=SIX2 {ECO:0000313|EMBL:AAH24033.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH24033.1};
RN   [1] {ECO:0000313|EMBL:AAH24033.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle {ECO:0000313|EMBL:AAH24033.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-ProRule:PRU00108,
CC       ECO:0000256|RuleBase:RU000682}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC024033; AAH24033.1; -; mRNA.
DR   RefSeq; NP_058628.3; NM_016932.4.
DR   PeptideAtlas; Q8TBA2; -.
DR   PRIDE; Q8TBA2; -.
DR   DNASU; 10736; -.
DR   GeneID; 10736; -.
DR   KEGG; hsa:10736; -.
DR   CTD; 10736; -.
DR   PharmGKB; PA35788; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   KO; K19472; -.
DR   OrthoDB; 1061244at2759; -.
DR   ChiTaRS; SIX2; human.
DR   GenomeRNAi; 10736; -.
DR   Genevisible; Q8TBA2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00108,
KW   ECO:0000256|RuleBase:RU000682, ECO:0000313|EMBL:AAH24033.1};
KW   Homeobox {ECO:0000256|PROSITE-ProRule:PRU00108,
KW   ECO:0000256|RuleBase:RU000682, ECO:0000313|EMBL:AAH24033.1};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00108,
KW   ECO:0000256|RuleBase:RU000682}.
FT   DOMAIN          122..182
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000259|PROSITE:PS50071"
FT   DNA_BIND        124..183
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00108"
FT   REGION          146..291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        173..192
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        193..230
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        231..257
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   291 AA;  32316 MW;  C288C3D3305B2AC1 CRC64;
     MSMLPTFGFT QEQVACVCEV LQQGGNIERL GRFLWSLPAC EHLHKNESVL KAKAVVAFHR
     GNFRELYKIL ESHQFSPHNH AKLQQLWLKA HYIEAEKLRG RPLGAVGKYR VRRKFPLPRS
     IWDGEETSYC FKEKSRSVLR EWYAHNPYPS PREKRELTEA TGLTTTQVSN WFKNRRQRDR
     AAEAKERENN ENSNSNSHNP LNGSGKSVLG SSEDEKTPSG TPDHSSSSPA LLLSPPPPGL
     PSLHSLGHPP GPSAVPVPVP GGGGADPLQH HHGLQDSILN PMSANLVDLG S
//
ID   SIX2_HUMAN              Reviewed;         291 AA.
AC   Q9NPC8; Q9BXH7;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 152.
DE   RecName: Full=Homeobox protein SIX2;
DE   AltName: Full=Sine oculis homeobox homolog 2;
GN   Name=SIX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10677303; DOI=10.1086/302779;
RA   Celli J., Van Beusekom E., Hennekam R.C.M., Gallardo M.E., Smeets D.F.C.M.,
RA   Rodriguez de Cordoba S., Innis J.W., Frydman M., Konig R., Kingston H.,
RA   Tolmie J., Lutgarde L.C.P., van Bokhoven H., Brunner H.G.;
RT   "Familial syndromic esophageal atresia maps to 2p23-p24.";
RL   Am. J. Hum. Genet. 66:436-444(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=10773454; DOI=10.1016/s0378-1119(00)00105-0;
RA   Boucher C.A., Winchester C.L., Hamilton G.M., Winter A.D., Johnson K.J.,
RA   Bailey M.E.S.;
RT   "Structure, mapping and expression of the human gene encoding the
RT   homeodomain protein, SIX2.";
RL   Gene 247:145-151(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Salivary gland;
RA   Hedrich K., Hehr A.J., Hansmann I., Hehr U.;
RT   "Molecular characterization of the human SIX2 gene: alternative
RT   polyadenylation and localization within the HPE2 critical region 2p21.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20515681; DOI=10.1016/j.ydbio.2010.05.509;
RA   He G., Tavella S., Hanley K.P., Self M., Oliver G., Grifone R., Hanley N.,
RA   Ward C., Bobola N.;
RT   "Inactivation of Six2 in mouse identifies a novel genetic mechanism
RT   controlling development and growth of the cranial base.";
RL   Dev. Biol. 344:720-730(2010).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=22703800; DOI=10.1016/j.jpedsurg.2012.03.034;
RA   Murphy A.J., Pierce J., de Caestecker C., Taylor C., Anderson J.R.,
RA   Perantoni A.O., de Caestecker M.P., Lovvorn H.N. III;
RT   "SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain
RT   active in primitive elements of Wilms' tumor.";
RL   J. Pediatr. Surg. 47:1239-1249(2012).
RN   [7]
RP   FUNCTION IN CELL MIGRATION AND CELL PROLIFERATION.
RX   PubMed=22995329; DOI=10.1016/j.humpath.2012.05.021;
RA   Senanayake U., Koller K., Pichler M., Leuschner I., Strohmaier H.,
RA   Hadler U., Das S., Hoefler G., Guertl B.;
RT   "The pluripotent renal stem cell regulator SIX2 is activated in renal
RT   neoplasms and influences cellular proliferation and migration.";
RL   Hum. Pathol. 44:336-345(2013).
RN   [8]
RP   VARIANTS PHE-43; LEU-241 AND ASN-276.
RX   PubMed=18305125; DOI=10.1681/asn.2006111282;
RA   Weber S., Taylor J.C., Winyard P., Baker K.F., Sullivan-Brown J.,
RA   Schild R., Knueppel T., Zurowska A.M., Caldas-Alfonso A., Litwin M.,
RA   Emre S., Ghiggeri G.M., Bakkaloglu A., Mehls O., Antignac C., Schaefer F.,
RA   Burdine R.D.;
RT   "SIX2 and BMP4 mutations associate with anomalous kidney development.";
RL   J. Am. Soc. Nephrol. 19:891-903(2008).
CC   -!- FUNCTION: Transcription factor that plays an important role in the
CC       development of several organs, including kidney, skull and stomach.
CC       During kidney development, maintains cap mesenchyme multipotent nephron
CC       progenitor cells in an undifferentiated state by opposing the inductive
CC       signals emanating from the ureteric bud and cooperates with WNT9B to
CC       promote renewing progenitor cells proliferation. Acts through its
CC       interaction with TCF7L2 and OSR1 in a canonical Wnt signaling
CC       independent manner preventing transcription of differentiation genes in
CC       cap mesenchyme such as WNT4. Also acts independently of OSR1 to
CC       activate expression of many cap mesenchyme genes, including itself,
CC       GDNF and OSR1. During craniofacial development plays a role in growth
CC       and elongation of the cranial base through regulation of chondrocyte
CC       differentiation. During stomach organogenesis, controls pyloric
CC       sphincter formation and mucosal growth through regulation of a gene
CC       network including NKX2-5, BMPR1B, BMP4, SOX9 and GREM1. During
CC       branchial arch development, acts to mediate HOXA2 control over the
CC       insulin-like growth factor pathway. Also may be involved in limb tendon
CC       and ligament development (By similarity). Plays a role in cell
CC       proliferation and migration. {ECO:0000250|UniProtKB:Q62232,
CC       ECO:0000269|PubMed:22995329}.
CC   -!- SUBUNIT: Interacts with TCF7L2; in a canonical Wnt signaling
CC       independent manner; prevents transcription of differentiation genes in
CC       cap mesenchyme. Interacts with OSR1; form a strong repressor complex
CC       with TCF7L2, TLE2 and TLE3 to prevent the activation of Wnt/beta-
CC       catenin target genes in the cap mesenchyme. Interacts with HOXA11, EYA1
CC       and EYA3. {ECO:0000250|UniProtKB:Q62232}.
CC   -!- INTERACTION:
CC       Q9NPC8; Q8N3C7: CLIP4; NbExp=3; IntAct=EBI-12695166, EBI-5655540;
CC       Q9NPC8; Q04726-4: TLE3; NbExp=3; IntAct=EBI-12695166, EBI-12014388;
CC       Q9NPC8; Q08117-2: TLE5; NbExp=3; IntAct=EBI-12695166, EBI-11741437;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q62232}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in skeletal muscle. Expressed in
CC       Wilms' tumor and in the cap mesenchyme of fetal kidney (at protein
CC       level). {ECO:0000269|PubMed:22703800}.
CC   -!- DEVELOPMENTAL STAGE: Found at 48 dpc in the anterior cranial base with
CC       detection concentrated in the sphenoid precursor. Expression is also
CC       detected in the pituitary gland. {ECO:0000269|PubMed:20515681}.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF136939; AAF69031.1; -; Genomic_DNA.
DR   EMBL; AF136940; AAF69032.1; -; mRNA.
DR   EMBL; AF332196; AAK16581.1; -; mRNA.
DR   EMBL; AF332197; AAK16582.1; -; mRNA.
DR   EMBL; AF332198; AAK16583.1; -; Genomic_DNA.
DR   EMBL; AF323498; AAK06773.1; -; Genomic_DNA.
DR   EMBL; BT020100; AAV38903.1; -; mRNA.
DR   CCDS; CCDS1822.1; -.
DR   RefSeq; NP_058628.3; NM_016932.4.
DR   SMR; Q9NPC8; -.
DR   BioGrid; 115959; 22.
DR   CORUM; Q9NPC8; -.
DR   IntAct; Q9NPC8; 21.
DR   STRING; 9606.ENSP00000304502; -.
DR   iPTMnet; Q9NPC8; -.
DR   PhosphoSitePlus; Q9NPC8; -.
DR   BioMuta; SIX2; -.
DR   DMDM; 12230598; -.
DR   EPD; Q9NPC8; -.
DR   jPOST; Q9NPC8; -.
DR   MassIVE; Q9NPC8; -.
DR   MaxQB; Q9NPC8; -.
DR   PaxDb; Q9NPC8; -.
DR   PeptideAtlas; Q9NPC8; -.
DR   PRIDE; Q9NPC8; -.
DR   ProteomicsDB; 81972; -.
DR   Antibodypedia; 29934; 164 antibodies.
DR   DNASU; 10736; -.
DR   Ensembl; ENST00000303077; ENSP00000304502; ENSG00000170577.
DR   GeneID; 10736; -.
DR   KEGG; hsa:10736; -.
DR   UCSC; uc002ruo.4; human.
DR   CTD; 10736; -.
DR   DisGeNET; 10736; -.
DR   GeneCards; SIX2; -.
DR   HGNC; HGNC:10888; SIX2.
DR   HPA; ENSG00000170577; Tissue enhanced (salivary gland, skeletal muscle).
DR   MalaCards; SIX2; -.
DR   MIM; 604994; gene.
DR   neXtProt; NX_Q9NPC8; -.
DR   OpenTargets; ENSG00000170577; -.
DR   Orphanet; 488437; SIX2-related frontonasal dysplasia.
DR   PharmGKB; PA35788; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00940000158292; -.
DR   HOGENOM; CLU_046914_2_0_1; -.
DR   InParanoid; Q9NPC8; -.
DR   KO; K19472; -.
DR   OMA; ASMNGNK; -.
DR   OrthoDB; 1061244at2759; -.
DR   PhylomeDB; Q9NPC8; -.
DR   TreeFam; TF315545; -.
DR   ChiTaRS; SIX2; human.
DR   GeneWiki; SIX2; -.
DR   GenomeRNAi; 10736; -.
DR   Pharos; Q9NPC8; Tbio.
DR   PRO; PR:Q9NPC8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9NPC8; protein.
DR   Bgee; ENSG00000170577; Expressed in tendon of biceps brachii and 122 other tissues.
DR   Genevisible; Q9NPC8; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005667; C:transcription factor complex; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; NAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0048856; P:anatomical structure development; IBA:GO_Central.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0072137; P:condensed mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IMP:UniProtKB.
DR   GO; GO:0072161; P:mesenchymal cell differentiation involved in kidney development; ISS:UniProtKB.
DR   GO; GO:0072038; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:0097168; P:mesenchymal stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007501; P:mesodermal cell fate specification; ISS:UniProtKB.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0072006; P:nephron development; ISS:UniProtKB.
DR   GO; GO:0072028; P:nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0090189; P:regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..291
FT                   /note="Homeobox protein SIX2"
FT                   /id="PRO_0000049297"
FT   DNA_BIND        124..183
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   VARIANT         43
FT                   /note="L -> F (in a renal hypodysplasia patient;
FT                   dbSNP:rs142188105)"
FT                   /evidence="ECO:0000269|PubMed:18305125"
FT                   /id="VAR_071207"
FT   VARIANT         241
FT                   /note="P -> L (in a renal hypodysplasia patient;
FT                   dbSNP:rs147806994)"
FT                   /evidence="ECO:0000269|PubMed:18305125"
FT                   /id="VAR_071208"
FT   VARIANT         276
FT                   /note="D -> N (in a renal hypodysplasia patient;
FT                   dbSNP:rs201675842)"
FT                   /evidence="ECO:0000269|PubMed:18305125"
FT                   /id="VAR_071209"
SQ   SEQUENCE   291 AA;  32286 MW;  8388C3C331575BDD CRC64;
     MSMLPTFGFT QEQVACVCEV LQQGGNIERL GRFLWSLPAC EHLHKNESVL KAKAVVAFHR
     GNFRELYKIL ESHQFSPHNH AKLQQLWLKA HYIEAEKLRG RPLGAVGKYR VRRKFPLPRS
     IWDGEETSYC FKEKSRSVLR EWYAHNPYPS PREKRELAEA TGLTTTQVSN WFKNRRQRDR
     AAEAKERENN ENSNSNSHNP LNGSGKSVLG SSEDEKTPSG TPDHSSSSPA LLLSPPPPGL
     PSLHSLGHPP GPSAVPVPVP GGGGADPLQH HHGLQDSILN PMSANLVDLG S
//
ID   SKI_HUMAN               Reviewed;         728 AA.
AC   P12755; Q5SYT7;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   22-APR-2020, entry version 192.
DE   RecName: Full=Ski oncogene;
DE   AltName: Full=Proto-oncogene c-Ski;
GN   Name=SKI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2762147; DOI=10.1093/nar/17.14.5489;
RA   Nomura N., Sasamoto S., Ishii S., Date T., Matsui M., Ishizaki R.;
RT   "Isolation of human cDNA clones of ski and the ski-related gene, sno.";
RL   Nucleic Acids Res. 17:5489-5500(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   INTERACTION WITH HIPK2; SMAD2; SMAD3 AND SMAD4.
RX   PubMed=12874272; DOI=10.1074/jbc.m307112200;
RA   Harada J., Kokura K., Kanei-Ishii C., Nomura T., Khan M.M., Kim Y.,
RA   Ishii S.;
RT   "Requirement of the co-repressor homeodomain-interacting protein kinase 2
RT   for ski-mediated inhibition of bone morphogenetic protein-induced
RT   transcriptional activation.";
RL   J. Biol. Chem. 278:38998-39005(2003).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH PRDM16 AND SMAD3.
RX   PubMed=19049980; DOI=10.1074/jbc.m808989200;
RA   Takahata M., Inoue Y., Tsuda H., Imoto I., Koinuma D., Hayashi M.,
RA   Ichikura T., Yamori T., Nagasaki K., Yoshida M., Matsuoka M., Morishita K.,
RA   Yuki K., Hanyu A., Miyazawa K., Inazawa J., Miyazono K., Imamura T.;
RT   "SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal
RT   in gastric cancer cells.";
RL   J. Biol. Chem. 284:3334-3344(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383; SER-432 AND SER-720, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANTS SGS LEU-31; VAL-32; PRO-32; CYS-34; VAL-34; SER-34; GLN-35;
RP   SER-35; 94-SER--SER-97 DEL AND 95-ASP--SER-97 DEL.
RX   PubMed=23103230; DOI=10.1016/j.ajhg.2012.10.002;
RA   Carmignac V., Thevenon J., Ades L., Callewaert B., Julia S.,
RA   Thauvin-Robinet C., Gueneau L., Courcet J.B., Lopez E., Holman K.,
RA   Renard M., Plauchu H., Plessis G., De Backer J., Child A., Arno G.,
RA   Duplomb L., Callier P., Aral B., Vabres P., Gigot N., Arbustini E.,
RA   Grasso M., Robinson P.N., Goizet C., Baumann C., Di Rocco M.,
RA   Sanchez Del Pozo J., Huet F., Jondeau G., Collod-Beroud G., Beroud C.,
RA   Amiel J., Cormier-Daire V., Riviere J.B., Boileau C., De Paepe A.,
RA   Faivre L.;
RT   "In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg
RT   syndrome.";
RL   Am. J. Hum. Genet. 91:950-957(2012).
RN   [9]
RP   VARIANTS SGS ARG-21; VAL-32; ASP-34; CYS-34; SER-34; SER-35; 95-ASP--SER-97
RP   DEL; GLU-116 AND ARG-117.
RX   PubMed=23023332; DOI=10.1038/ng.2421;
RA   Doyle A.J., Doyle J.J., Bessling S.L., Maragh S., Lindsay M.E.,
RA   Schepers D., Gillis E., Mortier G., Homfray T., Sauls K., Norris R.A.,
RA   Huso N.D., Leahy D., Mohr D.W., Caulfield M.J., Scott A.F., Destree A.,
RA   Hennekam R.C., Arn P.H., Curry C.J., Van Laer L., McCallion A.S.,
RA   Loeys B.L., Dietz H.C.;
RT   "Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome
RT   with aortic aneurysm.";
RL   Nat. Genet. 44:1249-1254(2012).
RN   [10]
RP   VARIANTS SGS SER-35 AND GLU-116.
RX   PubMed=24357594; DOI=10.1002/ajmg.a.36340;
RG   FORGE Canada Consortium;
RA   Au P.Y., Racher H.E., Graham J.M. Jr., Kramer N., Lowry R.B.,
RA   Parboosingh J.S., Innes A.M.;
RT   "De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg syndrome:
RT   two new cases and a clinical review.";
RL   Am. J. Med. Genet. A 164A:676-684(2014).
RN   [11]
RP   VARIANTS SGS THR-28; LEU-31; VAL-32; VAL-34; ALA-34; ASP-34; SER-34 AND
RP   SER-35.
RX   PubMed=24736733; DOI=10.1038/ejhg.2014.61;
RA   Schepers D., Doyle A.J., Oswald G., Sparks E., Myers L., Willems P.J.,
RA   Mansour S., Simpson M.A., Frysira H., Maat-Kievit A., Van Minkelen R.,
RA   Hoogeboom J.M., Mortier G.R., Titheradge H., Brueton L., Starr L.,
RA   Stark Z., Ockeloen C., Lourenco C.M., Blair E., Hobson E., Hurst J.,
RA   Maystadt I., Destree A., Girisha K.M., Miller M., Dietz H.C., Loeys B.,
RA   Van Laer L.;
RT   "The SMAD-binding domain of SKI: a hotspot for de novo mutations causing
RT   Shprintzen-Goldberg syndrome.";
RL   Eur. J. Hum. Genet. 23:224-228(2015).
CC   -!- FUNCTION: May play a role in terminal differentiation of skeletal
CC       muscle cells but not in the determination of cells to the myogenic
CC       lineage. Functions as a repressor of TGF-beta signaling.
CC       {ECO:0000269|PubMed:19049980}.
CC   -!- SUBUNIT: Interacts with SMAD2, SMAD3 and SMAD4. Interacts with HIPK2.
CC       Part of a complex with HIPK2 and SMAD1/2/3. Interacts with PRDM16 and
CC       SMAD3; the interaction with PRDM16 promotes the recruitment SMAD3-HDAC1
CC       complex on the promoter of TGF-beta target genes.
CC       {ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:19049980}.
CC   -!- INTERACTION:
CC       P12755; Q9QUI1: Fam89b; Xeno; NbExp=6; IntAct=EBI-347281, EBI-6503100;
CC       P12755; O75376: NCOR1; NbExp=4; IntAct=EBI-347281, EBI-347233;
CC       P12755; Q60974: Ncor1; Xeno; NbExp=5; IntAct=EBI-347281, EBI-349004;
CC       P12755; Q6ZSG1: RNF165; NbExp=2; IntAct=EBI-347281, EBI-2129206;
CC       P12755; Q8VI24: Satb2; Xeno; NbExp=2; IntAct=EBI-347281, EBI-5737999;
CC       P12755; Q96ST3: SIN3A; NbExp=3; IntAct=EBI-347281, EBI-347218;
CC       P12755; Q15796: SMAD2; NbExp=10; IntAct=EBI-347281, EBI-1040141;
CC       P12755; P84022: SMAD3; NbExp=8; IntAct=EBI-347281, EBI-347161;
CC       P12755; Q13485: SMAD4; NbExp=13; IntAct=EBI-347281, EBI-347263;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Ubiquitinated by RNF165, promoting proteasomal degradation,
CC       leading to enhance the BMP-Smad signaling.
CC       {ECO:0000250|UniProtKB:Q60698}.
CC   -!- DISEASE: Shprintzen-Goldberg craniosynostosis syndrome (SGS)
CC       [MIM:182212]: A very rare syndrome characterized by a marfanoid
CC       habitus, craniosynostosis, characteristic dysmorphic facial features,
CC       skeletal and cardiovascular abnormalities, mental retardation,
CC       developmental delay and learning disabilities.
CC       {ECO:0000269|PubMed:23023332, ECO:0000269|PubMed:23103230,
CC       ECO:0000269|PubMed:24357594, ECO:0000269|PubMed:24736733}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the SKI family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15218; CAA33288.1; -; mRNA.
DR   EMBL; AL590822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS39.1; -.
DR   PIR; S06053; TVHUSK.
DR   RefSeq; NP_003027.1; NM_003036.3.
DR   PDB; 1MR1; X-ray; 2.85 A; C/D=219-313.
DR   PDB; 1SBX; X-ray; 1.65 A; A=91-192.
DR   PDB; 5XOD; X-ray; 1.85 A; B=15-40.
DR   PDBsum; 1MR1; -.
DR   PDBsum; 1SBX; -.
DR   PDBsum; 5XOD; -.
DR   SMR; P12755; -.
DR   BioGrid; 112388; 128.
DR   CORUM; P12755; -.
DR   DIP; DIP-31514N; -.
DR   IntAct; P12755; 20.
DR   MINT; P12755; -.
DR   STRING; 9606.ENSP00000367797; -.
DR   iPTMnet; P12755; -.
DR   PhosphoSitePlus; P12755; -.
DR   BioMuta; SKI; -.
DR   DMDM; 134517; -.
DR   EPD; P12755; -.
DR   jPOST; P12755; -.
DR   MassIVE; P12755; -.
DR   MaxQB; P12755; -.
DR   PaxDb; P12755; -.
DR   PeptideAtlas; P12755; -.
DR   PRIDE; P12755; -.
DR   ProteomicsDB; 52865; -.
DR   Antibodypedia; 4180; 182 antibodies.
DR   Ensembl; ENST00000378536; ENSP00000367797; ENSG00000157933.
DR   GeneID; 6497; -.
DR   KEGG; hsa:6497; -.
DR   UCSC; uc001aja.5; human.
DR   CTD; 6497; -.
DR   DisGeNET; 6497; -.
DR   GeneCards; SKI; -.
DR   GeneReviews; SKI; -.
DR   HGNC; HGNC:10896; SKI.
DR   HPA; ENSG00000157933; Tissue enhanced (brain).
DR   MalaCards; SKI; -.
DR   MIM; 164780; gene.
DR   MIM; 182212; phenotype.
DR   neXtProt; NX_P12755; -.
DR   OpenTargets; ENSG00000157933; -.
DR   Orphanet; 1606; 1p36 deletion syndrome.
DR   Orphanet; 2462; Shprintzen-Goldberg syndrome.
DR   PharmGKB; PA35796; -.
DR   eggNOG; ENOG410IFDK; Eukaryota.
DR   eggNOG; ENOG410Y8AU; LUCA.
DR   GeneTree; ENSGT00940000160546; -.
DR   HOGENOM; CLU_025786_0_0_1; -.
DR   InParanoid; P12755; -.
DR   OMA; QIRVCDK; -.
DR   OrthoDB; 633642at2759; -.
DR   PhylomeDB; P12755; -.
DR   TreeFam; TF324133; -.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   SignaLink; P12755; -.
DR   SIGNOR; P12755; -.
DR   ChiTaRS; SKI; human.
DR   EvolutionaryTrace; P12755; -.
DR   GeneWiki; SKI_protein; -.
DR   GenomeRNAi; 6497; -.
DR   Pharos; P12755; Tbio.
DR   PRO; PR:P12755; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P12755; protein.
DR   Bgee; ENSG00000157933; Expressed in cerebellar hemisphere and 212 other tissues.
DR   Genevisible; P12755; HS.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005667; C:transcription factor complex; ISS:BHF-UCL.
DR   GO; GO:0017053; C:transcriptional repressor complex; ISS:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0046811; F:histone deacetylase inhibitor activity; ISS:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0046332; F:SMAD binding; IPI:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISS:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; TAS:Reactome.
DR   GO; GO:0060349; P:bone morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0043010; P:camera-type eye development; ISS:BHF-UCL.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0048870; P:cell motility; NAS:BHF-UCL.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060325; P:face morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISS:BHF-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; ISS:BHF-UCL.
DR   GO; GO:0014902; P:myotube differentiation; IDA:UniProtKB.
DR   GO; GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0010626; P:negative regulation of Schwann cell proliferation; IGI:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0001843; P:neural tube closure; ISS:BHF-UCL.
DR   GO; GO:0043585; P:nose morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0021772; P:olfactory bulb development; ISS:BHF-UCL.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; NAS:BHF-UCL.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISS:BHF-UCL.
DR   GO; GO:0060021; P:roof of mouth development; ISS:BHF-UCL.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISS:BHF-UCL.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISS:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; NAS:BHF-UCL.
DR   Gene3D; 3.10.260.20; -; 1.
DR   Gene3D; 3.10.390.10; -; 1.
DR   InterPro; IPR014890; c-SKI_SMAD4-bd_dom.
DR   InterPro; IPR009061; DNA-bd_dom_put_sf.
DR   InterPro; IPR010919; SAND-like_dom_sf.
DR   InterPro; IPR028760; Ski.
DR   InterPro; IPR003380; SKI/SNO/DAC.
DR   InterPro; IPR037000; Ski_DNA-bd_sf.
DR   InterPro; IPR023216; Tscrpt_reg_SKI_SnoN.
DR   PANTHER; PTHR10005; PTHR10005; 1.
DR   PANTHER; PTHR10005:SF15; PTHR10005:SF15; 1.
DR   Pfam; PF08782; c-SKI_SMAD_bind; 1.
DR   Pfam; PF02437; Ski_Sno; 1.
DR   SMART; SM01046; c-SKI_SMAD_bind; 1.
DR   SUPFAM; SSF46955; SSF46955; 1.
DR   SUPFAM; SSF63763; SSF63763; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Craniosynostosis; Disease mutation; Nucleus;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   CHAIN           1..728
FT                   /note="Ski oncogene"
FT                   /id="PRO_0000129382"
FT   COILED          536..710
FT                   /evidence="ECO:0000255"
FT   MOD_RES         383
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         432
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         480
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         720
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VARIANT         21
FT                   /note="L -> R (in SGS; dbSNP:rs869312902)"
FT                   /evidence="ECO:0000269|PubMed:23023332"
FT                   /id="VAR_071170"
FT   VARIANT         28
FT                   /note="S -> T (in SGS)"
FT                   /evidence="ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071659"
FT   VARIANT         31
FT                   /note="S -> L (in SGS)"
FT                   /evidence="ECO:0000269|PubMed:23103230,
FT                   ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071171"
FT   VARIANT         32
FT                   /note="L -> P (in SGS)"
FT                   /evidence="ECO:0000269|PubMed:23103230"
FT                   /id="VAR_071172"
FT   VARIANT         32
FT                   /note="L -> V (in SGS; dbSNP:rs387907304)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071173"
FT   VARIANT         34
FT                   /note="G -> A (in SGS)"
FT                   /evidence="ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071660"
FT   VARIANT         34
FT                   /note="G -> C (in SGS; dbSNP:rs387907306)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:23103230"
FT                   /id="VAR_071174"
FT   VARIANT         34
FT                   /note="G -> D (in SGS; dbSNP:rs387907305)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071175"
FT   VARIANT         34
FT                   /note="G -> S (in SGS; dbSNP:rs387907306)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071176"
FT   VARIANT         34
FT                   /note="G -> V (in SGS; dbSNP:rs387907305)"
FT                   /evidence="ECO:0000269|PubMed:23103230,
FT                   ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071177"
FT   VARIANT         35
FT                   /note="P -> Q (in SGS; dbSNP:rs397514589)"
FT                   /evidence="ECO:0000269|PubMed:23103230"
FT                   /id="VAR_071178"
FT   VARIANT         35
FT                   /note="P -> S (in SGS; dbSNP:rs397514590)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24357594,
FT                   ECO:0000269|PubMed:24736733"
FT                   /id="VAR_071179"
FT   VARIANT         94..97
FT                   /note="Missing (in SGS)"
FT                   /evidence="ECO:0000269|PubMed:23103230"
FT                   /id="VAR_071180"
FT   VARIANT         95..97
FT                   /note="Missing (in SGS)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:23103230"
FT                   /id="VAR_071181"
FT   VARIANT         116
FT                   /note="G -> E (in SGS; dbSNP:rs387907303)"
FT                   /evidence="ECO:0000269|PubMed:23023332,
FT                   ECO:0000269|PubMed:24357594"
FT                   /id="VAR_071182"
FT   VARIANT         117
FT                   /note="G -> R (in SGS; dbSNP:rs869312901)"
FT                   /evidence="ECO:0000269|PubMed:23023332"
FT                   /id="VAR_071183"
FT   HELIX           16..27
FT                   /evidence="ECO:0000244|PDB:5XOD"
FT   TURN            28..30
FT                   /evidence="ECO:0000244|PDB:5XOD"
FT   STRAND          101..105
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   STRAND          108..115
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   STRAND          118..122
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   HELIX           123..127
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   TURN            128..133
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   HELIX           136..145
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   HELIX           155..163
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   STRAND          175..178
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   HELIX           179..190
FT                   /evidence="ECO:0000244|PDB:1SBX"
FT   STRAND          219..222
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   STRAND          228..232
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   HELIX           234..236
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   STRAND          245..247
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   TURN            248..250
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   HELIX           256..259
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   STRAND          269..275
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   HELIX           278..280
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   HELIX           281..284
FT                   /evidence="ECO:0000244|PDB:1MR1"
FT   HELIX           296..310
FT                   /evidence="ECO:0000244|PDB:1MR1"
SQ   SEQUENCE   728 AA;  80005 MW;  9B78C4840A28C2DA CRC64;
     MEAAAGGRGC FQPHPGLQKT LEQFHLSSMS SLGGPAAFSA RWAQEAYKKE SAKEAGAAAV
     PAPVPAATEP PPVLHLPAIQ PPPPVLPGPF FMPSDRSTER CETVLEGETI SCFVVGGEKR
     LCLPQILNSV LRDFSLQQIN AVCDELHIYC SRCTADQLEI LKVMGILPFS APSCGLITKT
     DAERLCNALL YGGAYPPPCK KELAASLALG LELSERSVRV YHECFGKCKG LLVPELYSSP
     SAACIQCLDC RLMYPPHKFV VHSHKALENR TCHWGFDSAN WRAYILLSQD YTGKEEQARL
     GRCLDDVKEK FDYGNKYKRR VPRVSSEPPA SIRPKTDDTS SQSPAPSEKD KPSSWLRTLA
     GSSNKSLGCV HPRQRLSAFR PWSPAVSASE KELSPHLPAL IRDSFYSYKS FETAVAPNVA
     LAPPAQQKVV SSPPCAAAVS RAPEPLATCT QPRKRKLTVD TPGAPETLAP VAAPEEDKDS
     EAEVEVESRE EFTSSLSSLS SPSFTSSSSA KDLGSPGARA LPSAVPDAAA PADAPSGLEA
     ELEHLRQALE GGLDTKEAKE KFLHEVVKMR VKQEEKLSAA LQAKRSLHQE LEFLRVAKKE
     KLREATEAKR NLRKEIERLR AENEKKMKEA NESRLRLKRE LEQARQARVC DKGCEAGRLR
     AKYSAQIEDL QVKLQHAEAD REQLRADLLR EREAREHLEK VVKELQEQLW PRARPEAAGS
     EGAAELEP
//
ID   B4E1W8_HUMAN            Unreviewed;      1080 AA.
AC   B4E1W8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 69.
DE   SubName: Full=cDNA FLJ60213, highly similar to Tenascin {ECO:0000313|EMBL:BAG64930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64930.1};
RN   [1] {ECO:0000313|EMBL:BAG64930.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG64930.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK304015; BAG64930.1; -; mRNA.
DR   RefSeq; NP_002151.2; NM_002160.3.
DR   MaxQB; B4E1W8; -.
DR   PeptideAtlas; B4E1W8; -.
DR   PRIDE; B4E1W8; -.
DR   GeneID; 3371; -.
DR   KEGG; hsa:3371; -.
DR   CTD; 3371; -.
DR   KO; K06252; -.
DR   OrthoDB; 18592at2759; -.
DR   GenomeRNAi; 3371; -.
DR   Genevisible; B4E1W8; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IEA:InterPro.
DR   CDD; cd00063; FN3; 5.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR041161; EGF_Tenascin.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR46708:SF1; PTHR46708:SF1; 2.
DR   Pfam; PF07974; EGF_2; 4.
DR   Pfam; PF18720; EGF_Tenascin; 9.
DR   Pfam; PF00041; fn3; 5.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00060; FN3; 4.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS50853; FN3; 4.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           20..1080
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002804054"
FT   DOMAIN          186..217
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          280..311
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          373..404
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          466..497
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          559..590
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          625..715
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          716..804
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          805..896
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          961..1052
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   COILED          119..139
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   DISULFID        190..200
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        207..216
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        284..294
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        301..310
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        377..387
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        394..403
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        470..480
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        487..496
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        563..573
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        580..589
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   1080 AA;  118424 MW;  88ED7B4760FF9310 CRC64;
     MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
     GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
     ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
     KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
     GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
     CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
     CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
     GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
     VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGRG
     RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
     LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
     EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
     KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
     ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
     DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
     RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT ITAKFTTDLD
     SPRDLTATEV QSETALLTWR PPRASVTGYL LVYESVDGTV KEVIVGPDTT SYSLADLSPS
     LFLHFIQQKP EKQYCFHFKD MINIINIIMM MMMMKTKDFS RDLSFQNISG QYLIVFFFFK
//
ID   J3QSU6_HUMAN            Unreviewed;      2019 AA.
AC   J3QSU6;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   22-APR-2020, entry version 62.
DE   SubName: Full=Tenascin {ECO:0000313|Ensembl:ENSP00000339553};
GN   Name=TNC {ECO:0000313|Ensembl:ENSP00000339553};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000339553, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000339553, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000339553}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL162425; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006717161.1; XM_006717098.3.
DR   SwissPalm; J3QSU6; -.
DR   jPOST; J3QSU6; -.
DR   PeptideAtlas; J3QSU6; -.
DR   PRIDE; J3QSU6; -.
DR   Antibodypedia; 1348; 946 antibodies.
DR   Ensembl; ENST00000341037; ENSP00000339553; ENSG00000041982.
DR   GeneID; 3371; -.
DR   UCSC; uc064vgq.1; human.
DR   CTD; 3371; -.
DR   EuPathDB; HostDB:ENSG00000041982.15; -.
DR   HGNC; HGNC:5318; TNC.
DR   OpenTargets; ENSG00000041982; -.
DR   GeneTree; ENSGT00940000155188; -.
DR   OrthoDB; 18592at2759; -.
DR   ChiTaRS; TNC; human.
DR   GenomeRNAi; 3371; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000041982; Expressed in layer of synovial tissue and 212 other tissues.
DR   ExpressionAtlas; J3QSU6; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IEA:InterPro.
DR   CDD; cd00063; FN3; 13.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 13.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR041161; EGF_Tenascin.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR46708:SF1; PTHR46708:SF1; 3.
DR   Pfam; PF07974; EGF_2; 4.
DR   Pfam; PF18720; EGF_Tenascin; 9.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 13.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 13.
DR   SUPFAM; SSF49265; SSF49265; 10.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 13.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Proteomics identification {ECO:0000213|EPD:J3QSU6,
KW   ECO:0000213|MaxQB:J3QSU6, ECO:0000213|PeptideAtlas:J3QSU6,
KW   ECO:0000213|ProteomicsDB:J3QSU6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           20..2019
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003777214"
FT   DOMAIN          186..217
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          280..311
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          373..404
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          466..497
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          559..590
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          625..715
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          716..804
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          805..894
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          895..990
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          991..1075
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1076..1165
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1167..1259
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1260..1348
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1349..1438
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1440..1529
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1530..1619
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1620..1706
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1707..1795
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1793..2008
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51406"
FT   COILED          119..139
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   DISULFID        190..200
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        207..216
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        284..294
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        301..310
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        377..387
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        394..403
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        470..480
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        487..496
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        563..573
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        580..589
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   2019 AA;  220853 MW;  8390133DD3663EE9 CRC64;
     MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
     GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
     ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
     KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
     GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
     CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
     CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
     GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
     VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGQG
     RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
     LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
     EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
     KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
     ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
     DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
     RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT TLTGLRPGTE
     YGIGVSAVKE DKESNPATIN AATELDTPKD LQVSETAETS LTLLWKTPLA KFDRYRLNYS
     LPTGQWVGVQ LPRNTTSYVL RGLEPGQEYN VLLTAEKGRH KSKPARVKAS TEQAPELENL
     TVTEVGWDGL RLNWTAADQA YEHFIIQVQE ANKVEAARNL TVPGSLRAVD IPGLKAATPY
     TVSIYGVIQG YRTPVLSAEA STGETPNLGE VVVAEVGWDA LKLNWTAPEG AYEYFFIQVQ
     EADTVEAAQN LTVPGGLRST DLPGLKAATH YTITIRGVTQ DFSTTPLSVE VLTEDLPQLG
     DLAVSEVGWD GLRLNWTAAD NAYEHFVIQV QEVNKVEAAQ NLTLPGSLRA VDIPGLEAAT
     PYRVSIYGVI RGYRTPVLSA EASTAKEPEI GNLNVSDITP ESFNLSWMAT DGIFETFTIE
     IIDSNRLLET VEYNISGAER TAHISGLPPS TDFIVYLSGL APSIRTKTIS ATATTEAEPE
     VDNLLVSDAT PDGFRLSWTA DEGVFDNFVL KIRDTKKQSE PLEITLLAPE RTRDITGLRE
     ATEYEIELYG ISKGRRSQTV SAIATTAMGS PKEVIFSDIT ENSATVSWRA PTAQVESFRI
     TYVPITGGTP SMVTVDGTKT QTRLVKLIPG VEYLVSIIAM KGFEESEPVS GSFTTALDGP
     SGLVTANITD SEALARWQPA IATVDSYVIS YTGEKVPEIT RTVSGNTVEY ALTDLEPATE
     YTLRIFAEKG PQKSSTITAK FTTDLDSPRD LTATEVQSET ALLTWRPPRA SVTGYLLVYE
     SVDGTVKEVI VGPDTTSYSL ADLSPSTHYT AKIQALNGPL RSNMIQTIFT TIGLLYPFPK
     DCSQAMLNGD TTSGLYTIYL NGDKAEALEV FCDMTSDGGG WIVFLRRKNG RENFYQNWKA
     YAAGFGDRRE EFWLGLDNLN KITAQGQYEL RVDLRDHGET AFAVYDKFSV GDAKTRYKLK
     VEGYSGTAGD SMAYHNGRSF STFDKDTDSA ITNCALSYKG AFWYRNCHRV NLMGRYGDNN
     HSQGVNWFHW KGHEHSIQFA EMKLRPSNFR NLEGRRKRA
//
ID   TENA_HUMAN              Reviewed;        2201 AA.
AC   P24821; C9IYT7; C9J575; C9J6D9; C9J848; Q14583; Q15567; Q5T7S3;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 3.
DT   22-APR-2020, entry version 224.
DE   RecName: Full=Tenascin;
DE            Short=TN;
DE   AltName: Full=Cytotactin;
DE   AltName: Full=GMEM;
DE   AltName: Full=GP 150-225;
DE   AltName: Full=Glioma-associated-extracellular matrix antigen;
DE   AltName: Full=Hexabrachion;
DE   AltName: Full=JI;
DE   AltName: Full=Myotendinous antigen;
DE   AltName: Full=Neuronectin;
DE   AltName: Full=Tenascin-C;
DE            Short=TN-C;
DE   Flags: Precursor;
GN   Name=TNC; Synonyms=HXB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-539; LEU-1677 AND
RP   GLN-2008.
RX   PubMed=1704365;
RA   Nies D.E., Hemesath T.J., Kim J.H., Gulcher J.R., Stefansson K.;
RT   "The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain
RT   protein containing unique epidermal growth factor repeats.";
RL   J. Biol. Chem. 266:2818-2823(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4 AND 5), PROTEIN SEQUENCE OF
RP   23-32, AND VARIANTS ARG-680 AND GLN-2008.
RC   TISSUE=Fetal brain, and Melanoma;
RX   PubMed=1707164; DOI=10.1093/nar/19.3.525;
RA   Siri A., Carnemolla B., Saginati M., Leprini A., Casari G., Baralle F.,
RA   Zardi L.;
RT   "Human tenascin: primary structure, pre-mRNA splicing patterns and
RT   localization of the epitopes recognized by two monoclonal antibodies.";
RL   Nucleic Acids Res. 19:525-531(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-539; LEU-1677 AND
RP   GLN-2008.
RX   PubMed=1719530; DOI=10.1073/pnas.88.21.9438;
RA   Gulcher J.R., Nies D.E., Alexakos M.J., Ravikant N.A., Sturgill M.E.,
RA   Marton L.S., Stefansson K.;
RT   "Structure of the human hexabrachion (tenascin) gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9438-9442(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LEU-1677 AND GLN-2008.
RX   PubMed=7531707; DOI=10.1074/jbc.270.7.3429;
RA   Gherzi R., Carnemolla B., Siri A., Ponassi M., Balza E., Zardi L.;
RT   "Human tenascin gene. Structure of the 5'-region, identification, and
RT   characterization of the transcription regulatory sequences.";
RL   J. Biol. Chem. 270:3429-3434(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 46-125 (ISOFORMS 1/2/3/4/5/6).
RC   TISSUE=Fetal cartilage;
RX   PubMed=7524681; DOI=10.1016/0167-4781(94)90220-8;
RA   Glumoff V., Savontaus M., Vehanen J., Vuorio E.;
RT   "Analysis of aggrecan and tenascin gene expression in mouse skeletal
RT   tissues by northern and in situ hybridization using species specific cDNA
RT   probes.";
RL   Biochim. Biophys. Acta 1219:613-622(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 431-2055 (ISOFORMS 1 AND 6), AND VARIANTS
RP   ARG-539; LEU-1677 AND GLN-2008.
RC   TISSUE=Glioblastoma;
RX   PubMed=2466295; DOI=10.1073/pnas.86.5.1588;
RA   Gulcher J.R., Nies D.E., Marton L.S., Stefansson K.;
RT   "An alternatively spliced region of the human hexabrachion contains a
RT   repeat of potential N-glycosylation sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1588-1592(1989).
RN   [8]
RP   INTERACTION WITH CSPG4.
RX   PubMed=8824254; DOI=10.1074/jbc.271.42.26110;
RA   Burg M.A., Tillet E., Timpl R., Stallcup W.B.;
RT   "Binding of the NG2 proteoglycan to type VI collagen and other
RT   extracellular matrix molecules.";
RL   J. Biol. Chem. 271:26110-26116(1996).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1809.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-1079; ASN-1093;
RP   ASN-1261; ASN-1301; ASN-1485 AND ASN-2162.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1018; ASN-1034; ASN-1184;
RP   ASN-1275; ASN-1301; ASN-1366 AND ASN-1485.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=19884327; DOI=10.1096/fj.09-140491;
RA   Martina E., Degen M., Rueegg C., Merlo A., Lino M.M., Chiquet-Ehrismann R.,
RA   Brellier F.;
RT   "Tenascin-W is a specific marker of glioma-associated blood vessels and
RT   stimulates angiogenesis in vitro.";
RL   FASEB J. 24:778-787(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-70; SER-72 AND
RP   THR-905, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   PHOSPHORYLATION AT SER-72.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF FIBRONECTIN TYPE-III 3.
RX   PubMed=1279805; DOI=10.1126/science.1279805;
RA   Leahy D.J., Hendrickson W.A., Aukhil I., Erickson H.P.;
RT   "Structure of a fibronectin type III domain from tenascin phased by MAD
RT   analysis of the selenomethionyl protein.";
RL   Science 258:987-991(1992).
RN   [17]
RP   VARIANTS DFNA56 MET-1773 AND SER-1796.
RX   PubMed=23936043; DOI=10.1371/journal.pone.0069549;
RA   Zhao Y., Zhao F., Zong L., Zhang P., Guan L., Zhang J., Wang D., Wang J.,
RA   Chai W., Lan L., Li Q., Han B., Yang L., Jin X., Yang W., Hu X., Wang X.,
RA   Li N., Li Y., Petit C., Wang J., Wang H.Y., Wang Q.;
RT   "Exome sequencing and linkage analysis identified tenascin-C (TNC) as a
RT   novel causative gene in nonsyndromic hearing loss.";
RL   PLoS ONE 8:E69549-E69549(2013).
CC   -!- FUNCTION: Extracellular matrix protein implicated in guidance of
CC       migrating neurons as well as axons during development, synaptic
CC       plasticity as well as neuronal regeneration. Promotes neurite outgrowth
CC       from cortical neurons grown on a monolayer of astrocytes. Ligand for
CC       integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-
CC       V/beta-6. In tumors, stimulates angiogenesis by elongation, migration
CC       and sprouting of endothelial cells (PubMed:19884327).
CC       {ECO:0000269|PubMed:19884327}.
CC   -!- SUBUNIT: Homohexamer; disulfide-linked. A homotrimer may be formed in
CC       the triple coiled-coil region and may be stabilized by disulfide rings
CC       at both ends. Two of such half-hexabrachions may be disulfide linked
CC       within the central globule. Interacts with CSPG4.
CC       {ECO:0000269|PubMed:8824254}.
CC   -!- INTERACTION:
CC       P24821; P20908: COL5A1; NbExp=2; IntAct=EBI-9979894, EBI-2464511;
CC       P24821; O00206: TLR4; NbExp=4; IntAct=EBI-9979894, EBI-528701;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Isoforms are produced in a tissue- and time-specific manner
CC         during development.;
CC       Name=1;
CC         IsoId=P24821-1; Sequence=Displayed;
CC       Name=2; Synonyms=HT-5;
CC         IsoId=P24821-2; Sequence=VSP_001412, VSP_001413;
CC       Name=3;
CC         IsoId=P24821-3; Sequence=VSP_001412;
CC       Name=4; Synonyms=HT-33;
CC         IsoId=P24821-4; Sequence=VSP_001413;
CC       Name=5;
CC         IsoId=P24821-5; Sequence=VSP_001414;
CC       Name=6; Synonyms=P31;
CC         IsoId=P24821-6; Sequence=VSP_001415;
CC   -!- INDUCTION: By TGFB1.
CC   -!- DISEASE: Deafness, autosomal dominant, 56 (DFNA56) [MIM:615629]: A form
CC       of non-syndromic sensorineural hearing loss. Sensorineural deafness
CC       results from damage to the neural receptors of the inner ear, the nerve
CC       pathways to the brain, or the area of the brain that receives sound
CC       information. DFNA56 is characterized by progressive hearing impairment
CC       with post-lingual onset. {ECO:0000269|PubMed:23936043}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the tenascin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TNCID42597ch9q33.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M55618; AAA88083.1; -; mRNA.
DR   EMBL; X56160; CAA39628.1; -; mRNA.
DR   EMBL; X78565; CAA55309.1; -; mRNA.
DR   EMBL; AL162425; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X80280; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M24630; AAA52703.1; -; mRNA.
DR   CCDS; CCDS6811.1; -. [P24821-1]
DR   PIR; I38337; A32160.
DR   RefSeq; NP_002151.2; NM_002160.3. [P24821-1]
DR   RefSeq; XP_005252029.1; XM_005251972.3. [P24821-4]
DR   RefSeq; XP_005252031.1; XM_005251974.3. [P24821-5]
DR   RefSeq; XP_005252032.1; XM_005251975.3. [P24821-6]
DR   RefSeq; XP_011516931.1; XM_011518629.2. [P24821-2]
DR   PDB; 1TEN; X-ray; 1.80 A; A=802-891.
DR   PDB; 2RB8; X-ray; 1.45 A; A=802-893.
DR   PDB; 2RBL; X-ray; 2.10 A; A/B/M=802-893.
DR   PDB; 6BRB; X-ray; 2.82 A; D=809-893.
DR   PDB; 6QNV; X-ray; 1.40 A; A=1979-2196.
DR   PDBsum; 1TEN; -.
DR   PDBsum; 2RB8; -.
DR   PDBsum; 2RBL; -.
DR   PDBsum; 6BRB; -.
DR   PDBsum; 6QNV; -.
DR   SMR; P24821; -.
DR   BioGrid; 109602; 4.
DR   ComplexPortal; CPX-466; Tenascin-C complex.
DR   CORUM; P24821; -.
DR   IntAct; P24821; 4.
DR   STRING; 9606.ENSP00000265131; -.
DR   ChEMBL; CHEMBL3712856; -.
DR   GlyConnect; 1792; -.
DR   iPTMnet; P24821; -.
DR   PhosphoSitePlus; P24821; -.
DR   SwissPalm; P24821; -.
DR   BioMuta; TNC; -.
DR   DMDM; 281185495; -.
DR   CPTAC; non-CPTAC-2700; -.
DR   EPD; P24821; -.
DR   jPOST; P24821; -.
DR   MassIVE; P24821; -.
DR   MaxQB; P24821; -.
DR   PaxDb; P24821; -.
DR   PeptideAtlas; P24821; -.
DR   PRIDE; P24821; -.
DR   ProteomicsDB; 54225; -. [P24821-1]
DR   ProteomicsDB; 54226; -. [P24821-2]
DR   ProteomicsDB; 54227; -. [P24821-3]
DR   ProteomicsDB; 54228; -. [P24821-4]
DR   ProteomicsDB; 54229; -. [P24821-5]
DR   ProteomicsDB; 54230; -. [P24821-6]
DR   ABCD; P24821; -.
DR   Antibodypedia; 1348; 946 antibodies.
DR   Ensembl; ENST00000350763; ENSP00000265131; ENSG00000041982. [P24821-1]
DR   Ensembl; ENST00000537320; ENSP00000443478; ENSG00000041982. [P24821-6]
DR   GeneID; 3371; -.
DR   KEGG; hsa:3371; -.
DR   UCSC; uc004bjj.6; human. [P24821-1]
DR   CTD; 3371; -.
DR   DisGeNET; 3371; -.
DR   GeneCards; TNC; -.
DR   HGNC; HGNC:5318; TNC.
DR   HPA; ENSG00000041982; Tissue enhanced (smooth).
DR   MalaCards; TNC; -.
DR   MIM; 187380; gene.
DR   MIM; 615629; phenotype.
DR   neXtProt; NX_P24821; -.
DR   OpenTargets; ENSG00000041982; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA35103; -.
DR   eggNOG; KOG1225; Eukaryota.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   GeneTree; ENSGT00940000155188; -.
DR   HOGENOM; CLU_001162_1_1_1; -.
DR   InParanoid; P24821; -.
DR   KO; K06252; -.
DR   OMA; QFVIEVQ; -.
DR   OrthoDB; 18592at2759; -.
DR   PhylomeDB; P24821; -.
DR   TreeFam; TF329915; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SIGNOR; P24821; -.
DR   ChiTaRS; TNC; human.
DR   EvolutionaryTrace; P24821; -.
DR   GeneWiki; Tenascin_C; -.
DR   GenomeRNAi; 3371; -.
DR   Pharos; P24821; Tbio.
DR   PRO; PR:P24821; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P24821; protein.
DR   Bgee; ENSG00000041982; Expressed in layer of synovial tissue and 212 other tissues.
DR   ExpressionAtlas; P24821; baseline and differential.
DR   Genevisible; P24821; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005614; C:interstitial matrix; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0098966; C:perisynaptic extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; ISS:BHF-UCL.
DR   GO; GO:0045545; F:syndecan binding; IDA:MGI.
DR   GO; GO:0060447; P:bud outgrowth involved in lung branching; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0071799; P:cellular response to prostaglandin D stimulus; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0060739; P:mesenchymal-epithelial cell signaling involved in prostate gland development; IEA:Ensembl.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0007528; P:neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0014012; P:peripheral nervous system axon regeneration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEP:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   CDD; cd00063; FN3; 15.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 15.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR041161; EGF_Tenascin.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR46708:SF1; PTHR46708:SF1; 1.
DR   Pfam; PF07974; EGF_2; 4.
DR   Pfam; PF18720; EGF_Tenascin; 9.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 15.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 15.
DR   SUPFAM; SSF49265; SSF49265; 12.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 15.
DR   PROSITE; PS01186; EGF_2; 15.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 15.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Coiled coil; Deafness;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   EGF-like domain; Extracellular matrix; Glycoprotein;
KW   Non-syndromic deafness; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000269|PubMed:1707164"
FT   CHAIN           23..2201
FT                   /note="Tenascin"
FT                   /id="PRO_0000007741"
FT   DOMAIN          174..186
FT                   /note="EGF-like 1; incomplete"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          186..217
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          217..248
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          248..280
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          280..311
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          311..342
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          342..373
FT                   /note="EGF-like 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          373..404
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          404..435
FT                   /note="EGF-like 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          435..466
FT                   /note="EGF-like 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          466..497
FT                   /note="EGF-like 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          497..528
FT                   /note="EGF-like 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          528..559
FT                   /note="EGF-like 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          559..590
FT                   /note="EGF-like 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          590..621
FT                   /note="EGF-like 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          625..715
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          716..804
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          805..894
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          895..990
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          991..1075
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1076..1165
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1167..1256
FT                   /note="Fibronectin type-III 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1258..1350
FT                   /note="Fibronectin type-III 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1351..1439
FT                   /note="Fibronectin type-III 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1440..1531
FT                   /note="Fibronectin type-III 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1533..1621
FT                   /note="Fibronectin type-III 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1622..1711
FT                   /note="Fibronectin type-III 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1712..1801
FT                   /note="Fibronectin type-III 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1802..1888
FT                   /note="Fibronectin type-III 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1889..1977
FT                   /note="Fibronectin type-III 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1975..2190
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   COILED          118..145
FT                   /evidence="ECO:0000255"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         70
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         72
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|PubMed:26091039"
FT   MOD_RES         905
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401"
FT   CARBOHYD        327
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        788
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1018
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1034
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1079
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401"
FT   CARBOHYD        1093
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401"
FT   CARBOHYD        1119
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1210
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401"
FT   CARBOHYD        1275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1366
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1392
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1445
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1455
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1485
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1534
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1809
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        2162
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18780401"
FT   DISULFID        190..200
FT                   /evidence="ECO:0000250"
FT   DISULFID        194..205
FT                   /evidence="ECO:0000250"
FT   DISULFID        207..216
FT                   /evidence="ECO:0000250"
FT   DISULFID        221..231
FT                   /evidence="ECO:0000250"
FT   DISULFID        225..236
FT                   /evidence="ECO:0000250"
FT   DISULFID        238..247
FT                   /evidence="ECO:0000250"
FT   DISULFID        252..263
FT                   /evidence="ECO:0000250"
FT   DISULFID        256..268
FT                   /evidence="ECO:0000250"
FT   DISULFID        270..279
FT                   /evidence="ECO:0000250"
FT   DISULFID        284..294
FT                   /evidence="ECO:0000250"
FT   DISULFID        288..299
FT                   /evidence="ECO:0000250"
FT   DISULFID        301..310
FT                   /evidence="ECO:0000250"
FT   DISULFID        315..325
FT                   /evidence="ECO:0000250"
FT   DISULFID        319..330
FT                   /evidence="ECO:0000250"
FT   DISULFID        332..341
FT                   /evidence="ECO:0000250"
FT   DISULFID        346..356
FT                   /evidence="ECO:0000250"
FT   DISULFID        350..361
FT                   /evidence="ECO:0000250"
FT   DISULFID        363..372
FT                   /evidence="ECO:0000250"
FT   DISULFID        377..387
FT                   /evidence="ECO:0000250"
FT   DISULFID        381..392
FT                   /evidence="ECO:0000250"
FT   DISULFID        394..403
FT                   /evidence="ECO:0000250"
FT   DISULFID        408..418
FT                   /evidence="ECO:0000250"
FT   DISULFID        412..423
FT                   /evidence="ECO:0000250"
FT   DISULFID        425..434
FT                   /evidence="ECO:0000250"
FT   DISULFID        439..449
FT                   /evidence="ECO:0000250"
FT   DISULFID        443..454
FT                   /evidence="ECO:0000250"
FT   DISULFID        456..465
FT                   /evidence="ECO:0000250"
FT   DISULFID        470..480
FT                   /evidence="ECO:0000250"
FT   DISULFID        474..485
FT                   /evidence="ECO:0000250"
FT   DISULFID        487..496
FT                   /evidence="ECO:0000250"
FT   DISULFID        501..511
FT                   /evidence="ECO:0000250"
FT   DISULFID        505..516
FT                   /evidence="ECO:0000250"
FT   DISULFID        518..527
FT                   /evidence="ECO:0000250"
FT   DISULFID        532..542
FT                   /evidence="ECO:0000250"
FT   DISULFID        536..547
FT                   /evidence="ECO:0000250"
FT   DISULFID        549..558
FT                   /evidence="ECO:0000250"
FT   DISULFID        563..573
FT                   /evidence="ECO:0000250"
FT   DISULFID        567..578
FT                   /evidence="ECO:0000250"
FT   DISULFID        580..589
FT                   /evidence="ECO:0000250"
FT   DISULFID        594..604
FT                   /evidence="ECO:0000250"
FT   DISULFID        598..609
FT                   /evidence="ECO:0000250"
FT   DISULFID        611..620
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1072..1708
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:2466295"
FT                   /id="VSP_001415"
FT   VAR_SEQ         1072..1617
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:1707164"
FT                   /id="VSP_001414"
FT   VAR_SEQ         1072..1435
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1707164"
FT                   /id="VSP_001412"
FT   VAR_SEQ         1527..1617
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:1707164"
FT                   /id="VSP_001413"
FT   VARIANT         213
FT                   /note="G -> S (in dbSNP:rs7020958)"
FT                   /id="VAR_055778"
FT   VARIANT         539
FT                   /note="Q -> R (in dbSNP:rs1757095)"
FT                   /evidence="ECO:0000269|PubMed:1704365,
FT                   ECO:0000269|PubMed:1719530, ECO:0000269|PubMed:2466295"
FT                   /id="VAR_024266"
FT   VARIANT         605
FT                   /note="V -> I (in dbSNP:rs3827816)"
FT                   /id="VAR_024267"
FT   VARIANT         680
FT                   /note="Q -> R (in dbSNP:rs1061494)"
FT                   /evidence="ECO:0000269|PubMed:1707164"
FT                   /id="VAR_024268"
FT   VARIANT         850
FT                   /note="D -> H (in dbSNP:rs3748169)"
FT                   /id="VAR_055779"
FT   VARIANT         1677
FT                   /note="I -> L (in dbSNP:rs2104772)"
FT                   /evidence="ECO:0000269|PubMed:1704365,
FT                   ECO:0000269|PubMed:1719530, ECO:0000269|PubMed:2466295,
FT                   ECO:0000269|PubMed:7531707"
FT                   /id="VAR_060738"
FT   VARIANT         1773
FT                   /note="V -> M (in DFNA56; dbSNP:rs137933052)"
FT                   /evidence="ECO:0000269|PubMed:23936043"
FT                   /id="VAR_070984"
FT   VARIANT         1781
FT                   /note="A -> T (in dbSNP:rs2274750)"
FT                   /id="VAR_020169"
FT   VARIANT         1796
FT                   /note="T -> S (in DFNA56; dbSNP:rs431905513)"
FT                   /evidence="ECO:0000269|PubMed:23936043"
FT                   /id="VAR_070985"
FT   VARIANT         2008
FT                   /note="E -> Q (in dbSNP:rs13321)"
FT                   /evidence="ECO:0000269|PubMed:1704365,
FT                   ECO:0000269|PubMed:1707164, ECO:0000269|PubMed:1719530,
FT                   ECO:0000269|PubMed:2466295, ECO:0000269|PubMed:7531707"
FT                   /id="VAR_014665"
FT   CONFLICT        244
FT                   /note="Missing (in Ref. 2; CAA39628)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        370
FT                   /note="V -> L (in Ref. 1; no nucleotide entry, 3; AAA88083
FT                   and 4; CAA55309)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1066
FT                   /note="R -> H (in Ref. 1; no nucleotide entry, 3; AAA88083
FT                   and 7; AAA52703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1600..1608
FT                   /note="SGFTQGHQT -> LWLHPRASN (in Ref. 1; no nucleotide
FT                   entry, 3; AAA88083 and 7; AAA52703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2054
FT                   /note="F -> FLH (in Ref. 1; no nucleotide entry and 3;
FT                   AAA88083)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2055
FT                   /note="W -> L (in Ref. 7; AAA52703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2140..2143
FT                   /note="YKGA -> TRG (in Ref. 2; CAA39628)"
FT                   /evidence="ECO:0000305"
FT   STRAND          807..813
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   STRAND          819..824
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   HELIX           827..829
FT                   /evidence="ECO:0000244|PDB:2RBL"
FT   STRAND          831..839
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   STRAND          842..844
FT                   /evidence="ECO:0000244|PDB:2RBL"
FT   STRAND          847..852
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   HELIX           853..855
FT                   /evidence="ECO:0000244|PDB:6BRB"
FT   STRAND          857..860
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   STRAND          868..877
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   STRAND          885..890
FT                   /evidence="ECO:0000244|PDB:2RB8"
FT   HELIX           1984..1988
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   TURN            1989..1991
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          1996..2001
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2002..2004
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2008..2015
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2018..2020
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2023..2032
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2040..2045
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2052..2055
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2058..2065
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2070..2078
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2081..2092
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2095..2097
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2101..2110
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2115..2117
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2136..2140
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2147..2149
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2151..2153
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   TURN            2163..2165
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2166..2169
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2170..2173
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   STRAND          2180..2188
FT                   /evidence="ECO:0000244|PDB:6QNV"
FT   HELIX           2189..2193
FT                   /evidence="ECO:0000244|PDB:6QNV"
SQ   SEQUENCE   2201 AA;  240853 MW;  B2BEF378AA6F1D85 CRC64;
     MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
     GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
     ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
     KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
     GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
     CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
     CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
     GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
     VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGQG
     RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
     LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
     EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
     KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
     ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
     DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
     RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT TLTGLRPGTE
     YGIGVSAVKE DKESNPATIN AATELDTPKD LQVSETAETS LTLLWKTPLA KFDRYRLNYS
     LPTGQWVGVQ LPRNTTSYVL RGLEPGQEYN VLLTAEKGRH KSKPARVKAS TEQAPELENL
     TVTEVGWDGL RLNWTAADQA YEHFIIQVQE ANKVEAARNL TVPGSLRAVD IPGLKAATPY
     TVSIYGVIQG YRTPVLSAEA STGETPNLGE VVVAEVGWDA LKLNWTAPEG AYEYFFIQVQ
     EADTVEAAQN LTVPGGLRST DLPGLKAATH YTITIRGVTQ DFSTTPLSVE VLTEEVPDMG
     NLTVTEVSWD ALRLNWTTPD GTYDQFTIQV QEADQVEEAH NLTVPGSLRS MEIPGLRAGT
     PYTVTLHGEV RGHSTRPLAV EVVTEDLPQL GDLAVSEVGW DGLRLNWTAA DNAYEHFVIQ
     VQEVNKVEAA QNLTLPGSLR AVDIPGLEAA TPYRVSIYGV IRGYRTPVLS AEASTAKEPE
     IGNLNVSDIT PESFNLSWMA TDGIFETFTI EIIDSNRLLE TVEYNISGAE RTAHISGLPP
     STDFIVYLSG LAPSIRTKTI SATATTEALP LLENLTISDI NPYGFTVSWM ASENAFDSFL
     VTVVDSGKLL DPQEFTLSGT QRKLELRGLI TGIGYEVMVS GFTQGHQTKP LRAEIVTEAE
     PEVDNLLVSD ATPDGFRLSW TADEGVFDNF VLKIRDTKKQ SEPLEITLLA PERTRDITGL
     REATEYEIEL YGISKGRRSQ TVSAIATTAM GSPKEVIFSD ITENSATVSW RAPTAQVESF
     RITYVPITGG TPSMVTVDGT KTQTRLVKLI PGVEYLVSII AMKGFEESEP VSGSFTTALD
     GPSGLVTANI TDSEALARWQ PAIATVDSYV ISYTGEKVPE ITRTVSGNTV EYALTDLEPA
     TEYTLRIFAE KGPQKSSTIT AKFTTDLDSP RDLTATEVQS ETALLTWRPP RASVTGYLLV
     YESVDGTVKE VIVGPDTTSY SLADLSPSTH YTAKIQALNG PLRSNMIQTI FTTIGLLYPF
     PKDCSQAMLN GDTTSGLYTI YLNGDKAEAL EVFCDMTSDG GGWIVFLRRK NGRENFYQNW
     KAYAAGFGDR REEFWLGLDN LNKITAQGQY ELRVDLRDHG ETAFAVYDKF SVGDAKTRYK
     LKVEGYSGTA GDSMAYHNGR SFSTFDKDTD SAITNCALSY KGAFWYRNCH RVNLMGRYGD
     NNHSQGVNWF HWKGHEHSIQ FAEMKLRPSN FRNLEGRRKR A
//
ID   Q4LE33_HUMAN            Unreviewed;      2233 AA.
AC   Q4LE33;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   26-FEB-2020, entry version 114.
DE   SubName: Full=TNC variant protein {ECO:0000313|EMBL:BAE06120.1};
DE   Flags: Fragment;
GN   Name=TNC variant protein {ECO:0000313|EMBL:BAE06120.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06120.1};
RN   [1] {ECO:0000313|EMBL:BAE06120.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAE06120.1};
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,
RA   Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long cDNAs
RT   encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB210038; BAE06120.1; -; mRNA.
DR   RefSeq; NP_002151.2; NM_002160.3.
DR   PeptideAtlas; Q4LE33; -.
DR   PRIDE; Q4LE33; -.
DR   GeneID; 3371; -.
DR   KEGG; hsa:3371; -.
DR   CTD; 3371; -.
DR   PharmGKB; PA35103; -.
DR   eggNOG; KOG1225; Eukaryota.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   KO; K06252; -.
DR   OrthoDB; 18592at2759; -.
DR   ChiTaRS; TNC; human.
DR   GenomeRNAi; 3371; -.
DR   Genevisible; Q4LE33; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IEA:InterPro.
DR   CDD; cd00063; FN3; 15.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 15.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR041161; EGF_Tenascin.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR46708:SF1; PTHR46708:SF1; 1.
DR   Pfam; PF07974; EGF_2; 4.
DR   Pfam; PF18720; EGF_Tenascin; 9.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 15.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 15.
DR   SUPFAM; SSF49265; SSF49265; 12.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 15.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN          218..249
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          312..343
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          405..436
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          498..529
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          591..622
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          657..747
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          748..836
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          837..926
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          927..1022
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1023..1107
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1108..1197
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1199..1288
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1290..1382
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1383..1471
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1472..1563
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1565..1653
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1654..1743
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1744..1833
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1834..1920
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1921..2009
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          2007..2222
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51406"
FT   REGION          101..122
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          151..171
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   DISULFID        222..232
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        239..248
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        316..326
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        333..342
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        409..419
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        426..435
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        502..512
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        519..528
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        595..605
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   DISULFID        612..621
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAE06120.1"
SQ   SEQUENCE   2233 AA;  244404 MW;  3AB15331FB1E92E7 CRC64;
     SLLCASKSPI LLKVRYPRAL EPQQHPAKPT STMGAMTQLL AGVFLAFLAL ATEGGVLKKV
     IRHKRQSGVN ATLPEENQPV VFNHVYNIKL PVGSQCSVDL ESASGEKDLA PPSEPSESFQ
     EHTVDGENQI VFTHRINIPR RACGCAAAPD VKELLSRLEE LENLVSSLRE QCTAGAGCCL
     QPATGRLDTR PFCSGRGNFS TEGCGCVCEP GWKGPNCSEP ECPGNCHLRG RCIDGQCICD
     DGFTGEDCSQ LACPSDCNDQ GKCVNGVCIC FEGYAGADCS REICPVPCSE EHGTCVDGLC
     VCHDGFAGDD CNKPLCLNNC YNRGRCVENE CVCDEGFTGE DCSELICPND CFDRGRCING
     TCYCEEGFTG EDCGKPTCPH ACHTQGRCEE GQCVCDEGFA GVDCSEKRCP ADCHNRGRCV
     DGRCECDDGF TGADCGELKC PNGCSGHGRC VNGQCVCDEG YTGEDCSQLR CPNDCHSRGR
     CVEGKCVCEQ GFKGYDCSDM SCPNDCHQHG RCVNGMCVCD DGYTGEDCRD RQCPRDCSNR
     GLCVDGQCVC EDGFTGPDCA ELSCPNDCHG RGRCVNGQCV CHEGFMGKDC KEQRCPSDCH
     GQGRCVDGQC ICHEGFTGLD CGQHSCPSDC NNLGQCVSGR CICNEGYSGE DCSEVSPPKD
     LVVTEVTEET VNLAWDNEMR VTEYLVVYTP THEGGLEMQF RVPGDQTSTI IRELEPGVEY
     FIRVFAILEN KKSIPVSARV ATYLPAPEGL KFKSIKETSV EVEWDPLDIA FETWEIIFRN
     MNKEDEGEIT KSLRRPETSY RQTGLAPGQE YEISLHIVKN NTRGPGLKRV TTTRLDAPSQ
     IEVKDVTDTT ALITWFKPLA EIDGIELTYG IKDVPGDRTT IDLTEDENQY SIGNLKPDTE
     YEVSLISRRG DMSSNPAKET FTTGLDAPRN LRRVSQTDNS ITLEWRNGKA AIDSYRIKYA
     PISGGDHAEV DVPKSQQATT KTTLTGLRPG TEYGIGVSAV KEDKESNPAT INAATELDTP
     KDLQVSETAE TSLTLLWKTP LAKFDRYRLN YSLPTGQWVG VQLPRNTTSY VLRGLEPGQE
     YNVLLTAEKG RHKSKPAHVK ASTEQAPELE NLTVTEVGWD GLRLNWTAAD QAYEHFIIQV
     QEANKVEAAR NLTVPGSLRA VDIPGLKAAT PYTVSIYGVI QGYRTPVLSA EASTGETPNL
     GEVVVAEVGW DALKLNWTAP EGAYEYFFIQ VQEADTVEAA QNLTVPGGLR STDLPGLKAA
     THYTITIRGV TQDFSTTPLS VEVLTEEVPD MGNLTVTEVS WDALRLNWTT PDGTYDQFTI
     QVQEADQVEE AHNLTVPGSL RSMEIPGLRA GTPYTVTLHG EVRGHSTRPL AVEVVTEDLP
     QLGDLAVSEV GWDGLRLNWT AADNAYEHFV IQVQEVNKVE AAQNLTLPGS LRAVDIPGLE
     AATPYRVSIY GVIRGYRTPV LSAEASTAKE PEIGNLNVSD ITPESFNLSW MATDGIFETF
     TIEIIDSNRL LETVEYNISG AERTAHISGL PPSTDFIVYL SGLAPSIRTK TISATATTEA
     LPLLENLTIS DINPYGFTVS WMASENAFDS FLVTVVDSGK LLDPQEFTLS GTQRKLELRG
     LITGIGYEVM VSGFTQGHQT KPLRAEIVTE AEPEVDNLLV SDATPDGFRL SWTADEGVFD
     NFVLKIRDTK KQSEPLEITL LAPERTRDIT GLREATEYEI ELYGISKGRR SQTVSAIATT
     AMGSPKEVIF SDITENSATV SWRAPTAQVE SFRITYVPIT GGTPSMVTVD GTKTQTRLVK
     LIPGVEYLVS IIAMKGFEES EPVSGSFTTA LDGPSGLVTA NITDSEALAR WQPAIATVDS
     YVISYTGEKV PEITRTVSGN TVEYALTDLE PATEYTLRIF AEKGPQKSST ITAKFTTDLD
     SPRDLTATEV QSETALLTWR PPRASVTGYL LVYESVDGTV KEVIVGPDTT SYSLADLSPS
     THYTAKIQAL NGPLRSNMIQ TIFTTIGLLY PFPKDCSQAM LNGDTTSGLY TIYLNGDKAE
     ALEVFCDMTS DGGGWIVFLR RKNGRENFYQ NWKAYAAGFG DRREEFWLGL DNLNKITAQG
     QYELRVDLRD HGETAFAVYD KFSVGDAKTR YKLKVEGYSG TAGDSMAYHN GRSFSTFDKD
     TDSAITNCAL SYKGAFWYRN CHRVNLMGRY GDNNHSQGVN WFHWKGHEHS IQFAEMKLRP
     SNFRNLEGRR KRA
//
ID   B2RBI8_HUMAN            Unreviewed;      1124 AA.
AC   B2RBI8;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 72.
DE   SubName: Full=cDNA, FLJ95535, highly similar to Homo sapiens transcription factor 8 (represses interleukin 2 expression) (TCF8), mRNA {ECO:0000313|EMBL:BAG37235.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37235.1};
RN   [1] {ECO:0000313|EMBL:BAG37235.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG37235.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK314683; BAG37235.1; -; mRNA.
DR   RefSeq; NP_001121600.1; NM_001128128.2.
DR   RefSeq; NP_001167565.1; NM_001174094.1.
DR   RefSeq; NP_001167566.1; NM_001174095.1.
DR   RefSeq; NP_110378.3; NM_030751.5.
DR   PeptideAtlas; B2RBI8; -.
DR   PRIDE; B2RBI8; -.
DR   GeneID; 6935; -.
DR   KEGG; hsa:6935; -.
DR   CTD; 6935; -.
DR   PharmGKB; PA162409589; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   KO; K09299; -.
DR   GenomeRNAi; 6935; -.
DR   Genevisible; B2RBI8; HS.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR008598; Di19_Zn_binding_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          170..198
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          200..227
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          240..267
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          904..931
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          932..959
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          960..988
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          1..124
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..163
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          304..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          551..586
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          636..714
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          856..898
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          989..1124
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31..47
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        77..95
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        570..586
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        656..714
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        860..886
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        989..1004
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1027..1050
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1058..1085
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1124 AA;  124060 MW;  109715DD36D859D0 CRC64;
     MADGPRCKRR KQANPRRNNV TNYNTVVETN SDSDDEDKLH IVEEESVTDA ADCEGVPEDD
     LPTDQTVLPG RSSEREGNAK NCWEDDRKEG QEILGPEAQA DEAGCTVKDD ECESDAENEQ
     NHDPNVEEFL QQQDTAVIFP EAPEEDQRQG TPEASGHDEN GTPDAFSQLL TCPYCDRGYK
     RFTSLKEHIK YRHEKNEDNF SCSLCSYTFA YRTQLERHMT SHKSGRDQRH VTQSGCNRKF
     KCTECGKAFK YKHHLKEHLR IHSGEKPYEC PNCKKRFSHS GSYSSHISSK KCISLIPVNG
     RPRTGLKTSQ CSSPSLSASP GSPTRPQIRQ KIENKPLQEQ LSVNQIKTEP VDYEFKPIVV
     ASGINCSTPL QNGVFTGGGP LQATSSPQGM VQAVVLPTVG LVSPISINLS DIQNVLKVAV
     DGNVIRQVLE NNQANLASKE QETINASPIQ QGGHSVISAI SLPLVDQDGT TKIIINYSLE
     QPSQLQVVPQ NLKKENPVAT NSCKSEKLPE DLTVKSEKDK SFEGGVNDST CLLCDDCPGD
     INALPELKHY DLKQPTQPPP LPAAEAEKPE SSVSSATGDG NLSPSQPPLK NLLSLLKAYY
     ALNAQPSAEE LSKIADSVNL PLDVVKKWFE KMQAGQISVQ SSEPSSPEPG KVNIPAKNND
     QPQSANANEP QDSTVNLQSP LKMTNSPVLP VGSTTNGSRS STPSPSPLNL SSSRNTQGYL
     YTAEGAQEEP QVEPLDLSLP KQQGELLERS TITSVYQNSV YSVQEEPLNL SCAKKEPQKD
     SCVTDSEPVV NVIPPSANPI NIAIPTVTAQ LPTIVAIADQ NSVPCLRALA ANKQTILIPQ
     VAYTYSTTVS PAVQEPPLKV IQPNGNQDER QDTSSEGVSN VEDQNDSDST PPKKKMRKTE
     NGMYACDLCD KIFQKSSSLL RHKYEHTGKR PHECGICKKA FKHKHHLIEH MRLHSGEKPY
     QCDKCGKRFS HSGSYSQHMN HRYSYCKREA EERDSTEQEE AGPEILSNEH VGARASPSQG
     DSDERESLTR EEDDDSEKEE EEEDKEMEEL QEEKECEKPQ GDEEEEEEEE EVEEEEVEEA
     ENEGEEAKTE GLMKDDRAES QASSLGQKVG ESSEQVSEEK TNEA
//
ID   B4DGU2_HUMAN            Unreviewed;       906 AA.
AC   B4DGU2;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 61.
DE   SubName: Full=cDNA FLJ61244, highly similar to Transcription factor 8 {ECO:0000313|EMBL:BAG57903.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57903.1};
RN   [1] {ECO:0000313|EMBL:BAG57903.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG57903.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294775; BAG57903.1; -; mRNA.
DR   RefSeq; NP_001310570.1; NM_001323641.1.
DR   PeptideAtlas; B4DGU2; -.
DR   PRIDE; B4DGU2; -.
DR   GeneID; 6935; -.
DR   CTD; 6935; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   GenomeRNAi; 6935; -.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          22..49
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          686..713
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          714..741
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          742..770
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          85..109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          333..368
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          418..496
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          638..680
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          771..906
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        352..368
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        438..496
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        642..668
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        771..786
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        809..832
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        840..867
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   906 AA;  99336 MW;  C0D6C7726A054262 CRC64;
     MTSHKSGRDQ RHVTQSGCNR KFKCTECGKA FKYKHHLKEH LRIHSGEKPY ECPNCKKRFS
     HSGSYSSHIS SKKCISLIPV NGRPRTGLKT SQCSSPSLSA SPGSPTRPQI RQKIENKPLQ
     EQLSVNQIKT EPVDYEFKPI VVASGINCST PLQNGVFTGG GPLQATSSPQ GMVQAVVLPT
     VGLVSPISIN LSDIQNVLKV AVDGNVIRQV LENNQANLAS KEQEIINASP IQQGGHSVIS
     AISLPLVDQD GTTKIIINYS LEQPSQLQVV PQNLKKENPV ATNSCKSEKL PEDLTVKSEK
     DKSFEGGVND STCLLCDDCP GDINALPELK HYDLKQPTQP PPLPAAEAEK PESSVSSATG
     DGNLSPSQPP LKNLLSLLKA YYALNAQPSA EELSKIADSV NLPLDVVKKW FEKMQAGQIS
     VQSSEPSSPE PGKVNIPAKN NDQPQSANAN EPQDSTVNLQ SPLKMTNSPV LPVGSTTNGS
     RSSTPSPSPL NLSSSRNTQG YLYTAEGAQE EPQVEPLDLS LPKQQGELLE RSTITSVYQN
     SVYSVQEEPL NLSCAKKEPQ KDSCVTDSEP VVNVIPPSAN PINIAIPTVT AQLPTIVAIA
     DQNSVPCLRA LAANKQTILI PQVAYTYSTT VSPAVQEPPL KVIQPNGNQD ERQDTSSEGV
     SNVEDQNDSD STPPKKKMRK TENGMYACDL CDKIFQKSSS LLRHKYEHTG KRPHECGICK
     KAFKHKHHLI EHMRLHSGEK PYQCDKCGKR FSHSGSYSQH MNHRYSYCKR EAEERDSTEQ
     EEAGPEILSN EHVGARASPS QGDSDERESL TREEDEDSEK EEEEEDKEME ELQEEKECEK
     PQGDEEEEEE EEEVEEEEVE EAENEGEEAK TEGLMKDDRA ESQASSLGQK VGESSEQVSE
     EKTNEA
//
ID   ZEB1_HUMAN              Reviewed;        1124 AA.
AC   P37275; B4DJV0; B4DUW9; E9PCM7; F5H4I8; Q12924; Q13800; Q2KJ05; Q5T968;
AC   Q5VZ84; Q8NB68;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   22-APR-2020, entry version 204.
DE   RecName: Full=Zinc finger E-box-binding homeobox 1;
DE   AltName: Full=NIL-2-A zinc finger protein;
DE   AltName: Full=Negative regulator of IL2;
DE   AltName: Full=Transcription factor 8;
DE            Short=TCF-8;
GN   Name=ZEB1; Synonyms=AREB6, TCF8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8138542; DOI=10.1093/oxfordjournals.jbchem.a124267;
RA   Watanabe Y., Kawakami K., Hirayama Y., Nagano K.;
RT   "Transcription factors positively and negatively regulating the Na,K-ATPase
RT   alpha 1 subunit gene.";
RL   J. Biochem. 114:849-855(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Bachman N.J., Scarpulla R.C.;
RT   "A human zinc finger homeodomain protein homologous to the chicken delta-
RT   crystallin enhancer binding protein, delta EF1.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-798 (ISOFORM 5).
RC   TISSUE=Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 390-1124.
RX   PubMed=1840704; DOI=10.1126/science.1840704;
RA   Williams T.M., Moolten D., Burlein J., Romano J., Bhaerman R., Godillot A.,
RA   Mellon M., Rauscher F.J. III, Kant J.A.;
RT   "Identification of a zinc finger protein that inhibits IL-2 gene
RT   expression.";
RL   Science 254:1791-1794(1991).
RN   [8]
RP   INVOLVEMENT IN PPCD3.
RX   PubMed=16252232; DOI=10.1086/497348;
RA   Krafchak C.M., Pawar H., Moroi S.E., Sugar A., Lichter P.R., Mackey D.A.,
RA   Mian S., Nairus T., Elner V., Schteingart M.T., Downs C.A., Kijek T.G.,
RA   Johnson J.M., Trager E.H., Rozsa F.W., Mandal M.N.A., Epstein M.P.,
RA   Vollrath D., Ayyagari R., Boehnke M., Richards J.E.;
RT   "Mutations in TCF8 cause posterior polymorphous corneal dystrophy and
RT   ectopic expression of COL4A3 by corneal endothelial cells.";
RL   Am. J. Hum. Genet. 77:694-708(2005).
RN   [9]
RP   SUMOYLATION AT LYS-347 AND LYS-774.
RX   PubMed=16061479; DOI=10.1074/jbc.m504477200;
RA   Long J., Zuo D., Park M.;
RT   "Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates
RT   transcriptional repression of E-cadherin.";
RL   J. Biol. Chem. 280:35477-35489(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-322, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=19935649; DOI=10.1038/ncb1998;
RA   Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F., Sonntag A.,
RA   Waldvogel B., Vannier C., Darling D., zur Hausen A., Brunton V.G.,
RA   Morton J., Sansom O., Schuler J., Stemmler M.P., Herzberger C., Hopt U.,
RA   Keck T., Brabletz S., Brabletz T.;
RT   "The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-
RT   inhibiting microRNAs.";
RL   Nat. Cell Biol. 11:1487-1495(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642; SER-679 AND THR-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=20175752; DOI=10.1042/bj20091578;
RA   Papadopoulou V., Postigo A., Sanchez-Tillo E., Porter A.C., Wagner S.D.;
RT   "ZEB1 and CtBP form a repressive complex at a distal promoter element of
RT   the BCL6 locus.";
RL   Biochem. J. 427:541-550(2010).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SMARCA4, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20418909; DOI=10.1038/onc.2010.102;
RA   Sanchez-Tillo E., Lazaro A., Torrent R., Cuatrecasas M., Vaquero E.C.,
RA   Castells A., Engel P., Postigo A.;
RT   "ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF
RT   chromatin-remodeling protein BRG1.";
RL   Oncogene 29:3490-3500(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679 AND THR-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-186; LYS-195; LYS-307; LYS-331;
RP   LYS-335; LYS-347; LYS-439; LYS-493; LYS-504; LYS-515; LYS-548; LYS-553 AND
RP   LYS-774, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   STRUCTURE BY NMR OF 583-642.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain from human NIL-2-A zinc finger
RT   protein, transcription factor 8.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [26]
RP   VARIANTS FECD6 THR-78; ALA-649; PRO-810; PRO-840 AND THR-905.
RX   PubMed=20036349; DOI=10.1016/j.ajhg.2009.12.001;
RA   Riazuddin S.A., Zaghloul N.A., Al-Saif A., Davey L., Diplas B.H.,
RA   Meadows D.N., Eghrari A.O., Minear M.A., Li Y.J., Klintworth G.K.,
RA   Afshari N., Gregory S.G., Gottsch J.D., Katsanis N.;
RT   "Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and
RT   interact with FCD4 on chromosome 9p.";
RL   Am. J. Hum. Genet. 86:45-53(2010).
RN   [27]
RP   INVOLVEMENT IN FECD6 AND PPCD3, VARIANT FECD6 HIS-640, CHARACTERIZATION OF
RP   VARIANTS FECD6 THR-78 AND HIS-640, AND VARIANT GLU-525.
RX   PubMed=23599324; DOI=10.1167/iovs.13-11781;
RA   Lechner J., Dash D.P., Muszynska D., Hosseini M., Segev F., George S.,
RA   Frazer D.G., Moore J.E., Kaye S.B., Young T., Simpson D.A., Churchill A.J.,
RA   Heon E., Willoughby C.E.;
RT   "Mutational spectrum of the ZEB1 gene in corneal dystrophies supports a
RT   genotype-phenotype correlation.";
RL   Invest. Ophthalmol. Vis. Sci. 54:3215-3223(2013).
RN   [28]
RP   VARIANTS FECD6 THR-78; ALA-649; SER-696; PRO-810; PRO-840 AND GLY-905,
RP   CHARACTERIZATION OF VARIANTS FECD6 THR-78; ALA-649; SER-696; PRO-810;
RP   PRO-840 AND GLY-905, AND SUBCELLULAR LOCATION.
RX   PubMed=25190660; DOI=10.1167/iovs.14-15247;
RA   Chung D.W., Frausto R.F., Ann L.B., Jang M.S., Aldave A.J.;
RT   "Functional impact of ZEB1 mutations associated with posterior polymorphous
RT   and Fuchs' endothelial corneal dystrophies.";
RL   Invest. Ophthalmol. Vis. Sci. 55:6159-6166(2014).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Inhibits interleukin-2
CC       (IL-2) gene expression. Enhances or represses the promoter activity of
CC       the ATP1A1 gene depending on the quantity of cDNA and on the cell type.
CC       Represses E-cadherin promoter and induces an epithelial-mesenchymal
CC       transition (EMT) by recruiting SMARCA4/BRG1. Represses BCL6
CC       transcription in the presence of the corepressor CTBP1. Positively
CC       regulates neuronal differentiation. Represses RCOR1 transcription
CC       activation during neurogenesis. Represses transcription by binding to
CC       the E box (5'-CANNTG-3'). Promotes tumorigenicity by repressing
CC       stemness-inhibiting microRNAs. {ECO:0000269|PubMed:19935649,
CC       ECO:0000269|PubMed:20175752, ECO:0000269|PubMed:20418909}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with SMARCA4/BRG1.
CC       {ECO:0000269|PubMed:20418909}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20418909,
CC       ECO:0000269|PubMed:25190660}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P37275-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37275-2; Sequence=VSP_045184;
CC       Name=3;
CC         IsoId=P37275-3; Sequence=VSP_047280;
CC       Name=4;
CC         IsoId=P37275-4; Sequence=VSP_047281;
CC       Name=5;
CC         IsoId=P37275-5; Sequence=VSP_047279, VSP_045184;
CC   -!- TISSUE SPECIFICITY: Colocalizes with SMARCA4/BRG1 in E-cadherin-
CC       negative cells from established lines, and stroma of normal colon as
CC       well as in de-differentiated epithelial cells at the invasion front of
CC       colorectal carcinomas (at protein level). Expressed in heart and
CC       skeletal muscle, but not in liver, spleen, or pancreas.
CC       {ECO:0000269|PubMed:20418909}.
CC   -!- DISEASE: Corneal dystrophy, posterior polymorphous, 3 (PPCD3)
CC       [MIM:609141]: A subtype of posterior corneal dystrophy, a disease
CC       characterized by alterations of Descemet membrane presenting as
CC       vesicles, opacities or band-like lesions on slit-lamp examination and
CC       specular microscopy. Affected patient typically are asymptomatic.
CC       {ECO:0000269|PubMed:16252232, ECO:0000269|PubMed:23599324}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]:
CC       A corneal disease caused by loss of endothelium of the central cornea.
CC       It is characterized by focal wart-like guttata that arise from Descemet
CC       membrane and develop in the central cornea, epithelial blisters,
CC       reduced vision and pain. Descemet membrane is thickened by abnormal
CC       collagenous deposition. {ECO:0000269|PubMed:20036349,
CC       ECO:0000269|PubMed:23599324, ECO:0000269|PubMed:25190660}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the delta-EF1/ZFH-1 C2H2-type zinc-finger
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG62481.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D15050; BAA03646.1; -; mRNA.
DR   EMBL; U12170; AAA20602.1; -; mRNA.
DR   EMBL; AK091478; BAC03673.1; -; mRNA.
DR   EMBL; AK296244; BAG58962.1; -; mRNA.
DR   EMBL; AK300830; BAG62481.1; ALT_FRAME; mRNA.
DR   EMBL; AL158080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161935; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117340; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355148; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW85989.1; -; Genomic_DNA.
DR   EMBL; BC112392; AAI12393.1; -; mRNA.
DR   EMBL; M81699; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS44370.1; -. [P37275-5]
DR   CCDS; CCDS53505.1; -. [P37275-2]
DR   CCDS; CCDS53506.1; -. [P37275-4]
DR   CCDS; CCDS53507.1; -. [P37275-3]
DR   CCDS; CCDS7169.1; -. [P37275-1]
DR   PIR; JX0293; JX0293.
DR   RefSeq; NP_001121600.1; NM_001128128.2. [P37275-5]
DR   RefSeq; NP_001167564.1; NM_001174093.1. [P37275-4]
DR   RefSeq; NP_001167565.1; NM_001174094.1.
DR   RefSeq; NP_001167566.1; NM_001174095.1. [P37275-3]
DR   RefSeq; NP_001167567.1; NM_001174096.1. [P37275-2]
DR   RefSeq; NP_110378.3; NM_030751.5. [P37275-1]
DR   PDB; 2E19; NMR; -; A=586-642.
DR   PDBsum; 2E19; -.
DR   SMR; P37275; -.
DR   BioGrid; 112796; 40.
DR   CORUM; P37275; -.
DR   ELM; P37275; -.
DR   IntAct; P37275; 7.
DR   MINT; P37275; -.
DR   STRING; 9606.ENSP00000354487; -.
DR   iPTMnet; P37275; -.
DR   PhosphoSitePlus; P37275; -.
DR   BioMuta; ZEB1; -.
DR   DMDM; 6166575; -.
DR   EPD; P37275; -.
DR   jPOST; P37275; -.
DR   MassIVE; P37275; -.
DR   MaxQB; P37275; -.
DR   PaxDb; P37275; -.
DR   PeptideAtlas; P37275; -.
DR   PRIDE; P37275; -.
DR   ProteomicsDB; 19473; -.
DR   ProteomicsDB; 26586; -.
DR   ProteomicsDB; 55272; -. [P37275-1]
DR   ProteomicsDB; 61322; -.
DR   ProteomicsDB; 65678; -.
DR   Antibodypedia; 12930; 681 antibodies.
DR   Ensembl; ENST00000320985; ENSP00000319248; ENSG00000148516. [P37275-1]
DR   Ensembl; ENST00000361642; ENSP00000354487; ENSG00000148516. [P37275-2]
DR   Ensembl; ENST00000446923; ENSP00000391612; ENSG00000148516. [P37275-5]
DR   Ensembl; ENST00000542815; ENSP00000444891; ENSG00000148516. [P37275-3]
DR   Ensembl; ENST00000560721; ENSP00000452787; ENSG00000148516. [P37275-4]
DR   GeneID; 6935; -.
DR   KEGG; hsa:6935; -.
DR   UCSC; uc001ivs.5; human. [P37275-1]
DR   CTD; 6935; -.
DR   DisGeNET; 6935; -.
DR   GeneCards; ZEB1; -.
DR   HGNC; HGNC:11642; ZEB1.
DR   HPA; ENSG00000148516; Low tissue specificity.
DR   MalaCards; ZEB1; -.
DR   MIM; 189909; gene.
DR   MIM; 609141; phenotype.
DR   MIM; 613270; phenotype.
DR   neXtProt; NX_P37275; -.
DR   OpenTargets; ENSG00000148516; -.
DR   Orphanet; 98974; Fuchs endothelial corneal dystrophy.
DR   Orphanet; 98973; Posterior polymorphous corneal dystrophy.
DR   PharmGKB; PA162409589; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   GeneTree; ENSGT00950000183208; -.
DR   HOGENOM; CLU_005890_0_1_1; -.
DR   InParanoid; P37275; -.
DR   KO; K09299; -.
DR   OMA; CPYCARG; -.
DR   OrthoDB; 890458at2759; -.
DR   PhylomeDB; P37275; -.
DR   TreeFam; TF331759; -.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   SignaLink; P37275; -.
DR   SIGNOR; P37275; -.
DR   ChiTaRS; ZEB1; human.
DR   EvolutionaryTrace; P37275; -.
DR   GeneWiki; ZEB1; -.
DR   GenomeRNAi; 6935; -.
DR   Pharos; P37275; Tbio.
DR   PRO; PR:P37275; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P37275; protein.
DR   Bgee; ENSG00000148516; Expressed in myometrium and 237 other tissues.
DR   ExpressionAtlas; P37275; baseline and differential.
DR   Genevisible; P37275; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:BHF-UCL.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0010464; P:regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0051150; P:regulation of smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0033081; P:regulation of T cell differentiation in thymus; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR008598; Di19_Zn_binding_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Corneal dystrophy;
KW   Differentiation; Disease mutation; DNA-binding; Homeobox; Isopeptide bond;
KW   Metal-binding; Neurogenesis; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1124
FT                   /note="Zinc finger E-box-binding homeobox 1"
FT                   /id="PRO_0000047231"
FT   ZN_FING         170..193
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         200..222
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         240..262
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         268..292
FT                   /note="C2H2-type 4; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   DNA_BIND        581..640
FT                   /note="Homeobox; atypical"
FT   ZN_FING         904..926
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         932..954
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         960..981
FT                   /note="C2H2-type 7; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   COMPBIAS        989..1124
FT                   /note="Glu-rich (acidic)"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62947"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62947"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         642
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         679
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         686
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         693
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         700
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   MOD_RES         702
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         704
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64318"
FT   CROSSLNK        186
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        195
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        307
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        331
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        335
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        347
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT   CROSSLNK        347
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        439
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        493
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        504
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        515
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        548
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        553
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        774
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT   CROSSLNK        774
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..19
FT                   /note="MADGPRCKRRKQANPRRNN -> MK (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047279"
FT   VAR_SEQ         20..87
FT                   /note="VTNYNTVVETNSDSDDEDKLHIVEEESVTDAADCEGVPEDDLPTDQTVLPGR
FT                   SSEREGNAKNCWEDDR -> G (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047280"
FT   VAR_SEQ         87..107
FT                   /note="RKEGQEILGPEAQADEAGCTV -> I (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047281"
FT   VAR_SEQ         87
FT                   /note="R -> TG (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045184"
FT   VARIANT         78
FT                   /note="N -> T (in FECD6; no effect on protein expression;
FT                   no effect on nuclear localization; dbSNP:rs80194531)"
FT                   /evidence="ECO:0000269|PubMed:20036349,
FT                   ECO:0000269|PubMed:23599324, ECO:0000269|PubMed:25190660"
FT                   /id="VAR_063759"
FT   VARIANT         90
FT                   /note="G -> R (in dbSNP:rs12217419)"
FT                   /id="VAR_052731"
FT   VARIANT         525
FT                   /note="G -> E (found in a patient with FECD6)"
FT                   /evidence="ECO:0000269|PubMed:23599324"
FT                   /id="VAR_072897"
FT   VARIANT         553
FT                   /note="K -> R (in dbSNP:rs35753967)"
FT                   /id="VAR_031824"
FT   VARIANT         640
FT                   /note="Q -> H (in FECD6; down-regulation of several
FT                   collagen genes expression; dbSNP:rs779148597)"
FT                   /evidence="ECO:0000269|PubMed:23599324"
FT                   /id="VAR_072898"
FT   VARIANT         649
FT                   /note="P -> A (in FECD6; no effect on protein expression;
FT                   no effect on nuclear localization; dbSNP:rs781750314)"
FT                   /evidence="ECO:0000269|PubMed:20036349,
FT                   ECO:0000269|PubMed:25190660"
FT                   /id="VAR_063760"
FT   VARIANT         696
FT                   /note="N -> S (in FECD6; no effect on protein expression;
FT                   no effect on nuclear localization; dbSNP:rs567252241)"
FT                   /evidence="ECO:0000269|PubMed:25190660"
FT                   /id="VAR_072899"
FT   VARIANT         810
FT                   /note="Q -> P (in FECD6; no effect on protein expression;
FT                   no effect on nuclear localization; dbSNP:rs199944415)"
FT                   /evidence="ECO:0000269|PubMed:20036349,
FT                   ECO:0000269|PubMed:25190660"
FT                   /id="VAR_063761"
FT   VARIANT         840
FT                   /note="Q -> P (in FECD6; no effect on protein expression;
FT                   no effect on nuclear localization; dbSNP:rs118020901)"
FT                   /evidence="ECO:0000269|PubMed:20036349,
FT                   ECO:0000269|PubMed:25190660"
FT                   /id="VAR_063762"
FT   VARIANT         905
FT                   /note="A -> G (in FECD6; no effect on protein expression;
FT                   no effect on nuclear localization; dbSNP:rs78449005)"
FT                   /evidence="ECO:0000269|PubMed:25190660"
FT                   /id="VAR_072900"
FT   VARIANT         905
FT                   /note="A -> T (in FECD6)"
FT                   /evidence="ECO:0000269|PubMed:20036349"
FT                   /id="VAR_063763"
FT   CONFLICT        12
FT                   /note="Q -> R (in Ref. 3; BAC03673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        81
FT                   /note="N -> S (in Ref. 3; BAC03673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        84
FT                   /note="E -> K (in Ref. 3; BAC03673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="T -> A (in Ref. 3; BAG62481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        390
FT                   /note="M -> T (in Ref. 3; BAG62481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420
FT                   /note="V -> I (in Ref. 2; AAA20602)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        472
FT                   /note="K -> R (in Ref. 3; BAG58962)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        609
FT                   /note="E -> Q (in Ref. 7; M81699)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        654
FT                   /note="I -> T (in Ref. 2; AAA20602)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        672
FT                   /note="D -> H (in Ref. 7; M81699)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        681
FT                   /note="L -> S (in Ref. 7; M81699)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        775
FT                   /note="K -> T (in Ref. 3; BAG62481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        793..794
FT                   /note="IP -> KY (in Ref. 3; BAG58962)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        797
FT                   /note="A -> N (in Ref. 3; BAG58962)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        818
FT                   /note="A -> V (in Ref. 3; BAG62481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        838
FT                   /note="I -> T (in Ref. 3; BAC03673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1066
FT                   /note="E -> G (in Ref. 3; BAC03673)"
FT                   /evidence="ECO:0000305"
FT   HELIX           590..600
FT                   /evidence="ECO:0000244|PDB:2E19"
FT   HELIX           608..618
FT                   /evidence="ECO:0000244|PDB:2E19"
FT   HELIX           622..634
FT                   /evidence="ECO:0000244|PDB:2E19"
SQ   SEQUENCE   1124 AA;  124074 MW;  0A2714CC37C848D1 CRC64;
     MADGPRCKRR KQANPRRNNV TNYNTVVETN SDSDDEDKLH IVEEESVTDA ADCEGVPEDD
     LPTDQTVLPG RSSEREGNAK NCWEDDRKEG QEILGPEAQA DEAGCTVKDD ECESDAENEQ
     NHDPNVEEFL QQQDTAVIFP EAPEEDQRQG TPEASGHDEN GTPDAFSQLL TCPYCDRGYK
     RFTSLKEHIK YRHEKNEDNF SCSLCSYTFA YRTQLERHMT SHKSGRDQRH VTQSGCNRKF
     KCTECGKAFK YKHHLKEHLR IHSGEKPYEC PNCKKRFSHS GSYSSHISSK KCISLIPVNG
     RPRTGLKTSQ CSSPSLSASP GSPTRPQIRQ KIENKPLQEQ LSVNQIKTEP VDYEFKPIVV
     ASGINCSTPL QNGVFTGGGP LQATSSPQGM VQAVVLPTVG LVSPISINLS DIQNVLKVAV
     DGNVIRQVLE NNQANLASKE QETINASPIQ QGGHSVISAI SLPLVDQDGT TKIIINYSLE
     QPSQLQVVPQ NLKKENPVAT NSCKSEKLPE DLTVKSEKDK SFEGGVNDST CLLCDDCPGD
     INALPELKHY DLKQPTQPPP LPAAEAEKPE SSVSSATGDG NLSPSQPPLK NLLSLLKAYY
     ALNAQPSAEE LSKIADSVNL PLDVVKKWFE KMQAGQISVQ SSEPSSPEPG KVNIPAKNND
     QPQSANANEP QDSTVNLQSP LKMTNSPVLP VGSTTNGSRS STPSPSPLNL SSSRNTQGYL
     YTAEGAQEEP QVEPLDLSLP KQQGELLERS TITSVYQNSV YSVQEEPLNL SCAKKEPQKD
     SCVTDSEPVV NVIPPSANPI NIAIPTVTAQ LPTIVAIADQ NSVPCLRALA ANKQTILIPQ
     VAYTYSTTVS PAVQEPPLKV IQPNGNQDER QDTSSEGVSN VEDQNDSDST PPKKKMRKTE
     NGMYACDLCD KIFQKSSSLL RHKYEHTGKR PHECGICKKA FKHKHHLIEH MRLHSGEKPY
     QCDKCGKRFS HSGSYSQHMN HRYSYCKREA EERDSTEQEE AGPEILSNEH VGARASPSQG
     DSDERESLTR EEDEDSEKEE EEEDKEMEEL QEEKECEKPQ GDEEEEEEEE EVEEEEVEEA
     ENEGEEAKTE GLMKDDRAES QASSLGQKVG ESSEQVSEEK TNEA
//
